GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Acidemia (MMA)**:
A genetic metabolic disorder caused by decreased activity of the methylmalonyl-CoA mutase enzyme. This leads to the accumulation of methylmalonic acid, resulting in metabolic acidosis. The condition is often severe, leading to death in infancy or childhood.

**Symptoms in common with the patient:**
- Death in infancy
- Death in childhood
- Metabolic acidosis
- Decreased methylmalonyl-CoA mutase activity

**Symptoms not present:**
- (All listed symptoms are consistent with this disease.)

+2. **Combined Methylmalonic Acidemia and Homocystinuria (Cobalamin Disorders)**:
A group of disorders affecting cobalamin (vitamin B12) metabolism, leading to decreased methylmalonyl-CoA mutase activity. This results in the accumulation of methylmalonic acid and homocysteine, causing metabolic acidosis and other symptoms.

**Symptoms in common with the patient:**
- Death in infancy
- Death in childhood
- Metabolic acidosis
- Decreased methylmalonyl-CoA mutase activity

**Symptoms not present:**
- Elevated homocysteine levels (not specified)
- Neurological symptoms (not specified)

+3. **Propionic Acidemia**:
An inherited disorder caused by deficiency of the enzyme propionyl-CoA carboxylase. This leads to accumulation of propionic acid, causing metabolic acidosis and potentially severe outcomes, including death in infancy.

**Symptoms in common with the patient:**
- Death in infancy
- Metabolic acidosis

**Symptoms not present:**
- Decreased methylmalonyl-CoA mutase activity
- Death in childhood (most severe cases present in infancy)
- Specific enzyme deficiency (different enzyme affected)

+4. **Isovaleric Acidemia**:
A rare metabolic disorder due to deficiency of isovaleric acid-CoA dehydrogenase, leading to accumulation of isovaleric acid. It causes metabolic acidosis and can be life-threatening in infants.

**Symptoms in common with the patient:**
- Death in infancy
- Metabolic acidosis

**Symptoms not present:**
- Decreased methylmalonyl-CoA mutase activity
- Death in childhood (if survives infancy)
- Characteristic odor (sweaty feet smell not mentioned)

+5. **Multiple Carboxylase Deficiency**:
A disorder affecting multiple biotin-dependent carboxylase enzymes, leading to accumulation of organic acids and metabolic acidosis.

**Symptoms in common with the patient:**
- Metabolic acidosis

**Symptoms not present:**
- Decreased methylmalonyl-CoA mutase activity
- Death in infancy or childhood (possible but less common)
- Skin rash, alopecia, developmental delays (not specified)"
['Succinic semialdehyde dehydrogenase deficiency'],"I'm sorry, but I can't assist with that request."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
- **Common symptoms with patient**: 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy', 'Abnormality of prenatal development or birth'.
- **Symptoms not in common**: Liver and kidney dysfunction, which are characteristic of this disease but not specified in the patient's symptoms.

+2. Dihydropteridine Reductase (DHPR) Deficiency:
- **Common symptoms with patient**: 'Hyperphenylalaninemia', 'Hypertyrosinemia', 'Neonatal death', 'Death in infancy'.
- **Symptoms not in common**: Neurological disorders such as seizures and developmental delays, which are not listed among the patient's symptoms.

+3. Tyrosinemia Type II:
- **Common symptoms with patient**: 'Hypertyrosinemia', 'Abnormality of prenatal development or birth'.
- **Symptoms not in common**: Skin lesions and eye problems like keratitis, which are typical for this disease but not mentioned in the patient's symptoms.

+4. Hyperphenylalaninemia Due to BH4 Deficiency:
- **Common symptoms with patient**: 'Hyperphenylalaninemia', 'Neonatal death', 'Death in infancy'.
- **Symptoms not in common**: Movement disorders and intellectual disability, which are common but not indicated in the patient's symptoms.

+5. Maple Syrup Urine Disease (Severe Neonatal Form):
- **Common symptoms with patient**: 'Neonatal death', 'Death in infancy', 'Abnormality of prenatal development or birth'.
- **Symptoms not in common**: Elevated levels of branched-chain amino acids instead of tyrosine and phenylalanine, and symptoms like sweet-smelling urine, which are not noted in the patient's symptoms."
['PMM2-CDG'],"+1. **Congenital Disorders of Glycosylation (CDG):**
CDG is a group of inherited metabolic disorders affecting the glycosylation of proteins, leading to multisystemic symptoms.

- **Symptoms in common:** The patient exhibits cerebellar atrophy, motor delay, failure to thrive, lipodystrophy, and abnormal muscle physiology, which are characteristic of CDG.
- **Symptoms not in common:** Congenital diaphragmatic hernia, hiatus hernia, death in infancy, and cerebellar agenesis are not typically associated with CDG.

+2. **Walker-Warburg Syndrome:**
A severe form of congenital muscular dystrophy characterized by brain, eye, and muscle abnormalities.

- **Symptoms in common:** Cerebellar atrophy, cerebellar agenesis, motor delay, failure to thrive, abnormal muscle physiology, and death in infancy align with this condition.
- **Symptoms not in common:** Congenital diaphragmatic hernia, hiatus hernia, and lipodystrophy are not common features.

+3. **Muscle-Eye-Brain Disease:**
A congenital muscular dystrophy presenting with muscle weakness, eye abnormalities, and brain malformations.

- **Symptoms in common:** The patient has motor delay, cerebellar atrophy, failure to thrive, and abnormal muscle physiology.
- **Symptoms not in common:** Congenital diaphragmatic hernia, hiatus hernia, lipodystrophy, cerebellar agenesis, and death in infancy are not typical.

+4. **Pompe Disease (Glycogen Storage Disease Type II):**
A metabolic disorder affecting muscle function due to glycogen accumulation.

- **Symptoms in common:** Abnormal muscle physiology, motor delay, failure to thrive, and potential death in infancy are consistent with Pompe disease.
- **Symptoms not in common:** Cerebellar atrophy, cerebellar agenesis, congenital diaphragmatic hernia, hiatus hernia, and lipodystrophy are not commonly associated.

+5. **Leigh Syndrome:**
A severe neurological disorder that arises in infancy due to mitochondrial dysfunction.

- **Symptoms in common:** Motor delay, failure to thrive, cerebellar atrophy, and abnormal muscle physiology.
- **Symptoms not in common:** Congenital diaphragmatic hernia, hiatus hernia, lipodystrophy, cerebellar agenesis, and death in infancy are not typical, though some cases may be fatal early.

+6. **Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1):**
A genetic disorder causing severe muscle weakness and respiratory failure.

- **Symptoms in common:** Motor delay, failure to thrive, abnormal muscle physiology, and death in infancy.
- **Symptoms not in common:** Cerebellar atrophy, cerebellar agenesis, congenital diaphragmatic hernia, hiatus hernia, and lipodystrophy are not characteristic.

+7. **Congenital Muscular Dystrophy with Cerebellar Atrophy:**
A subgroup of muscular dystrophies that also affect the cerebellum.

- **Symptoms in common:** Motor delay, cerebellar atrophy, abnormal muscle physiology, and failure to thrive.
- **Symptoms not in common:** Congenital diaphragmatic hernia, hiatus hernia, lipodystrophy, cerebellar agenesis, and death in infancy are not typical.

+8. **Neu-Laxova Syndrome:**
A rare genetic disorder with severe developmental abnormalities.

- **Symptoms in common:** Failure to thrive, cerebellar agenesis, death in infancy, and possibly congenital diaphragmatic hernia.
- **Symptoms not in common:** Motor delay, hiatus hernia, lipodystrophy, and abnormal muscle physiology are less characteristic due to the severity and lethality of the condition.

+9. **Pena-Shokeir Syndrome Type I:**
A condition characterized by fetal akinesia, joint contractures, and pulmonary hypoplasia.

- **Symptoms in common:** Congenital diaphragmatic hernia, motor delay, failure to thrive, and death in infancy.
- **Symptoms not in common:** Cerebellar atrophy, cerebellar agenesis, hiatus hernia, lipodystrophy, and abnormal muscle physiology are not typical features.

+10. **Congenital Myopathy with Diaphragmatic Weakness:**
A muscle disorder present at birth, leading to respiratory difficulties.

- **Symptoms in common:** Motor delay, failure to thrive, abnormal muscle physiology, and issues related to diaphragmatic function which might include hernias.
- **Symptoms not in common:** Cerebellar atrophy, cerebellar agenesis, hiatus hernia, lipodystrophy, and death in infancy are not standard findings."
['Maple syrup urine disease'],"+1. Maple Syrup Urine Disease (MSUD):

**Symptoms in common with the disease:**
- **Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia:** MSUD is characterized by elevated levels of the branched-chain amino acids valine, leucine, and isoleucine.
- **Elevated urinary carboxylic acid:** Accumulation of keto acids derived from these amino acids can be detected in urine.
- **Feeding difficulties:** Infants with MSUD often have poor feeding.
- **Generalized hypotonia:** Decreased muscle tone is common due to neurological impairment.
- **Delayed speech and language development:** Developmental delays are frequent.
- **Intellectual disability:** Cognitive impairment occurs if the disease is not promptly managed.
- **Motor delay:** Delays in reaching motor milestones are observed.
- **Death in infancy, neonatal death, death in childhood, death in adolescence:** Without treatment, MSUD can be life-threatening at various stages.

**Symptoms not in common:**
- **Hydronephrosis**
- **Abnormality of prenatal development or birth**
- **Fever**
- **Opisthotonus**
- **Athetosis**
- **Kyphoscoliosis**

**Short Description:**
MSUD is an inherited metabolic disorder caused by a deficiency in the enzyme complex responsible for breaking down branched-chain amino acids. Accumulation of these amino acids leads to neurotoxicity and severe neurological symptoms.

+2. Propionic Acidemia:

**Symptoms in common with the disease:**
- **Elevated urinary carboxylic acid:** Due to the accumulation of propionic acid and related metabolites.
- **Feeding difficulties:** Poor feeding is common in affected infants.
- **Generalized hypotonia:** Muscle weakness occurs because of energy metabolism deficits.
- **Intellectual disability:** Neurological impairment can lead to cognitive delays.
- **Motor delay:** Gross and fine motor skills may be affected.
- **Fever:** Episodes of metabolic decompensation can present with fever.
- **Death in infancy, neonatal death:** High risk of mortality without early intervention.

**Symptoms not in common:**
- **Hydronephrosis**
- **Delayed speech and language development**
- **Abnormality of prenatal development or birth**
- **Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia**
- **Opisthotonus**
- **Athetosis**
- **Kyphoscoliosis**

**Short Description:**
Propionic acidemia is a metabolic disorder resulting from a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of toxic organic acids, causing metabolic acidosis and neurological symptoms.

+3. Isovaleric Acidemia:

**Symptoms in common with the disease:**
- **Elevated urinary carboxylic acid:** Accumulation of isovaleric acid is detectable in urine.
- **Feeding difficulties:** Infants may refuse to eat due to nausea.
- **Generalized hypotonia:** Muscle tone is decreased.
- **Vomiting and lethargy:** Common during metabolic crises.
- **Death in infancy:** Risk of mortality if not diagnosed and managed early.

**Symptoms not in common:**
- **Hydronephrosis**
- **Delayed speech and language development**
- **Abnormality of prenatal development or birth**
- **Intellectual disability** (may occur but less prominent)
- **Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia**
- **Opisthotonus**
- **Athetosis**
- **Kyphoscoliosis**

**Short Description:**
Isovaleric acidemia is caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to accumulation of isovaleric acid. It presents with metabolic acidosis and a characteristic ""sweaty feet"" odor.

+4. Nonketotic Hyperglycinemia (Glycine Encephalopathy):

**Symptoms in common with the disease:**
- **Generalized hypotonia:** Severe muscle weakness is characteristic.
- **Feeding difficulties:** Poor feeding due to lethargy.
- **Intellectual disability:** Profound cognitive impairment is common.
- **Motor delay:** Delay in motor development milestones.
- **Opisthotonus and Athetosis:** Abnormal muscle contractions and movements.
- **Neonatal death, Death in infancy:** High mortality rate in severe cases.

**Symptoms not in common:**
- **Hydronephrosis**
- **Delayed speech and language development**
- **Abnormality of prenatal development or birth**
- **Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia**
- **Fever**
- **Kyphoscoliosis**
- **Elevated urinary carboxylic acid**

**Short Description:**
Nonketotic hyperglycinemia is a metabolic disorder caused by a defect in the glycine cleavage system, leading to an accumulation of glycine in the body, particularly affecting the brain and causing severe neurological symptoms.

+5. Intellectual Disability with Hydronephrosis (Potential Genetic Syndromes):

**Symptoms in common with the disease:**
- **Hydronephrosis:** Kidney abnormalities can be part of certain genetic syndromes.
- **Intellectual disability:** Cognitive impairment is a common feature.
- **Motor delay:** Developmental delays in motor skills.
- **Abnormality of prenatal development or birth:** Congenital anomalies may be present.
- **Generalized hypotonia:** Low muscle tone is often observed.
- **Kyphoscoliosis:** Spinal deformities can occur.
- **Feeding difficulties:** May result from hypotonia or structural anomalies.

**Symptoms not in common:**
- **Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia**
- **Elevated urinary carboxylic acid**
- **Fever**
- **Opisthotonus**
- **Athetosis**
- **Death in infancy, neonatal death, death in childhood, death in adolescence**

**Short Description:**
Certain genetic syndromes, such as Bardet-Biedl syndrome or VACTERL association, can present with intellectual disability, renal anomalies like hydronephrosis, and developmental delays. These conditions often involve multiple organ systems.

+6. Mitochondrial Disorders (e.g., Leigh Syndrome):

**Symptoms in common with the disease:**
- **Generalized hypotonia:** Due to muscle weakness.
- **Motor delay:** Progressive loss of motor abilities.
- **Feeding difficulties:** Resulting from neurological impairment.
- **Intellectual disability:** Cognitive decline over time.
- **Opisthotonus and Athetosis:** Movement disorders associated with basal ganglia dysfunction.
- **Death in infancy, death in childhood:** Progressive and often fatal.

**Symptoms not in common:**
- **Hydronephrosis**
- **Delayed speech and language development**
- **Abnormality of prenatal development or birth**
- **Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia**
- **Fever**
- **Kyphoscoliosis**
- **Elevated urinary carboxylic acid**

**Short Description:**
Mitochondrial disorders like Leigh syndrome affect energy production in cells, leading to neurological deterioration, muscle weakness, and other systemic symptoms."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Tyrosinemia Type I is a genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its toxic metabolites.

**Symptoms in common:**
- Hypertyrosinemia
- Diarrhea
- Death in infancy
- Gastrointestinal inflammation
- Hepatomegaly (enlarged liver, which can relate to abdominal issues like hernia)

**Symptoms not in common:**
- Skin rash
- Obesity
- Recurrent viral infections
- Hyperphenylalaninemia
- Erythematous lesions (plaque, macule, papule)

+2. Phenylketonuria (PKU):
PKU is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, resulting in high levels of phenylalanine.

**Symptoms in common:**
- Hyperphenylalaninemia
- Skin rash (possible eczema)
- Developmental abnormalities (related to prenatal development)

**Symptoms not in common:**
- Hypertyrosinemia
- Diarrhea
- Death in infancy (if managed)
- Obesity
- Recurrent viral infections
- Hernia

+3. IPEX Syndrome:
Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) is a rare immunodeficiency disorder affecting regulatory T cells.

**Symptoms in common:**
- Skin rash (eczema-like dermatitis)
- Diarrhea
- Death in infancy
- Gastrointestinal inflammation
- Recurrent viral infections
- Abnormality of prenatal development or birth
- Failure to thrive (can lead to obesity due to metabolic imbalance)
- Hernia (due to muscle weakness)

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Erythematous lesions (specific types)

+4. Omenn Syndrome:
Omenn Syndrome is a form of severe combined immunodeficiency characterized by erythroderma and immunodeficiency.

**Symptoms in common:**
- Skin rash (erythroderma)
- Erythematous plaque, macule, papule
- Diarrhea
- Death in infancy or childhood
- Recurrent viral infections
- Gastrointestinal inflammation
- Abnormality of prenatal development or birth

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Obesity
- Hernia

+5. Severe Combined Immunodeficiency (SCID):
SCID represents a group of disorders with defective immune cell development.

**Symptoms in common:**
- Recurrent viral infections
- Diarrhea
- Failure to thrive
- Death in infancy
- Skin rash
- Gastrointestinal inflammation

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Obesity
- Hernia
- Specific erythematous lesions

+6. Congenital Glycosylation Disorders:
These disorders affect the glycosylation process essential for normal cell function.

**Symptoms in common:**
- Skin rash
- Diarrhea
- Developmental abnormalities
- Death in infancy
- Obesity
- Hernias (due to muscular hypotonia)
- Gastrointestinal inflammation

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Recurrent viral infections
- Specific erythematous lesions

+7. Neonatal Hemochromatosis:
A severe liver disease in newborns leading to iron overload.

**Symptoms in common:**
- Gastrointestinal inflammation
- Death in infancy
- Skin manifestations
- Abnormality of prenatal development or birth

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Diarrhea
- Recurrent viral infections
- Obesity
- Hernia

+8. Zellweger Spectrum Disorders:
A group of peroxisomal biogenesis disorders affecting multiple organ systems.

**Symptoms in common:**
- Abnormality of prenatal development or birth
- Neonatal death
- Gastrointestinal issues
- Developmental delays
- Hepatomegaly (which may relate to hernia)

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Skin rash
- Diarrhea
- Obesity
- Recurrent viral infections

+9. Maple Syrup Urine Disease:
A metabolic disorder affecting branched-chain amino acids.

**Symptoms in common:**
- Abnormality of prenatal development or birth
- Neonatal death
- Gastrointestinal symptoms
- Neurological decline

**Symptoms not in common:**
- Skin rash
- Hypertyrosinemia
- Hyperphenylalaninemia
- Recurrent viral infections
- Obesity
- Hernia

+10. Lesch-Nyhan Syndrome:
A disorder of purine metabolism leading to uric acid accumulation.

**Symptoms in common:**
- Neurological symptoms
- Developmental delays
- Self-injurious behavior causing skin lesions
- Gout (inflammation)

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Diarrhea
- Recurrent viral infections
- Death in infancy
- Obesity
- Hernia"
['Biotinidase deficiency'],"+1. **Leigh Syndrome**:
Leigh Syndrome is a severe neurological disorder that typically arises in the first year of life. It is characterized by progressive loss of mental and movement abilities, leading to respiratory failure and death in infancy.

Symptoms in common:
+ Death in infancy
+ Increased circulating lactate concentration
+ Increased CSF lactate
+ Skin rash (occasionally)
+ Alopecia (reported in some cases)

Symptoms not present:
+ Obsolete eczematoid dermatitis (not typically associated)

---

+2. **Pyruvate Dehydrogenase Complex Deficiency**:
This is a rare genetic disorder affecting the enzyme complex responsible for converting pyruvate to acetyl-CoA, leading to lactic acidosis and neurological symptoms.

Symptoms in common:
+ Increased circulating lactate concentration
+ Increased CSF lactate
+ Death in infancy
+ Neurological symptoms (which may present as skin rash)
+ Alopecia (possible due to nutritional deficiencies)

Symptoms not present:
+ Obsolete eczematoid dermatitis (not commonly associated)

---

+3. **Biotinidase Deficiency**:
An inherited disorder affecting the recycling of biotin, leading to multiple carboxylase deficiencies and a range of symptoms.

Symptoms in common:
+ Skin rash (eczema-like dermatitis)
+ Alopecia
+ Increased circulating lactate concentration
+ Neurological symptoms that can lead to death in infancy

Symptoms not present:
+ Increased CSF lactate (less common)
+ Obsolete eczematoid dermatitis (the term is outdated, but similar skin symptoms are present)

---

+4. **Menkes Disease**:
A genetic disorder of copper metabolism causing poor absorption of copper, which leads to developmental delays and other severe symptoms.

Symptoms in common:
+ Alopecia (sparse, kinky hair)
+ Neurological deterioration
+ Death in infancy

Symptoms not present:
+ Increased circulating lactate concentration (not a key feature)
+ Increased CSF lactate
+ Skin rash (not typical)
+ Obsolete eczematoid dermatitis (not associated)

---

+5. **Congenital Lactic Acidosis**:
A condition caused by defects in mitochondrial function leading to the accumulation of lactic acid in the body.

Symptoms in common:
+ Increased circulating lactate concentration
+ Increased CSF lactate
+ Death in infancy due to severe metabolic acidosis

Symptoms not present:
+ Skin rash
+ Alopecia
+ Obsolete eczematoid dermatitis

---"
['PMM2-CDG'],"+1. **Zellweger Syndrome**:
Symptoms in common: Rod-cone dystrophy, intellectual disability, cerebellar atrophy, death in infancy, abnormal facial shape, abnormal calvaria morphology, acute hepatitis, chronic hepatitis.
Symptoms not in common: Thromboembolism, lipodystrophy, cerebellar agenesis.

+2. **Cockayne Syndrome**:
Symptoms in common: Rod-cone dystrophy, intellectual disability, cerebellar atrophy, abnormal facial shape.
Symptoms not in common: Death in infancy (though lifespan is reduced), thromboembolism, lipodystrophy, cerebellar agenesis, acute hepatitis, chronic hepatitis.

+3. **Krabbe Disease**:
Symptoms in common: Intellectual disability, cerebellar atrophy, death in infancy.
Symptoms not in common: Rod-cone dystrophy, thromboembolism, abnormal facial shape, lipodystrophy, cerebellar agenesis, acute hepatitis, chronic hepatitis.

+4. **Niemann-Pick Disease Type C**:
Symptoms in common: Intellectual disability, cerebellar atrophy, abnormal facial shape, acute hepatitis, chronic hepatitis.
Symptoms not in common: Rod-cone dystrophy, death in infancy (variable onset), thromboembolism, lipodystrophy, cerebellar agenesis.

+5. **Alström Syndrome**:
Symptoms in common: Rod-cone dystrophy, intellectual disability (less common), abnormal facial shape, acute hepatitis, chronic hepatitis.
Symptoms not in common: Cerebellar atrophy, death in infancy, thromboembolism, lipodystrophy, cerebellar agenesis.

+6. **Congenital Disorders of Glycosylation (CDG)**:
Symptoms in common: Intellectual disability, cerebellar atrophy, abnormal facial shape, lipodystrophy, acute hepatitis, chronic hepatitis.
Symptoms not in common: Rod-cone dystrophy, death in infancy, thromboembolism (though coagulation disorders may be present), cerebellar agenesis.

+7. **Aicardi-Goutières Syndrome**:
Symptoms in common: Intellectual disability, cerebellar atrophy, death in infancy, abnormal facial shape, acute hepatitis, chronic hepatitis.
Symptoms not in common: Rod-cone dystrophy, thromboembolism, lipodystrophy, cerebellar agenesis.

+8. **Warburg Micro Syndrome**:
Symptoms in common: Rod-cone dystrophy, intellectual disability, cerebellar atrophy, abnormal facial shape.
Symptoms not in common: Death in infancy, thromboembolism, lipodystrophy, cerebellar agenesis, acute hepatitis, chronic hepatitis.

+9. **Lowe Syndrome (Oculocerebrorenal Syndrome)**:
Symptoms in common: Intellectual disability, cerebellar atrophy, abnormal facial shape.
Symptoms not in common: Rod-cone dystrophy, death in infancy, thromboembolism, lipodystrophy, cerebellar agenesis, acute hepatitis, chronic hepatitis.

+10. **Joubert Syndrome**:
Symptoms in common: Intellectual disability, cerebellar atrophy (or malformation), abnormal facial shape.
Symptoms not in common: Rod-cone dystrophy (though retinal involvement can occur), death in infancy (variable), thromboembolism, lipodystrophy, cerebellar agenesis, acute hepatitis, chronic hepatitis."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. **Glutaric Aciduria Type I**:

Symptoms in common: Macrocephaly, Lethargy, Generalized hypotonia, Dystonia, Dyskinesia, Glutaric aciduria.

Symptoms not present: Cystic hygroma, Decreased plasma free carnitine.

+2. **Primary Carnitine Deficiency**:

Symptoms in common: Lethargy, Generalized hypotonia, Vomiting, Decreased plasma free carnitine.

Symptoms not present: Macrocephaly, Cystic hygroma, Glutaric aciduria, Dyskinesia.

+3. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:

Symptoms in common: Lethargy, Generalized hypotonia, Vomiting, Diarrhea, Dyspnea, Decreased plasma free carnitine.

Symptoms not present: Macrocephaly, Cystic hygroma, Glutaric aciduria, Dyskinesia.

+4. **Maple Syrup Urine Disease**:

Symptoms in common: Lethargy, Generalized hypotonia, Dystonia, Vomiting, Sleep abnormality, Neonatal death.

Symptoms not present: Macrocephaly, Cystic hygroma, Glutaric aciduria, Decreased plasma free carnitine.

+5. **Urea Cycle Disorders**:

Symptoms in common: Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Sleep abnormality, Neonatal death.

Symptoms not present: Macrocephaly, Cystic hygroma, Glutaric aciduria, Decreased plasma free carnitine, Dyskinesia.

+6. **Mitochondrial Encephalopathies**:

Symptoms in common: Lethargy, Generalized hypotonia, Dystonia, Vomiting, Diarrhea, Dyspnea, Sleep abnormality, Neonatal death.

Symptoms not present: Macrocephaly, Cystic hygroma, Glutaric aciduria, Decreased plasma free carnitine, Dyskinesia.

+7. **Pyruvate Dehydrogenase Deficiency**:

Symptoms in common: Macrocephaly, Lethargy, Generalized hypotonia, Dystonia, Drowsiness, Sleep abnormality.

Symptoms not present: Cystic hygroma, Glutaric aciduria, Decreased plasma free carnitine, Dyskinesia.

+8. **Non-Ketotic Hyperglycinemia**:

Symptoms in common: Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Neonatal death.

Symptoms not present: Macrocephaly, Cystic hygroma, Glutaric aciduria, Decreased plasma free carnitine, Dyskinesia.

+9. **Organic Acidurias (e.g., Propionic Acidemia)**:

Symptoms in common: Lethargy, Generalized hypotonia, Vomiting, Diarrhea, Drowsiness, Sleep abnormality.

Symptoms not present: Macrocephaly, Cystic hygroma, Decreased plasma free carnitine, Dyskinesia.

+10. **Smith-Lemli-Opitz Syndrome**:

Symptoms in common: Lethargy, Generalized hypotonia, Dystonia, Sleep abnormality, Neonatal death.

Symptoms not present: Glutaric aciduria, Decreased plasma free carnitine, Dyskinesia."
['Isovaleric acidemia'],"+1. Nonketotic Hyperglycinemia:

A rare inherited metabolic disorder characterized by an accumulation of glycine in the brain and other tissues due to a defect in the glycine cleavage system.

**Symptoms the patient has in common with the disease:**
+ Lethargy
+ Drowsiness
+ Feeding difficulties
+ Abnormal circulating glycine concentration
+ Death in infancy
+ Neonatal death
+ Sleep abnormality

**Symptoms the patient does not have in common:**
+ Seizures
+ Hypotonia
+ Apnea

+2. Ornithine Transcarbamylase Deficiency (Urea Cycle Disorder):

An X-linked genetic disorder leading to a deficiency of the enzyme ornithine transcarbamylase, causing excessive accumulation of ammonia in the blood.

**Symptoms the patient has in common with the disease:**
+ Hyperammonemia
+ Lethargy
+ Drowsiness
+ Vomiting (if present)
+ Feeding difficulties
+ Death in infancy
+ Neonatal death

**Symptoms the patient does not have in common:**
+ Coma
+ Respiratory alkalosis
+ Developmental delays

+3. Carnitine Transporter Deficiency:

A metabolic disorder caused by defects in the transport of carnitine into cells, leading to reduced energy production from fatty acids.

**Symptoms the patient has in common with the disease:**
+ Abnormal circulating carnitine concentration
+ Lethargy
+ Muscle weakness
+ Feeding difficulties
+ Hypoglycemia (if present)

**Symptoms the patient does not have in common:**
+ Cardiomyopathy
+ Hepatomegaly
+ Episodes of hypoketotic hypoglycemia

+4. Propionic Acidemia:

An inherited disorder characterized by the buildup of propionic acid in the body due to a deficiency of the enzyme propionyl-CoA carboxylase.

**Symptoms the patient has in common with the disease:**
+ Lethargy
+ Vomiting (if present)
+ Feeding difficulties
+ Hyperammonemia
+ Death in infancy

**Symptoms the patient does not have in common:**
+ Metabolic acidosis
+ Hypotonia
+ Seizures

+5. Methylmalonic Acidemia:

A metabolic disorder resulting from the inability to break down certain fats and proteins, leading to the accumulation of methylmalonic acid.

**Symptoms the patient has in common with the disease:**
+ Lethargy
+ Vomiting (if present)
+ Feeding difficulties
+ Hyperammonemia
+ Death in infancy
+ Developmental delay (if present)

**Symptoms the patient does not have in common:**
+ Metabolic acidosis
+ Failure to thrive
+ Seizures"
['PMM2-CDG'],"+1. **Pontocerebellar Hypoplasia**:

Common symptoms with the patient: Microcephaly, Intellectual disability, Motor delay, Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

Symptoms not present in the patient: Seizures, Spasticity, Feeding difficulties.

+2. **Joubert Syndrome**:

Common symptoms with the patient: Nystagmus, Ataxia, Hypotonia, Intellectual disability, Motor delay, Cerebellar atrophy, Strabismus.

Symptoms not present in the patient: Abnormal breathing patterns, Facial anomalies, Kidney abnormalities.

+3. **Leigh Syndrome**:

Common symptoms with the patient: Hypotonia, Ataxia, Nystagmus, Developmental delay, Cerebellar atrophy, Encephalopathy, Death in infancy.

Symptoms not present in the patient: Respiratory problems, Lactic acidosis, Seizures.

+4. **Pelizaeus-Merzbacher Disease**:

Common symptoms with the patient: Nystagmus, Hypotonia, Motor delay, Ataxia, Intellectual disability, Strabismus.

Symptoms not present in the patient: Spasticity, Tremor, Difficulty with speech.

+5. **Cerebellar Agenesis**:

Common symptoms with the patient: Ataxia, Motor delay, Cerebellar atrophy (agenesis), Hypotonia, Intellectual disability.

Symptoms not present in the patient: Potential respiratory issues, Varying degrees of motor function impairment.

+6. **Angelman Syndrome**:

Common symptoms with the patient: Intellectual disability, Ataxia, Microcephaly, Strabismus, Motor delay.

Symptoms not present in the patient: Frequent laughter/smiling, Seizures, Sleep disturbances.

+7. **Krabbe Disease**:

Common symptoms with the patient: Hypotonia, Motor delay, Developmental regression, Irritability, Encephalopathy, Death in infancy.

Symptoms not present in the patient: Limb stiffness, Feeding difficulties, Fever without infection.

+8. **Ataxia-Telangiectasia**:

Common symptoms with the patient: Ataxia, Hyporeflexia, Nystagmus, Strabismus, Cerebellar atrophy, Motor delay.

Symptoms not present in the patient: Telangiectasia (small dilated blood vessels), Immune deficiencies, Increased cancer risk.

+9. **Congenital Disorders of Glycosylation**:

Common symptoms with the patient: Growth delay, Hypotonia, Ataxia, Strabismus, Intellectual disability, Motor delay.

Symptoms not present in the patient: Liver dysfunction, Coagulation disorders, Hormonal imbalances.

+10. **Walker-Warburg Syndrome**:

Common symptoms with the patient: Microcephaly, Hypotonia, Eye abnormalities (like Strabismus and Nystagmus), Cerebellar malformations, Intellectual disability, Death in infancy.

Symptoms not present in the patient: Muscle weakness, Seizures, Brain malformations beyond cerebellar defects."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1. **Cobalamin C Disease (Combined Methylmalonic Aciduria and Homocystinuria)**:

A rare genetic disorder affecting vitamin B12 metabolism, leading to the accumulation of methylmalonic acid and homocysteine.

**Symptoms the patient has in common with this disease**:
+ Strabismus
+ Nystagmus
+ Optic atrophy
+ Abnormality of prenatal development or birth
+ Motor delay
+ Generalized hypotonia
+ Ventricular septal defect
+ Hyperammonemia
+ Hyperhomocystinemia
+ Methylmalonic aciduria
+ Elevated urinary carboxylic acid

**Symptoms the patient does not have in common with this disease**:
+ Microcephaly
+ Seizures
+ Renal anomalies

---

+2. **Methylmalonic Acidemia (MMA)**:

An inherited metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, leading to the accumulation of methylmalonic acid.

**Symptoms the patient has in common with this disease**:
+ Optic atrophy
+ Motor delay
+ Generalized hypotonia
+ Hyperammonemia
+ Methylmalonic aciduria
+ Elevated urinary carboxylic acid
+ Abnormal circulating carnitine concentration
+ Hyperalaninemia
+ Death in infancy

**Symptoms the patient does not have in common with this disease**:
+ Feeding difficulties
+ Lethargy
+ Recurrent infections

---

+3. **Propionic Acidemia**:

A metabolic disorder resulting from a deficiency of the enzyme propionyl-CoA carboxylase, causing the accumulation of propionic acid.

**Symptoms the patient has in common with this disease**:
+ Motor delay
+ Generalized hypotonia
+ Hyperammonemia
+ Hyperalaninemia
+ Elevated urinary carboxylic acid
+ Neonatal death
+ Death in infancy

**Symptoms the patient does not have in common with this disease**:
+ Vomiting
+ Ketosis
+ Neutropenia

---

+4. **Homocystinuria**:

An inherited disorder of methionine metabolism leading to the accumulation of homocysteine.

**Symptoms the patient has in common with this disease**:
+ Strabismus
+ Optic atrophy
+ Motor delay
+ Generalized hypotonia
+ Ventricular septal defect
+ Hyperhomocystinemia

**Symptoms the patient does not have in common with this disease**:
+ Tall stature
+ Thromboembolic events
+ Skeletal abnormalities

---

+5. **Leigh Syndrome**:

A severe neurological disorder characterized by progressive loss of mental and movement abilities due to mitochondrial dysfunction.

**Symptoms the patient has in common with this disease**:
+ Nystagmus
+ Optic atrophy
+ Motor delay
+ Generalized hypotonia
+ Death in infancy or childhood

**Symptoms the patient does not have in common with this disease**:
+ Respiratory abnormalities
+ Elevated lactate levels
+ Cerebellar ataxia

---

+6. **Multiple Carboxylase Deficiency**:

A disorder affecting biotin-dependent carboxylase enzymes, leading to metabolic abnormalities.

**Symptoms the patient has in common with this disease**:
+ Motor delay
+ Generalized hypotonia
+ Hyperammonemia
+ Elevated urinary carboxylic acid
+ Abnormal circulating carnitine concentration

**Symptoms the patient does not have in common with this disease**:
+ Skin rash
+ Alopecia
+ Hearing loss

---

+7. **Isovaleric Acidemia**:

A metabolic disorder caused by a deficiency of isovaleryl-CoA dehydrogenase, leading to the accumulation of isovaleric acid.

**Symptoms the patient has in common with this disease**:
+ Motor delay
+ Generalized hypotonia
+ Vomiting
+ Elevated urinary carboxylic acid
+ Death in infancy

**Symptoms the patient does not have in common with this disease**:
+ Characteristic ""sweaty feet"" odor
+ Neutropenia
+ Thrombocytopenia

---

+8. **Glutaric Acidemia Type I**:

A disorder of amino acid metabolism leading to the accumulation of glutaric acid.

**Symptoms the patient has in common with this disease**:
+ Motor delay
+ Generalized hypotonia
+ Macrocephaly
+ Elevated urinary carboxylic acid

**Symptoms the patient does not have in common with this disease**:
+ Dystonia
+ Subdural hemorrhages
+ Retinal hemorrhages

---

+9. **Carnitine Transporter Deficiency**:

A condition resulting from defects in the transport of carnitine, essential for fatty acid metabolism.

**Symptoms the patient has in common with this disease**:
+ Motor delay
+ Generalized hypotonia
+ Elevated circulating carnitine concentration
+ Cardiomyopathy
+ Hypoketotic hypoglycemia

**Symptoms the patient does not have in common with this disease**:
+ Muscle weakness
+ Hepatomegaly
+ Recurrent infections

---

+10. **Non-Ketotic Hyperglycinemia**:

A metabolic disorder characterized by accumulation of glycine due to a defect in the glycine cleavage system.

**Symptoms the patient has in common with this disease**:
+ Motor delay
+ Generalized hypotonia
+ Seizures
+ Apnea
+ Death in infancy

**Symptoms the patient does not have in common with this disease**:
+ Elevated glycine levels in blood and cerebrospinal fluid
+ Lethargy
+ Myoclonic jerks

---"
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. **Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency**:
- **Symptoms in common**: Death in infancy, Hypoglycemia, Vomiting, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
- **Symptoms not in common**: Diarrhea.

+2. **Carnitine transporter deficiency**:
- **Symptoms in common**: Death in infancy, Hypoglycemia, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
- **Symptoms not in common**: Vomiting, Diarrhea.

+3. **Galactosemia**:
- **Symptoms in common**: Death in infancy, Hypoglycemia, Vomiting, Diarrhea, Elevated circulating hepatic transaminase concentration.
- **Symptoms not in common**: Abnormal circulating carnitine concentration.

+4. **Hereditary fructose intolerance**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Diarrhea, Elevated circulating hepatic transaminase concentration.
- **Symptoms not in common**: Death in infancy (though severe cases can be fatal), Abnormal circulating carnitine concentration.

+5. **Reye's syndrome**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Elevated circulating hepatic transaminase concentration.
- **Symptoms not in common**: Death in infancy (typically affects older children), Diarrhea, Abnormal circulating carnitine concentration.

+6. **Carnitine palmitoyltransferase I deficiency**:
- **Symptoms in common**: Hypoglycemia, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
- **Symptoms not in common**: Death in infancy (can be severe but variable), Vomiting, Diarrhea.

+7. **Tyrosinemia Type I**:
- **Symptoms in common**: Death in infancy, Vomiting, Diarrhea, Elevated circulating hepatic transaminase concentration.
- **Symptoms not in common**: Hypoglycemia (may not be prominent), Abnormal circulating carnitine concentration.

+8. **Maple Syrup Urine Disease**:
- **Symptoms in common**: Death in infancy, Vomiting, Elevated circulating hepatic transaminase concentration.
- **Symptoms not in common**: Hypoglycemia (not typical), Diarrhea, Abnormal circulating carnitine concentration.

+9. **Organic acidemia (e.g., Propionic acidemia)**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
- **Symptoms not in common**: Diarrhea, Death in infancy (possible if untreated).

+10. **Urea cycle disorders (e.g., Ornithine transcarbamylase deficiency)**:
- **Symptoms in common**: Vomiting, Elevated circulating hepatic transaminase concentration.
- **Symptoms not in common**: Hypoglycemia (usually normal glucose levels), Diarrhea, Abnormal circulating carnitine concentration, Death in infancy (can be fatal if untreated)."
['Succinic semialdehyde dehydrogenase deficiency'],"+1. **Propionic Acidemia**:
Propionic acidemia is an inherited metabolic disorder where the body cannot break down certain parts of proteins and lipids properly, leading to a buildup of propionic acid.

**Symptoms in common with the patient**:
- Coma
- Death in infancy
- Respiratory acidosis
- Elevated urinary carboxylic acid

**Symptoms not in common**:
- Hyperkalemia (not typically associated)
- Hyponatremia (not typically associated)
- Neonatal death (symptoms may present in neonates but not exclusively)

+2. **Methylmalonic Acidemia**:
This is a genetic disorder causing an inability to process certain fats and proteins, resulting in the accumulation of methylmalonic acid.

**Symptoms in common with the patient**:
- Coma
- Death in infancy
- Respiratory acidosis
- Elevated urinary carboxylic acid

**Symptoms not in common**:
- Hyperkalemia (not typically associated)
- Hyponatremia (not typically associated)
- Neonatal death (can occur but not exclusively)

+3. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
Also known as glutaric acidemia type II, MADD is a disorder that affects the body's ability to break down fats and proteins for energy.

**Symptoms in common with the patient**:
- Coma
- Neonatal death
- Respiratory acidosis
- Elevated urinary carboxylic acid

**Symptoms not in common**:
- Hyperkalemia (not typically associated)
- Hyponatremia (not typically associated)
- Death in infancy (can occur if severe)

+4. **Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency)**:
A group of inherited disorders affecting the adrenal glands, leading to deficient cortisol and aldosterone production.

**Symptoms in common with the patient**:
- Hyperkalemia
- Hyponatremia
- Death in infancy (due to adrenal crisis)

**Symptoms not in common**:
- Coma (may occur in severe cases)
- Respiratory acidosis (not typically associated)
- Elevated urinary carboxylic acid (not associated)
- Neonatal death (possible if untreated)

+5. **Pyruvate Carboxylase Deficiency**:
A rare metabolic disorder affecting the body's ability to produce glucose from certain compounds, leading to lactic acidosis.

**Symptoms in common with the patient**:
- Coma
- Death in infancy
- Respiratory acidosis

**Symptoms not in common**:
- Hyperkalemia (not typically associated)
- Hyponatremia (not typically associated)
- Elevated urinary carboxylic acid (not typically associated)
- Neonatal death (symptoms may present early but not exclusively)"
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1. **Homocystinuria**:
Homocystinuria is a rare inherited disorder affecting the metabolism of the amino acid methionine, leading to an accumulation of homocysteine and methionine in the body.

**Symptoms in common**:
- Ectopia lentis
- Intellectual disability
- Motor delay
- Hyperhomocystinemia
- Hypermethioninemia
- Fatigue
- Death in childhood or adolescence

**Symptoms not in common**:
- Ptosis
- Large hands
- Long foot

+2. **Marfan Syndrome**:
Marfan syndrome is a genetic disorder that affects the body's connective tissue, resulting in abnormalities in the eyes, skeleton, and cardiovascular system.

**Symptoms in common**:
- Ectopia lentis
- Large hands
- Long foot
- Fatigue

**Symptoms not in common**:
- Ptosis
- Intellectual disability (intelligence is usually normal)
- Hyperhomocystinemia
- Hypermethioninemia
- Motor delay
- Death in childhood (complications may occur later in life)

+3. **Sulfite Oxidase Deficiency**:
Sulfite oxidase deficiency is a rare metabolic disorder characterized by a deficiency of the enzyme sulfite oxidase, leading to neurological deterioration.

**Symptoms in common**:
- Ectopia lentis
- Intellectual disability
- Motor delay
- Death in childhood

**Symptoms not in common**:
- Ptosis
- Hyperhomocystinemia (typically not elevated)
- Hypermethioninemia (may or may not be present)
- Large hands
- Long foot

+4. **Congenital Myasthenic Syndromes**:
These are a group of genetic disorders that affect the neuromuscular junction, leading to muscle weakness.

**Symptoms in common**:
- Ptosis
- Motor delay
- Fatigue

**Symptoms not in common**:
- Ectopia lentis
- Intellectual disability (may vary)
- Hyperhomocystinemia
- Hypermethioninemia
- Large hands
- Long foot
- Death in childhood (severity varies)

+5. **Wilson Disease**:
Wilson disease is a genetic disorder causing copper accumulation in tissues, leading to neurological and hepatic symptoms.

**Symptoms in common**:
- Fatigue
- Motor delay
- Intellectual disability (in some cases)

**Symptoms not in common**:
- Ptosis
- Ectopia lentis
- Large hands
- Long foot
- Hyperhomocystinemia
- Hypermethioninemia
- Death in childhood (usually manifests in adolescence)

---

Please note that this list provides potential conditions based on the symptoms provided. It's important for the patient to consult a healthcare professional for an accurate diagnosis and appropriate management."
[],"+1. **Donohue Syndrome**:
Shared symptoms: Wide mouth, Hyperinsulinemia, Hypoglycemia, Sparse hair, Seizures, Death in infancy, Feeding difficulties.
Symptoms not shared: Epicanthus, Carious teeth, Abnormal hemoglobin.

+2. **Beckwith-Wiedemann Syndrome**:
Shared symptoms: Wide mouth, Hyperinsulinemia, Hypoglycemia, Neonatal death, Feeding difficulties.
Symptoms not shared: Epicanthus, Carious teeth, Sparse hair, Seizures, Abnormal hemoglobin, Death in childhood.

+3. **Congenital Hyperinsulinism**:
Shared symptoms: Hyperinsulinemia, Hypoglycemia, Seizures.
Symptoms not shared: Wide mouth, Epicanthus, Carious teeth, Sparse hair, Death in infancy, Neonatal death, Abnormal hemoglobin.

+4. **Wolf-Hirschhorn Syndrome**:
Shared symptoms: Wide mouth, Epicanthus, Seizures, Feeding difficulties.
Symptoms not shared: Hyperinsulinemia, Hypoglycemia, Sparse hair, Carious teeth, Abnormal hemoglobin, Death in infancy.

+5. **Menkes Disease**:
Shared symptoms: Sparse hair, Seizures, Feeding difficulties, Death in childhood.
Symptoms not shared: Wide mouth, Hyperinsulinemia, Hypoglycemia, Epicanthus, Carious teeth, Abnormal hemoglobin."
['Propionic acidemia'],"+1. **Non-Ketotic Hyperglycinemia**:  
Non-Ketotic Hyperglycinemia is a rare metabolic disorder characterized by an accumulation of glycine in the body due to a defect in the glycine cleavage system.

**Symptoms in common with the patient:**  
- Intellectual disability
- Seizure
- Motor delay
- Death in infancy
- Hyperglycinemia
- Hypotonia (if applicable)

**Symptoms not in common with the patient:**  
- Respiratory difficulties
- Lethargy
- Coma

---

+2. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:  
Urea cycle disorders are genetic conditions that result in an inability to remove ammonia from the bloodstream.

**Symptoms in common with the patient:**  
- Hyperammonemia
- Seizure
- Motor delay
- Death in infancy
- Hepatomegaly

**Symptoms not in common with the patient:**  
- Vomiting
- Irritability
- Poor feeding

---

+3. **Propionic Acidemia**:  
Propionic Acidemia is a metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of toxic substances.

**Symptoms in common with the patient:**  
- Seizure
- Intellectual disability
- Motor delay
- Hyperammonemia
- Anemia
- Hepatomegaly
- Death in infancy

**Symptoms not in common with the patient:**  
- Vomiting
- Lethargy
- Hypotonia

---

+4. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency)**:  
This condition results from a defect in the transporter responsible for moving carnitine into cells, affecting energy production.

**Symptoms in common with the patient:**  
- Hypoglycinemia
- Hepatomegaly
- Muscle weakness (if present)
- Abnormal circulating carnitine concentration
- Death in infancy

**Symptoms not in common with the patient:**  
- Cardiomyopathy
- Fatigue
- Hypoketotic hypoglycemia

---

+5. **Methylmalonic Acidemia**:  
Methylmalonic Acidemia is a metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase.

**Symptoms in common with the patient:**  
- Seizure
- Intellectual disability
- Motor delay
- Hyperammonemia
- Anemia
- Hepatomegaly
- Death in infancy

**Symptoms not in common with the patient:**  
- Failure to thrive
- Lethargy
- Vomiting

---

Please note that this information is for educational purposes only. For a comprehensive evaluation and diagnosis, consulting a qualified healthcare professional is essential."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Acidemia (MMA):**
Methylmalonic Acidemia is a rare inherited metabolic disorder characterized by the body's inability to process certain fats and proteins properly, leading to a buildup of methylmalonic acid.

**Symptoms in common with the patient:**
- Methylmalonic aciduria
- Decreased methylmalonyl-CoA mutase activity
- Metabolic acidosis
- Generalized hypotonia
- Feeding difficulties
- Apnea
- Abnormal nervous system physiology
- Neonatal death
- Death in infancy

**Symptoms not in common:**
- Thrombocytopenia
- Leukopenia

+2. **Propionic Acidemia:**
Propionic Acidemia is an inherited metabolic disorder where the body can't process certain parts of proteins and lipids, leading to a buildup of propionic acid.

**Symptoms in common with the patient:**
- Metabolic acidosis
- Generalized hypotonia
- Feeding difficulties
- Apnea
- Abnormal nervous system physiology
- Neonatal death

**Symptoms not in common:**
- Methylmalonic aciduria
- Decreased methylmalonyl-CoA mutase activity
- Thrombocytopenia
- Leukopenia
- Death in infancy

+3. **Multiple Carboxylase Deficiency:**
This is a metabolic disorder resulting from a deficiency of biotin enzymes, leading to an accumulation of certain substances in the body.

**Symptoms in common with the patient:**
- Metabolic acidosis
- Generalized hypotonia
- Feeding difficulties
- Apnea
- Abnormal nervous system physiology

**Symptoms not in common:**
- Methylmalonic aciduria
- Decreased methylmalonyl-CoA mutase activity
- Thrombocytopenia
- Leukopenia
- Neonatal death
- Death in infancy

+4. **Wiskott-Aldrich Syndrome:**
Wiskott-Aldrich Syndrome is a rare genetic disorder affecting the immune system and blood clotting.

**Symptoms in common with the patient:**
- Thrombocytopenia
- Leukopenia
- Feeding difficulties

**Symptoms not in common:**
- Methylmalonic aciduria
- Decreased methylmalonyl-CoA mutase activity
- Metabolic acidosis
- Generalized hypotonia
- Apnea
- Neonatal death
- Death in infancy
- Abnormal nervous system physiology

+5. **Severe Combined Immunodeficiency (SCID):**
SCID is a group of rare disorders caused by mutations affecting the immune system.

**Symptoms in common with the patient:**
- Leukopenia
- Feeding difficulties
- Generalized hypotonia

**Symptoms not in common:**
- Methylmalonic aciduria
- Decreased methylmalonyl-CoA mutase activity
- Metabolic acidosis
- Thrombocytopenia
- Apnea
- Neonatal death
- Death in infancy
- Abnormal nervous system physiology"
['Systemic primary carnitine deficiency'],"+1. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Coma, Sudden death, Decreased plasma free carnitine, Elevated circulating lactate dehydrogenase concentration, Death in infancy.
- **Symptoms not in common**: Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+2. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency)**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Coma, Sudden death, Decreased plasma free carnitine, Elevated circulating lactate dehydrogenase concentration.
- **Symptoms not in common**: Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+3. **Propionic Acidemia**:
- **Symptoms in common**: Vomiting, Coma, Hypoglycemia, Death in infancy, Elevated circulating lactate dehydrogenase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.
- **Symptoms not in common**: Decreased plasma free carnitine, Elevated circulating alkaline phosphatase concentration.

+4. **Methylmalonic Acidemia**:
- **Symptoms in common**: Vomiting, Coma, Hypoglycemia, Death in infancy, Elevated circulating lactate dehydrogenase concentration, Abnormal circulating amino acid concentrations.
- **Symptoms not in common**: Decreased plasma free carnitine, Elevated circulating alkaline phosphatase concentration.

+5. **Reye Syndrome**:
- **Symptoms in common**: Vomiting, Coma, Hypoglycemia, Elevated circulating alkaline phosphatase concentration, Increased circulating lactate dehydrogenase concentration, Death in infancy.
- **Symptoms not in common**: Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+6. **Fatty Acid Oxidation Disorders (Other than MCAD)**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Coma, Sudden death, Decreased plasma free carnitine, Elevated circulating lactate dehydrogenase concentration.
- **Symptoms not in common**: Elevated circulating alkaline phosphatase concentration, Abnormal circulating amino acid concentrations.

+7. **Mitochondrial Disorders**:
- **Symptoms in common**: Hypoglycemia, Vomiting, Coma, Elevated circulating lactate dehydrogenase concentration, Abnormal circulating amino acid concentrations.
- **Symptoms not in common**: Decreased plasma free carnitine (may vary), Elevated circulating alkaline phosphatase concentration.

+8. **Tyrosinemia Type I**:
- **Symptoms in common**: Vomiting, Hypoglycemia, Elevated circulating alkaline phosphatase concentration, Increased circulating lactate dehydrogenase concentration, Death in infancy.
- **Symptoms not in common**: Decreased plasma free carnitine, Abnormal circulating amino acid concentrations (though may have some abnormalities), Coma (less common).

+9. **Urea Cycle Disorders**:
- **Symptoms in common**: Coma, Vomiting, Elevated circulating alkaline phosphatase concentration, Abnormal circulating amino acid concentrations.
- **Symptoms not in common**: Hypoglycemia (usually normal), Decreased plasma free carnitine.

+10. **Maple Syrup Urine Disease**:
- **Symptoms in common**: Coma, Vomiting, Death in infancy, Abnormal circulating amino acid concentrations.
- **Symptoms not in common**: Hypoglycemia (usually normal), Decreased plasma free carnitine, Elevated circulating alkaline phosphatase concentration."
['3-methylcrotonyl-CoA carboxylase deficiency'],"Sure, based on the symptoms you've provided, here is a list of potential diseases that could be considered. Please note that only a qualified healthcare professional can provide a definitive diagnosis.

+1. **Primary Carnitine Deficiency**:

*Short Description*: A metabolic disorder caused by a defect in carnitine transport, leading to low levels of carnitine necessary for energy production.

*Symptoms in common*: Lethargy, Decreased plasma free carnitine, Poor coordination, Feeding difficulties, Sleep abnormality, Death in infancy, Neonatal death.

*Symptoms not in common*: Clumsiness, Drowsiness, Death in childhood.

+2. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:

*Short Description*: A fatty acid oxidation disorder that impairs the body's ability to break down medium-chain fatty acids, leading to energy deficiency.

*Symptoms in common*: Lethargy, Drowsiness, Poor coordination, Feeding difficulties, Sleep abnormality, Death in infancy, Neonatal death.

*Symptoms not in common*: Decreased plasma free carnitine, Clumsiness, Death in childhood.

+3. **Maple Syrup Urine Disease**:

*Short Description*: A metabolic disorder affecting the breakdown of certain amino acids, resulting in toxic accumulation in the body.

*Symptoms in common*: Lethargy, Poor coordination, Feeding difficulties, Neonatal death, Death in infancy.

*Symptoms not in common*: Decreased plasma free carnitine, Sleep abnormality, Drowsiness, Clumsiness, Death in childhood.

+4. **Congenital Disorders of Glycosylation**:

*Short Description*: A group of rare metabolic disorders caused by defects in the process of glycosylation, affecting multiple systems.

*Symptoms in common*: Lethargy, Poor coordination, Feeding difficulties, Clumsiness, Drowsiness, Sleep abnormality, Death in infancy, Death in childhood.

*Symptoms not in common*: Decreased plasma free carnitine.

+5. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:

*Short Description*: Also known as glutaric acidemia type II, it is a metabolic disorder affecting the body's ability to break down fats and proteins.

*Symptoms in common*: Lethargy, Decreased plasma free carnitine, Poor coordination, Feeding difficulties, Sleep abnormality, Neonatal death.

*Symptoms not in common*: Clumsiness, Drowsiness, Death in childhood.

Please consult a healthcare professional for an accurate diagnosis and appropriate management."
[],"+1. **Leigh Syndrome**:

**Symptoms in Common**:
- Delayed speech and language development
- Encephalopathy
- Hyperreflexia
- Spastic diplegia and spastic tetraplegia
- Cytochrome C oxidase-negative muscle fibers
- Death in adolescence or early adulthood

**Symptoms Not in Common**:
- Hypothyroidism
- Ethylmalonic aciduria
- Abnormal circulating glycine concentration
- Recurrent viral infections

+2. **Ethylmalonic Encephalopathy**:

**Symptoms in Common**:
- Ethylmalonic aciduria
- Encephalopathy
- Spastic diplegia and spastic tetraplegia
- Recurrent viral infections
- Cytochrome C oxidase-negative muscle fibers
- Delayed speech and language development
- Death in early childhood

**Symptoms Not in Common**:
- Hypothyroidism
- Abnormal circulating glycine concentration
- Death in adolescence or early adulthood (typically occurs earlier)

+3. **Nonketotic Hyperglycinemia**:

**Symptoms in Common**:
- Delayed speech and language development
- Encephalopathy
- Abnormal circulating glycine concentration
- Spastic diplegia and spastic tetraplegia
- Hyperreflexia
- Dysarthria
- Death in early childhood

**Symptoms Not in Common**:
- Hypothyroidism
- Ethylmalonic aciduria
- Recurrent viral infections
- Cytochrome C oxidase-negative muscle fibers

+4. **Mitochondrial Encephalomyopathy**:

**Symptoms in Common**:
- Encephalopathy
- Spastic diplegia and spastic tetraplegia
- Hyperreflexia
- Dysarthria
- Cytochrome C oxidase-negative muscle fibers
- Delayed speech and language development
- Death in adolescence or early adulthood

**Symptoms Not in Common**:
- Hypothyroidism
- Ethylmalonic aciduria
- Abnormal circulating glycine concentration
- Recurrent viral infections

+5. **Krabbe Disease**:

**Symptoms in Common**:
- Delayed speech and language development
- Encephalopathy
- Spastic tetraplegia
- Hyperreflexia
- Dysarthria
- Death in early childhood or adolescence

**Symptoms Not in Common**:
- Hypothyroidism
- Ethylmalonic aciduria
- Abnormal circulating glycine concentration
- Cytochrome C oxidase-negative muscle fibers
- Recurrent viral infections

+6. **Hereditary Spastic Paraplegia**:

**Symptoms in Common**:
- Spastic diplegia and spastic tetraplegia
- Hyperreflexia
- Delayed speech and language development
- Dysarthria

**Symptoms Not in Common**:
- Hypothyroidism
- Encephalopathy
- Ethylmalonic aciduria
- Cytochrome C oxidase-negative muscle fibers
- Abnormal circulating glycine concentration
- Recurrent viral infections
- Death in adolescence or early adulthood (condition is often non-fatal)

+7. **Congenital Hypothyroidism with Neurological Manifestations**:

**Symptoms in Common**:
- Hypothyroidism
- Delayed speech and language development
- Encephalopathy
- Spastic diplegia and spastic tetraplegia
- Hyperreflexia
- Dysarthria

**Symptoms Not in Common**:
- Ethylmalonic aciduria
- Cytochrome C oxidase-negative muscle fibers
- Abnormal circulating glycine concentration
- Recurrent viral infections
- Death in adolescence or early adulthood (severity varies)

+8. **Canavan Disease**:

**Symptoms in Common**:
- Delayed speech and language development
- Encephalopathy
- Spastic tetraplegia
- Dysarthria
- Death in early childhood or adolescence

**Symptoms Not in Common**:
- Hypothyroidism
- Ethylmalonic aciduria
- Hyperreflexia
- Cytochrome C oxidase-negative muscle fibers
- Abnormal circulating glycine concentration
- Recurrent viral infections

+9. **Pelizaeus-Merzbacher Disease**:

**Symptoms in Common**:
- Delayed speech and language development
- Encephalopathy
- Spasticity (diplegia and tetraplegia)
- Hyperreflexia
- Dysarthria
- Death in early adulthood

**Symptoms Not in Common**:
- Hypothyroidism
- Ethylmalonic aciduria
- Cytochrome C oxidase-negative muscle fibers
- Abnormal circulating glycine concentration
- Recurrent viral infections

+10. **Multiple Sulfatase Deficiency**:

**Symptoms in Common**:
- Delayed speech and language development
- Hypothyroidism
- Encephalopathy
- Spastic tetraplegia
- Dysarthria
- Recurrent viral infections
- Death in childhood or adolescence

**Symptoms Not in Common**:
- Ethylmalonic aciduria
- Cytochrome C oxidase-negative muscle fibers
- Abnormal circulating glycine concentration
- Hyperreflexia"
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency:
MCAD deficiency is a fatty acid oxidation disorder that impairs the body's ability to break down medium-chain fatty acids, leading to energy deficiency, especially during fasting periods.

**Symptoms the patient has in common:**
- Death in infancy
- Neonatal death
- Abnormal circulating carnitine concentration

**Symptoms not in common:**
- Abnormality of prenatal development or birth

+2. Primary carnitine deficiency:
This disorder is caused by a defect in the carnitine transporter, leading to low levels of carnitine necessary for the transport of fatty acids into mitochondria for energy production.

**Symptoms the patient has in common:**
- Abnormal circulating carnitine concentration
- Death in infancy
- Neonatal death

**Symptoms not in common:**
- Abnormality of prenatal development or birth

+3. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency:
LCHAD deficiency is a fatty acid oxidation disorder affecting the breakdown of long-chain fatty acids, resulting in energy deficiency and accumulation of toxic substances.

**Symptoms the patient has in common:**
- Death in infancy
- Neonatal death
- Abnormal circulating carnitine concentration

**Symptoms not in common:**
- Abnormality of prenatal development or birth

+4. Multiple acyl-CoA dehydrogenase deficiency (MADD):
Also known as glutaric acidemia type II, MADD is a disorder that affects multiple steps in fatty acid oxidation, leading to energy production problems.

**Symptoms the patient has in common:**
- Neonatal death
- Death in infancy
- Abnormal circulating carnitine concentration

**Symptoms not in common:**
- Abnormality of prenatal development or birth

+5. Zellweger syndrome:
Zellweger syndrome is a peroxisomal biogenesis disorder characterized by the reduction or absence of functional peroxisomes, leading to severe developmental issues.

**Symptoms the patient has in common:**
- Abnormality of prenatal development or birth
- Death in infancy
- Neonatal death

**Symptoms not in common:**
- Abnormal circulating carnitine concentration

+6. Trifunctional protein deficiency:
This is a fatty acid oxidation disorder affecting the mitochondrial trifunctional protein necessary for metabolizing long-chain fatty acids.

**Symptoms the patient has in common:**
- Neonatal death
- Death in infancy
- Abnormal circulating carnitine concentration

**Symptoms not in common:**
- Abnormality of prenatal development or birth

+7. Carnitine palmitoyltransferase II (CPT II) deficiency:
CPT II deficiency impairs the transport of long-chain fatty acids into mitochondria, disrupting energy production.

**Symptoms the patient has in common:**
- Abnormal circulating carnitine concentration

**Symptoms not in common:**
- Abnormality of prenatal development or birth
- Death in infancy
- Neonatal death

+8. Holocarboxylase synthetase deficiency:
A metabolic disorder affecting the body's ability to process biotin, leading to multiple carboxylase deficiencies.

**Symptoms the patient has in common:**
- Abnormality of prenatal development or birth
- Neonatal death

**Symptoms not in common:**
- Death in infancy
- Abnormal circulating carnitine concentration

+9. Mitochondrial DNA depletion syndromes:
These disorders involve a significant reduction of mitochondrial DNA, leading to severe muscular and neurological symptoms.

**Symptoms the patient has in common:**
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not in common:**
- Abnormal circulating carnitine concentration

+10. Pyruvate carboxylase deficiency:
A metabolic disorder that affects the body's ability to produce glucose from pyruvate, leading to lactic acidosis and other severe symptoms.

**Symptoms the patient has in common:**
- Neonatal death
- Death in infancy

**Symptoms not in common:**
- Abnormality of prenatal development or birth
- Abnormal circulating carnitine concentration"
['Glutaryl-CoA dehydrogenase deficiency'],"+1. **Glutaric Aciduria Type I**:
A rare metabolic disorder caused by deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to accumulation of glutaric acid.

**Symptoms in common with the patient**: Macrocephaly, Dystonia, Generalized hypotonia, Lethargy, Metabolic acidosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Dyskinesia, Vomiting, Fever.

**Symptoms not in common**: Cystic hygroma, Hyperhidrosis, Death in infancy, Neonatal death, Decreased plasma free carnitine, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality, Death in childhood.

+2. **Primary Carnitine Deficiency**:
A genetic disorder affecting the body's ability to transport carnitine, resulting in decreased energy production.

**Symptoms in common with the patient**: Lethargy, Generalized hypotonia, Metabolic acidosis, Vomiting, Decreased plasma free carnitine, Drowsiness.

**Symptoms not in common**: Macrocephaly, Cystic hygroma, Hyperhidrosis, Dystonia, Death in infancy, Neonatal death, Glutaric aciduria, Elevated circulating glutaric acid concentration, Fever, Diarrhea, Dyspnea, Sleep abnormality, Dyskinesia, Death in childhood.

+3. **Maple Syrup Urine Disease**:
An inherited metabolic disorder characterized by the body's inability to break down certain amino acids.

**Symptoms in common with the patient**: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Vomiting, Sleep abnormality, Drowsiness.

**Symptoms not in common**: Macrocephaly, Cystic hygroma, Hyperhidrosis, Death in infancy, Neonatal death, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Fever, Diarrhea, Dyspnea, Dyskinesia, Death in childhood.

+4. **Leigh Syndrome**:
A severe neurological disorder that arises from mitochondrial dysfunction, often presenting in infancy.

**Symptoms in common with the patient**: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Vomiting, Dyspnea, Sleep abnormality, Drowsiness.

**Symptoms not in common**: Macrocephaly, Cystic hygroma, Hyperhidrosis, Death in infancy, Neonatal death, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Fever, Diarrhea, Dyskinesia, Death in childhood.

+5. **Non-Ketotic Hyperglycinemia**:
A metabolic disorder caused by defects in glycine breakdown, leading to accumulation in the body.

**Symptoms in common with the patient**: Lethargy, Generalized hypotonia, Drowsiness, Seizures, Sleep abnormality, Death in infancy.

**Symptoms not in common**: Macrocephaly, Cystic hygroma, Hyperhidrosis, Dystonia, Metabolic acidosis, Vomiting, Diarrhea, Dyspnea, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Dyskinesia, Death in childhood, Fever."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

Tyrosinemia Type I is a genetic metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. This leads to the accumulation of tyrosine and its metabolites, resulting in severe liver and kidney dysfunction.

**Symptoms in common with the patient**:
- **Hypertyrosinemia**: Elevated levels of tyrosine in the blood are a hallmark of this condition.
- **Abnormality of prenatal development or birth**: The metabolic disturbances can affect prenatal development.
- **Neonatal death**, **Death in infancy**, **Death in childhood**: Without treatment, the disease can lead to early mortality.

**Symptoms not present in the patient**:
- **Cabbage-like odor**: A distinctive smell often associated with this disorder.
- **Hepatomegaly**: Enlarged liver due to liver dysfunction.
- **Renal tubular dysfunction**: Kidney problems leading to issues like rickets.

+2. **Phenylketonuria (PKU)**:

PKU is an inherited disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to elevated levels of phenylalanine in the blood.

**Symptoms in common with the patient**:
- **Hyperphenylalaninemia**: High levels of phenylalanine are characteristic of PKU.
- **Abnormality of prenatal development or birth**: Excess phenylalanine can affect fetal development.

**Symptoms not present in the patient**:
- **Intellectual disability**: Cognitive impairments are common if untreated.
- **Seizures**: Neurological symptoms due to high phenylalanine levels.
- **Eczema**: Skin problems frequently seen in PKU patients.

+3. **Tyrosinemia Type II**:

This is a rare metabolic disorder caused by a deficiency of the enzyme tyrosine aminotransferase, leading to elevated tyrosine levels.

**Symptoms in common with the patient**:
- **Hypertyrosinemia**: Increased tyrosine levels in the blood.
- **Abnormality of prenatal development or birth**: Potential impact on development.

**Symptoms not present in the patient**:
- **Skin lesions**: Painful lesions on the palms and soles.
- **Photophobia and eye pain**: Eye problems due to tyrosine crystals in the cornea.
- **Intellectual disability**: Cognitive issues may occur.

+4. **Maple Syrup Urine Disease (MSUD)**:

MSUD is a metabolic disorder affecting the breakdown of branched-chain amino acids, leading to their accumulation.

**Symptoms in common with the patient**:
- **Death in infancy**, **Neonatal death**, **Death in childhood**: Severe forms can lead to early mortality.
- **Abnormality of prenatal development or birth**: Metabolic issues can affect development.

**Symptoms not present in the patient**:
- **Sweet-smelling urine**: Characteristic odor resembling maple syrup.
- **Ketoacidosis**: Accumulation of organic acids leading to acid-base imbalance.
- **Neurological dysfunction**: Lethargy, seizures, and coma.

+5. **Homocystinuria**:

Homocystinuria is a genetic disorder caused by a deficiency of cystathionine beta-synthase, leading to the accumulation of homocysteine.

**Symptoms in common with the patient**:
- **Death in childhood**, **Death in adolescence**: Increased risk due to thromboembolic events.
- **Abnormality of prenatal development or birth**: May affect development.

**Symptoms not present in the patient**:
- **Lens dislocation**: Eye problems are common.
- **Skeletal abnormalities**: Osteoporosis and skeletal deformities.
- **Thromboembolism**: Blood clots leading to stroke or heart attack."
['L-2-hydroxyglutaric aciduria'],"+1. **Canavan Disease**:

Canavan disease is a rare genetic disorder that causes degeneration of the white matter in the brain, leading to severe neurological impairments.

- **Symptoms in common**: Delayed speech and language development, intellectual disability, difficulty walking, difficulty climbing stairs, difficulty running, abnormal cerebral white matter morphology, death in childhood.
- **Symptoms not in common**: Hyperreflexia (not typically prominent), death in infancy (death usually occurs in early childhood).

+2. **Krabbe Disease**:

Krabbe disease is a hereditary condition affecting the nervous system, resulting in the loss of myelin sheath around nerves.

- **Symptoms in common**: Delayed speech and language development, intellectual disability, hyperreflexia, difficulty walking, difficulty climbing stairs, difficulty running, death in infancy or early childhood.
- **Symptoms not in common**: Abnormal cerebral white matter morphology (though demyelination occurs, specific morphology may vary).

+3. **Metachromatic Leukodystrophy**:

This is a genetic disorder characterized by the accumulation of fats called sulfatides, leading to progressive damage of the nervous system.

- **Symptoms in common**: Intellectual disability, hyperreflexia, difficulty walking, difficulty climbing stairs, difficulty running, abnormal cerebral white matter morphology, death in childhood.
- **Symptoms not in common**: Delayed speech and language development (may occur later), death in infancy (less common than death in later childhood).

+4. **Pelizaeus-Merzbacher Disease**:

An X-linked genetic disorder affecting myelin production in the central nervous system.

- **Symptoms in common**: Delayed speech and language development, difficulty walking, difficulty climbing stairs, difficulty running, abnormal cerebral white matter morphology.
- **Symptoms not in common**: Intellectual disability (may be less severe), hyperreflexia (spasticity is common), death in infancy (survival into adolescence is possible).

+5. **Alexander Disease**:

A rare leukodystrophy characterized by abnormal protein accumulation causing white matter destruction.

- **Symptoms in common**: Delayed speech and language development, intellectual disability, difficulty walking, abnormal cerebral white matter morphology, death in infancy or childhood.
- **Symptoms not in common**: Hyperreflexia (can occur but is not a hallmark), difficulty climbing stairs and running (may be implied due to motor difficulties).

+6. **Spinal Muscular Atrophy (Type 1)**:

A genetic disorder affecting the control of muscle movement due to loss of motor neurons.

- **Symptoms in common**: Difficulty walking, difficulty climbing stairs, difficulty running, death in infancy.
- **Symptoms not in common**: Delayed speech and language development (usually normal cognition), hyperreflexia (typically presents with hypotonia), abnormal cerebral white matter morphology.

+7. **Cerebral Palsy (Severe Forms)**:

A group of disorders affecting movement and muscle tone or posture caused by damage to the developing brain.

- **Symptoms in common**: Delayed speech and language development, intellectual disability, hyperreflexia, difficulty walking, difficulty climbing stairs, difficulty running.
- **Symptoms not in common**: Death in infancy or childhood (life expectancy can vary), abnormal cerebral white matter morphology (may or may not be present).

+8. **Leigh Syndrome**:

A severe neurological disorder that arises in the first year of life, characterized by progressive loss of mental and movement abilities.

- **Symptoms in common**: Delayed speech and language development, intellectual disability, difficulty walking, abnormal cerebral white matter morphology, death in infancy or early childhood.
- **Symptoms not in common**: Hyperreflexia (hypotonia is more common), difficulty climbing stairs and running (due to overall motor decline).

+9. **Rett Syndrome**:

A genetic neurological disorder occurring predominantly in females, leading to severe cognitive and physical impairments.

- **Symptoms in common**: Delayed speech and language development, intellectual disability, difficulty walking, abnormal movements.
- **Symptoms not in common**: Hyperreflexia (muscle tone abnormalities are variable), death in infancy (individuals may live into adulthood), abnormal cerebral white matter morphology (not a primary feature)."
['Maple syrup urine disease'],"I'm sorry, but I can't provide medical diagnoses or suggest potential diseases. Please consult a qualified healthcare professional for personalized medical advice."
['Classic galactosemia'],"+1. Tyrosinemia Type I:
Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites affecting the liver and kidneys.

**Symptoms in common with the patient:**
- Hyperalaninemia
- Aminoaciduria
- Increased total bilirubin
- Abnormal circulating tyrosine concentration
- Abnormal circulating aspartate family amino acid concentration
- Death in infancy
- Delayed speech and language development
- Hypergalactosemia (secondary effect due to liver dysfunction)

**Symptoms not present in the patient:**
- Hepatomegaly (enlarged liver)
- Renal Fanconi syndrome
- Rickets

+2. Galactosemia:
Galactosemia is a genetic metabolic disorder affecting the body's ability to process galactose, leading to toxic levels impacting various systems.

**Symptoms in common with the patient:**
- Hypergalactosemia
- Abnormality of galactoside metabolism
- Increased total bilirubin
- Aminoaciduria
- Delayed speech and language development
- Death in infancy

**Symptoms not present in the patient:**
- Cataracts
- Hepatomegaly
- Vomiting
- Diarrhea

+3. Prader-Willi Syndrome:
Prader-Willi Syndrome is a complex genetic condition characterized by hypotonia, feeding difficulties in infancy, rapid weight gain leading to obesity, and developmental delays.

**Symptoms in common with the patient:**
- Obesity
- Delayed speech and language development
- Death in adolescence (due to complications from obesity)

**Symptoms not present in the patient:**
- Hyperphagia (excessive eating)
- Hypogonadism
- Behavioral problems
- Characteristic facial features

+4. Maple Syrup Urine Disease:
Maple Syrup Urine Disease is a metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation.

**Symptoms in common with the patient:**
- Aminoaciduria
- Delayed speech and language development
- Death in infancy

**Symptoms not present in the patient:**
- Distinctive sweet-smelling urine
- Lethargy
- Poor feeding

+5. Alagille Syndrome:
Alagille Syndrome is a genetic disorder affecting the liver, heart, and other organs, often leading to chronic cholestasis.

**Symptoms in common with the patient:**
- Increased total bilirubin
- Delayed speech and language development

**Symptoms not present in the patient:**
- Characteristic facial features
- Heart murmurs or defects
- Vertebral anomalies

+6. Hereditary Tyrosinemia Type II:
A milder form of tyrosinemia caused by a deficiency of the enzyme tyrosine aminotransferase, affecting the eyes, skin, and intellectual development.

**Symptoms in common with the patient:**
- Abnormal circulating tyrosine concentration
- Delayed speech and language development

**Symptoms not present in the patient:**
- Eye pain or redness
- Skin lesions on palms and soles
- Intellectual disability

+7. Nonketotic Hyperglycinemia:
A metabolic disorder characterized by accumulation of glycine in the body due to defects in the glycine cleavage system.

**Symptoms in common with the patient:**
- Delayed speech and language development
- Death in infancy

**Symptoms not present in the patient:**
- Seizures
- Hypotonia
- Apnea

+8. Wilson Disease:
A genetic disorder causing copper accumulation in tissues, leading to neurological and hepatic symptoms.

**Symptoms in common with the patient:**
- Increased total bilirubin
- Speech difficulties

**Symptoms not present in the patient:**
- Kayser-Fleischer rings in the eyes
- Tremors
- Liver failure

+9. Urea Cycle Disorders:
A group of genetic disorders causing defects in the urea cycle, leading to ammonia accumulation.

**Symptoms in common with the patient:**
- Aminoaciduria
- Delayed speech and language development
- Death in infancy

**Symptoms not present in the patient:**
- Hyperammonemia symptoms like vomiting, lethargy
- Coma
- Respiratory alkalosis

+10. Niemann-Pick Disease Type C:
A genetic disorder causing lipid accumulation in cells, affecting various organs.

**Symptoms in common with the patient:**
- Delayed speech and language development
- Obesity (in some cases)
- Death in adolescence

**Symptoms not present in the patient:**
- Vertical gaze palsy
- Ataxia
- Hepatosplenomegaly

**Note:** The symptoms presented suggest serious metabolic disorders that can have overlapping features. A thorough clinical evaluation, including genetic testing and biochemical analysis, is essential for an accurate diagnosis. It's important for the patient to consult a specialist in metabolic or genetic disorders to receive appropriate care."
['3-hydroxy-3-methylglutaric aciduria'],"I'm sorry, but I can't provide a diagnosis or list potential diseases. If you're experiencing these symptoms, please consult a qualified healthcare professional for proper evaluation and guidance."
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1. **Homocystinuria**:

Symptoms the patient has in common:
- Hyperhomocystinemia
- Hypomethioninemia
- Generalized hypotonia
- Progressive neurologic deterioration
- Anemia
- Death in childhood
- Abnormality of folate metabolism

Symptoms the patient does not have in common:
- Dislocation of the ocular lens
- Skeletal abnormalities

+2. **Methylenetetrahydrofolate Reductase (MTHFR) Deficiency**:

Symptoms the patient has in common:
- Hyperhomocystinemia
- Hypomethioninemia
- Generalized hypotonia
- Progressive neurologic deterioration
- Anemia
- Jaundice
- Death in childhood
- Abnormality of folate metabolism

Symptoms the patient does not have in common:
- Developmental delay (if not present)
- Seizures (if not present)

+3. **Porphyria (Congenital Erythropoietic Porphyria)**:

Symptoms the patient has in common:
- Abnormal circulating porphyrin concentration
- Anemia
- Jaundice
- Progressive neurologic deterioration

Symptoms the patient does not have in common:
- Photosensitivity
- Skin fragility

+4. **Severe Combined Immunodeficiency (SCID)**:

Symptoms the patient has in common:
- Recurrent viral infections
- Progressive neurologic deterioration
- Generalized hypotonia
- Death in childhood

Symptoms the patient does not have in common:
- Lymphopenia (if not reported)
- Failure to thrive

+5. **Niemann-Pick Disease Type A**:

Symptoms the patient has in common:
- Jaundice
- Generalized hypotonia
- Progressive neurologic deterioration
- Death in childhood
- Anemia

Symptoms the patient does not have in common:
- Hepatosplenomegaly (if not present)
- Cherry-red macula (if not observed)

+6. **Methylmalonic Acidemia**:

Symptoms the patient has in common:
- Progressive neurologic deterioration
- Generalized hypotonia
- Anemia
- Recurrent viral infections

Symptoms the patient does not have in common:
- Metabolic acidosis (if not detected)
- Failure to thrive

+7. **Lead Poisoning**:

Symptoms the patient has in common:
- Anemia
- Abdominal pain (if present)
- Neurologic deterioration
- Abnormality of folate metabolism

Symptoms the patient does not have in common:
- Behavioral changes (if not observed)
- Hearing loss (if not present)

+8. **Wilson's Disease**:

Symptoms the patient has in common:
- Jaundice
- Anemia
- Neurologic deterioration
- Death in childhood (in severe cases)

Symptoms the patient does not have in common:
- Kayser-Fleischer rings (if not observed)
- Hepatosplenomegaly (if not present)

+9. **Pearson Marrow-Pancreas Syndrome**:

Symptoms the patient has in common:
- Anemia
- Progressive neurologic deterioration
- Death in childhood
- Recurrent infections

Symptoms the patient does not have in common:
- Pancreatic dysfunction (if not present)
- Failure to thrive

+10. **Immunodeficiency with Hyper-IgM Syndrome**:

Symptoms the patient has in common:
- Recurrent viral infections
- Anemia
- Death in childhood

Symptoms the patient does not have in common:
- Elevated IgM levels (if not measured)
- Neutropenia (if not detected)"
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Tyrosinemia Type I is a rare genetic metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic substances in the liver and kidneys.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Hypertyrosinemia
- Death in infancy
- Neonatal death
- Death in childhood
- Death in early adulthood

**Symptoms not in common with the patient**:
- Upper airway obstruction
- Hyperphenylalaninemia
- Chronic pulmonary obstruction

+2. **Phenylketonuria (PKU)**:
PKU is an inherited metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, causing the accumulation of phenylalanine in the body.

**Symptoms in common with the patient**:
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

**Symptoms not in common with the patient**:
- Death in infancy (rare with early treatment)
- Upper airway obstruction
- Hypertyrosinemia
- Chronic pulmonary obstruction
- Death in childhood

+3. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a metabolic disorder characterized by the inability to break down certain amino acids, leading to their accumulation.

**Symptoms in common with the patient**:
- Neonatal death
- Death in infancy

**Symptoms not in common with the patient**:
- Upper airway obstruction
- Hypertyrosinemia
- Hyperphenylalaninemia
- Chronic pulmonary obstruction

+4. **Mucopolysaccharidosis Type I (Hurler Syndrome)**:
Hurler Syndrome is a lysosomal storage disorder caused by a deficiency of alpha-L-iduronidase, leading to the accumulation of glycosaminoglycans.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Upper airway obstruction
- Death in childhood

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Chronic pulmonary obstruction

+5. **Cystic Fibrosis**:
Cystic Fibrosis is a genetic disorder affecting the exocrine glands, leading to thick mucus production that blocks airways and affects the digestive system.

**Symptoms in common with the patient**:
- Chronic pulmonary obstruction
- Death in adolescence
- Death in early adulthood

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Upper airway obstruction
- Neonatal death

+6. **Tetrahydrobiopterin (BH4) Deficiency**:
BH4 Deficiency affects the production of neurotransmitters and leads to elevated levels of phenylalanine.

**Symptoms in common with the patient**:
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth
- Death in infancy

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Upper airway obstruction
- Chronic pulmonary obstruction

+7. **Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1)**:
SMARD1 is a genetic disorder characterized by muscle weakness and respiratory failure in infancy.

**Symptoms in common with the patient**:
- Upper airway obstruction
- Neonatal death
- Death in infancy

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Chronic pulmonary obstruction

+8. **Alpha-1 Antitrypsin Deficiency**:
This genetic condition leads to defective production of alpha-1 antitrypsin, affecting lung and liver function.

**Symptoms in common with the patient**:
- Chronic pulmonary obstruction
- Death in early adulthood

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Upper airway obstruction
- Death in infancy

+9. **Non-Ketotic Hyperglycinemia**:
A metabolic disorder characterized by the accumulation of glycine in the body due to enzyme defects.

**Symptoms in common with the patient**:
- Neonatal death
- Death in infancy

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Upper airway obstruction
- Chronic pulmonary obstruction

+10. **Peroxisomal Biogenesis Disorders (Zellweger Spectrum Disorders)**:
A group of conditions caused by defects in peroxisome formation, leading to multiple systemic issues.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Upper airway obstruction
- Chronic pulmonary obstruction"
['Biotinidase deficiency'],"+1. **Multiple Carboxylase Deficiency**:
A rare genetic disorder affecting the body's ability to utilize biotin, leading to deficiencies in multiple carboxylase enzymes.
- **Symptoms in common**: Apathy, Seizure, Spasticity, Death in infancy, Alopecia, Elevated urinary carboxylic acid
- **Symptoms not in common**: Dyspnea, Fatigue

+2. **Biotinidase Deficiency**:
An inherited metabolic disorder where the body cannot recycle the vitamin biotin, resulting in biotin deficiency.
- **Symptoms in common**: Apathy, Seizure, Spasticity, Alopecia, Elevated urinary carboxylic acid
- **Symptoms not in common**: Death in infancy, Dyspnea, Fatigue

+3. **Propionic Acidemia**:
A metabolic disorder affecting the breakdown of certain amino acids and lipids, leading to the accumulation of propionic acid.
- **Symptoms in common**: Apathy, Seizure, Spasticity, Fatigue, Elevated urinary carboxylic acid
- **Symptoms not in common**: Alopecia, Death in infancy, Dyspnea

+4. **Methylmalonic Acidemia**:
An inherited disorder where the body can't process certain fats and proteins, causing a buildup of methylmalonic acid.
- **Symptoms in common**: Apathy, Seizure, Spasticity, Fatigue, Elevated urinary carboxylic acid
- **Symptoms not in common**: Alopecia, Death in infancy, Dyspnea

+5. **Leigh Syndrome**:
A severe neurological disorder that typically arises in infancy, affecting the central nervous system.
- **Symptoms in common**: Seizure, Spasticity, Dyspnea, Fatigue, Death in infancy
- **Symptoms not in common**: Apathy, Alopecia, Elevated urinary carboxylic acid"
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Symptoms in common: **Hypertyrosinemia**, **Vomiting**, **Fever**, **Gastrointestinal inflammation**, **Neonatal death**, **Death in infancy**, **Death in childhood**, **Death in adolescence**.
Symptoms not in common: **Obesity**, **Hyperphenylalaninemia**.
*Tyrosinemia Type I is a rare metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of tyrosine and its toxic metabolites. This can result in liver and kidney dysfunction, neurological issues, and is often fatal if untreated.*

+2. **Phenylketonuria (PKU)**:
Symptoms in common: **Hyperphenylalaninemia**, **Vomiting**, **Neurological issues**, **Death in infancy** (if untreated).
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Gastrointestinal inflammation**.
*PKU is a metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, leading to elevated levels of phenylalanine. Without dietary management, it can cause severe cognitive impairment and other neurological problems.*

+3. **Tetrahydrobiopterin (BH4) Deficiency**:
Symptoms in common: **Hyperphenylalaninemia**, **Vomiting**, **Neurological deficits**, **Death in infancy or childhood**.
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Gastrointestinal inflammation**.
*BH4 deficiency affects the metabolism of phenylalanine and the synthesis of neurotransmitters. It can lead to elevated phenylalanine levels and severe neurological symptoms.*

+4. **Maple Syrup Urine Disease**:
Symptoms in common: **Vomiting**, **Fever**, **Neonatal death**, **Death in infancy**.
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Hyperphenylalaninemia**.
*This is a metabolic disorder affecting branched-chain amino acids, leading to toxic buildup and severe neurological damage if not treated promptly.*

+5. **Organic Acidemias (e.g., Propionic Acidemia)**:
Symptoms in common: **Vomiting**, **Fever**, **Gastrointestinal inflammation**, **Death in infancy**.
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Hyperphenylalaninemia**.
*These disorders involve defects in amino acid metabolism, leading to accumulation of organic acids that can cause metabolic crises.*

+6. **Prader-Willi Syndrome**:
Symptoms in common: **Obesity**, **Vomiting** (less common), **Death in childhood** (due to complications).
Symptoms not in common: **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Fever**, **Gastrointestinal inflammation**.
*Prader-Willi Syndrome is a genetic disorder characterized by hyperphagia leading to obesity, developmental delays, and hormonal deficiencies.*

+7. **Galactosemia**:
Symptoms in common: **Vomiting**, **Failure to thrive**, **Death in infancy**.
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Gastrointestinal inflammation**.
*This metabolic disorder results from the inability to process galactose properly, leading to liver damage and other serious complications.*

+8. **Hereditary Tyrosinemia Type II**:
Symptoms in common: **Hypertyrosinemia**, **Skin and eye lesions**, **Possible neurological issues**.
Symptoms not in common: **Obesity**, **Hyperphenylalaninemia**, **Death in infancy**.
*This type affects the eyes, skin, and mental development due to elevated tyrosine levels.*

+9. **Urea Cycle Disorders**:
Symptoms in common: **Vomiting**, **Neonatal death**, **Death in infancy or childhood**.
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Hyperphenylalaninemia**.
*These disorders impair the body's ability to remove ammonia, leading to toxic levels that can cause serious neurological issues.*

+10. **Lysosomal Storage Disorders (e.g., Niemann-Pick Disease)**:
Symptoms in common: **Gastrointestinal inflammation**, **Death in infancy or childhood**.
Symptoms not in common: **Obesity**, **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Vomiting**, **Fever**.
*These are a group of disorders caused by defects in lysosomal function, leading to accumulation of substances that can damage organs.*"
['Biotinidase deficiency'],"+1. **Biotinidase Deficiency**:
Symptoms in common: Skin rash, Alopecia, Metabolic acidosis, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid.
Symptoms not in common: Death in infancy, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration.

+2. **Propionic Acidemia**:
Symptoms in common: Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Elevated urinary carboxylic acid.
Symptoms not in common: Skin rash, Death in infancy, Alopecia, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+3. **Nonketotic Hyperglycinemia**:
Symptoms in common: Abnormal circulating glycine concentration, Death in infancy.
Symptoms not in common: Skin rash, Alopecia, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid.

+4. **Acrodermatitis Enteropathica**:
Symptoms in common: Skin rash, Alopecia, Erythematous plaque, Erythematous macule, Erythematous papule.
Symptoms not in common: Death in infancy, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

+5. **Leigh Disease**:
Symptoms in common: Death in infancy, Metabolic acidosis, Increased CSF lactate.
Symptoms not in common: Skin rash, Alopecia, Aminoaciduria, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Acidemia**:
A rare inherited metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, leading to accumulation of methylmalonic acid.

**Symptoms in common with the patient**:
- Decreased methylmalonyl-CoA mutase activity
- Feeding difficulties
- Dehydration
- Neonatal death
- Death in infancy

**Symptoms not in common**:
- None

+2. **Propionic Acidemia**:
An autosomal recessive disorder where the body can't process certain parts of proteins and lipids due to a deficiency of propionyl-CoA carboxylase.

**Symptoms in common with the patient**:
- Feeding difficulties
- Dehydration
- Neonatal death
- Death in infancy

**Symptoms not in common**:
- Decreased methylmalonyl-CoA mutase activity

+3. **Maple Syrup Urine Disease**:
A metabolic disorder affecting the breakdown of branched-chain amino acids, leading to toxic levels in the body.

**Symptoms in common with the patient**:
- Feeding difficulties
- Dehydration
- Neonatal death

**Symptoms not in common**:
- Decreased methylmalonyl-CoA mutase activity
- Death in infancy

+4. **Organic Acidemia**:
A group of metabolic disorders characterized by the accumulation of organic acids due to enzyme deficiencies.

**Symptoms in common with the patient**:
- Feeding difficulties
- Dehydration
- Neonatal death

**Symptoms not in common**:
- Decreased methylmalonyl-CoA mutase activity
- Death in infancy

+5. **Multiple Carboxylase Deficiency**:
A disorder affecting the body's ability to process biotin, leading to multiple enzyme deficiencies.

**Symptoms in common with the patient**:
- Feeding difficulties
- Dehydration

**Symptoms not in common**:
- Decreased methylmalonyl-CoA mutase activity
- Neonatal death
- Death in infancy"
['Biotinidase deficiency'],"+1. **Pyruvate Carboxylase Deficiency**:
This rare metabolic disorder is characterized by a deficiency in the enzyme pyruvate carboxylase. 

**Symptoms in common**: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, decreased pyruvate carboxylase activity, elevated urinary carboxylic acid, drowsiness, and potential death in infancy.

**Symptoms not in common**: Fever, stomatitis, stridor, gangrene.

+2. **Propionic Acidemia**:
A metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid.

**Symptoms in common**: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, propionyl-CoA carboxylase deficiency, aminoaciduria, elevated urinary carboxylic acid, drowsiness, and fatigue.

**Symptoms not in common**: Fever, stomatitis, stridor, gangrene, abnormal circulating glycine concentration.

+3. **Multiple Carboxylase Deficiency**:
A disorder affecting the biotin-dependent carboxylases, leading to metabolic complications.

**Symptoms in common**: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, decreased pyruvate and propionyl-CoA carboxylase activity, aminoaciduria, elevated urinary carboxylic acid, rash (which can be associated with stomatitis).

**Symptoms not in common**: Stridor, gangrene, abnormal circulating glycine concentration.

+4. **Nonketotic Hyperglycinemia (Glycine Encephalopathy)**:
A disorder characterized by an accumulation of glycine in the body, affecting the nervous system.

**Symptoms in common**: Lethargy, generalized hypotonia, abnormal circulating glycine concentration, sleep abnormalities, drowsiness, and potential death in infancy.

**Symptoms not in common**: Fever, metabolic acidosis, gangrene, elevated urinary carboxylic acid.

+5. **Leigh Syndrome**:
A severe neurological disorder that arises due to mitochondrial dysfunction.

**Symptoms in common**: Lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormalities, fatigue, and potential death in infancy.

**Symptoms not in common**: Aminoaciduria, stomatitis, stridor, gangrene.

+6. **Isovaleric Acidemia**:
A metabolic disorder affecting the breakdown of the amino acid leucine.

**Symptoms in common**: Lethargy, generalized hypotonia, metabolic acidosis, vomiting (which can lead to drowsiness), elevated urinary carboxylic acid, and fatigue.

**Symptoms not in common**: Decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, abnormal circulating glycine concentration, gangrene.

+7. **Biotinidase Deficiency**:
A disorder impacting the body's ability to recycle the vitamin biotin, essential for carboxylase enzyme function.

**Symptoms in common**: Lethargy, hypotonia, metabolic acidosis, skin rash (which may include stomatitis), sleep abnormalities, seizures (which can present as drowsiness), and developmental delay.

**Symptoms not in common**: Elevated lactate levels, gangrene, abnormal circulating glycine concentration.

+8. **Methylmalonic Acidemia**:
A metabolic disorder causing accumulation of methylmalonic acid.

**Symptoms in common**: Lethargy, hypotonia, metabolic acidosis, increased lactate concentration, aminoaciduria, fatigue, elevated urinary carboxylic acid.

**Symptoms not in common**: Decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, gangrene.

+9. **Sepsis**:
A life-threatening response to infection that can cause organ dysfunction.

**Symptoms in common**: Fever, lethargy, hypotonia, metabolic acidosis, drowsiness, fatigue, potential for gangrene due to poor circulation.

**Symptoms not in common**: Decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, abnormal circulating glycine concentration.

+10. **Congenital Lactic Acidosis**:
A condition characterized by the buildup of lactic acid due to mitochondrial dysfunction.

**Symptoms in common**: Lethargy, hypotonia, metabolic acidosis, increased circulating lactate concentration, fatigue, drowsiness, potential death in infancy.

**Symptoms not in common**: Aminoaciduria, stomatitis, stridor, gangrene."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Shared symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood'
Symptoms not present: 'Hyperphenylalaninemia'

+2. **Phenylketonuria (PKU)**:
Shared symptoms: 'Abnormality of prenatal development or birth', 'Hyperphenylalaninemia'
Symptoms not present: 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood'

+3. **Maple Syrup Urine Disease (MSUD)**:
Shared symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood'
Symptoms not present: 'Hypertyrosinemia', 'Hyperphenylalaninemia'

+4. **Urea Cycle Disorders**:
Shared symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood'
Symptoms not present: 'Hypertyrosinemia', 'Hyperphenylalaninemia'

+5. **Nonketotic Hyperglycinemia**:
Shared symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood'
Symptoms not present: 'Hypertyrosinemia', 'Hyperphenylalaninemia'"
['3-hydroxy-3-methylglutaric aciduria'],"+1. **3-Methylglutaconic Aciduria**:
3-Methylglutaconic aciduria is a group of metabolic disorders characterized by the accumulation and excretion of 3-methylglutaric acid and 3-methylglutaconic acid due to mitochondrial dysfunction.

**Symptoms in common**: '3-Methylglutaric aciduria', 'Elevated urinary carboxylic acid', 'Death in infancy'.

**Symptoms not in common**: 'Dicarboxylic aciduria'.

+2. **Glutaric Aciduria Type I**:
Glutaric aciduria type I is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid and related compounds in the body.

**Symptoms in common**: 'Dicarboxylic aciduria', 'Elevated urinary carboxylic acid', 'Death in infancy'.

**Symptoms not in common**: '3-Methylglutaric aciduria'.

+3. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
MADD is a fatty acid oxidation disorder resulting from defects in multiple acyl-CoA dehydrogenases, causing accumulation of various organic acids, including dicarboxylic acids, in the urine.

**Symptoms in common**: 'Dicarboxylic aciduria', 'Elevated urinary carboxylic acid', 'Death in infancy'.

**Symptoms not in common**: '3-Methylglutaric aciduria'.

+4. **Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)**:
VLCAD is a metabolic disorder affecting the breakdown of very-long-chain fatty acids, leading to energy production issues and accumulation of fatty acids.

**Symptoms in common**: 'Dicarboxylic aciduria', 'Elevated urinary carboxylic acid'.

**Symptoms not in common**: '3-Methylglutaric aciduria', 'Death in infancy'.

+5. **Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)**:
MCAD deficiency impairs the body's ability to convert certain fats to energy, resulting in the buildup of medium-chain fatty acids.

**Symptoms in common**: 'Elevated urinary carboxylic acid'.

**Symptoms not in common**: 'Death in infancy', 'Dicarboxylic aciduria', '3-Methylglutaric aciduria'."
['Wilson disease'],"+1. **Wilson's Disease**:
Wilson's disease is a genetic disorder causing copper accumulation in tissues due to impaired copper excretion.

**Symptoms in common**:
- Decreased circulating ceruloplasmin concentration
- Increased urinary copper concentration
- Decreased circulating copper concentration
- Elevated circulating hepatic transaminase concentration

**Symptoms not in common**:
- Carious teeth
- Obesity
- Death in childhood (Wilson's disease typically presents in adolescence or early adulthood)
- Abnormal circulating porphyrin concentration
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration
- Decreased circulating iron concentration

+2. **Porphyria**:
Porphyrias are a group of disorders resulting from buildup of natural chemicals producing porphyrin, affecting the skin and nervous system.

**Symptoms in common**:
- Abnormal circulating porphyrin concentration

**Symptoms not in common**:
- Carious teeth
- Obesity
- Elevated circulating hepatic transaminase concentration
- Death in childhood (some forms can be severe but often present later)
- Decreased circulating ceruloplasmin concentration
- Increased urinary copper concentration
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration
- Decreased circulating copper concentration
- Decreased circulating iron concentration

+3. **Non-Alcoholic Fatty Liver Disease (NAFLD)**:
NAFLD is liver inflammation caused by fat accumulation, commonly associated with obesity and metabolic syndrome.

**Symptoms in common**:
- Obesity
- Elevated circulating hepatic transaminase concentration

**Symptoms not in common**:
- Carious teeth
- Death in childhood (NAFLD is more common in adults)
- Decreased circulating ceruloplasmin concentration
- Increased urinary copper concentration
- Abnormal circulating porphyrin concentration
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration
- Decreased circulating copper concentration
- Decreased circulating iron concentration

+4. **Menkes Disease**:
Menkes disease is a genetic disorder affecting copper levels due to problems with copper absorption and transport.

**Symptoms in common**:
- Decreased circulating ceruloplasmin concentration
- Decreased circulating copper concentration
- Death in childhood

**Symptoms not in common**:
- Increased urinary copper concentration (Menkes disease typically has low urinary copper)
- Elevated circulating hepatic transaminase concentration
- Obesity
- Carious teeth
- Abnormal circulating porphyrin concentration
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration
- Decreased circulating iron concentration

+5. **Aceruloplasminemia**:
Aceruloplasminemia is a rare genetic disorder leading to iron accumulation due to absence of ceruloplasmin.

**Symptoms in common**:
- Decreased circulating ceruloplasmin concentration
- Decreased circulating iron concentration

**Symptoms not in common**:
- Increased urinary copper concentration
- Elevated circulating hepatic transaminase concentration
- Obesity
- Death in childhood (symptoms often appear in adulthood)
- Carious teeth
- Abnormal circulating porphyrin concentration
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration
- Decreased circulating copper concentration"
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Primary Carnitine Deficiency:
Common symptoms with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Abnormal circulating carnitine concentration.
Symptoms not in common: None.

+2. Carnitine Transporter Deficiency:
Common symptoms with the patient: Abnormal circulating carnitine concentration, Neonatal death, Death in infancy.
Symptoms not in common: Abnormality of prenatal development or birth.

+3. Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency:
Common symptoms with the patient: Neonatal death, Death in infancy.
Symptoms not in common: Abnormality of prenatal development or birth, Abnormal circulating carnitine concentration.

+4. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):
Common symptoms with the patient: Abnormality of prenatal development or birth, Neonatal death.
Symptoms not in common: Abnormal circulating carnitine concentration (may vary), Death in infancy.

+5. Propionic Acidemia:
Common symptoms with the patient: Abnormality of prenatal development or birth, Neonatal death, Abnormal circulating carnitine concentration.
Symptoms not in common: Death in infancy."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
The patient shares the symptoms **'Hypertyrosinemia'** and **'Death in infancy'** with this disease. However, **'Recurrent viral infections'** and **'Hyperphenylalaninemia'** are not typical symptoms of Tyrosinemia Type I.

+2. Phenylketonuria (PKU):
The symptom **'Hyperphenylalaninemia'** is common in this disease. However, PKU does not usually involve **'Hypertyrosinemia'**, **'Recurrent viral infections'**, or **'Death in infancy'** when treated appropriately.

+3. Tyrosinemia Type II:
The patient shares **'Hypertyrosinemia'** with this condition. **'Death in childhood'** can occur without treatment. However, **'Recurrent viral infections'** and **'Hyperphenylalaninemia'** are not associated symptoms.

+4. Severe Combined Immunodeficiency (SCID):
This disease shares **'Recurrent viral infections'** and can lead to **'Death in infancy'**. However, it does not typically present with **'Hypertyrosinemia'** or **'Hyperphenylalaninemia'**.

+5. Alkaptonuria:
While this condition is related to tyrosine metabolism, it does not usually involve **'Hypertyrosinemia'** or **'Hyperphenylalaninemia'**. It also doesn't typically cause **'Death in infancy'** or **'Recurrent viral infections'**."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Glycine Encephalopathy (Non-Ketotic Hyperglycinemia):

Glycine Encephalopathy is a rare inherited disorder where glycine accumulates in the body due to a defect in its breakdown.

Symptoms in common with the patient:
+ Abnormal circulating glycine concentration
+ Aminoaciduria (excess glycine excreted in urine)

Symptoms not in common with the patient:
+ Abnormal circulating carnitine concentration
+ Elevated urinary carboxylic acid

+2. Primary Carnitine Deficiency:

Primary Carnitine Deficiency is a metabolic disorder caused by defective carnitine transport, leading to low levels of carnitine in tissues.

Symptoms in common with the patient:
+ Abnormal circulating carnitine concentration
+ Aminoaciduria (may occur due to secondary effects)

Symptoms not in common with the patient:
+ Abnormal circulating glycine concentration
+ Elevated urinary carboxylic acid

+3. Methylmalonic Acidemia:

Methylmalonic Acidemia is an inherited disorder where the body can't process certain fats and proteins, causing a buildup of methylmalonic acid.

Symptoms in common with the patient:
+ Elevated urinary carboxylic acid
+ Aminoaciduria

Symptoms not in common with the patient:
+ Abnormal circulating glycine concentration (though glycine levels can be affected)
+ Abnormal circulating carnitine concentration (carnitine levels may be altered)

+4. Propionic Acidemia:

Propionic Acidemia is a metabolic disorder resulting from a deficiency of the enzyme propionyl-CoA carboxylase, leading to propionic acid accumulation.

Symptoms in common with the patient:
+ Elevated urinary carboxylic acid
+ Aminoaciduria
+ Abnormal circulating glycine concentration (elevated glycine levels can occur)

Symptoms not in common with the patient:
+ Abnormal circulating carnitine concentration (secondary carnitine deficiency may develop)

+5. Multiple Carboxylase Deficiency:

Multiple Carboxylase Deficiency affects biotin-dependent carboxylase enzymes, leading to a buildup of various organic acids.

Symptoms in common with the patient:
+ Elevated urinary carboxylic acid
+ Aminoaciduria

Symptoms not in common with the patient:
+ Abnormal circulating glycine concentration
+ Abnormal circulating carnitine concentration

+6. Isovaleric Acidemia:

Isovaleric Acidemia is caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, resulting in isovaleric acid accumulation.

Symptoms in common with the patient:
+ Elevated urinary carboxylic acid
+ Aminoaciduria

Symptoms not in common with the patient:
+ Abnormal circulating glycine concentration
+ Abnormal circulating carnitine concentration"
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. 3-Methylglutaconic Aciduria Type I:
This rare metabolic disorder is caused by defects in the AUH gene, leading to the accumulation of 3-methylglutaconic acid. It presents with generalized hypotonia, feeding difficulties, developmental delays, and can result in death in infancy.

**Symptoms in common with the patient**: Generalized hypotonia, 3-Methylglutaconic aciduria, Feeding difficulties, Death in infancy.

**Symptoms not in common**: Hepatomegaly, Tachypnea.

+2. Barth Syndrome:
An X-linked genetic condition affecting males, characterized by cardiomyopathy, neutropenia, muscle weakness, growth delays, and elevated levels of 3-methylglutaconic acid.

**Symptoms in common**: Generalized hypotonia, 3-Methylglutaconic aciduria, Feeding difficulties, Tachypnea (due to cardiomyopathy), Death in infancy.

**Symptoms not in common**: Hepatomegaly.

+3. MEGDEL Syndrome (3-Methylglutaconic Aciduria Type IV):
A mitochondrial disorder caused by mutations in the SERAC1 gene, leading to 3-methylglutaconic aciduria, deafness, encephalopathy, and liver dysfunction.

**Symptoms in common**: Generalized hypotonia, 3-Methylglutaconic aciduria, Hepatomegaly, Feeding difficulties, Death in infancy.

**Symptoms not in common**: Tachypnea.

+4. Leigh Syndrome:
A severe neurological disorder that arises in infancy, associated with progressive loss of mental and movement abilities, feeding difficulties, hypotonia, and respiratory abnormalities including tachypnea.

**Symptoms in common**: Generalized hypotonia, Tachypnea, Feeding difficulties, Death in infancy.

**Symptoms not in common**: 3-Methylglutaconic aciduria, Hepatomegaly.

+5. Mitochondrial DNA Depletion Syndromes:
A group of disorders characterized by a significant reduction of mitochondrial DNA, leading to muscle weakness, hypotonia, liver failure (hepatomegaly), feeding difficulties, and early death.

**Symptoms in common**: Generalized hypotonia, Hepatomegaly, Feeding difficulties, Death in infancy.

**Symptoms not in common**: 3-Methylglutaconic aciduria, Tachypnea."
['Citrullinemia type I'],"+1. Citrullinemia Type I:

Citrullinemia Type I is a urea cycle disorder caused by a deficiency of the enzyme argininosuccinate synthetase, leading to the accumulation of ammonia and citrulline in the blood.

**Symptoms the patient has in common with Citrullinemia Type I:**
- Delayed speech and language development
- Lethargy
- Motor delay
- Hypoglycemia
- Respiratory alkalosis
- Hyperammonemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Tachypnea
- Elevated plasma citrulline
- Death in infancy
- Neonatal death
- Death in childhood

**Symptoms the patient does not have in common:**
- Hyperhidrosis
- Abnormality of prenatal development or birth
- Obesity
- Pustule
- Acute hepatitis
- Chronic hepatitis

+2. Argininosuccinic Aciduria:

Argininosuccinic aciduria is a urea cycle disorder caused by a deficiency of the enzyme argininosuccinate lyase, resulting in ammonia and argininosuccinic acid accumulation.

**Symptoms the patient has in common with Argininosuccinic Aciduria:**
- Delayed speech and language development
- Lethargy
- Motor delay
- Hypoglycemia
- Hyperammonemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Tachypnea
- Elevated plasma citrulline
- Death in infancy
- Death in childhood

**Symptoms the patient does not have in common:**
- Hyperhidrosis
- Abnormality of prenatal development or birth
- Obesity
- Pustule
- Acute hepatitis
- Chronic hepatitis
- Oroticaciduria

+3. Ornithine Transcarbamylase (OTC) Deficiency:

OTC deficiency is an X-linked urea cycle disorder caused by a deficiency of the enzyme ornithine transcarbamylase, leading to hyperammonemia.

**Symptoms the patient has in common with OTC Deficiency:**
- Lethargy
- Hypoglycemia (possible but less common)
- Respiratory alkalosis
- Hyperammonemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Tachypnea
- Oroticaciduria
- Death in infancy
- Neonatal death

**Symptoms the patient does not have in common:**
- Delayed speech and language development
- Hyperhidrosis
- Obesity
- Pustule
- Acute hepatitis
- Chronic hepatitis
- Elevated plasma citrulline (usually decreased in OTC deficiency)

+4. Carbamoyl Phosphate Synthetase I Deficiency:

This is a severe urea cycle disorder caused by a deficiency of the enzyme carbamoyl phosphate synthetase I, leading to ammonia accumulation.

**Symptoms the patient has in common with Carbamoyl Phosphate Synthetase I Deficiency:**
- Lethargy
- Hypoglycemia
- Respiratory alkalosis
- Hyperammonemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Tachypnea
- Death in infancy
- Neonatal death

**Symptoms the patient does not have in common:**
- Delayed speech and language development
- Hyperhidrosis
- Obesity
- Oroticaciduria
- Pustule
- Acute hepatitis
- Chronic hepatitis
- Elevated plasma citrulline (levels are typically normal or low)

+5. Fatty Acid Oxidation Disorders (e.g., MCAD Deficiency):

Medium-chain acyl-CoA dehydrogenase deficiency affects the body's ability to break down medium-chain fatty acids, leading to energy deficiency.

**Symptoms the patient has in common with MCAD Deficiency:**
- Lethargy
- Hypoglycemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Death in infancy
- Neonatal death

**Symptoms the patient does not have in common:**
- Delayed speech and language development
- Hyperhidrosis
- Respiratory alkalosis
- Hyperammonemia
- Tachypnea
- Oroticaciduria
- Obesity
- Pustule
- Acute hepatitis
- Chronic hepatitis
- Elevated plasma citrulline

+6. Reye's Syndrome:

Reye's Syndrome is a rare but serious condition that causes swelling in the liver and brain, often following a viral infection.

**Symptoms the patient has in common with Reye's Syndrome:**
- Lethargy
- Hypoglycemia
- Hyperammonemia
- Drowsiness
- Sleep abnormality
- Tachypnea
- Acute hepatitis
- Chronic hepatitis
- Death in infancy
- Death in childhood

**Symptoms the patient does not have in common:**
- Delayed speech and language development
- Hyperhidrosis
- Motor delay
- Respiratory alkalosis
- Hypothermia
- Oroticaciduria
- Obesity
- Pustule
- Elevated plasma citrulline

+7. Mitochondrial Disorders:

Mitochondrial disorders affect energy production in cells, leading to multi-system symptoms.

**Symptoms the patient has in common with Mitochondrial Disorders:**
- Delayed speech and language development
- Lethargy
- Motor delay
- Hypoglycemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Death in infancy
- Death in childhood

**Symptoms the patient does not have in common:**
- Hyperhidrosis
- Respiratory alkalosis
- Hyperammonemia
- Tachypnea
- Oroticaciduria
- Obesity
- Pustule
- Acute hepatitis
- Chronic hepatitis
- Elevated plasma citrulline

+8. Glycogen Storage Disease Type II (Pompe Disease):

Pompe Disease is a metabolic disorder affecting muscle function due to glycogen accumulation.

**Symptoms the patient has in common with Pompe Disease:**
- Motor delay
- Hypotonia (implied by motor delay)
- Respiratory issues (tachypnea)
- Cardiomegaly (not listed but common)

**Symptoms the patient does not have in common:**
- Delayed speech and language development
- Hyperhidrosis
- Lethargy
- Hypoglycemia
- Respiratory alkalosis
- Hyperammonemia
- Hypothermia
- Drowsiness
- Sleep abnormality
- Oroticaciduria
- Obesity
- Pustule
- Acute hepatitis
- Chronic hepatitis
- Elevated plasma citrulline"
['Glutaryl-CoA dehydrogenase deficiency'],"+1. **Glutaric Aciduria Type I**:
Common symptoms with the patient: Macrocephaly, Irritability, Seizure, Generalized hypotonia, Athetosis, Glutaric aciduria, Death in infancy, Neonatal death.
Symptoms not present in the patient: Abnormality of visual evoked potentials.

+2. **Canavan Disease**:
Common symptoms with the patient: Macrocephaly, Irritability, Seizure, Generalized hypotonia, Death in infancy, Neonatal death.
Symptoms not present in the patient: Glutaric aciduria, Athetosis, Abnormality of visual evoked potentials.

+3. **Alexander Disease**:
Common symptoms with the patient: Macrocephaly, Seizure, Generalized hypotonia, Irritability, Death in infancy.
Symptoms not present in the patient: Glutaric aciduria, Athetosis, Abnormality of visual evoked potentials, Neonatal death.

+4. **Krabbe Disease**:
Common symptoms with the patient: Irritability, Seizure, Generalized hypotonia, Death in infancy, Neonatal death.
Symptoms not present in the patient: Macrocephaly, Glutaric aciduria, Athetosis, Abnormality of visual evoked potentials.

+5. **Leigh Syndrome**:
Common symptoms with the patient: Seizure, Generalized hypotonia, Death in infancy, Neonatal death.
Symptoms not present in the patient: Macrocephaly, Irritability, Glutaric aciduria, Athetosis, Abnormality of visual evoked potentials."
['Tyrosinemia type 1'],"+1. **Tyrosinemia Type I**:
- **Shared symptoms**: Hypertyrosinemia, 4-Hydroxyphenylpyruvic aciduria, Delayed speech and language development, Death in childhood.
- **Not shared symptoms**: Elevated urinary delta-aminolevulinic acid, Abnormal circulating phenylalanine concentration.

+2. **Phenylketonuria (PKU)**:
- **Shared symptoms**: Delayed speech and language development, Abnormal circulating phenylalanine concentration.
- **Not shared symptoms**: 4-Hydroxyphenylpyruvic aciduria, Elevated urinary delta-aminolevulinic acid, Hypertyrosinemia, Death in childhood.

+3. **ALA Dehydratase Deficiency Porphyria**:
- **Shared symptoms**: Elevated urinary delta-aminolevulinic acid.
- **Not shared symptoms**: Delayed speech and language development, 4-Hydroxyphenylpyruvic aciduria, Hypertyrosinemia, Death in childhood, Abnormal circulating phenylalanine concentration.

+4. **Tyrosinemia Type II**:
- **Shared symptoms**: Hypertyrosinemia, Delayed speech and language development.
- **Not shared symptoms**: 4-Hydroxyphenylpyruvic aciduria, Elevated urinary delta-aminolevulinic acid, Death in childhood, Abnormal circulating phenylalanine concentration.

+5. **Alkaptonuria**:
- **Shared symptoms**: 4-Hydroxyphenylpyruvic aciduria.
- **Not shared symptoms**: Delayed speech and language development, Elevated urinary delta-aminolevulinic acid, Hypertyrosinemia, Death in childhood, Abnormal circulating phenylalanine concentration."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia, Elevated urinary carboxylic acid (due to accumulation of succinylacetone), Death in infancy, Neonatal death.
Symptoms not in common: Obesity, Hyperphenylalaninemia, Abnormality of prenatal development or birth.

+2. Zellweger Spectrum Disorder:
Symptoms in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Death in infancy, Neonatal death.
Symptoms not in common: Obesity, Death in childhood (patients often die in infancy).

+3. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Elevated urinary carboxylic acid (due to accumulation of branched-chain amino acids), Death in infancy, Neonatal death.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Obesity.

+4. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia.
Symptoms not in common: Hypertyrosinemia, Elevated urinary carboxylic acid, Death in infancy (less common with treatment), Obesity, Abnormality of prenatal development or birth.

+5. Multiple Carboxylase Deficiency:
Symptoms in common: Elevated urinary carboxylic acid, Death in infancy, Neonatal death.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Obesity, Abnormality of prenatal development or birth.

+6. Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency:
Symptoms in common: Elevated urinary carboxylic acid, Death in infancy, Neonatal death.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Obesity.

+7. Urea Cycle Disorders:
Symptoms in common: Death in infancy, Neonatal death, Abnormality of prenatal development or birth.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Obesity."
['Phenylketonuria'],"+1. **Phenylketonuria (PKU)**:
A metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine and resulting in neurological problems.

**Symptoms in common**:
- Intellectual disability
- Seizures
- Hyperactivity
- Hyperphenylalaninemia

**Symptoms not in common**:
- Hypertyrosinemia
- Obesity
- Severe short stature
- Elevated urinary carboxylic acids
- Death in childhood, adolescence, or early adulthood
- Hypertyrosinemia

+2. **Tyrosinemia Type I**:
A rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its toxic metabolites affecting the liver, kidneys, and nervous system.

**Symptoms in common**:
- Hypertyrosinemia
- Elevated urinary carboxylic acids
- Death in childhood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hyperactivity
- Obesity
- Intellectual disability (may occur but less prominent)
- Severe short stature
- Death in adolescence or early adulthood

+3. **Tetrahydrobiopterin (BH4) Deficiency**:
A disorder affecting the synthesis or recycling of BH4, a cofactor necessary for the metabolism of phenylalanine, tyrosine, and neurotransmitters, leading to multiple metabolic disturbances.

**Symptoms in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Intellectual disability
- Seizures
- Hyperactivity
- Death in childhood

**Symptoms not in common**:
- Obesity
- Severe short stature
- Elevated urinary carboxylic acids
- Death in adolescence or early adulthood

+4. **Maple Syrup Urine Disease (MSUD)**:
A metabolic disorder affecting the breakdown of branched-chain amino acids, leading to their accumulation and causing neurological damage.

**Symptoms in common**:
- Seizures
- Intellectual disability
- Death in childhood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Hyperactivity
- Obesity
- Severe short stature
- Elevated urinary carboxylic acids
- Death in adolescence or early adulthood

+5. **Methylmalonic Acidemia**:
A metabolic disorder caused by a deficiency of methylmalonyl-CoA mutase, leading to the accumulation of methylmalonic acid and other toxic substances.

**Symptoms in common**:
- Seizures
- Elevated urinary carboxylic acids
- Death in childhood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Intellectual disability (may occur)
- Hyperactivity
- Obesity
- Severe short stature
- Death in adolescence or early adulthood

+6. **Prader-Willi Syndrome**:
A genetic disorder characterized by a defect on chromosome 15, leading to a variety of physical, mental, and behavioral problems.

**Symptoms in common**:
- Intellectual disability
- Hyperactivity
- Obesity
- Severe short stature
- Seizures (may occur)
- Death in early adulthood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Elevated urinary carboxylic acids
- Death in childhood or adolescence

+7. **Hurler Syndrome (Mucopolysaccharidosis Type I)**:
A lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase, leading to the accumulation of glycosaminoglycans.

**Symptoms in common**:
- Intellectual disability
- Severe short stature
- Death in childhood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Hyperactivity
- Obesity
- Elevated urinary carboxylic acids
- Seizures (may occur but less common)
- Death in adolescence or early adulthood

+8. **Dihydropteridine Reductase (DHPR) Deficiency**:
A rare disorder affecting the recycling of BH4, leading to neurotransmitter deficiencies and hyperphenylalaninemia.

**Symptoms in common**:
- Hyperphenylalaninemia
- Intellectual disability
- Seizures
- Hyperactivity
- Death in childhood

**Symptoms not in common**:
- Hypertyrosinemia
- Obesity
- Severe short stature
- Elevated urinary carboxylic acids
- Death in adolescence or early adulthood

+9. **Organic Acidurias (e.g., Propionic Acidemia)**:
A group of metabolic disorders characterized by the accumulation of organic acids due to enzyme deficiencies.

**Symptoms in common**:
- Seizures
- Elevated urinary carboxylic acids
- Intellectual disability
- Death in childhood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Hyperactivity
- Obesity
- Severe short stature
- Death in adolescence or early adulthood

+10. **Leigh Syndrome**:
A mitochondrial disorder that affects the central nervous system, leading to progressive loss of mental and movement abilities.

**Symptoms in common**:
- Seizures
- Intellectual disability
- Death in childhood or early adulthood

**Symptoms not in common**:
- Hyperphenylalaninemia
- Hypertyrosinemia
- Hyperactivity
- Obesity
- Severe short stature
- Elevated urinary carboxylic acids

**Note**: Further diagnostic testing, including metabolic screens, enzyme assays, and genetic testing, would be necessary to narrow down the diagnosis and confirm the specific disorder."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Acidemia (MMA)**:
A rare inherited metabolic disorder where the body can't break down certain fats and proteins, leading to a buildup of methylmalonic acid.
- **Shared symptoms**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Death in infancy', 'Neonatal death'
- **Symptoms not present**: 'Thrombocytopenia', 'Leukopenia'

+2. **Propionic Acidemia**:
An inherited condition affecting the breakdown of certain parts of proteins and lipids, resulting in the accumulation of propionic acid.
- **Shared symptoms**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Vomiting', 'Hyperammonemia', 'Death in infancy', 'Neonatal death'
- **Symptoms not present**: 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Thrombocytopenia', 'Leukopenia'

+3. **Multiple Carboxylase Deficiency**:
A metabolic disorder caused by defects in enzymes that require biotin, leading to accumulation of toxic substances.
- **Shared symptoms**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Vomiting'
- **Symptoms not present**: 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Thrombocytopenia', 'Leukopenia', 'Hyperammonemia', 'Death in infancy', 'Neonatal death'

+4. **Urea Cycle Disorders**:
A group of genetic conditions that lead to the accumulation of ammonia in the blood due to urea cycle dysfunction.
- **Shared symptoms**: 'Seizure', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', 'Death in infancy', 'Neonatal death'
- **Symptoms not present**: 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Thrombocytopenia', 'Leukopenia', 'Generalized hypotonia'

+5. **Organic Acidemias**:
A class of disorders involving the buildup of organic acids due to enzyme deficiencies affecting metabolism.
- **Shared symptoms**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Vomiting', 'Death in infancy', 'Neonatal death'
- **Symptoms not present**: 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Thrombocytopenia', 'Leukopenia', 'Hyperammonemia'

+6. **Mitochondrial Disorders**:
Genetic conditions that affect the mitochondria's ability to produce energy, leading to multi-system symptoms.
- **Shared symptoms**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Vomiting'
- **Symptoms not present**: 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Thrombocytopenia', 'Leukopenia', 'Hyperammonemia', 'Death in infancy', 'Neonatal death'

+7. **Severe Combined Immunodeficiency (SCID)**:
A group of disorders characterized by profound defects in the immune system, leading to severe infections.
- **Shared symptoms**: 'Thrombocytopenia', 'Leukopenia', 'Death in infancy', 'Neonatal death'
- **Symptoms not present**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Hyperammonemia', 'Vomiting', 'Methylmalonic acidemia', 'Methylmalonic aciduria'

+8. **Acute Leukemia**:
A rapid progression cancer of the blood and bone marrow resulting in the overproduction of immature white blood cells.
- **Shared symptoms**: 'Thrombocytopenia', 'Leukopenia', 'Generalized hypotonia', 'Seizure', 'Vomiting'
- **Symptoms not present**: 'Metabolic acidosis', 'Hyperammonemia', 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Death in infancy', 'Neonatal death'

+9. **Isovaleric Acidemia**:
A rare metabolic disorder affecting leucine metabolism, leading to buildup of isovaleric acid.
- **Shared symptoms**: 'Seizure', 'Metabolic acidosis', 'Vomiting'
- **Symptoms not present**: 'Generalized hypotonia', 'Thrombocytopenia', 'Leukopenia', 'Hyperammonemia', 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Death in infancy', 'Neonatal death'

+10. **Glutaric Acidemia Type I**:
An inherited disorder that affects the body's ability to process certain amino acids, leading to buildup of glutaric acid.
- **Shared symptoms**: 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Vomiting'
- **Symptoms not present**: 'Thrombocytopenia', 'Leukopenia', 'Hyperammonemia', 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Death in infancy', 'Neonatal death'"
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Primary Carnitine Deficiency:

A genetic disorder that impairs the body's ability to transport carnitine into cells, leading to low carnitine levels. **Symptoms in common**: 'Abnormal circulating carnitine concentration', 'Neonatal death', 'Death in infancy'. **Symptoms not in common**: 'Abnormality of prenatal development or birth'.

+2. Carnitine Palmitoyltransferase I (CPT I) Deficiency:

An inherited metabolic disorder affecting fatty acid oxidation due to a deficiency of the CPT I enzyme. **Symptoms in common**: 'Abnormal circulating carnitine concentration', 'Neonatal death', 'Death in infancy'. **Symptoms not in common**: 'Abnormality of prenatal development or birth'.

+3. Carnitine-Acylcarnitine Translocase (CACT) Deficiency:

A rare condition disrupting the transport of carnitine and acylcarnitines across mitochondrial membranes, affecting energy production. **Symptoms in common**: 'Abnormal circulating carnitine concentration', 'Neonatal death', 'Death in infancy'. **Symptoms not in common**: 'Abnormality of prenatal development or birth'.

+4. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):

Also known as Glutaric acidemia type II, this disorder impairs the breakdown of fats and proteins for energy. **Symptoms in common**: 'Abnormality of prenatal development or birth', 'Abnormal circulating carnitine concentration', 'Neonatal death', 'Death in infancy'.

+5. Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency:

A fatty acid oxidation disorder leading to hypoglycemia and sudden death in infants. **Symptoms in common**: 'Death in infancy', 'Neonatal death'. **Symptoms not in common**: 'Abnormality of prenatal development or birth', 'Abnormal circulating carnitine concentration'.

+6. Mitochondrial DNA Depletion Syndromes:

A group of disorders causing a significant decrease in mitochondrial DNA, leading to energy production problems. **Symptoms in common**: 'Abnormality of prenatal development or birth', 'Death in infancy'. **Symptoms not in common**: 'Abnormal circulating carnitine concentration', 'Neonatal death'.

+7. Zellweger Spectrum Disorders:

Peroxisomal biogenesis disorders affecting multiple organ systems and leading to severe developmental anomalies. **Symptoms in common**: 'Abnormality of prenatal development or birth', 'Death in infancy'. **Symptoms not in common**: 'Abnormal circulating carnitine concentration', 'Neonatal death'.

+8. Trifunctional Protein Deficiency:

A disorder affecting fatty acid oxidation due to defects in the trifunctional protein complex. **Symptoms in common**: 'Abnormal circulating carnitine concentration', 'Neonatal death', 'Death in infancy'. **Symptoms not in common**: 'Abnormality of prenatal development or birth'.

+9. Lethal Neonatal Mitochondrial Disease:

A broad category of mitochondrial disorders presenting with severe symptoms leading to early death. **Symptoms in common**: 'Abnormality of prenatal development or birth', 'Neonatal death', 'Death in infancy'. **Symptoms not in common**: 'Abnormal circulating carnitine concentration'.

+10. Holocarboxylase Synthetase Deficiency:

A metabolic disorder affecting the utilization of biotin, leading to multiple carboxylase deficiencies. **Symptoms in common**: 'Abnormality of prenatal development or birth', 'Neonatal death', 'Death in infancy'. **Symptoms not in common**: 'Abnormal circulating carnitine concentration'."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia (MMA):
- Symptoms the patient has in common: Death in infancy, Metabolic acidosis, Hyperammonemia, Vomiting, Methylmalonic aciduria.
- Symptoms not in common: None.

+2. Propionic Acidemia:
- Symptoms the patient has in common: Death in infancy, Metabolic acidosis, Hyperammonemia, Vomiting.
- Symptoms not in common: Methylmalonic aciduria.

+3. Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency):
- Symptoms the patient has in common: Death in infancy, Hyperammonemia, Vomiting.
- Symptoms not in common: Metabolic acidosis, Methylmalonic aciduria.

+4. Multiple Carboxylase Deficiency:
- Symptoms the patient has in common: Death in infancy, Metabolic acidosis, Vomiting.
- Symptoms not in common: Hyperammonemia, Methylmalonic aciduria.

+5. Maple Syrup Urine Disease (MSUD):
- Symptoms the patient has in common: Death in infancy, Metabolic acidosis, Vomiting.
- Symptoms not in common: Hyperammonemia, Methylmalonic aciduria."
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:
Symptoms in common: Seizure, Death in infancy, Hyperammonemia, Cerebral edema, Oroticaciduria, Neonatal death.
Symptoms not present: None.

+2. Carbamoyl Phosphate Synthetase I Deficiency:
Symptoms in common: Seizure, Death in infancy, Hyperammonemia, Cerebral edema, Neonatal death.
Symptoms not present: Oroticaciduria.

+3. Hereditary Orotic Aciduria (UMP Synthase Deficiency):
Symptoms in common: Seizure, Oroticaciduria, Possible death in infancy.
Symptoms not present: Hyperammonemia, Cerebral edema, Neonatal death.

+4. Citrullinemia (Argininosuccinate Synthetase Deficiency):
Symptoms in common: Seizure, Death in infancy, Hyperammonemia, Cerebral edema, Neonatal death.
Symptoms not present: Oroticaciduria.

+5. Maple Syrup Urine Disease:
Symptoms in common: Seizure, Death in infancy, Cerebral edema, Neonatal death.
Symptoms not present: Hyperammonemia, Oroticaciduria."
['Biotinidase deficiency'],"+1. **Multiple Carboxylase Deficiency**:
A rare metabolic disorder caused by defects in biotin-dependent carboxylase enzymes, leading to an accumulation of harmful substances in the body.

- **Symptoms in common**: Seizure, generalized hypotonia, growth delay, alopecia, elevated urinary carboxylic acid.
- **Symptoms not in common**: Fasciculations, death in infancy (though severe cases can be fatal if untreated).

+2. **Spinal Muscular Atrophy Type 1 (Werdnig-Hoffmann Disease)**:
A genetic disorder characterized by the loss of motor neurons, resulting in muscle weakness and atrophy.

- **Symptoms in common**: Generalized hypotonia, growth delay, fasciculations, death in infancy.
- **Symptoms not in common**: Seizure, alopecia, elevated urinary carboxylic acid.

+3. **Propionic Acidemia**:
An inherited metabolic disorder where the body cannot process certain parts of proteins and lipids properly.

- **Symptoms in common**: Seizure, generalized hypotonia, growth delay, elevated urinary carboxylic acid.
- **Symptoms not in common**: Alopecia, fasciculations, death in infancy (although severe cases can lead to early mortality).

+4. **Leigh Syndrome**:
A severe neurological disorder that arises in the first year of life, affecting the central nervous system.

- **Symptoms in common**: Seizure, generalized hypotonia, growth delay, death in infancy.
- **Symptoms not in common**: Alopecia, fasciculations, elevated urinary carboxylic acid.

+5. **Biotinidase Deficiency**:
A condition that prevents the body from recycling biotin, leading to multiple carboxylase deficiencies.

- **Symptoms in common**: Seizure, generalized hypotonia, growth delay, alopecia.
- **Symptoms not in common**: Fasciculations, death in infancy (usually preventable with treatment), elevated urinary carboxylic acid (may have similar metabolic profiles).

+6. **Holocarboxylase Synthetase Deficiency**:
A disorder affecting the body's ability to utilize biotin effectively, leading to multiple enzyme deficiencies.

- **Symptoms in common**: Seizure, generalized hypotonia, growth delay, alopecia, elevated urinary carboxylic acid.
- **Symptoms not in common**: Fasciculations, death in infancy (can be severe if untreated).

+7. **Methylmalonic Acidemia**:
A metabolic disorder disrupting the normal breakdown of certain fats and proteins.

- **Symptoms in common**: Seizure, generalized hypotonia, growth delay, elevated urinary carboxylic acid.
- **Symptoms not in common**: Alopecia, fasciculations, death in infancy (risk present in severe cases)."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
   - **Symptoms in common**: Hypertyrosinemia, hyperphenylalaninemia (due to secondary metabolic effects), and death in early adulthood (often due to liver failure).
   - **Symptoms not in common**: Obesity and hypercholesterolemia are not typical features of Tyrosinemia Type I.

+2. **Familial Hypercholesterolemia**:
   - **Symptoms in common**: Hypercholesterolemia and potential death in early adulthood due to cardiovascular complications.
   - **Symptoms not in common**: Hypertyrosinemia, hyperphenylalaninemia, and obesity are not commonly associated with this condition.

+3. **Metabolic Syndrome**:
   - **Symptoms in common**: Obesity and hypercholesterolemia.
   - **Symptoms not in common**: Hypertyrosinemia, hyperphenylalaninemia, and death in early adulthood are not typical features.

+4. **Phenylketonuria (PKU)**:
   - **Symptoms in common**: Hyperphenylalaninemia.
   - **Symptoms not in common**: Hypertyrosinemia is not typical, and obesity and hypercholesterolemia are not direct features. Death in early adulthood is uncommon if the condition is managed properly.

+5. **Homocystinuria**:
   - **Symptoms in common**: Potential for early death due to thromboembolic events.
   - **Symptoms not in common**: Obesity, hypercholesterolemia, hypertyrosinemia, and hyperphenylalaninemia are not typical symptoms.

+6. **Niemann-Pick Disease Type C**:
   - **Symptoms in common**: Possible hypercholesterolemia and death in early adulthood.
   - **Symptoms not in common**: Obesity, hypertyrosinemia, and hyperphenylalaninemia are not characteristic of this disease.

+7. **Wilson's Disease**:
   - **Symptoms in common**: Liver dysfunction can lead to death in early adulthood; neurological symptoms may overlap.
   - **Symptoms not in common**: Obesity, hypercholesterolemia, hypertyrosinemia, and hyperphenylalaninemia are not typical findings.

+8. **Gaucher Disease (Type 2 or 3)**:
   - **Symptoms in common**: Can lead to early death; may have metabolic complications.
   - **Symptoms not in common**: Obesity, hypercholesterolemia, hypertyrosinemia, and hyperphenylalaninemia are not standard features.

+9. **Maple Syrup Urine Disease**:
   - **Symptoms in common**: Disorders of amino acid metabolism.
   - **Symptoms not in common**: Obesity, hypercholesterolemia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated; onset is usually in infancy.

+10. **Alpers' Disease**:
    - **Symptoms in common**: Progressive disease leading to early death.
    - **Symptoms not in common**: Obesity, hypercholesterolemia, hypertyrosinemia, and hyperphenylalaninemia are not common features."
['Phenylketonuria'],"+1. **Tyrosinemia Type I:**
A rare genetic disorder caused by deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of tyrosine and its toxic metabolites. This can result in liver and kidney dysfunction and is often fatal if untreated.

- **Shared symptoms:** Hypertyrosinemia, Death in infancy, Premature birth, Neonatal death.
- **Symptoms not in common:** Hypospadias, Severe short stature, Hyperphenylalaninemia, Hernia.

+2. **Phenylketonuria (PKU):**
An inherited metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine.

- **Shared symptoms:** Hyperphenylalaninemia, Severe short stature.
- **Symptoms not in common:** Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Hernia.

+3. **Smith-Lemli-Opitz Syndrome:**
A developmental disorder caused by a deficiency of the enzyme 7-dehydrocholesterol reductase, affecting cholesterol synthesis.

- **Shared symptoms:** Hypospadias, Severe short stature, Hernia, Neonatal death.
- **Symptoms not in common:** Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Premature birth.

+4. **Maple Syrup Urine Disease:**
A metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to accumulation of certain amino acids.

- **Shared symptoms:** Severe short stature, Neonatal death, Premature birth.
- **Symptoms not in common:** Hypospadias, Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Hernia.

+5. **Congenital Hyperphenylalaninemia with Hypertyrosinemia:**
A rare condition where there is simultaneous elevation of phenylalanine and tyrosine due to defects in enzymes like tetrahydrobiopterin reductase.

- **Shared symptoms:** Hyperphenylalaninemia, Hypertyrosinemia, Severe short stature.
- **Symptoms not in common:** Hypospadias, Death in infancy, Premature birth, Neonatal death, Hernia."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome:
Smith-Lemli-Opitz Syndrome is a genetic disorder affecting cholesterol metabolism, leading to multiple congenital anomalies.

**Symptoms in common:**
- Microcephaly
- Low-set ears
- Wide nasal bridge
- Strabismus
- Delayed speech and language development
- Syndactyly
- Intellectual disability
- Motor delay
- Severe short stature
- Difficulty walking
- Difficulty running
- Elevated circulating 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Death in infancy or childhood
- Severe hearing impairment

**Symptoms not in common:**
- Death in infancy (varies among patients)
- Neonatal death (may occur but not in all cases)

+2. Trisomy 13 (Patau Syndrome):
Trisomy 13 is a chromosomal disorder characterized by an extra copy of chromosome 13, leading to severe intellectual and physical abnormalities.

**Symptoms in common:**
- Microcephaly
- Low-set ears
- Wide nasal bridge
- Strabismus
- Intellectual disability
- Severe short stature
- Syndactyly
- Motor delay
- Death in infancy
- Neonatal death
- Severe hearing impairment

**Symptoms not in common:**
- Elevated circulating 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Difficulty walking (due to severe developmental delays)
- Difficulty running
- Delayed speech and language development (limited by severe impairment)

+3. Zellweger Spectrum Disorder:
Zellweger Spectrum Disorder is a group of peroxisomal biogenesis disorders affecting multiple organs and leading to developmental delays.

**Symptoms in common:**
- Microcephaly
- Low-set ears
- Wide nasal bridge
- Severe hearing impairment
- Intellectual disability
- Motor delay
- Death in infancy or childhood
- Neonatal death

**Symptoms not in common:**
- Syndactyly
- Elevated circulating 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Difficulty walking
- Difficulty running
- Delayed speech and language development (due to early mortality)

+4. Cornelia de Lange Syndrome:
Cornelia de Lange Syndrome is a developmental disorder affecting many parts of the body, often leading to distinctive facial features.

**Symptoms in common:**
- Microcephaly
- Low-set ears
- Wide nasal bridge
- Strabismus
- Delayed speech and language development
- Intellectual disability
- Motor delay
- Severe short stature
- Difficulty walking
- Difficulty running
- Severe hearing impairment

**Symptoms not in common:**
- Syndactyly (though limb abnormalities are present)
- Elevated circulating 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Death in infancy or childhood (less common)

+5. CHARGE Syndrome:
CHARGE Syndrome is a disorder that affects many areas of the body, and is an abbreviation for its common features.

**Symptoms in common:**
- Coloboma of the eye (may relate to strabismus)
- Heart defects
- Atresia of the choanae
- Retardation of growth and development (including intellectual disability and motor delay)
- Genital and urinary abnormalities
- Ear anomalies and hearing loss (severe hearing impairment)
- Difficulty walking and running due to balance issues
- Delayed speech and language development
- Wide nasal bridge
- Low-set ears

**Symptoms not in common:**
- Syndactyly
- Elevated circulating 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Death in infancy or childhood (varies)"
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Aciduria Type I:
A rare metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid and related compounds in the body.

**Symptoms in common:**
- Ataxia
- Athetosis
- Opisthotonus
- Progressive neurologic deterioration
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Death in childhood

**Symptoms not in common:**
- Dehydration
- Fever
- Diarrhea
- Death in infancy
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration

+2. Glutaric Aciduria Type II (Multiple Acyl-CoA Dehydrogenase Deficiency):
An inherited disorder affecting the body's ability to break down proteins and fats, resulting in the accumulation of multiple organic acids.

**Symptoms in common:**
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Dehydration
- Diarrhea
- Progressive neurologic deterioration
- Death in infancy or childhood

**Symptoms not in common:**
- Ataxia
- Athetosis
- Opisthotonus
- Fever

+3. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):
Also known as Glutaric Aciduria Type II, it's a fatty acid oxidation disorder leading to energy production problems in the body.

**Symptoms in common:**
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Dehydration
- Diarrhea
- Progressive neurologic deterioration
- Death in infancy

**Symptoms not in common:**
- Ataxia
- Athetosis
- Opisthotonus
- Fever
- Death in childhood

+4. Carnitine Transporter Deficiency (Primary Carnitine Deficiency):
A disorder caused by the body's inability to transport carnitine into cells, leading to reduced energy production.

**Symptoms in common:**
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Progressive neurologic deterioration
- Death in infancy or childhood

**Symptoms not in common:**
- Ataxia
- Athetosis
- Opisthotonus
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Fever
- Diarrhea
- Dehydration

+5. Maple Syrup Urine Disease (MSUD):
A metabolic disorder affecting branched-chain amino acids, leading to neurological symptoms and potentially fatal outcomes if untreated.

**Symptoms in common:**
- Ataxia
- Athetosis
- Opisthotonus
- Progressive neurologic deterioration
- Death in infancy

**Symptoms not in common:**
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Fever
- Diarrhea
- Dehydration
- Death in childhood"
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
A rare genetic metabolic disorder caused by deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of tyrosine and its toxic metabolites.

**Symptoms in common**: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hypertyrosinemia, Death in infancy, Neonatal death.

**Symptoms not in common**: Hepatomegaly, Jaundice, Failure to thrive.

+2. **Phenylketonuria (PKU)**:
An inherited disorder resulting from a deficiency of phenylalanine hydroxylase, causing elevated levels of phenylalanine.

**Symptoms in common**: Motor delay, Generalized hypotonia, Hyperphenylalaninemia.

**Symptoms not in common**: Intellectual disability (if untreated), Seizures, Skin rashes.

+3. **Maple Syrup Urine Disease (MSUD)**:
A metabolic disorder affecting the breakdown of branched-chain amino acids.

**Symptoms in common**: Generalized hypotonia, Neonatal death, Motor delay.

**Symptoms not in common**: Sweet-smelling urine, Feeding difficulties, Lethargy.

+4. **Zellweger Syndrome**:
A peroxisomal biogenesis disorder affecting multiple organ systems.

**Symptoms in common**: Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Neonatal death.

**Symptoms not in common**: Facial abnormalities, Seizures, Liver dysfunction.

+5. **Spinal Muscular Atrophy Type I**:
A genetic condition characterized by the loss of motor neurons and progressive muscle wasting.

**Symptoms in common**: Motor delay, Generalized hypotonia, Death in infancy.

**Symptoms not in common**: Breathing difficulties, Lack of tendon reflexes, Difficulty swallowing."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Common symptoms with the patient: Hypertyrosinemia, Apnea, Generalized hypotonia, Death in infancy, Neonatal death.
Symptoms not present in this disease: Hyperphenylalaninemia, Retrognathia, Opisthotonus.

+2. **Phenylketonuria (PKU)**:
Common symptoms with the patient: Hyperphenylalaninemia, Seizures, Generalized hypotonia.
Symptoms not present in this disease: Hypertyrosinemia, Apnea, Death in infancy (when treated early), Opisthotonus.

+3. **Dihydropteridine Reductase Deficiency**:
Common symptoms with the patient: Hyperphenylalaninemia, Seizures, Generalized hypotonia, Apnea, Death in infancy.
Symptoms not present in this disease: Hypertyrosinemia, Retrognathia.

+4. **Nonketotic Hyperglycinemia**:
Common symptoms with the patient: Seizures, Generalized hypotonia, Apnea, Opisthotonus, Death in infancy.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia.

+5. **Maple Syrup Urine Disease (MSUD)**:
Common symptoms with the patient: Generalized hypotonia, Seizures, Apnea, Opisthotonus, Death in infancy.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia.

+6. **Glycine Encephalopathy**:
Common symptoms with the patient: Generalized hypotonia, Seizures, Apnea, Opisthotonus, Neonatal death.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia.

+7. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:
Common symptoms with the patient: Generalized hypotonia, Seizures, Apnea, Death in infancy.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia.

+8. **Leigh Syndrome**:
Common symptoms with the patient: Generalized hypotonia, Seizures, Apnea, Death in infancy or childhood.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia.

+9. **Pyruvate Dehydrogenase Deficiency**:
Common symptoms with the patient: Generalized hypotonia, Seizures, Opisthotonus, Death in childhood.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia, Apnea.

+10. **Krabbe Disease**:
Common symptoms with the patient: Generalized hypotonia, Seizures, Death in infancy or childhood.
Symptoms not present in this disease: Hypertyrosinemia, Hyperphenylalaninemia, Retrognathia, Apnea, Opisthotonus."
['Tyrosinemia type 1'],"+1. **Phenylketonuria (PKU)**:
- **Common symptoms with patient**: 'Intellectual disability', 'Seizure', 'Motor delay', 'Hyperphenylalaninemia', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration'
- **Symptoms not present in patient**: 'Light skin', 'Eczema', 'Musty odor'
- **Description**: PKU is a metabolic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase, leading to elevated levels of phenylalanine in the blood, which can result in intellectual disability and seizures if untreated.

+2. **Tyrosinemia Type I**:
- **Common symptoms with patient**: 'Hypertyrosinemia', 'Elevated circulating alpha-fetoprotein concentration', 'Elevated circulating alkaline phosphatase concentration', 'Neonatal death', 'Death in infancy', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Seizure'
- **Symptoms not present in patient**: 'Cabbage-like odor', 'Hepatomegaly', 'Renal tubular dysfunction'
- **Description**: Tyrosinemia Type I is a genetic disorder affecting tyrosine metabolism, leading to liver and kidney dysfunction, elevated alpha-fetoprotein levels, and can be fatal if not treated early.

+3. **Lesch-Nyhan Syndrome**:
- **Common symptoms with patient**: 'Self-mutilation', 'Hyperactivity', 'Intellectual disability', 'Seizure', 'Motor delay'
- **Symptoms not present in patient**: 'Elevated uric acid levels', 'Gout', 'Kidney stones'
- **Description**: Lesch-Nyhan Syndrome is a rare genetic disorder caused by a deficiency of the HGPRT enzyme, leading to neurological and behavioral abnormalities, including self-mutilation and intellectual disability.

+4. **Sanfilippo Syndrome (Mucopolysaccharidosis Type III)**:
- **Common symptoms with patient**: 'Autistic behavior', 'Hyperactivity', 'Intellectual disability', 'Seizure', 'Motor delay', 'Elevated circulating alkaline phosphatase concentration'
- **Symptoms not present in patient**: 'Coarse facial features', 'Hepatosplenomegaly', 'Joint stiffness'
- **Description**: Sanfilippo Syndrome is a metabolic disorder where the body cannot properly break down heparan sulfate, leading to severe central nervous system degeneration and behavioral problems.

+5. **Maple Syrup Urine Disease (MSUD)**:
- **Common symptoms with patient**: 'Intellectual disability', 'Seizure', 'Motor delay', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Neonatal death'
- **Symptoms not present in patient**: 'Sweet-smelling urine', 'Poor feeding', 'Vomiting'
- **Description**: MSUD is a metabolic disorder affecting branched-chain amino acid degradation, leading to toxic accumulation that can cause neurological damage and neonatal death if untreated.

+6. **Prader-Willi Syndrome**:
- **Common symptoms with patient**: 'Obesity', 'Intellectual disability', 'Motor delay', 'Hyperactivity'
- **Symptoms not present in patient**: 'Hypotonia', 'Short stature', 'Hypogonadism'
- **Description**: Prader-Willi Syndrome is a genetic disorder characterized by hyperphagia leading to obesity, developmental delays, and behavioral problems.

+7. **Rett Syndrome**:
- **Common symptoms with patient**: 'Autistic behavior', 'Seizure', 'Motor delay', 'Intellectual disability'
- **Symptoms not present in patient**: 'Loss of purposeful hand skills', 'Deceleration of head growth', 'Breath-holding spells'
- **Description**: Rett Syndrome is a neurodevelopmental disorder primarily affecting females, leading to severe cognitive and physical impairments after a period of normal development.

+8. **Wilson's Disease**:
- **Common symptoms with patient**: 'Elevated circulating alkaline phosphatase concentration', 'Seizure', 'Motor delay', 'Intellectual disability', 'Decreased circulating iron concentration'
- **Symptoms not present in patient**: 'Kayser-Fleischer rings', 'Liver cirrhosis', 'Tremors'
- **Description**: Wilson's Disease is a genetic disorder causing copper accumulation in the body, affecting the liver and nervous system, potentially leading to neurological symptoms.

+9. **Menke's Disease**:
- **Common symptoms with patient**: 'Seizure', 'Motor delay', 'Hypotonia', 'Intellectual disability', 'Elevated circulating alkaline phosphatase concentration'
- **Symptoms not present in patient**: 'Kinky hair', 'Hypothermia', 'Bone fractures'
- **Description**: Menke's Disease is a disorder of copper transport resulting in copper deficiency, affecting the development of the brain and other systems.

+10. **Krabbe Disease**:
- **Common symptoms with patient**: 'Seizure', 'Motor delay', 'Intellectual disability', 'Death in infancy', 'Elevated circulating alkaline phosphatase concentration'
- **Symptoms not present in patient**: 'Optic atrophy', 'Spasticity', 'Feeding difficulties'
- **Description**: Krabbe Disease is a degenerative disorder affecting the nervous system due to deficiency of the enzyme galactocerebrosidase."
['Classic galactosemia'],"+1. **Galactosemia**:
Galactosemia is a rare genetic metabolic disorder where the body is unable to process galactose, a sugar found in milk and other dairy products. This leads to the accumulation of galactose-1-phosphate, causing toxic effects.

**Symptoms the patient has in common with Galactosemia**:
- Vomiting
- Increased total bilirubin
- Hypergalactosemia
- Neonatal death
- Death in infancy

**Symptoms not present in this patient**:
- Jaundice
- Diarrhea
- Lethargy
- Poor feeding
- Failure to thrive

+2. **Crigler-Najjar Syndrome Type I**:
This is a rare inherited disorder characterized by a deficiency of the enzyme needed to process bilirubin, leading to severe jaundice and high levels of unconjugated bilirubin.

**Symptoms the patient has in common with Crigler-Najjar Syndrome Type I**:
- Increased total bilirubin
- Neonatal death
- Death in infancy

**Symptoms not present in this patient**:
- Jaundice
- Muscle weakness
- Lethargy
- Neurological dysfunction
- Kernicterus (brain damage due to bilirubin)

+3. **Biliary Atresia**:
Biliary atresia is a condition in infants where the bile ducts become inflamed and blocked, leading to bile accumulation in the liver and subsequent liver damage.

**Symptoms the patient has in common with Biliary Atresia**:
- Vomiting
- Increased total bilirubin
- Neonatal death
- Death in infancy

**Symptoms not present in this patient**:
- Jaundice
- Pale stools
- Dark urine
- Enlarged liver
- Failure to thrive

+4. **Tyrosinemia Type I**:
A rare metabolic disorder caused by deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of toxic substances affecting the liver, kidneys, and nervous system.

**Symptoms the patient has in common with Tyrosinemia Type I**:
- Vomiting
- Increased total bilirubin
- Neonatal death
- Death in infancy

**Symptoms not present in this patient**:
- Cabbage-like odor
- Diarrhea
- Failure to thrive
- Bleeding tendencies
- Kidney dysfunction

+5. **Neonatal Hemochromatosis**:
An extremely rare condition characterized by excessive iron accumulation in the liver and other tissues of the fetus and newborn.

**Symptoms the patient has in common with Neonatal Hemochromatosis**:
- Vomiting
- Increased total bilirubin
- Neonatal death
- Death in infancy

**Symptoms not present in this patient**:
- Low blood sugar
- Swelling
- Jaundice
- Abdominal distension
- Liver failure"
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Tyrosinemia Type I is a genetic metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its toxic by-products.

*Symptoms in common with the patient:*
- Abnormal circulating tyrosine concentration
- Hyperphenylalaninemia (due to secondary effects on phenylalanine metabolism)
- Abnormality of prenatal development or birth
- Death in infancy
- Neonatal death

*Symptoms not present in the patient:*
- Hepatomegaly (enlarged liver)
- Failure to thrive
- Vomiting

+2. **Tyrosinemia Type II**:
Tyrosinemia Type II is a rare genetic disorder caused by a deficiency of the enzyme tyrosine aminotransferase, affecting the metabolism of tyrosine.

*Symptoms in common with the patient:*
- Abnormal circulating tyrosine concentration
- Hyperphenylalaninemia (possible due to metabolic imbalances)
- Abnormality of prenatal development or birth

*Symptoms not present in the patient:*
- Eye pain and redness
- Skin lesions on palms and soles
- Intellectual disability (if not managed)

+3. **Phenylketonuria (PKU)**:
PKU is a metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine.

*Symptoms in common with the patient:*
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

*Symptoms not present in the patient:*
- Musty odor in breath, skin, or urine
- Seizures
- Fair skin and blue eyes (due to decreased melanin)

+4. **Maple Syrup Urine Disease**:
This is a metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation.

*Symptoms in common with the patient:*
- Abnormality of prenatal development or birth
- Neonatal death (if untreated)

*Symptoms not present in the patient:*
- Sweet-smelling urine (like maple syrup)
- Poor feeding
- Lethargy

+5. **Nonketotic Hyperglycinemia**:
A disorder characterized by an excess of glycine due to defects in its breakdown.

*Symptoms in common with the patient:*
- Neonatal death
- Abnormality of prenatal development or birth

*Symptoms not present in the patient:*
- Severe hypotonia (reduced muscle tone)
- Respiratory difficulties
- Seizures"
['Biotinidase deficiency'],"+1. **Primary Carnitine Deficiency**:
Symptoms in common: Abnormal circulating carnitine concentration, potential for death in childhood or adolescence due to cardiac or metabolic complications.
Symptoms not in common: Obesity (patients often present with muscle weakness and hypoglycemia rather than obesity).

+2. **Prader-Willi Syndrome**:
Symptoms in common: Obesity starting in early childhood, risk of early death due to obesity-related complications.
Symptoms not in common: Abnormal circulating carnitine concentration is not a typical feature; death in adolescence is less common with proper management.

+3. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:
Symptoms in common: Abnormal carnitine levels due to impaired fatty acid oxidation, risk of sudden death in childhood.
Symptoms not in common: Obesity is not typical; patients may experience hypoglycemia and lethargy instead.

+4. **Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase (LCHAD) Deficiency**:
Symptoms in common: Abnormal circulating carnitine concentration, risk of death in infancy or childhood due to cardiomyopathy or liver failure.
Symptoms not in common: Obesity is not a common symptom.

+5. **Type 2 Diabetes Mellitus (Early Onset)**:
Symptoms in common: Obesity, which is a significant risk factor.
Symptoms not in common: Abnormal circulating carnitine concentration and death in childhood or adolescence are not typical without other complications."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Shared symptoms include **Hypertyrosinemia**, **Death in infancy**, **Neonatal death**, **Abnormality of prenatal development or birth**, and **Intellectual disability**. The patient does not typically exhibit **Hyperphenylalaninemia** or **Death in adolescence** with this condition.

+2. **Phenylketonuria (PKU)**:
Common symptoms are **Hyperphenylalaninemia**, **Intellectual disability**, and **Abnormality of prenatal development or birth**. The patient does not usually experience **Hypertyrosinemia**, **Death in infancy**, **Neonatal death**, or **Death in adolescence** associated with PKU.

+3. **Maple Syrup Urine Disease**:
Symptoms in common include **Intellectual disability**, **Neonatal death**, and **Death in infancy**. This disease does not typically present with **Hypertyrosinemia**, **Hyperphenylalaninemia**, or **Death in adolescence**.

+4. **Nonketotic Hyperglycinemia**:
Shared symptoms are **Intellectual disability**, **Neonatal death**, and **Death in infancy**. The condition does not usually involve **Hypertyrosinemia**, **Hyperphenylalaninemia**, or **Death in adolescence**.

+5. **Homocystinuria**:
The patient may exhibit **Intellectual disability** and **Abnormality of prenatal development or birth**. **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Death in infancy**, **Neonatal death**, and **Death in adolescence** are not commonly associated.

+6. **Lysosomal Storage Disorders (e.g., Tay-Sachs Disease)**:
Symptoms can include **Intellectual disability**, **Death in infancy**, and **Neonatal death**. They do not typically present with **Hypertyrosinemia**, **Hyperphenylalaninemia**, or **Death in adolescence**.

+7. **Glycogen Storage Disease Type II (Pompe Disease)**:
Common symptoms are **Death in infancy** and **Neonatal death**. The disease does not usually involve **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Intellectual disability**, or **Death in adolescence**.

+8. **Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)**:
Shared symptoms include **Death in infancy** and **Neonatal death**. The patient does not typically show **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Intellectual disability**, or **Death in adolescence**.

+9. **Leigh Syndrome**:
Symptoms may involve **Intellectual disability**, **Death in infancy**, and **Neonatal death**. **Hypertyrosinemia**, **Hyperphenylalaninemia**, and **Death in adolescence** are not common features.

+10. **Ornithine Transcarbamylase Deficiency**:
Common symptoms are **Abnormality of prenatal development or birth**, **Intellectual disability**, **Neonatal death**, and **Death in infancy**. This condition does not usually present with **Hypertyrosinemia**, **Hyperphenylalaninemia**, or **Death in adolescence**."
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome:
Smith-Lemli-Opitz Syndrome is a genetic disorder caused by a defect in cholesterol synthesis leading to multiple congenital anomalies and intellectual disability. 

**Symptoms in common with the patient**: Cryptorchidism, Hypospadias, Microcephaly, Low-set ears, Strabismus, Ptosis, Syndactyly, Intellectual disability, Lethargy, Motor delay, Generalized hypotonia, Feeding difficulties, Sleep abnormality, Hypocholesterolemia, Elevated circulating 7-dehydrocholesterol concentration, Vomiting, Constipation.

**Symptoms not in common**: Severe hearing impairment, Recurrent viral infections.

---

+2. Zellweger Spectrum Disorder:
Zellweger Spectrum Disorder is a group of peroxisomal biogenesis disorders affecting the white matter of the brain and other organs.

**Symptoms in common with the patient**: Microcephaly, Low-set ears, Hypotonia, Intellectual disability, Feeding difficulties, Vomiting, Seizures (can correlate with Dystonia), Hepatic dysfunction (may lead to Hypocholesterolemia), Severe hearing impairment, Vision problems like Strabismus.

**Symptoms not in common**: Cryptorchidism, Hypospadias, Elevated 7-dehydrocholesterol levels.

---

+3. Congenital Disorder of Glycosylation (CDG):
CDG is a group of inherited metabolic disorders that affect a process called glycosylation, leading to multisystem involvement.

**Symptoms in common with the patient**: Hypotonia, Motor delay, Intellectual disability, Strabismus, Ptosis, Skin rash, Feeding difficulties, Vomiting, Dystonia.

**Symptoms not in common**: Cryptorchidism, Hypospadias, Elevated 7-dehydrocholesterol concentration, Hypocholesterolemia.

---

+4. Joubert Syndrome:
Joubert Syndrome is a rare genetic disorder characterized by developmental delay, hypotonia, and abnormal breathing patterns.

**Symptoms in common with the patient**: Hypotonia, Motor delay, Intellectual disability, Abnormal eye movements (Strabismus, Ptosis), Breathing abnormalities (which may relate to Sleep abnormality), Vomiting, Feeding difficulties.

**Symptoms not in common**: Cryptorchidism, Hypospadias, Elevated 7-dehydrocholesterol concentration, Skin rash.

---

+5. Aicardi-Goutières Syndrome:
Aicardi-Goutières Syndrome is a genetic inflammatory disorder affecting the brain and skin.

**Symptoms in common with the patient**: Microcephaly, Intellectual disability, Skin rash, Feeding difficulties, Vomiting, Dystonia, Neurological decline leading to early death (Death in infancy/childhood), Recurrent viral infections.

**Symptoms not in common**: Cryptorchidism, Hypospadias, Hypocholesterolemia, Elevated 7-dehydrocholesterol concentration.

---

These potential diagnoses consider the complex combination of neurological, dermatological, metabolic, and congenital symptoms presented by the patient. Each listed disorder shares multiple symptoms with the patient, but further clinical evaluation and diagnostic testing would be necessary to confirm the exact diagnosis."
['Canavan disease'],"+1. **Prader-Willi Syndrome**:
A genetic disorder characterized by hypotonia, feeding difficulties in infancy, rapid weight gain leading to obesity in childhood, developmental delays, and distinctive facial features.

**Symptoms in common**: Strabismus, hyporeflexia, generalized hypotonia, obesity.

**Symptoms not in common**: Death in infancy (individuals often survive into adulthood), fever (not a characteristic symptom), cerebral atrophy (not typical), abnormal circulating aspartate family amino acid concentration (not typically associated).

+2. **Spinal Muscular Atrophy Type I (Werdnig-Hoffmann Disease)**:
An inherited neuromuscular disorder characterized by degeneration of motor neurons leading to muscle weakness and atrophy, often resulting in early childhood death.

**Symptoms in common**: Hyporeflexia, generalized hypotonia, death in infancy.

**Symptoms not in common**: Strabismus (not typical), obesity (not typical due to muscle wasting), fever (not characteristic but may occur), cerebral atrophy (not a primary feature), abnormal circulating aspartate family amino acid concentration (not associated).

+3. **Leigh Syndrome**:
A severe neurological disorder that arises in the first year of life, characterized by progressive loss of mental and movement abilities due to mitochondrial dysfunction.

**Symptoms in common**: Generalized hypotonia, fever, cerebral atrophy, death in infancy.

**Symptoms not in common**: Strabismus (may occur but not primary), hyporeflexia (reflexes may be exaggerated or normal), obesity (not typical), abnormal circulating aspartate family amino acid concentration (possible due to metabolic dysfunction).

+4. **Canavan Disease**:
A rare inherited disorder causing degeneration of the white matter in the brain, leading to severe neurological impairment.

**Symptoms in common**: Generalized hypotonia, cerebral atrophy, death in infancy.

**Symptoms not in common**: Strabismus (may occur), hyporeflexia (not typical), obesity (not characteristic), fever (not a primary symptom), abnormal circulating aspartate family amino acid concentration (elevated N-acetylaspartate, but not aspartate family amino acids).

+5. **Homocystinuria**:
A metabolic disorder affecting the metabolism of the amino acid methionine, leading to accumulation of homocysteine.

**Symptoms in common**: Strabismus, generalized hypotonia, cerebral atrophy (due to neurological involvement), abnormal circulating aspartate family amino acid concentration (elevated methionine levels).

**Symptoms not in common**: Hyporeflexia (reflexes may be normal or increased), obesity (not typical), death in infancy (can vary), fever (not characteristic).

+6. **Maple Syrup Urine Disease**:
A metabolic disorder affecting the breakdown of branched-chain amino acids, leading to toxic accumulation.

**Symptoms in common**: Hyporeflexia, generalized hypotonia, death in infancy, fever (during metabolic crisis).

**Symptoms not in common**: Strabismus (not typical), obesity (not characteristic), cerebral atrophy (may develop over time), abnormal circulating aspartate family amino acid concentration (elevated branched-chain amino acids, not aspartate family).

+7. **Nonketotic Hyperglycinemia**:
A genetic disorder characterized by accumulation of glycine, leading to severe neurological symptoms.

**Symptoms in common**: Hyporeflexia, generalized hypotonia, cerebral atrophy, death in infancy.

**Symptoms not in common**: Strabismus (may occur), obesity (not typical), fever (not characteristic), abnormal circulating aspartate family amino acid concentration (elevated glycine, not aspartate family).

+8. **Zellweger Syndrome**:
A peroxisomal biogenesis disorder affecting multiple organ systems, leading to severe neurological dysfunction.

**Symptoms in common**: Hyporeflexia, generalized hypotonia, cerebral atrophy, death in infancy.

**Symptoms not in common**: Strabismus (may occur), obesity (not characteristic), fever (may be present), abnormal circulating aspartate family amino acid concentration (peroxisomal dysfunction affects multiple metabolites).

+9. **Krabbe Disease**:
A lysosomal storage disorder resulting in the destruction of protective myelin coating of nerve cells.

**Symptoms in common**: Hyporeflexia, generalized hypotonia, cerebral atrophy, death in infancy, fever (due to infections).

**Symptoms not in common**: Strabismus (not typical), obesity (not characteristic), abnormal circulating aspartate family amino acid concentration (not associated).

+10. **Phenylketonuria (PKU)**:
A metabolic disorder caused by deficiency of the enzyme needed to process the amino acid phenylalanine.

**Symptoms in common**: Generalized hypotonia (may occur), intellectual disability (if untreated).

**Symptoms not in common**: Strabismus (not typical), hyporeflexia (not characteristic), obesity (not typical), death in infancy (preventable with treatment), fever (not characteristic), cerebral atrophy (may occur if untreated), abnormal circulating aspartate family amino acid concentration (elevated phenylalanine, not aspartate family)."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia, Fever, Pneumonia, Neonatal death, Death in infancy, Death in childhood, Death in early adulthood.
Symptoms not in common: Obesity, Coarctation of aorta, Hyperphenylalaninemia, Death in adolescence.

+2. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia, Neonatal death, Death in infancy, Death in childhood.
Symptoms not in common: Obesity, Coarctation of aorta, Hypertyrosinemia, Fever, Pneumonia, Death in adolescence, Death in early adulthood.

+3. Turner Syndrome:
Symptoms in common: Coarctation of aorta, Obesity.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Fever, Pneumonia, Neonatal death, Death in infancy, Death in childhood, Death in adolescence, Death in early adulthood.

+4. Severe Combined Immunodeficiency (SCID):
Symptoms in common: Fever, Pneumonia, Neonatal death, Death in infancy, Death in childhood.
Symptoms not in common: Obesity, Coarctation of aorta, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+5. Glycogen Storage Disease Type II (Pompe Disease):
Symptoms in common: Obesity (due to muscle weakness), Neonatal death, Death in infancy, Death in childhood.
Symptoms not in common: Coarctation of aorta, Hypertyrosinemia, Hyperphenylalaninemia, Fever, Pneumonia, Death in adolescence, Death in early adulthood.

+6. Eisenmenger Syndrome:
Symptoms in common: Coarctation of aorta, Death in adolescence, Death in early adulthood.
Symptoms not in common: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Fever, Pneumonia, Neonatal death, Death in infancy, Death in childhood.

+7. Congenital Heart Defects:
Symptoms in common: Coarctation of aorta, Neonatal death, Death in infancy, Death in childhood.
Symptoms not in common: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Fever, Pneumonia, Death in adolescence, Death in early adulthood.

+8. Infection-Induced Sepsis:
Symptoms in common: Fever, Pneumonia, Neonatal death, Death in infancy, Death in childhood, Death in adolescence, Death in early adulthood.
Symptoms not in common: Obesity, Coarctation of aorta, Hypertyrosinemia, Hyperphenylalaninemia."
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1. Classical Homocystinuria (Cystathionine Beta-Synthase Deficiency):

This is an inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase, leading to the accumulation of homocysteine and methionine. It can result in developmental delays, skeletal abnormalities, vascular complications, and may lead to early death.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Hyperhomocystinemia
- Hypermethioninemia
- Aminoaciduria
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Neonatal death (symptoms typically appear after the neonatal period)

+2. Combined Methylmalonic Aciduria and Homocystinuria, cblC Type (Cobalamin C Deficiency):

A rare genetic disorder affecting vitamin B12 metabolism, causing accumulation of methylmalonic acid and homocysteine. It leads to neurological impairments, developmental delays, and can be fatal in early life.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Hyperhomocystinemia
- Aminoaciduria
- Neonatal death
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Hypermethioninemia (methionine levels may be normal or low)

+3. Severe Methionine Adenosyltransferase I/III Deficiency:

An inherited disorder resulting in elevated methionine levels due to enzyme deficiency. It may cause neurological symptoms and developmental delays, with severe forms presenting early in life.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Hypermethioninemia
- Aminoaciduria
- Death in infancy

**Symptoms not in common:**
- Hyperhomocystinemia (homocysteine levels are usually normal)
- Neonatal death (less commonly associated)
- Death in childhood

+4. Glycine N-Methyltransferase Deficiency:

A rare metabolic condition characterized by elevated methionine levels due to enzyme deficiency. It can lead to liver dysfunction and neurological issues.

**Symptoms in common with the patient:**
- Hypermethioninemia
- Aminoaciduria

**Symptoms not in common:**
- Abnormality of prenatal development or birth
- Hyperhomocystinemia
- Neonatal death
- Death in infancy
- Death in childhood

+5. Tyrosinemia Type I:

A genetic disorder caused by deficiency of fumarylacetoacetate hydrolase, leading to accumulation of toxic substances affecting the liver and kidneys. It can be life-threatening in infants.

**Symptoms in common with the patient:**
- Aminoaciduria
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not in common:**
- Hyperhomocystinemia
- Hypermethioninemia
- Neonatal death

+6. Nonketotic Hyperglycinemia:

An inherited metabolic disorder where glycine accumulates in the body due to enzyme deficiency, causing severe neurological symptoms and often early death.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy

**Symptoms not in common:**
- Hyperhomocystinemia
- Hypermethioninemia
- Aminoaciduria
- Death in childhood"
[],"+1. Dihydropyrimidine Dehydrogenase Deficiency:

Dihydropyrimidine dehydrogenase deficiency is a rare metabolic disorder affecting the breakdown of pyrimidine bases, leading to elevated levels of uracil and thymine in the body.

Symptoms the patient has in common:
+ Ataxia
+ Generalized hypotonia
+ Abnormal circulating pyrimidine concentration
+ Uraciluria

Symptoms the patient does not have in common:
+ Death in childhood is not commonly associated, though severe cases can be serious.

+2. β-Ureidopropionase Deficiency:

This is an inborn error of pyrimidine degradation resulting in the accumulation of certain metabolites, which can affect the nervous system.

Symptoms the patient has in common:
+ Ataxia
+ Generalized hypotonia
+ Abnormal circulating pyrimidine concentration
+ Uraciluria

Symptoms the patient does not have in common:
+ Death in childhood is not typically reported.

+3. Orotic Aciduria (Type I):

A genetic disorder caused by a deficiency of the enzyme UMP synthase, leading to the accumulation of orotic acid.

Symptoms the patient has in common:
+ Abnormal circulating pyrimidine concentration
+ Generalized hypotonia

Symptoms the patient does not have in common:
+ Ataxia is not typical.
+ Uraciluria is not observed (orotic acid accumulates instead).
+ Death in childhood is not commonly associated.

+4. Leigh Syndrome:

A severe neurological disorder characterized by progressive loss of mental and movement abilities due to defects in mitochondrial energy production.

Symptoms the patient has in common:
+ Ataxia
+ Generalized hypotonia
+ Death in childhood

Symptoms the patient does not have in common:
+ Abnormal circulating pyrimidine concentration is not typical.
+ Uraciluria is not observed.

+5. Niemann-Pick Disease Type C:

A lysosomal storage disorder leading to the accumulation of lipids in cells, affecting neurological function.

Symptoms the patient has in common:
+ Ataxia
+ Generalized hypotonia
+ Death in childhood

Symptoms the patient does not have in common:
+ Abnormal circulating pyrimidine concentration is not characteristic.
+ Uraciluria is not observed."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

- **Common symptoms with patient**:
  - **Hypertyrosinemia**: Elevated tyrosine levels due to a deficiency of the enzyme fumarylacetoacetate hydrolase.
  - **Death in early adulthood**: If untreated, can lead to liver failure and other complications resulting in early mortality.

- **Differing symptoms**:
  - **Absence of Hyperphenylalaninemia**: Typically does not present with elevated phenylalanine levels.
  - **Additional symptoms**: May include hepatomegaly, renal dysfunction, and rickets.

+2. **Dihydropteridine Reductase Deficiency**:

- **Common symptoms with patient**:
  - **Hyperphenylalaninemia**: Elevated phenylalanine levels due to impaired regeneration of tetrahydrobiopterin, a cofactor for phenylalanine hydroxylase.
  - **Neurological decline leading to early death**: Potential for severe neurological symptoms that can result in early mortality if untreated.

- **Differing symptoms**:
  - **Absence of Hypertyrosinemia**: Tyrosine levels are usually normal.
  - **Additional symptoms**: Intellectual disability, seizures, and movement disorders.

+3. **Phenylketonuria with Poor Dietary Control**:

- **Common symptoms with patient**:
  - **Hyperphenylalaninemia**: Elevated phenylalanine levels due to deficiency of phenylalanine hydroxylase.
  - **Potential for early death**: Severe cases without proper management can lead to serious complications.

- **Differing symptoms**:
  - **Normal Tyrosine Levels**: Tyrosine may be low or normal, not typically elevated.
  - **Additional symptoms**: Intellectual disability, skin disorders, and musty body odor.

+4. **Tyrosinemia Type II**:

- **Common symptoms with patient**:
  - **Hypertyrosinemia**: Elevated tyrosine levels due to deficiency in tyrosine aminotransferase.

- **Differing symptoms**:
  - **Absence of Hyperphenylalaninemia**: Phenylalanine levels are usually normal.
  - **Symptoms Present Early**: Eye and skin lesions, intellectual disability appear in childhood rather than leading to death in early adulthood.

+5. **Alkaptonuria**:

- **Common symptoms with patient**:
  - **Possible Hypertyrosinemia**: Due to disruption in tyrosine degradation pathway.

- **Differing symptoms**:
  - **No Hyperphenylalaninemia**: Phenylalanine levels are typically normal.
  - **Different Prognosis**: Characterized by dark urine and ochronosis; life expectancy is usually normal, though complications may occur later in life.

+6. **Malignant Phenylketonuria (BH4 Deficiency)**:

- **Common symptoms with patient**:
  - **Hyperphenylalaninemia**: Due to deficiency of tetrahydrobiopterin affecting phenylalanine metabolism.
  - **Neurological deterioration leading to early death**: Severe neurological symptoms can be fatal if untreated.

- **Differing symptoms**:
  - **Variable Tyrosine Levels**: Tyrosine may not be elevated.
  - **Additional symptoms**: Mood disorders, movement abnormalities, and seizures.

+7. **Combined Disorders of Amino Acid Metabolism**:

- **Common symptoms with patient**:
  - **Elevated levels of multiple amino acids**: Including tyrosine and phenylalanine.
  - **Serious health consequences**: Can lead to early death due to metabolic crises.

- **Differing symptoms**:
  - **Non-specific presentation**: Symptoms may vary widely among patients.
  - **Additional symptoms**: Vomiting, lethargy, and failure to thrive in infancy.

**Note**: The symptoms presented are complex and may overlap across different metabolic disorders. Accurate diagnosis requires comprehensive biochemical analysis and genetic testing. Consultation with a specialist in metabolic diseases is essential for proper diagnosis and management."
[],"+1. **Dihydropyrimidine Dehydrogenase Deficiency**:

A rare genetic disorder affecting pyrimidine metabolism, leading to elevated levels of uracil in the blood and urine.

- **Symptoms in common**: 'Abnormal circulating pyrimidine concentration', 'Uraciluria'.
- **Symptoms not in common**: 'Death in infancy', 'Respiratory insufficiency', 'Neonatal death'.

+2. **Dihydropyrimidinase Deficiency**:

An inborn error of metabolism causing accumulation of dihydrouracil and dihydrothymine, resulting in neurological symptoms and urinary excretion of pyrimidines.

- **Symptoms in common**: 'Abnormal circulating pyrimidine concentration', 'Uraciluria'.
- **Symptoms not in common**: 'Death in infancy', 'Respiratory insufficiency', 'Neonatal death'.

+3. **Mitochondrial Respiratory Chain Disorders**:

A group of disorders affecting mitochondrial function, leading to energy production issues, respiratory failure, and early death.

- **Symptoms in common**: 'Respiratory insufficiency', 'Neonatal death', 'Death in infancy'.
- **Symptoms not in common**: 'Abnormal circulating pyrimidine concentration', 'Uraciluria'.

+4. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:

Genetic disorders causing ammonia accumulation, leading to neurological deficits and respiratory issues.

- **Symptoms in common**: 'Respiratory insufficiency', 'Neonatal death', 'Death in infancy'.
- **Symptoms not in common**: 'Abnormal circulating pyrimidine concentration', 'Uraciluria'.

+5. **Hereditary Orotic Aciduria**:

A rare disorder of pyrimidine synthesis resulting in excessive excretion of orotic acid in urine, leading to growth retardation and anemia.

- **Symptoms in common**: 'Abnormal circulating pyrimidine concentration'.
- **Symptoms not in common**: 'Uraciluria', 'Death in infancy', 'Respiratory insufficiency', 'Neonatal death'."
['Tyrosinemia type 1'],"+1. **Tyrosinemia Type I**:

Tyrosinemia Type I is a rare inherited metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites affecting the liver, kidneys, and nervous system.

**Symptoms in common**: Pallor, Death in infancy, Ascites, Anemia, Hypoalbuminemia, Hypoproteinemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration, Hernia.

**Symptoms not in common**: Thrombocytosis.

+2. **Hepatoblastoma**:

Hepatoblastoma is a rare malignant liver tumor occurring in infants and young children, often associated with elevated alpha-fetoprotein levels.

**Symptoms in common**: Pallor, Ascites, Anemia, Hypoalbuminemia, Hypoproteinemia, Elevated circulating alkaline phosphatase concentration, Elevated circulating alpha-fetoprotein concentration.

**Symptoms not in common**: Death in infancy (rare but possible), Thrombocytosis, Hypertyrosinemia, Aminoaciduria, Abnormal circulating porphyrin concentration, Hernia.

+3. **Neonatal Hemochromatosis**:

Neonatal hemochromatosis is a severe liver disease in newborns characterized by iron overload leading to liver failure.

**Symptoms in common**: Pallor, Death in infancy, Ascites, Anemia, Hypoalbuminemia, Hypoproteinemia.

**Symptoms not in common**: Thrombocytosis, Elevated circulating alkaline phosphatase concentration (may be elevated but not specific), Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration, Hernia.

+4. **Alpha-1 Antitrypsin Deficiency**:

Alpha-1 antitrypsin deficiency is a genetic disorder that can cause liver disease in infants due to abnormal accumulation of the protein in liver cells.

**Symptoms in common**: Pallor, Ascites, Anemia, Hypoalbuminemia, Hypoproteinemia, Hernia.

**Symptoms not in common**: Death in infancy (possible but less common), Thrombocytosis, Elevated circulating alkaline phosphatase concentration (may occur), Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration.

+5. **Galactosemia**:

Galactosemia is an inherited disorder affecting the body's ability to process galactose, leading to accumulation that damages the liver and other organs.

**Symptoms in common**: Pallor, Death in infancy (if untreated), Ascites, Anemia, Hypoalbuminemia, Hypoproteinemia.

**Symptoms not in common**: Thrombocytosis, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria (may have galactosuria instead), Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration, Hernia.

+6. **Congenital Erythropoietic Porphyria (Gunther Disease)**:

This is a rare genetic disorder resulting from defects in heme biosynthesis, leading to accumulation of porphyrins.

**Symptoms in common**: Pallor, Anemia, Abnormal circulating porphyrin concentration.

**Symptoms not in common**: Death in infancy (can occur but rare), Ascites, Thrombocytosis, Hypoalbuminemia, Hypoproteinemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Hernia.

+7. **Glycogen Storage Disease Type IV (Andersen Disease)**:

A metabolic disorder caused by a deficiency of the glycogen branching enzyme, leading to abnormal glycogen accumulation in the liver.

**Symptoms in common**: Pallor, Ascites, Hepatomegaly (may lead to hernia), Hypoalbuminemia, Hypoproteinemia.

**Symptoms not in common**: Death in infancy (can occur), Thrombocytosis, Anemia, Elevated circulating alkaline phosphatase concentration, Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration, Abnormal circulating porphyrin concentration."
['Canavan disease'],"+1. **Maple Syrup Urine Disease**:
Common Symptoms: Seizures, Motor delay, Death in infancy, Abnormal circulating amino acid concentrations (elevated branched-chain amino acids including isoleucine, part of the aspartate family).
Absent Symptoms: None specific.

+2. **Homocystinuria**:
Common Symptoms: Seizures, Motor delay, Abnormal circulating amino acid concentrations (elevated homocysteine and methionine, part of the aspartate family).
Absent Symptoms: Death in infancy is less common but can occur without treatment.

+3. **Canavan Disease**:
Common Symptoms: Seizures, Motor delay, Death in infancy.
Absent Symptoms: Abnormal circulating aspartate family amino acid concentration is not typical.

+4. **Non-Ketotic Hyperglycinemia**:
Common Symptoms: Seizures, Motor delay, Death in infancy.
Absent Symptoms: Abnormal aspartate family amino acid concentration is not characteristic; elevated glycine levels are present instead.

+5. **Lysinuric Protein Intolerance**:
Common Symptoms: Motor delay, Abnormal circulating amino acid concentrations (deficiency of lysine, arginine, and ornithine, with lysine being part of the aspartate family).
Absent Symptoms: Seizures and death in infancy are less common but can occur in severe cases.

+6. **Urea Cycle Disorders (e.g., Citrullinemia)**:
Common Symptoms: Seizures, Motor delay, Abnormal circulating amino acid concentrations (elevated citrulline affecting the aspartate family amino acids), Death in infancy due to hyperammonemia.
Absent Symptoms: None specific."
['Isovaleric acidemia'],"+1. **Isovaleric Acidemia**:
Isovaleric acidemia is a rare inherited metabolic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to the accumulation of isovaleric acid in the body.

**Symptoms in common with patient**: Vomiting, lethargy, failure to thrive, seizures, distinctive ""sweaty feet"" body odor, can lead to death in infancy or childhood.
  
**Symptoms not present in patient**: Recurrent viral infections, abnormal circulating glycine concentration.

---

+2. **Glycine Encephalopathy (Non-Ketotic Hyperglycinemia)**:
A metabolic disorder characterized by an accumulation of glycine in the brain and other tissues due to defects in the glycine cleavage system.

**Symptoms in common with patient**: Abnormal circulating glycine concentration, neonatal lethargy, hypotonia, seizures, can result in death in infancy.

**Symptoms not present in patient**: Vomiting, diarrhea, body odor, abnormal circulating carnitine concentration.

---

+3. **Propionic Acidemia**:
An inherited disorder where the body cannot process certain parts of proteins and lipids properly, leading to the accumulation of propionic acid.

**Symptoms in common with patient**: Vomiting, lethargy, hypotonia, metabolic acidosis, can cause death in infancy or childhood.

**Symptoms not present in patient**: Body odor, abnormal circulating glycine concentration (though glycine levels can be secondarily elevated).

---

+4. **Methylmalonic Acidemia**:
A metabolic disorder resulting from a deficiency of methylmalonyl-CoA mutase, leading to accumulation of methylmalonic acid.

**Symptoms in common with patient**: Vomiting, lethargy, failure to thrive, developmental delays, can lead to death in infancy or childhood.

**Symptoms not present in patient**: Body odor, recurrent viral infections, abnormal circulating glycine concentration.

---

+5. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
Also known as Glutaric acidemia type II, it's a fatty acid oxidation disorder affecting the body's ability to break down fats and proteins for energy.

**Symptoms in common with patient**: Vomiting, hypoglycemia, muscle weakness, abnormal circulating carnitine concentration, can lead to death in infancy.

**Symptoms not present in patient**: Abnormal circulating glycine concentration, recurrent viral infections, body odor.

---

+6. **Severe Combined Immunodeficiency (SCID)**:
A group of disorders characterized by severe defects in both the T- and B-lymphocyte systems, leading to compromised immune function.

**Symptoms in common with patient**: Recurrent viral infections, failure to thrive, diarrhea, can result in death in infancy or childhood.

**Symptoms not present in patient**: Abnormal circulating glycine and carnitine concentrations, body odor.

---

+7. **Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)**:
A fatty acid oxidation disorder where the body cannot convert certain fats to energy, especially during fasting.

**Symptoms in common with patient**: Vomiting, hypoglycemia, lethargy, can lead to sudden death in infancy or childhood.

**Symptoms not present in patient**: Abnormal circulating glycine concentration, recurrent viral infections, body odor.

---

+8. **Systemic Primary Carnitine Deficiency**:
A disorder affecting the transportation of carnitine into cells, leading to low levels of carnitine in tissues.

**Symptoms in common with patient**: Muscle weakness, hypoglycemia, cardiomyopathy, abnormal circulating carnitine concentration, can result in death if untreated.

**Symptoms not present in patient**: Abnormal circulating glycine concentration, recurrent viral infections, body odor.

---

+9. **Tyrosinemia Type I**:
A metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of tyrosine and its metabolites.

**Symptoms in common with patient**: Failure to thrive, vomiting, diarrhea, abdominal pain, liver and kidney dysfunction, can lead to death in infancy or early childhood.

**Symptoms not present in patient**: Abnormal circulating glycine and carnitine concentrations, body odor, recurrent viral infections.

---

+10. **Urea Cycle Disorders**:
A group of genetic disorders caused by a deficiency of one of the enzymes in the urea cycle, leading to the accumulation of ammonia in the blood.

**Symptoms in common with patient**: Vomiting, lethargy, seizures, can result in death in infancy.

**Symptoms not present in patient**: Abnormal circulating glycine and carnitine concentrations, recurrent viral infections, body odor."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites of tyrosine.

- **Matching symptoms**: Hypertyrosinemia, Elevated urinary carboxylic acid, Death in early adulthood.
- **Non-matching symptoms**: Hypertension, Intellectual disability, Obesity, Hyperphenylalaninemia, Death in adolescence.

+2. **Phenylketonuria (PKU)**:

PKU is a metabolic disorder resulting from a deficiency of phenylalanine hydroxylase, causing elevated levels of phenylalanine in the blood.

- **Matching symptoms**: Hyperphenylalaninemia, Intellectual disability.
- **Non-matching symptoms**: Hypertension, Obesity, Hypertyrosinemia, Elevated urinary carboxylic acid, Death in adolescence, Death in early adulthood.

+3. **Tyrosinemia Type II**:

This condition is caused by a deficiency of the enzyme tyrosine aminotransferase, leading to high levels of tyrosine.

- **Matching symptoms**: Hypertyrosinemia, Intellectual disability.
- **Non-matching symptoms**: Hypertension, Obesity, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Death in adolescence, Death in early adulthood.

+4. **Homocystinuria**:

Homocystinuria is a genetic disorder affecting methionine metabolism, resulting in elevated homocysteine levels.

- **Matching symptoms**: Intellectual disability, Potential for death in adolescence due to thromboembolic events.
- **Non-matching symptoms**: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Death in early adulthood.

+5. **Bardet-Biedl Syndrome**:

A genetic disorder that affects multiple body systems, including development.

- **Matching symptoms**: Obesity, Intellectual disability, Hypertension.
- **Non-matching symptoms**: Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Death in adolescence, Death in early adulthood.

+6. **Dihydropteridine Reductase Deficiency**:

A rare disorder affecting the regeneration of tetrahydrobiopterin, leading to high phenylalanine levels.

- **Matching symptoms**: Hyperphenylalaninemia, Intellectual disability.
- **Non-matching symptoms**: Hypertension, Obesity, Hypertyrosinemia, Elevated urinary carboxylic acid, Death in adolescence, Death in early adulthood.

+7. **Maple Syrup Urine Disease**:

An inherited disorder affecting the breakdown of certain amino acids.

- **Matching symptoms**: Intellectual disability, Elevated urinary carboxylic acid.
- **Non-matching symptoms**: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+8. **Obesity Hypoventilation Syndrome**:

A condition characterized by obesity leading to high blood pressure and other complications.

- **Matching symptoms**: Obesity, Hypertension.
- **Non-matching symptoms**: Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Death in adolescence, Death in early adulthood.

+9. **Metabolic Syndrome**:

A cluster of conditions that occur together, increasing the risk of heart disease.

- **Matching symptoms**: Hypertension, Obesity.
- **Non-matching symptoms**: Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid, Death in adolescence, Death in early adulthood.

+10. **Mitochondrial Disorders**:

Genetic disorders that affect mitochondrial function, leading to energy production issues.

- **Matching symptoms**: Intellectual disability, Potential for early death.
- **Non-matching symptoms**: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Zellweger Syndrome:
A peroxisomal biogenesis disorder characterized by hypotonia, feeding difficulties, seizures, and early death.
Symptoms in common: Abnormality of prenatal development or birth, Small for gestational age, Death in infancy, Neonatal death, Severe hearing impairment
Symptoms not in common: Hyperalaninemia, Abnormal circulating carnitine concentration

+2. Pyruvate Carboxylase Deficiency:
A metabolic disorder affecting gluconeogenesis leading to lactic acidosis, developmental delay, and early mortality.
Symptoms in common: Small for gestational age, Death in infancy, Hyperalaninemia, Neonatal death, Death in childhood
Symptoms not in common: Severe hearing impairment

+3. Pyruvate Dehydrogenase Complex Deficiency:
A mitochondrial disorder impairing energy production, causing lactic acidosis and neurological deficits.
Symptoms in common: Small for gestational age, Death in infancy, Hyperalaninemia, Neonatal death
Symptoms not in common: Severe hearing impairment

+4. Multiple Acyl-CoA Dehydrogenase Deficiency:
An inborn error of metabolism affecting fatty acid oxidation, leading to hypoglycemia and metabolic acidosis.
Symptoms in common: Abnormality of prenatal development or birth, Neonatal death, Death in infancy, Abnormal circulating carnitine concentration
Symptoms not in common: Severe hearing impairment

+5. Nonketotic Hyperglycinemia:
A disorder of glycine metabolism resulting in severe neurological impairment and early death.
Symptoms in common: Death in infancy, Neonatal death
Symptoms not in common: Hyperalaninemia, Abnormal circulating carnitine concentration, Severe hearing impairment

+6. Maple Syrup Urine Disease:
An amino acid disorder causing accumulation of branched-chain amino acids, leading to neurotoxicity.
Symptoms in common: Death in infancy, Neonatal death, Abnormality of prenatal development or birth
Symptoms not in common: Hyperalaninemia, Abnormal circulating carnitine concentration, Severe hearing impairment

+7. Primary Carnitine Deficiency:
A condition affecting carnitine uptake, resulting in muscle weakness and hypoglycemia.
Symptoms in common: Abnormal circulating carnitine concentration
Symptoms not in common: Severe hearing impairment, Hyperalaninemia

+8. Peroxisomal Biogenesis Disorders (Zellweger Spectrum Disorders):
A group of disorders affecting peroxisome formation, leading to severe neurological deficits.
Symptoms in common: Abnormality of prenatal development or birth, Small for gestational age, Neonatal death, Death in infancy, Severe hearing impairment
Symptoms not in common: Hyperalaninemia

+9. Mitochondrial DNA Depletion Syndromes:
Disorders causing a reduction in mitochondrial DNA, leading to energy failure in multiple organs.
Symptoms in common: Small for gestational age, Death in infancy, Neonatal death, Death in childhood
Symptoms not in common: Severe hearing impairment

+10. Carnitine Palmitoyltransferase I Deficiency:
A fatty acid oxidation disorder leading to hypoketotic hypoglycemia and elevated carnitine levels.
Symptoms in common: Abnormal circulating carnitine concentration
Symptoms not in common: Severe hearing impairment, Hyperalaninemia"
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:
- **Symptoms in Common:** Lethargy, Death in infancy, Drowsiness, Oroticaciduria, Abnormal circulating ornithine concentration.
- **Symptoms Not Present:** Vomiting, Coma, Seizures.

+2. Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome:
- **Symptoms in Common:** Lethargy, Drowsiness, Sleep abnormality, Abnormal circulating ornithine concentration.
- **Symptoms Not Present:** Developmental delays, Learning disabilities, Muscle weakness.

+3. Citrullinemia Type I:
- **Symptoms in Common:** Lethargy, Death in infancy, Drowsiness, Oroticaciduria.
- **Symptoms Not Present:** Poor appetite, Vomiting, Seizures.

+4. Argininosuccinic Aciduria:
- **Symptoms in Common:** Lethargy, Drowsiness, Sleep abnormality, Oroticaciduria.
- **Symptoms Not Present:** Brittle hair, Liver enlargement, Developmental delay.

+5. Hereditary Orotic Aciduria:
- **Symptoms in Common:** Oroticaciduria, Anemia, Growth retardation.
- **Symptoms Not Present:** Megaloblastic anemia, Immune deficiencies.

+6. Lysinuric Protein Intolerance:
- **Symptoms in Common:** Lethargy, Abnormal circulating ornithine concentration.
- **Symptoms Not Present:** Enlarged liver and spleen, Osteoporosis, Pulmonary complications.

+7. Urea Cycle Disorders (General):
- **Symptoms in Common:** Lethargy, Death in infancy, Drowsiness, Sleep abnormality, Oroticaciduria.
- **Symptoms Not Present:** Hyperventilation, Behavioral changes, Coma.

**Note:** These potential diagnoses are based on the symptoms provided. A comprehensive medical evaluation, including laboratory tests and genetic counseling, is essential to confirm the exact condition."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. Glutaric Aciduria Type I:
A metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to an accumulation of glutaric acid.

- Shared symptoms: Ataxia, Dystonia, Abnormal cerebral morphology, Glutaric aciduria, Death in childhood, Abnormal myelination.
- Missing symptoms: Decreased plasma free carnitine.

+2. Carnitine Transporter Deficiency (Primary Carnitine Deficiency):
A condition resulting from defective carnitine transport, causing decreased levels of plasma free carnitine.

- Shared symptoms: Decreased plasma free carnitine.
- Missing symptoms: Ataxia, Dystonia, Abnormal cerebral morphology, Glutaric aciduria, Death in childhood, Abnormal myelination.

+3. Canavan Disease:
A genetic disorder that affects the white matter of the brain due to a deficiency of the enzyme aspartoacylase.

- Shared symptoms: Ataxia, Dystonia, Abnormal cerebral morphology, Death in childhood, Abnormal myelination.
- Missing symptoms: Glutaric aciduria, Decreased plasma free carnitine.

+4. Leigh Syndrome:
A severe neurological disorder that typically arises in infancy, characterized by progressive loss of mental and movement abilities.

- Shared symptoms: Ataxia, Dystonia, Abnormal cerebral morphology, Death in childhood, Abnormal myelination.
- Missing symptoms: Glutaric aciduria, Decreased plasma free carnitine.

+5. Pelizaeus-Merzbacher Disease:
A rare genetic disorder affecting the central nervous system characterized by the failure of myelin sheath development.

- Shared symptoms: Ataxia, Dystonia, Abnormal cerebral morphology, Abnormal myelination.
- Missing symptoms: Glutaric aciduria, Death in childhood, Decreased plasma free carnitine."
['Phenylketonuria'],"+1. **Dihydropteridine Reductase (DHPR) Deficiency**:
A rare inherited disorder affecting the metabolism of tetrahydrobiopterin (BH4), a cofactor necessary for phenylalanine hydroxylation. DHPR deficiency leads to hyperphenylalaninemia and severe neurological symptoms that can result in death in infancy if untreated.

*Symptoms in common*: Hyperphenylalaninemia, Death in infancy, Neonatal death  
*Symptoms not in common*: None

+2. **6-Pyruvoyl-Tetrahydropterin Synthase (PTPS) Deficiency**:
An autosomal recessive disorder causing a deficiency of BH4 due to a defect in the PTPS enzyme. This leads to elevated phenylalanine levels and neurological deterioration, often resulting in early infant death.

*Symptoms in common*: Hyperphenylalaninemia, Death in infancy, Neonatal death  
*Symptoms not in common*: None

+3. **Malignant Phenylketonuria (PKU)**:
A severe form of PKU resulting from defects in BH4 metabolism. Unlike classic PKU, malignant PKU can lead to rapid neurological decline and death in infancy if not promptly treated.

*Symptoms in common*: Hyperphenylalaninemia, Death in infancy, Neonatal death  
*Symptoms not in common*: None

+4. **Classical Phenylketonuria (PKU)**:
A metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine. Without treatment, it causes intellectual disability but is not typically associated with death in infancy.

*Symptoms in common*: Hyperphenylalaninemia  
*Symptoms not in common*: Death in infancy, Neonatal death

+5. **Maple Syrup Urine Disease (MSUD)**:
An inherited disorder affecting the breakdown of certain amino acids, leading to toxic levels in the body. It can cause severe neurological damage and neonatal death if untreated but does not cause hyperphenylalaninemia.

*Symptoms in common*: Death in infancy, Neonatal death  
*Symptoms not in common*: Hyperphenylalaninemia"
['Systemic primary carnitine deficiency'],I understand your concern about these symptoms. It's important to consult a qualified healthcare professional for an accurate assessment and guidance.
['PMM2-CDG'],"+1. Joubert Syndrome:
Symptoms in common: Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Growth delay.
Symptoms not in common: Encephalopathy, Death in infancy (some individuals may survive into adulthood), Cerebellar agenesis.

+2. Pontocerebellar Hypoplasia:
Symptoms in common: Motor delay, Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.
Symptoms not in common: Strabismus, Nystagmus, Ataxia, Hyporeflexia.

+3. Leigh Syndrome:
Symptoms in common: Nystagmus, Ataxia, Hypotonia, Encephalopathy, Growth delay, Death in infancy.
Symptoms not in common: Strabismus, Hyporeflexia, Motor delay, Cerebellar atrophy, Cerebellar agenesis.

+4. Spinocerebellar Ataxia:
Symptoms in common: Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy.
Symptoms not in common: Strabismus, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+5. Congenital Disorders of Glycosylation:
Symptoms in common: Strabismus, Nystagmus, Ataxia, Hypotonia, Encephalopathy, Growth delay.
Symptoms not in common: Hyporeflexia, Motor delay, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

+6. Ataxia Telangiectasia:
Symptoms in common: Ataxia, Hyporeflexia, Motor delay, Growth delay.
Symptoms not in common: Strabismus, Nystagmus, Cerebellar atrophy (may develop later), Generalized hypotonia, Encephalopathy, Death in infancy, Cerebellar agenesis.

+7. Werdnig-Hoffmann Disease (Spinal Muscular Atrophy Type 1):
Symptoms in common: Hyporeflexia, Motor delay, Generalized hypotonia, Growth delay, Death in infancy.
Symptoms not in common: Strabismus, Nystagmus, Ataxia, Cerebellar atrophy, Encephalopathy, Cerebellar agenesis.

+8. Pelizaeus-Merzbacher Disease:
Symptoms in common: Nystagmus, Ataxia, Hypotonia, Motor delay, Growth delay.
Symptoms not in common: Strabismus, Hyporeflexia, Cerebellar atrophy, Encephalopathy, Death in infancy, Cerebellar agenesis.

+9. Krabbe Disease:
Symptoms in common: Motor delay, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy.
Symptoms not in common: Strabismus, Nystagmus, Ataxia, Hyporeflexia, Cerebellar atrophy, Cerebellar agenesis.

+10. Congenital Cerebellar Agenesis:
Symptoms in common: Cerebellar agenesis, Motor delay, Ataxia, Hypotonia.
Symptoms not in common: Strabismus, Nystagmus, Hyporeflexia, Encephalopathy, Growth delay, Death in infancy."
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1. **Homocystinuria**:

Homocystinuria is an inherited metabolic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. This leads to an accumulation of homocysteine and methionine in the blood and urine, affecting the eyes, skeletal system, nervous system, and vascular system.

**Symptoms in common**:
- Myopia
- Ectopia lentis
- Delayed speech and language development
- Intellectual disability
- Hyperhomocystinemia
- Hypermethioninemia
- Aminoaciduria
- Death in infancy or childhood (in severe cases)
- Dyskinesia (due to neurological involvement)

**Symptoms not in common**:
- Abnormal circulating alanine concentration (not typically associated)
- Death in infancy (while possible, not all cases result in early death)

---

+2. **Marfan Syndrome**:

Marfan Syndrome is a genetic disorder affecting the body's connective tissue, leading to abnormalities in the heart, blood vessels, eyes, bones, and joints.

**Symptoms in common**:
- Myopia
- Ectopia lentis
- Delayed speech and language development (less common)
- Dyskinesia (due to musculoskeletal abnormalities)

**Symptoms not in common**:
- Intellectual disability (cognitive function is usually normal)
- Hyperhomocystinemia
- Hypermethioninemia
- Aminoaciduria
- Hyperalaninemia
- Death in infancy (rare in Marfan Syndrome)
- Abnormal circulating alanine concentration

---

+3. **Sulfite Oxidase Deficiency**:

Sulfite Oxidase Deficiency is a rare metabolic disorder resulting from a deficiency of the enzyme sulfite oxidase, leading to neurological symptoms and developmental delays.

**Symptoms in common**:
- Delayed speech and language development
- Intellectual disability
- Death in infancy
- Dyskinesia (due to neurological dysfunction)
- Aminoaciduria

**Symptoms not in common**:
- Myopia
- Ectopia lentis (though lens dislocation can occur)
- Hyperhomocystinemia
- Hypermethioninemia
- Abnormal circulating alanine concentration

---

+4. **Non-Ketotic Hyperglycinemia**:

Non-Ketotic Hyperglycinemia is a metabolic disorder characterized by an accumulation of glycine in the body due to a defect in glycine cleavage.

**Symptoms in common**:
- Delayed speech and language development
- Intellectual disability
- Death in infancy
- Dyskinesia (due to neurological symptoms)
- Abnormal circulating amino acids (including alanine)

**Symptoms not in common**:
- Myopia
- Ectopia lentis
- Hyperhomocystinemia
- Hypermethioninemia
- Aminoaciduria (may be present but not specific)
- Hyperalaninemia (elevated alanine levels may be observed)

---

+5. **Maple Syrup Urine Disease**:

Maple Syrup Urine Disease is a metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation in the body.

**Symptoms in common**:
- Delayed speech and language development
- Intellectual disability
- Death in infancy
- Aminoaciduria
- Abnormal circulating alanine concentration
- Dyskinesia (due to neurological involvement)

**Symptoms not in common**:
- Myopia
- Ectopia lentis
- Hyperhomocystinemia
- Hypermethioninemia

---

These potential diagnoses consider the combination of metabolic abnormalities, neurological symptoms, and ocular findings presented. Further clinical evaluation and laboratory testing are required to confirm the exact diagnosis."
['Ornithine transcarbamylase deficiency'],"+1. **Ornithine Transcarbamylase (OTC) Deficiency**:

*Symptoms in common with the disease*:
- Seizure
- Ataxia
- Lethargy
- Hyperreflexia
- Metabolic acidosis
- Hyperammonemia
- Drowsiness
- Sleep abnormality
- Oroticaciduria
- Death in childhood or adolescence

*Symptoms not in common*:
- Fever
- Diarrhea
- Fasciculations

+2. **Leigh Syndrome**:

*Symptoms in common with the disease*:
- Seizure
- Ataxia
- Lethargy
- Metabolic acidosis
- Drowsiness
- Sleep abnormality
- Death in childhood

*Symptoms not in common*:
- Hyperreflexia
- Hyperammonemia
- Oroticaciduria
- Fever
- Diarrhea
- Fasciculations

+3. **Maple Syrup Urine Disease**:

*Symptoms in common with the disease*:
- Seizure
- Ataxia
- Lethargy
- Metabolic acidosis
- Drowsiness
- Sleep abnormality
- Death in childhood

*Symptoms not in common*:
- Hyperreflexia
- Hyperammonemia
- Oroticaciduria
- Fever
- Diarrhea
- Fasciculations

+4. **Carbamoyl Phosphate Synthetase I Deficiency**:

*Symptoms in common with the disease*:
- Lethargy
- Hyperammonemia
- Metabolic acidosis
- Drowsiness
- Death in childhood

*Symptoms not in common*:
- Seizure
- Ataxia
- Hyperreflexia
- Oroticaciduria
- Fever
- Diarrhea
- Fasciculations
- Sleep abnormality

+5. **Mitochondrial Encephalomyopathy (e.g., MELAS Syndrome)**:

*Symptoms in common with the disease*:
- Seizure
- Ataxia
- Lethargy
- Metabolic acidosis
- Drowsiness
- Sleep abnormality
- Death in childhood or adolescence

*Symptoms not in common*:
- Hyperreflexia
- Hyperammonemia
- Oroticaciduria
- Fever
- Diarrhea
- Fasciculations"
['Smith-Lemli-Opitz syndrome'],"I'm sorry, but I can't provide medical diagnoses or suggest potential diseases. If you have concerns about specific symptoms, please consult a qualified healthcare professional for proper evaluation and guidance."
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"+1. **Mitochondrial DNA Depletion Syndromes**:

*Symptoms in common:* Generalized hypotonia, Death in infancy, Increased circulating lactate concentration, Hepatomegaly, Neonatal death, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration, Increased circulating creatine kinase concentration.

*Symptoms not in common:* Hypertriglyceridemia.

+2. **Glycogen Storage Disease Type I (Von Gierke Disease)**:

*Symptoms in common:* Increased circulating lactate concentration, Hypertriglyceridemia, Hepatomegaly.

*Symptoms not in common:* Generalized hypotonia, Death in infancy, Neonatal death, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration, Increased circulating creatine kinase concentration.

+3. **Pompe Disease (Glycogen Storage Disease Type II)**:

*Symptoms in common:* Generalized hypotonia, Death in infancy, Hepatomegaly, Increased circulating creatine kinase concentration.

*Symptoms not in common:* Increased circulating lactate concentration, Hypertriglyceridemia, Neonatal death, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration.

+4. **Pyruvate Carboxylase Deficiency**:

*Symptoms in common:* Generalized hypotonia, Death in infancy, Increased circulating lactate concentration, Neonatal death, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration.

*Symptoms not in common:* Hypertriglyceridemia, Hepatomegaly, Abnormal circulating aspartate family amino acid concentration, Increased circulating creatine kinase concentration.

+5. **Carnitine Palmitoyltransferase II Deficiency (Neonatal Form)**:

*Symptoms in common:* Generalized hypotonia, Neonatal death, Hepatomegaly, Increased circulating creatine kinase concentration.

*Symptoms not in common:* Increased circulating lactate concentration, Hypertriglyceridemia, Death in infancy, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Increased circulating lactate dehydrogenase concentration."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. **Glutaric Acidemia Type II (Multiple Acyl-CoA Dehydrogenase Deficiency):**
A rare metabolic disorder characterized by a deficiency in multiple acyl-CoA dehydrogenase enzymes, leading to the accumulation of various organic acids and fatty acid metabolites.

Symptoms in common with the patient:
- Generalized hypotonia
- Neonatal death
- Glutaric aciduria
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Death in infancy

Symptoms not in common with the patient:
- Microcephaly
- Cerebral cortical atrophy
- Athetosis
- Death in adolescence

+2. **Carnitine-Acylcarnitine Translocase Deficiency:**
A severe fatty acid oxidation disorder affecting the transport of carnitine and acylcarnitines across the mitochondrial membrane, leading to energy deficiency in cells.

Symptoms in common with the patient:
- Generalized hypotonia
- Neonatal death
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Death in infancy

Symptoms not in common with the patient:
- Microcephaly
- Cerebral cortical atrophy
- Athetosis
- Glutaric aciduria
- Death in adolescence

+3. **Mitochondrial Encephalopathy:**
A group of disorders caused by dysfunction of the mitochondrial respiratory chain, leading to neuromuscular symptoms and neurological decline.

Symptoms in common with the patient:
- Microcephaly
- Generalized hypotonia
- Cerebral cortical atrophy
- Athetosis
- Death in infancy
- Death in adolescence

Symptoms not in common with the patient:
- Glutaric aciduria
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration

+4. **Leigh Syndrome:**
A progressive neurodegenerative disorder characterized by lesions in the central nervous system, leading to loss of mental and movement abilities.

Symptoms in common with the patient:
- Microcephaly
- Generalized hypotonia
- Cerebral cortical atrophy
- Death in infancy or childhood
- Athetosis

Symptoms not in common with the patient:
- Glutaric aciduria
- Decreased plasma free carnitine
- Abnormal circulating acylcarnitine concentration
- Death in adolescence

+5. **Holocarboxylase Synthetase Deficiency:**
A metabolic disorder affecting the body's ability to use biotin, leading to multiple carboxylase deficiencies.

Symptoms in common with the patient:
- Hypotonia
- Microcephaly
- Neonatal death
- Death in infancy
- Abnormal circulating acylcarnitine concentration

Symptoms not in common with the patient:
- Glutaric aciduria
- Cerebral cortical atrophy
- Athetosis
- Decreased plasma free carnitine
- Death in adolescence"
['Propionic acidemia'],"+1. **Propionic Acidemia**:
Propionic acidemia is a rare inherited metabolic disorder characterized by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid.

- **Shared symptoms**: Hyperammonemia, vomiting, hyperglycinemia, hyperglycinuria, hyperalaninemia, elevated urinary carboxylic acids, abnormal circulating carnitine concentration, death in infancy or childhood.
- **Symptoms not present**: Ichthyosis.

+2. **Methylmalonic Acidemia**:
Methylmalonic acidemia is a metabolic disorder resulting from a deficiency of methylmalonyl-CoA mutase, causing a buildup of methylmalonic acid.

- **Shared symptoms**: Hyperammonemia, vomiting, hyperglycinemia, hyperglycinuria, hyperalaninemia, elevated urinary carboxylic acids, abnormal circulating carnitine concentration, death in infancy or childhood.
- **Symptoms not present**: Ichthyosis.

+3. **Non-Ketotic Hyperglycinemia**:
Also known as glycine encephalopathy, this is a genetic disorder where glycine accumulates in the body due to defective glycine cleavage system.

- **Shared symptoms**: Hyperglycinemia, hyperglycinuria, vomiting, lethargy, death in infancy.
- **Symptoms not present**: Hyperammonemia, ichthyosis, abnormal circulating carnitine concentration.

+4. **Ornithine Transcarbamylase Deficiency**:
An X-linked genetic disorder affecting the urea cycle, leading to ammonia accumulation in the blood.

- **Shared symptoms**: Hyperammonemia, vomiting, death in infancy or childhood.
- **Symptoms not present**: Hyperglycinemia, hyperglycinuria, hyperalaninemia, ichthyosis, elevated urinary carboxylic acids.

+5. **Multiple Carboxylase Deficiency**:
A disorder caused by defects in biotin metabolism, leading to deficiencies of multiple carboxylase enzymes.

- **Shared symptoms**: Vomiting, elevated urinary carboxylic acids, abnormal circulating carnitine concentration, skin rash (which may present similarly to ichthyosis).
- **Symptoms not present**: Hyperglycinemia, hyperglycinuria, hyperalaninemia.

+6. **Sjögren-Larsson Syndrome**:
A rare genetic disorder characterized by a deficiency of the enzyme fatty aldehyde dehydrogenase.

- **Shared symptoms**: Ichthyosis, elevated lipid levels in tissues.
- **Symptoms not present**: Hyperammonemia, hyperglycinemia, hyperglycinuria, hyperalaninemia, elevated urinary carboxylic acids.

+7. **Carnitine Transporter Deficiency**:
A metabolic disorder resulting from defective carnitine transport, leading to decreased energy production.

- **Shared symptoms**: Abnormal circulating carnitine concentration, vomiting, elevated urinary carboxylic acids.
- **Symptoms not present**: Hyperammonemia, hyperglycinemia, hyperglycinuria, ichthyosis.

+8. **Maple Syrup Urine Disease**:
A metabolic disorder affecting branched-chain amino acids processing.

- **Shared symptoms**: Vomiting, lethargy, potential death in infancy.
- **Symptoms not present**: Hyperammonemia, ichthyosis, elevated glycine levels.

+9. **Glutaric Acidemia Type II**:
A disorder affecting multiple acyl-CoA dehydrogenases, leading to energy production issues.

- **Shared symptoms**: Vomiting, elevated urinary carboxylic acids, abnormal circulating carnitine concentration.
- **Symptoms not present**: Hyperglycinemia, hyperglycinuria, ichthyosis.

+10. **Carbamoyl Phosphate Synthetase I Deficiency**:
A urea cycle disorder causing ammonia accumulation.

- **Shared symptoms**: Hyperammonemia, vomiting, lethargy.
- **Symptoms not present**: Hyperglycinemia, hyperglycinuria, ichthyosis."
['Succinic semialdehyde dehydrogenase deficiency'],"+1. **Propionic Acidemia**: A rare inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid in the body.

- **Symptoms in common**: Intellectual disability, Motor delay, Elevated urinary carboxylic acid, Abnormal circulating monocarboxylic acid concentration, Death in childhood (can occur in severe cases).
- **Symptoms not in common**: Abnormal facial shape, Abnormal calvaria morphology (not typically associated).

+2. **Methylmalonic Acidemia**: An inherited disorder resulting from a deficiency of the enzyme methylmalonyl-CoA mutase, causing buildup of methylmalonic acid.

- **Symptoms in common**: Intellectual disability, Motor delay, Elevated urinary carboxylic acid, Abnormal circulating monocarboxylic acid concentration.
- **Symptoms not in common**: Abnormal facial shape (may occur but is less common), Abnormal calvaria morphology, Death in childhood (possible in severe cases).

+3. **Glutaric Acidemia Type I**: A metabolic disorder affecting the breakdown of certain amino acids, leading to accumulation of glutaric acid.

- **Symptoms in common**: Motor delay, Abnormal facial shape (such as prominent forehead), Elevated urinary carboxylic acid.
- **Symptoms not in common**: Intellectual disability (may develop over time), Abnormal calvaria morphology (macrocephaly is common), Death in childhood (can occur), Abnormal circulating monocarboxylic acid concentration.

+4. **Pyruvate Carboxylase Deficiency**: A rare genetic disorder affecting gluconeogenesis, leading to lactic acid buildup.

- **Symptoms in common**: Intellectual disability, Motor delay, Elevated urinary carboxylic acid, Death in childhood (common in severe forms).
- **Symptoms not in common**: Abnormal facial shape, Abnormal calvaria morphology, Abnormal circulating monocarboxylic acid concentration.

+5. **Smith-Lemli-Opitz Syndrome**: A developmental disorder caused by defects in cholesterol synthesis.

- **Symptoms in common**: Intellectual disability, Motor delay, Abnormal facial shape, Death in childhood (possible in severe cases).
- **Symptoms not in common**: Elevated urinary carboxylic acid, Abnormal circulating monocarboxylic acid concentration, Abnormal calvaria morphology.

+6. **Non-Ketotic Hyperglycinemia**: A metabolic disorder characterized by accumulation of glycine in body tissues and fluids.

- **Symptoms in common**: Intellectual disability, Motor delay, Death in childhood (common in severe cases).
- **Symptoms not in common**: Abnormal facial shape, Abnormal calvaria morphology, Elevated urinary carboxylic acid, Abnormal circulating monocarboxylic acid concentration.

+7. **Leigh Syndrome**: A severe neurological disorder that arises from mitochondrial dysfunction.

- **Symptoms in common**: Intellectual disability, Motor delay, Death in childhood.
- **Symptoms not in common**: Abnormal facial shape, Abnormal calvaria morphology, Elevated urinary carboxylic acid, Abnormal circulating monocarboxylic acid concentration.

+8. **Wolf-Hirschhorn Syndrome**: A genetic disorder resulting from deletion of genetic material near the end of chromosome 4.

- **Symptoms in common**: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology.
- **Symptoms not in common**: Elevated urinary carboxylic acid, Abnormal circulating monocarboxylic acid concentration, Death in childhood (may occur due to complications).

+9. **Maple Syrup Urine Disease**: A metabolic disorder affecting amino acid degradation, leading to accumulation of branched-chain amino acids.

- **Symptoms in common**: Intellectual disability, Motor delay, Elevated urinary carboxylic acid, Death in childhood (if untreated).
- **Symptoms not in common**: Abnormal facial shape, Abnormal calvaria morphology, Abnormal circulating monocarboxylic acid concentration.

+10. **Lactic Acidosis due to Pyruvate Dehydrogenase Complex Deficiency**: A metabolic disorder leading to energy production deficiencies.

- **Symptoms in common**: Intellectual disability, Motor delay, Elevated urinary carboxylic acid, Death in childhood.
- **Symptoms not in common**: Abnormal facial shape, Abnormal calvaria morphology, Abnormal circulating monocarboxylic acid concentration.

These potential conditions share various symptoms with the patient, including intellectual disability, motor delays, and metabolic abnormalities such as elevated urinary carboxylic acid levels. However, the presence or absence of specific features like abnormal facial shape and calvaria morphology helps narrow down the differential diagnoses. Further diagnostic investigations, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Classic galactosemia'],"+1. **Classical Galactosemia**:
Classical galactosemia is a metabolic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase, leading to the accumulation of galactose-1-phosphate.

**Symptoms in common**:
- Hypergalactosemia
- Abnormality of galactoside metabolism
- Hepatic failure
- Increased total bilirubin
- Prolonged partial thromboplastin time
- Diarrhea
- Intellectual disability
- Motor delay
- Delayed speech and language development
- Death in infancy or childhood
- Neonatal death

**Symptoms not in common**:
- Premature birth (not typically associated)
- Abnormal circulating aspartate family amino acid concentration (may not be directly related)
- Abnormal circulating alanine concentration (may not be directly related)

+2. **Hereditary Tyrosinemia Type I**:
A rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic tyrosine metabolites.

**Symptoms in common**:
- Hepatic failure
- Increased total bilirubin
- Prolonged partial thromboplastin time
- Diarrhea
- Intellectual disability
- Motor delay
- Death in infancy or childhood
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration

**Symptoms not in common**:
- Hypergalactosemia
- Abnormality of galactoside metabolism
- Premature birth (not typically associated)
- Hypergalactosemia (not present)

+3. **Urea Cycle Disorders (e.g., Citrullinemia Type I)**:
Genetic disorders that result in a deficiency of enzymes involved in the urea cycle, leading to hyperammonemia.

**Symptoms in common**:
- Intellectual disability
- Motor delay
- Delayed speech and language development
- Diarrhea
- Increased total bilirubin (secondary to liver dysfunction)
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration
- Death in infancy or childhood

**Symptoms not in common**:
- Hypergalactosemia
- Abnormality of galactoside metabolism
- Hepatic failure (liver dysfunction occurs but not primary hepatic failure)
- Premature birth (not typically associated)

+4. **Neonatal Hemochromatosis**:
A severe liver disease in newborns characterized by iron overload leading to liver failure.

**Symptoms in common**:
- Hepatic failure
- Increased total bilirubin
- Prolonged partial thromboplastin time
- Death in infancy or neonatal death
- Diarrhea (due to liver dysfunction)

**Symptoms not in common**:
- Hypergalactosemia
- Abnormality of galactoside metabolism
- Intellectual disability (less common as the condition is acute)
- Motor delay (may not present due to early onset)
- Premature birth (can be associated but not a direct symptom)
- Abnormal amino acid concentrations (not typically present)"
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1. **Citrullinemia Type I**:
Citrullinemia Type I is a urea cycle disorder caused by deficiency of the enzyme argininosuccinate synthetase, leading to the accumulation of citrulline and ammonia in the blood.

- **Shared symptoms**: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria, Death in infancy, Neonatal death.
- **Symptoms not present**: Abnormality of prenatal development or birth, Death in childhood, Abnormal circulating proline concentration.

+2. **Argininosuccinic Aciduria**:
Argininosuccinic aciduria is a urea cycle disorder resulting from a deficiency of argininosuccinate lyase, causing accumulation of argininosuccinic acid and ammonia.

- **Shared symptoms**: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria, Death in infancy, Neonatal death, Death in childhood.
- **Symptoms not present**: Abnormality of prenatal development or birth, Abnormal circulating proline concentration.

+3. **Hyperprolinemia Type I**:
Hyperprolinemia Type I is a metabolic disorder characterized by elevated levels of proline due to deficiency of proline oxidase.

- **Shared symptoms**: Abnormal circulating proline concentration, Aminoaciduria.
- **Symptoms not present**: Hyperammonemia, Elevated plasma citrulline, Death in infancy, Neonatal death, Death in childhood.

+4. **Ornithine Transcarbamylase Deficiency**:
This is an X-linked urea cycle disorder caused by deficiency of ornithine transcarbamylase, leading to hyperammonemia.

- **Shared symptoms**: Hyperammonemia, Death in infancy, Neonatal death.
- **Symptoms not present**: Elevated plasma citrulline, Aminoaciduria, Abnormal circulating proline concentration, Death in childhood.

+5. **Carbamoyl Phosphate Synthetase I Deficiency**:
A rare urea cycle disorder due to deficiency of carbamoyl phosphate synthetase I, resulting in high ammonia levels.

- **Shared symptoms**: Hyperammonemia, Death in infancy, Neonatal death.
- **Symptoms not present**: Elevated plasma citrulline, Aminoaciduria, Abnormal circulating proline concentration, Death in childhood.

+6. **Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome**:
HHH syndrome is a disorder affecting the transport of ornithine into mitochondria, causing hyperammonemia.

- **Shared symptoms**: Hyperammonemia, Aminoaciduria.
- **Symptoms not present**: Elevated plasma citrulline, Abnormal circulating proline concentration, Death in infancy, Neonatal death.

+7. **Prolidase Deficiency**:
A rare metabolic disorder characterized by a defect in the enzyme prolidase, leading to imbalanced proline levels.

- **Shared symptoms**: Abnormal circulating proline concentration.
- **Symptoms not present**: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria, Death in infancy, Neonatal death, Death in childhood.

+8. **Lysinuric Protein Intolerance**:
A disorder affecting the transport of certain amino acids, leading to abnormal amino acid levels and hyperammonemia.

- **Shared symptoms**: Hyperammonemia, Aminoaciduria.
- **Symptoms not present**: Elevated plasma citrulline, Abnormal circulating proline concentration, Death in infancy, Neonatal death.

+9. **Maple Syrup Urine Disease**:
An inherited disorder affecting branched-chain amino acid metabolism.

- **Shared symptoms**: Aminoaciduria, Death in infancy, Neonatal death.
- **Symptoms not present**: Hyperammonemia, Elevated plasma citrulline, Abnormal circulating proline concentration, Death in childhood.

+10. **Pyruvate Carboxylase Deficiency**:
A metabolic disorder leading to lactic acidosis and hyperammonemia.

- **Shared symptoms**: Hyperammonemia, Death in infancy, Neonatal death.
- **Symptoms not present**: Elevated plasma citrulline, Aminoaciduria, Abnormal circulating proline concentration, Death in childhood."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Symptoms in common:
+ **Hypertyrosinemia**: Elevated levels of tyrosine due to enzyme deficiency.
+ **Elevated urinary carboxylic acid**: Accumulation of metabolites like succinylacetone.
+ **Decreased circulating ferritin concentration**: Resulting from liver dysfunction.
+ **Fever**: Common symptom due to liver complications.
+ **Death in infancy, childhood, or adolescence**: Variable age of onset and severity.

Symptoms not in common:
+ **Hyperphenylalaninemia**: Not typically observed in Tyrosinemia Type I.
+ **Recurrent viral infections**: Not a characteristic feature.
+ **Abnormal circulating porphyrin concentration**: Not associated with this condition.

+2. **Phenylketonuria (PKU)**:
Symptoms in common:
+ **Hyperphenylalaninemia**: Elevated phenylalanine levels due to enzyme deficiency.
+ **Possible death in childhood**: If left untreated, severe neurological damage can occur.

Symptoms not in common:
+ **Hypertyrosinemia**: Tyrosine levels are usually normal or low in PKU.
+ **Abnormal circulating porphyrin concentration**: Not related to PKU.
+ **Recurrent viral infections**: Not a typical symptom.
+ **Elevated urinary carboxylic acid**: Not characteristic of PKU.

+3. **Maple Syrup Urine Disease**:
Symptoms in common:
+ **Elevated urinary carboxylic acid**: Due to accumulation of branched-chain amino acids.
+ **Death in infancy**: Rapid progression if untreated.

Symptoms not in common:
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not elevated in this disease.
+ **Abnormal circulating porphyrin concentration**: Not associated.
+ **Recurrent viral infections**: Not a feature of this condition.

+4. **Acute Intermittent Porphyria**:
Symptoms in common:
+ **Abnormal circulating porphyrin concentration**: Due to defects in heme synthesis.
+ **Fever**: Can occur during acute attacks.

Symptoms not in common:
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not present.
+ **Death in infancy or childhood**: Typically presents in adolescence or adulthood.
+ **Recurrent viral infections**: Not a characteristic symptom.

+5. **Severe Combined Immunodeficiency (SCID)**:
Symptoms in common:
+ **Recurrent viral infections**: Due to impaired immune system.
+ **Death in infancy**: High mortality without treatment.

Symptoms not in common:
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not associated.
+ **Abnormal circulating porphyrin concentration**: Not related.
+ **Elevated urinary carboxylic acid**: Not typical in SCID.

+6. **Hereditary Hemochromatosis**:
Symptoms in common:
+ **Abnormal iron metabolism**: Though typically results in increased ferritin, advanced cases can deplete iron stores.
+ **Fever**: Possible symptom.

Symptoms not in common:
+ **Decreased circulating ferritin concentration**: Opposite is usually observed.
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not associated.
+ **Recurrent viral infections**: Not a primary feature.
+ **Elevated urinary carboxylic acid**: Not characteristic.

+7. **Organic Acidurias (e.g., Methylmalonic Aciduria)**:
Symptoms in common:
+ **Elevated urinary carboxylic acid**: Due to accumulation of organic acids.
+ **Death in infancy**: If untreated.
+ **Fever**: Common during metabolic crises.

Symptoms not in common:
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not typically elevated.
+ **Abnormal circulating porphyrin concentration**: Not associated.
+ **Recurrent viral infections**: Not a direct symptom.

+8. **Multiple Carboxylase Deficiency**:
Symptoms in common:
+ **Elevated urinary carboxylic acid**: Due to impaired biotin-dependent carboxylases.
+ **Death in infancy**: Without prompt treatment.
+ **Fever**: Can be present during episodes.

Symptoms not in common:
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not characteristic.
+ **Abnormal circulating porphyrin concentration**: Not related.
+ **Recurrent viral infections**: Not a primary feature.

+9. **Congenital Dyserythropoietic Anemia**:
Symptoms in common:
+ **Decreased circulating ferritin concentration**: Due to ineffective erythropoiesis.
+ **Abnormal circulating porphyrin concentration**: Possible in some types.

Symptoms not in common:
+ **Hypertyrosinemia and Hyperphenylalaninemia**: Not associated.
+ **Recurrent viral infections**: Not characteristic.
+ **Elevated urinary carboxylic acid**: Not typical.

+10. **Liver Failure (Various Etiologies)**:
Symptoms in common:
+ **Hypertyrosinemia**: Due to impaired liver function.
+ **Decreased circulating ferritin concentration**: From disrupted iron storage.
+ **Abnormal circulating porphyrin concentration**: Possible with liver dysfunction.
+ **Fever**: Common symptom.
+ **Death in infancy, childhood, or adolescence**: Depending on severity and cause.

Symptoms not in common:
+ **Hyperphenylalaninemia**: Not usually elevated.
+ **Recurrent viral infections**: Unless immunocompromised.
+ **Elevated urinary carboxylic acid**: Not specifically associated.

---

Based on the symptoms provided, **Tyrosinemia Type I** appears to have the most overlapping features, including elevated tyrosine levels, liver dysfunction leading to decreased ferritin, elevated urinary metabolites, and potential early death. Further clinical evaluation and diagnostic testing are recommended to confirm the diagnosis."
['Maple syrup urine disease'],"+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Lethargy, Generalized hypotonia, Tremor, Death in infancy, Opisthotonus, Drowsiness, Sleep abnormality, Neonatal death, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor.
Symptoms not in common: None.

+2. Propionic Acidemia:
Symptoms in common: Lethargy, Generalized hypotonia, Tremor, Drowsiness, Neonatal death, Elevated urinary carboxylic acid.
Symptoms not in common: Death in infancy, Opisthotonus, Sleep abnormality, Abnormal circulating leucine concentration, Body odor.

+3. Methylmalonic Acidemia:
Symptoms in common: Lethargy, Generalized hypotonia, Tremor, Drowsiness, Neonatal death, Elevated urinary carboxylic acid.
Symptoms not in common: Death in infancy, Opisthotonus, Sleep abnormality, Abnormal circulating leucine concentration, Body odor.

+4. Nonketotic Hyperglycinemia:
Symptoms in common: Lethargy, Generalized hypotonia, Tremor, Opisthotonus, Drowsiness, Sleep abnormality, Neonatal death.
Symptoms not in common: Death in infancy, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor.

+5. Isovaleric Acidemia:
Symptoms in common: Lethargy, Generalized hypotonia, Tremor, Drowsiness, Neonatal death, Body odor, Elevated urinary carboxylic acid.
Symptoms not in common: Death in infancy, Opisthotonus, Sleep abnormality, Abnormal circulating leucine concentration.

+6. Urea Cycle Disorders:
Symptoms in common: Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Neonatal death.
Symptoms not in common: Tremor, Death in infancy, Opisthotonus, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor.

+7. Leigh Syndrome:
Symptoms in common: Lethargy, Generalized hypotonia, Tremor, Drowsiness, Sleep abnormality, Death in infancy.
Symptoms not in common: Opisthotonus, Neonatal death, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, Body odor.

+8. Phenylketonuria (PKU):
Symptoms in common: Lethargy, Generalized hypotonia, Drowsiness, Body odor.
Symptoms not in common: Tremor, Death in infancy, Opisthotonus, Sleep abnormality, Neonatal death, Abnormal circulating leucine concentration, Elevated urinary carboxylic acid."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
This rare metabolic disorder is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic substances in the body. **Symptoms in common** with the patient include **hypertyrosinemia**, **generalized hypotonia**, **anemia**, **premature birth**, **neonatal death**, **death in infancy**, and **death in childhood**. **Symptoms not in common** may include liver and kidney dysfunctions not specified in the patient's symptoms.

+2. Iron-Deficiency Anemia in Pregnancy:
A condition where the mother has low iron levels during pregnancy, affecting the fetus. **Symptoms in common** include **anemia**, **decreased circulating iron concentration**, **decreased circulating ferritin concentration**, **premature birth**, and **pregnancy exposure**. **Symptoms not in common** are **hypertyrosinemia** and **hyperphenylalaninemia**.

+3. Vitamin D Metabolism Disorders:
These disorders affect the body's ability to process vitamin D, leading to various complications. **Symptoms in common** are **abnormality of vitamin D metabolism**, **generalized hypotonia**, **anemia**, and **death in infancy** or **childhood**. **Symptoms not in common** include the specific metabolic abnormalities like **hypertyrosinemia**.

+4. Phenylketonuria (PKU):
A metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase. **Symptoms in common** include **hyperphenylalaninemia**, **generalized hypotonia**, and potential **developmental delays** leading to **death in childhood** if untreated. **Symptoms not in common** are **hypertyrosinemia** and iron-related issues.

+5. Congenital Hypotonia:
A condition characterized by decreased muscle tone present at birth. **Symptoms in common** are **generalized hypotonia**, **premature birth**, and possibly **anemia**. **Symptoms not in common** include the metabolic disturbances like **hypertyrosinemia** and **hyperphenylalaninemia**.

+6. Inborn Errors of Iron Metabolism:
Genetic disorders affecting iron utilization in the body. **Symptoms in common** include **anemia**, **decreased circulating iron concentration**, **decreased circulating ferritin concentration**, and **generalized hypotonia**. **Symptoms not in common** are the amino acid metabolism issues.

+7. Metabolic Acidosis in Neonates:
A condition where acid builds up in the body due to metabolic problems. **Symptoms in common** include **generalized hypotonia**, **neonatal death**, and **anemia**. **Symptoms not in common** are specific amino acid metabolite elevations like **hypertyrosinemia**.

+8. Perinatal Asphyxia:
Lack of oxygen to the baby's brain during birth. **Symptoms in common** are **generalized hypotonia**, **neonatal death**, and **death in infancy**. **Symptoms not in common** include metabolic abnormalities affecting tyrosine and phenylalanine levels.

+9. Hereditary Hemochromatosis (Neonatal Form):
A rare condition causing iron overload in newborns. **Symptoms in common** include **anemia**, **decreased circulating ferritin concentration**, and **death in infancy**. **Symptoms not in common** are decreased iron levels and amino acid metabolism disorders.

+10. Nonketotic Hyperglycinemia:
A metabolic disorder affecting glycine breakdown. **Symptoms in common** are **generalized hypotonia**, **death in infancy**, and **neonatal death**. **Symptoms not in common** include the iron and amino acid abnormalities specific to tyrosine and phenylalanine."
['Smith-Lemli-Opitz syndrome'],"+1. **Smith-Lemli-Opitz Syndrome**:
Smith-Lemli-Opitz Syndrome is a genetic disorder caused by a defect in cholesterol metabolism. It leads to multiple congenital anomalies and developmental delays.

**Symptoms in common**:
- Hypertelorism
- Anteverted nares
- Syndactyly
- Intellectual disability
- Seizure
- Motor delay
- Death in infancy
- Abnormal foot morphology
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Neonatal death
- Death in childhood
- Elevated circulating 7-dehydrocholesterol concentration
- Severe hearing impairment

**Symptoms not in common**:
- Self-mutilation
- Delayed speech and language development
- Hyperactivity

+2. **Cornelia de Lange Syndrome**:
Cornelia de Lange Syndrome is a developmental disorder affecting many parts of the body, characterized by distinctive facial features and growth delays.

**Symptoms in common**:
- Hypertelorism
- Anteverted nares
- Self-mutilation
- Delayed speech and language development
- Hyperactivity
- Intellectual disability
- Seizure
- Motor delay
- Abnormal foot morphology
- Severe hearing impairment

**Symptoms not in common**:
- Syndactyly
- Death in infancy
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Neonatal death
- Death in childhood
- Elevated circulating 7-dehydrocholesterol concentration

+3. **Lesch-Nyhan Syndrome**:
Lesch-Nyhan Syndrome is a rare inherited disorder marked by neurological and behavioral abnormalities and overproduction of uric acid.

**Symptoms in common**:
- Self-mutilation
- Delayed speech and language development
- Hyperactivity
- Intellectual disability
- Seizure
- Motor delay

**Symptoms not in common**:
- Hypertelorism
- Anteverted nares
- Syndactyly
- Death in infancy
- Abnormal foot morphology
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Neonatal death
- Death in childhood
- Elevated circulating 7-dehydrocholesterol concentration
- Severe hearing impairment

+4. **Aarskog Syndrome**:
Aarskog Syndrome is a genetic disorder characterized by short stature, facial anomalies, and musculoskeletal abnormalities.

**Symptoms in common**:
- Hypertelorism
- Anteverted nares
- Delayed speech and language development
- Hyperactivity
- Intellectual disability
- Motor delay
- Syndactyly

**Symptoms not in common**:
- Self-mutilation
- Seizure
- Death in infancy
- Abnormal foot morphology
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Neonatal death
- Death in childhood
- Elevated circulating 7-dehydrocholesterol concentration
- Severe hearing impairment

+5. **Rubenstein-Taybi Syndrome**:
Rubenstein-Taybi Syndrome is a condition characterized by short stature, moderate to severe intellectual disability, and distinctive facial features.

**Symptoms in common**:
- Hypertelorism
- Anteverted nares
- Delayed speech and language development
- Hyperactivity
- Intellectual disability
- Seizure
- Motor delay

**Symptoms not in common**:
- Self-mutilation
- Syndactyly
- Death in infancy
- Abnormal foot morphology
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Neonatal death
- Death in childhood
- Elevated circulating 7-dehydrocholesterol concentration
- Severe hearing impairment"
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Acidemia (MMA)**:
A metabolic disorder resulting from a deficiency of methylmalonyl-CoA mutase activity, leading to the accumulation of methylmalonic acid.

**Symptoms in common**: 'Methylmalonic acidemia', 'Decreased methylmalonyl-CoA mutase activity', 'Metabolic acidosis', 'Hyperammonemia', 'Hypoglycemia', 'Elevated circulating lactate concentration', 'Failure to thrive', 'Feeding difficulties', 'Developmental delays', 'Intellectual disability', 'Hypotonia', 'Microcephaly', 'Anemia', 'Elevated circulating creatinine concentration', 'Chronic kidney disease', 'Elevated urinary carboxylic acid', 'Hyperglycinemia', 'Hyperglycinuria'.

**Symptoms not in common**: 'Pneumonia', 'Hypothermia', 'Splenomegaly'.

+2. **Propionic Acidemia**:
An inherited disorder affecting the breakdown of certain proteins and fats, leading to the accumulation of propionic acid.

**Symptoms in common**: 'Metabolic acidosis', 'Hyperammonemia', 'Hypoglycemia', 'Elevated circulating lactate concentration', 'Failure to thrive', 'Feeding difficulties', 'Developmental delays', 'Intellectual disability', 'Hypotonia', 'Anemia', 'Hyperglycinemia'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperglycinuria', 'Elevated urinary carboxylic acid'.

+3. **Isovaleric Acidemia**:
A disorder affecting leucine metabolism, leading to the buildup of isovaleric acid.

**Symptoms in common**: 'Metabolic acidosis', 'Hypoglycemia', 'Elevated circulating lactate concentration', 'Failure to thrive', 'Feeding difficulties', 'Developmental delays', 'Hypotonia', 'Anemia', 'Elevated urinary carboxylic acid'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperammonemia', 'Hyperglycinemia'.

+4. **Nonketotic Hyperglycinemia (Glycine Encephalopathy)**:
A defect in glycine breakdown causing accumulation in body tissues and fluids.

**Symptoms in common**: 'Hyperglycinemia', 'Hyperglycinuria', 'Developmental delays', 'Intellectual disability', 'Hypotonia', 'Seizures', 'Microcephaly'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Metabolic acidosis', 'Elevated circulating lactate concentration'.

+5. **Maple Syrup Urine Disease (MSUD)**:
A disorder affecting the breakdown of branched-chain amino acids, leading to their accumulation.

**Symptoms in common**: 'Metabolic acidosis', 'Hypoglycemia', 'Elevated circulating lactate concentration', 'Failure to thrive', 'Feeding difficulties', 'Developmental delays', 'Hypotonia'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperglycinemia', 'Hyperammonemia'.

+6. **Homocystinuria**:
A metabolic disorder resulting in the accumulation of homocysteine.

**Symptoms in common**: 'Abnormal circulating homocysteine concentration', 'Intellectual disability', 'Developmental delays', 'Failure to thrive', 'Hypotonia', 'Microcephaly', 'Elevated circulating C-reactive protein concentration'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperglycinemia', 'Hyperammonemia'.

+7. **Glutaric Acidemia Type I**:
A disorder leading to the accumulation of glutaric acid due to enzyme deficiency.

**Symptoms in common**: 'Metabolic acidosis', 'Elevated circulating lactate concentration', 'Failure to thrive', 'Feeding difficulties', 'Developmental delays', 'Hypotonia', 'Macrocephaly (opposite of microcephaly)', 'Elevated urinary carboxylic acid'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperglycinemia', 'Hyperammonemia'.

+8. **Pyruvate Carboxylase Deficiency**:
A rare metabolic disorder affecting energy production.

**Symptoms in common**: 'Metabolic acidosis', 'Elevated circulating lactate concentration', 'Hyperammonemia', 'Failure to thrive', 'Developmental delays', 'Hypotonia', 'Feeding difficulties'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperglycinemia', 'Anemia'.

+9. **Galactosemia**:
An inability to process galactose leading to its accumulation.

**Symptoms in common**: 'Failure to thrive', 'Feeding difficulties', 'Hypoglycemia', 'Hepatomegaly', 'Intellectual disability', 'Developmental delays', 'Anemia'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Hyperammonemia', 'Metabolic acidosis'.

+10. **Wilson Disease**:
A disorder causing copper accumulation in tissues.

**Symptoms in common**: 'Hepatomegaly', 'Anemia', 'Elevated circulating creatinine concentration', 'Splenomegaly', 'Failure to thrive', 'Feeding difficulties', 'Neurological symptoms'.

**Symptoms not in common**: 'Methylmalonic acidemia', 'Metabolic acidosis', 'Hyperglycinemia'."
[],"+1. Hereditary Orotic Aciduria:
- **Symptoms in common**: Ataxia, Lethargy, Generalized hypotonia, Drowsiness, Abnormal circulating pyrimidine concentration, Uraciluria.
- **Symptoms not in common**: Death in infancy, Sleep abnormality.

+2. Dihydropyrimidine Dehydrogenase Deficiency:
- **Symptoms in common**: Lethargy, Generalized hypotonia, Sleep abnormality, Abnormal circulating pyrimidine concentration, Uraciluria.
- **Symptoms not in common**: Ataxia, Death in infancy, Drowsiness.

+3. Ornithine Transcarbamylase Deficiency:
- **Symptoms in common**: Lethargy, Generalized hypotonia, Drowsiness, Death in infancy, Sleep abnormality.
- **Symptoms not in common**: Ataxia, Abnormal circulating pyrimidine concentration, Uraciluria.

+4. Maple Syrup Urine Disease:
- **Symptoms in common**: Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Death in infancy.
- **Symptoms not in common**: Ataxia, Abnormal circulating pyrimidine concentration, Uraciluria.

+5. Mitochondrial Encephalomyopathy:
- **Symptoms in common**: Ataxia, Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality.
- **Symptoms not in common**: Death in infancy, Abnormal circulating pyrimidine concentration, Uraciluria.

+6. Leigh Syndrome:
- **Symptoms in common**: Ataxia, Generalized hypotonia, Drowsiness, Sleep abnormality, Death in infancy.
- **Symptoms not in common**: Lethargy, Abnormal circulating pyrimidine concentration, Uraciluria.

Please consult a healthcare professional for an accurate diagnosis and appropriate management."
['Isovaleric acidemia'],"+1. **Propionic Acidemia**:
Propionic acidemia is a rare inherited metabolic disorder where the body cannot process certain parts of proteins and lipids properly, leading to the accumulation of propionic acid.

**Symptoms in common**:
- Abnormality of prenatal development or birth
- Hyperammonemia
- Neonatal death
- Death in infancy or childhood
- Abnormal circulating glycine concentration
- Abnormal circulating carnitine concentration

**Symptoms not present**:
- *(None of the listed symptoms are absent in this condition.)*

+2. **Methylmalonic Acidemia**:
Methylmalonic acidemia is a genetic disorder affecting the body's ability to break down certain fats and proteins, causing a buildup of methylmalonic acid.

**Symptoms in common**:
- Abnormality of prenatal development or birth
- Hyperammonemia
- Neonatal death
- Death in infancy or childhood
- Abnormal circulating carnitine concentration

**Symptoms not present**:
- Abnormal circulating glycine concentration

+3. **Non-Ketotic Hyperglycinemia**:
Non-ketotic hyperglycinemia is a genetic disorder characterized by an accumulation of glycine in the body, leading to severe neurological symptoms.

**Symptoms in common**:
- Abnormality of prenatal development or birth
- Death in infancy or childhood
- Neonatal death
- Abnormal circulating glycine concentration

**Symptoms not present**:
- Hyperammonemia
- Abnormal circulating carnitine concentration

+4. **Carnitine Transporter Deficiency**:
This condition impairs the transport of carnitine into cells, disrupting energy production from fatty acids.

**Symptoms in common**:
- Death in infancy or childhood
- Neonatal death
- Abnormal circulating carnitine concentration

**Symptoms not present**:
- Abnormality of prenatal development or birth
- Hyperammonemia
- Abnormal circulating glycine concentration

+5. **Ornithine Transcarbamylase (OTC) Deficiency**:
OTC deficiency is a urea cycle disorder causing the accumulation of ammonia in the blood due to enzyme deficiency.

**Symptoms in common**:
- Hyperammonemia
- Neonatal death
- Death in infancy or childhood
- Abnormality of prenatal development or birth

**Symptoms not present**:
- Abnormal circulating glycine concentration
- Abnormal circulating carnitine concentration

+6. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
Also known as glutaric acidemia type II, MADD affects the body's ability to break down fats and proteins for energy.

**Symptoms in common**:
- Neonatal death
- Death in infancy or childhood
- Abnormal circulating carnitine concentration

**Symptoms not present**:
- Hyperammonemia
- Abnormal circulating glycine concentration
- Abnormality of prenatal development or birth

+7. **Urea Cycle Disorders (Various Enzymes)**:
These are genetic disorders that result in the accumulation of ammonia due to defects in the urea cycle.

**Symptoms in common**:
- Hyperammonemia
- Neonatal death
- Death in infancy or childhood
- Abnormality of prenatal development or birth

**Symptoms not present**:
- Abnormal circulating glycine concentration
- Abnormal circulating carnitine concentration

**Note**: The symptoms presented can be associated with several serious metabolic disorders. It's important for the patient to undergo comprehensive medical evaluation, including genetic testing and metabolic studies, to determine the exact cause. Early diagnosis and intervention are crucial in managing these conditions."
['Biotinidase deficiency'],"+1. **Multiple Carboxylase Deficiency**:
This is a metabolic disorder caused by a deficiency of enzymes involved in biotin-dependent carboxylation reactions. It leads to accumulation of carboxylic acids in the urine.

**Symptoms in common**: Seizures, generalized hypotonia, death in infancy, elevated urinary carboxylic acid.

**Symptoms not present**: Skin rash, alopecia (hair loss).

+2. **Propionic Acidemia**:
A genetic disorder resulting from a deficiency of the enzyme propionyl-CoA carboxylase, leading to the buildup of propionic acid.

**Symptoms in common**: Seizures, generalized hypotonia, death in infancy, elevated urinary carboxylic acid.

**Symptoms not present**: Vomiting, lethargy, neutropenia (low levels of neutrophils).

+3. **Methylmalonic Acidemia**:
Caused by a deficiency of methylmalonyl-CoA mutase enzyme, this disorder leads to the accumulation of methylmalonic acid.

**Symptoms in common**: Seizures, generalized hypotonia, death in infancy, elevated urinary carboxylic acid.

**Symptoms not present**: Feeding difficulties, developmental delays.

+4. **Glutaric Acidemia Type I**:
A metabolic disorder due to deficiency of glutaryl-CoA dehydrogenase, leading to accumulation of glutaric acid.

**Symptoms in common**: Seizures, generalized hypotonia, elevated urinary carboxylic acid.

**Symptoms not present**: Macrocephaly (enlarged head), dystonia (muscle contractions).

+5. **Maple Syrup Urine Disease**:
A disorder affecting branched-chain amino acid metabolism, leading to accumulation of certain amino acids and their toxic byproducts.

**Symptoms in common**: Seizures, generalized hypotonia, death in infancy.

**Symptoms not present**: Sweet-smelling urine, poor feeding, lethargy."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. **Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD):**

A rare inherited disorder affecting the oxidation of long-chain fatty acids due to a deficiency of the LCHAD enzyme.

**Symptoms in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Decreased plasma free carnitine
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Delayed speech and language development

---

+2. **Mitochondrial trifunctional protein deficiency:**

An autosomal recessive disorder affecting fatty acid oxidation due to defects in the mitochondrial trifunctional protein complex.

**Symptoms in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Decreased plasma free carnitine
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Delayed speech and language development

---

+3. **Primary carnitine deficiency:**

A metabolic disorder caused by mutations affecting carnitine transport, leading to decreased levels of plasma free carnitine.

**Symptoms in common:**
- Decreased plasma free carnitine
- Delayed speech and language development
- Abnormality of prenatal development or birth
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level

---

+4. **Zellweger spectrum disorder:**

A group of peroxisomal biogenesis disorders characterized by impaired peroxisome function affecting multiple systems.

**Symptoms in common:**
- Abnormality of prenatal development or birth
- Delayed speech and language development
- Neonatal death
- Death in infancy

**Symptoms not in common:**
- Decreased plasma free carnitine
- Decreased 3-hydroxyacyl-CoA dehydrogenase level

---

+5. **Medium-chain acyl-CoA dehydrogenase deficiency (MCADD):**

A fatty acid oxidation disorder affecting the breakdown of medium-chain fatty acids.

**Symptoms in common:**
- Decreased plasma free carnitine
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Delayed speech and language development
- Abnormality of prenatal development or birth

---

+6. **Isovaleric acidemia:**

An organic acidemia resulting from a defect in leucine metabolism.

**Symptoms in common:**
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy
- Delayed speech and language development

**Symptoms not in common:**
- Decreased plasma free carnitine
- Decreased 3-hydroxyacyl-CoA dehydrogenase level

---

+7. **Holocarboxylase synthetase deficiency:**

A multiple carboxylase deficiency affecting the body's ability to use certain vitamins in metabolism.

**Symptoms in common:**
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy
- Delayed speech and language development

**Symptoms not in common:**
- Decreased plasma free carnitine
- Decreased 3-hydroxyacyl-CoA dehydrogenase level

---

These potential diagnoses highlight disorders that share symptoms with the patient's presentation. Further clinical evaluation and laboratory testing are essential to narrow down the exact condition."
['Maple syrup urine disease'],I'm sorry to hear that you're experiencing these symptoms. It's important to consult a qualified healthcare professional for a thorough evaluation and proper diagnosis.
['Propionic acidemia'],"Based on the symptoms provided, here is a list of potential diseases to consider:

+1. **Propionic Acidemia**:
Propionic acidemia is a rare inherited metabolic disorder where the body cannot process certain parts of proteins and lipids properly, leading to a buildup of propionic acid.

- **Symptoms in common**: 
  - Hyperammonemia
  - Elevated urinary carboxylic acid
  - Elevated blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Hyperglycinemia
  - Hyperalaninemia
  - Intellectual disability
  - Psychosis
  - Severe short stature
  - Body odor
  - Death in early adulthood

- **Symptoms not in common**: 
  - Osteoporosis
  - Anemia
  - Cerebral atrophy
  - Kyphoscoliosis
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment

+2. **Methylmalonic Acidemia**:
A genetic disorder affecting the body's ability to break down certain fats and proteins, leading to a buildup of methylmalonic acid.

- **Symptoms in common**: 
  - Hyperammonemia
  - Elevated urinary carboxylic acid
  - Elevated blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Hyperglycinemia
  - Hyperalaninemia
  - Intellectual disability
  - Psychosis
  - Severe short stature
  - Severe hearing impairment
  - Death in early adulthood

- **Symptoms not in common**: 
  - Osteoporosis
  - Anemia
  - Cerebral atrophy
  - Kyphoscoliosis
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Body odor

+3. **Homocystinuria**:
An inherited disorder affecting the metabolism of the amino acid methionine, leading to a buildup of homocysteine.

- **Symptoms in common**: 
  - Osteoporosis
  - Intellectual disability
  - Psychosis
  - Kyphoscoliosis
  - Severe short stature
  - Thromboembolism (not listed but common)
  - Death in adolescence or early adulthood

- **Symptoms not in common**: 
  - Hyperammonemia
  - Anemia
  - Cerebral atrophy
  - Hyperglycinemia
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Hyperalaninemia
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment
  - Elevated urinary carboxylic acid
  - Body odor

+4. **Maple Syrup Urine Disease (MSUD)**:
A metabolic disorder characterized by the inability to break down certain amino acids, leading to sweet-smelling urine resembling maple syrup.

- **Symptoms in common**: 
  - Intellectual disability
  - Psychosis
  - Hyperglycinemia
  - Elevated urinary carboxylic acid
  - Severe short stature
  - Body odor
  - Death in early childhood or adolescence

- **Symptoms not in common**: 
  - Osteoporosis
  - Anemia
  - Hyperammonemia
  - Cerebral atrophy
  - Kyphoscoliosis
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Hyperalaninemia
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment

+5. **Tyrosinemia Type I**:
A disorder affecting the metabolism of the amino acid tyrosine, leading to liver and kidney dysfunction.

- **Symptoms in common**: 
  - Osteoporosis
  - Anemia
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Abnormal circulating porphyrin concentration
  - Severe short stature
  - Body odor (cabbage-like smell)
  - Death in early childhood or adolescence

- **Symptoms not in common**: 
  - Psychosis
  - Hyperammonemia
  - Cerebral atrophy
  - Hyperglycinemia
  - Hyperalaninemia
  - Kyphoscoliosis
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment
  - Elevated urinary carboxylic acid
  - Intellectual disability

+6. **Multiple Carboxylase Deficiency**:
A metabolic disorder affecting the body's ability to use biotin, leading to multiple carboxylase enzyme deficiencies.

- **Symptoms in common**: 
  - Psychosis
  - Intellectual disability
  - Hyperglycinemia
  - Hyperalaninemia
  - Elevated urinary carboxylic acid
  - Skin rash (not listed but common)
  - Body odor
  - Death in early childhood

- **Symptoms not in common**: 
  - Osteoporosis
  - Anemia
  - Hyperammonemia
  - Cerebral atrophy
  - Kyphoscoliosis
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment

+7. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:
A group of genetic disorders causing the accumulation of ammonia in the blood due to urea cycle dysfunction.

- **Symptoms in common**: 
  - Hyperammonemia
  - Cerebral atrophy
  - Psychosis
  - Intellectual disability
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Death in early adulthood

- **Symptoms not in common**: 
  - Osteoporosis
  - Anemia
  - Hyperglycinemia
  - Hyperalaninemia
  - Kyphoscoliosis
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment
  - Elevated urinary carboxylic acid
  - Severe short stature
  - Body odor

+8. **Carnitine Transporter Deficiency**:
A disorder affecting the transport of carnitine, essential for fatty acid metabolism.

- **Symptoms in common**: 
  - Abnormal circulating carnitine concentration
  - Muscle weakness (not listed but common)
  - Cardiomyopathy (not listed but common)
  - Hypoglycemia (not listed but common)
  - Death in adolescence or early adulthood

- **Symptoms not in common**: 
  - Psychosis
  - Hyperammonemia
  - Osteoporosis
  - Anemia
  - Cerebral atrophy
  - Hyperglycinemia
  - Hyperalaninemia
  - Kyphoscoliosis
  - Severe hearing impairment
  - Elevated urinary carboxylic acid
  - Severe short stature
  - Body odor

+9. **Porphyrias**:
A group of disorders resulting from buildup of natural chemicals producing porphyrin in the body.

- **Symptoms in common**: 
  - Psychosis
  - Abnormal circulating porphyrin concentration
  - Anemia

- **Symptoms not in common**: 
  - Hyperammonemia
  - Osteoporosis
  - Cerebral atrophy
  - Hyperglycinemia
  - Hyperalaninemia
  - Kyphoscoliosis
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Abnormal circulating carnitine concentration
  - Severe hearing impairment
  - Elevated urinary carboxylic acid
  - Severe short stature
  - Body odor

+10. **Mucopolysaccharidosis Types (e.g., Hurler Syndrome)**:
A group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes.

- **Symptoms in common**: 
  - Severe short stature
  - Intellectual disability
  - Kyphoscoliosis
  - Severe hearing impairment
  - Death in adolescence

- **Symptoms not in common**: 
  - Hyperammonemia
  - Osteoporosis
  - Anemia
  - Cerebral atrophy
  - Hyperglycinemia
  - Hyperalaninemia
  - Increased blood urea nitrogen
  - Elevated circulating creatinine concentration
  - Abnormal circulating porphyrin concentration
  - Abnormal circulating carnitine concentration
  - Elevated urinary carboxylic acid
  - Body odor

It's important to note that this list is not exhaustive, and the overlapping of symptoms can occur in various disorders. A comprehensive medical evaluation, including genetic testing and metabolic studies, is essential for accurate diagnosis. Please consult a healthcare professional or a geneticist for further evaluation and personalized medical advice."
['L-2-hydroxyglutaric aciduria'],"+1. **L-2-hydroxyglutaric aciduria**:

This is a rare inherited metabolic disorder characterized by the accumulation of L-2-hydroxyglutaric acid in the body.

**Symptoms in common**: Intellectual disability, seizures, ataxia, tremor, death in childhood, L-2-hydroxyglutaric aciduria (specific finding).

**Symptoms not present**: None; all listed symptoms align with this disorder.

+2. **Leigh Syndrome**:

A severe neurological disorder that typically arises in infancy or early childhood due to mitochondrial dysfunction.

**Symptoms in common**: Intellectual disability, seizures, ataxia, tremor, death in childhood.

**Symptoms not present**: L-2-hydroxyglutaric aciduria.

+3. **Canavan Disease**:

An inherited disorder that causes progressive damage to nerve cells in the brain.

**Symptoms in common**: Intellectual disability, seizures, ataxia, death in childhood.

**Symptoms not present**: Tremor, L-2-hydroxyglutaric aciduria.

+4. **Wilson's Disease**:

A genetic disorder leading to copper accumulation in tissues, affecting the liver and brain.

**Symptoms in common**: Tremor, ataxia, intellectual disability, seizures.

**Symptoms not present**: L-2-hydroxyglutaric aciduria, death in childhood (unless severe and untreated).

+5. **Mitochondrial Encephalomyopathy**:

A group of disorders caused by dysfunctional mitochondria affecting neurological and muscular function.

**Symptoms in common**: Intellectual disability, seizures, ataxia, tremor.

**Symptoms not present**: L-2-hydroxyglutaric aciduria, death in childhood (varies by specific condition).

+6. **Phenylketonuria (PKU)**:

A metabolic disorder resulting from a deficiency of the enzyme needed to process phenylalanine.

**Symptoms in common**: Intellectual disability, seizures.

**Symptoms not present**: Ataxia, tremor, death in childhood (if managed), L-2-hydroxyglutaric aciduria.

+7. **Rett Syndrome**:

A genetic neurological disorder occurring almost exclusively in females.

**Symptoms in common**: Intellectual disability, seizures, ataxia, tremor.

**Symptoms not present**: L-2-hydroxyglutaric aciduria, death in childhood (can have reduced lifespan but many live into adulthood).

+8. **Krabbe Disease**:

An inherited disorder affecting the nervous system due to demyelination.

**Symptoms in common**: Intellectual disability, seizures, death in childhood.

**Symptoms not present**: Ataxia, tremor, L-2-hydroxyglutaric aciduria.

+9. **Tay-Sachs Disease**:

A fatal genetic disorder causing progressive destruction of nerve cells in the brain and spinal cord.

**Symptoms in common**: Intellectual disability, seizures, death in childhood.

**Symptoms not present**: Ataxia, tremor, L-2-hydroxyglutaric aciduria.

+10. **Maple Syrup Urine Disease**:

A metabolic disorder affecting the breakdown of certain amino acids.

**Symptoms in common**: Intellectual disability, seizures, death in childhood.

**Symptoms not present**: Ataxia, tremor, L-2-hydroxyglutaric aciduria."
['Canavan disease'],"+1. **Canavan Disease**:
This is a rare inherited disorder that affects the brain's ability to send and receive signals. 

**Shared symptoms**: Motor delay, death in infancy, and abnormal levels of N-acetylaspartic acid (related to aspartate metabolism) in the blood.

**Unshared symptoms**: Macrocephaly (enlarged head), hypotonia (reduced muscle tone), and developmental regression.

+2. **Argininosuccinic Aciduria**:
A urea cycle disorder caused by a deficiency of the enzyme argininosuccinate lyase.

**Shared symptoms**: Motor delay and potential death in infancy due to hyperammonemia.

**Unshared symptoms**: Elevated levels of argininosuccinic acid, vomiting, lethargy, seizures, and episodes of coma.

+3. **Maple Syrup Urine Disease**:
An inherited disorder affecting the metabolism of certain amino acids.

**Shared symptoms**: Motor delay and risk of death in infancy if untreated.

**Unshared symptoms**: Sweet-smelling urine resembling maple syrup, poor feeding, vomiting, and elevated branched-chain amino acids (not aspartate family).

+4. **Nonketotic Hyperglycinemia**:
A metabolic disorder characterized by an accumulation of glycine.

**Shared symptoms**: Motor delay and potential death in infancy.

**Unshared symptoms**: Elevated glycine levels in blood and cerebrospinal fluid, seizures, lethargy, and severe intellectual disability.

+5. **Citrullinemia Type I**:
A urea cycle disorder due to argininosuccinate synthetase deficiency.

**Shared symptoms**: Motor delay and possible death in infancy.

**Unshared symptoms**: High levels of citrulline, hyperammonemia, vomiting, refusal to eat, and seizures.

+6. **Homocystinuria**:
A disorder affecting the metabolism of the amino acid methionine.

**Shared symptoms**: Motor delay.

**Unshared symptoms**: Dislocation of the eye lens, skeletal abnormalities, thromboembolic events, and elevated homocysteine levels.

+7. **Krabbe Disease**:
A lysosomal storage disorder affecting the nervous system.

**Shared symptoms**: Motor delay and death in infancy.

**Unshared symptoms**: Irritability, muscle stiffness, developmental regression, and absent reflexes.

+8. **Tay-Sachs Disease**:
A genetic disorder that destroys nerve cells in the brain and spinal cord.

**Shared symptoms**: Motor delay and death in infancy.

**Unshared symptoms**: Loss of motor skills, exaggerated startle reaction, seizures, vision and hearing loss, and a cherry-red spot in the eye.

+9. **Metachromatic Leukodystrophy**:
A genetic disorder affecting the myelin sheath of nerves.

**Shared symptoms**: Motor delay.

**Unshared symptoms**: Muscle wasting, weakness, seizures, and progressive loss of vision leading to blindness.

+10. **Canavan-like Leukodystrophy**:
Similar to Canavan disease, affecting the white matter of the brain.

**Shared symptoms**: Motor delay and abnormal amino acid concentrations related to aspartate metabolism.

**Unshared symptoms**: Developmental regression and spasticity."
['Citrullinemia type I'],"+1. Citrullinemia Type I:
Citrullinemia Type I is a urea cycle disorder caused by a deficiency of the enzyme argininosuccinate synthase, leading to the accumulation of citrulline and ammonia in the blood.

Symptoms the patient has in common:
+ Hyperammonemia
+ Elevated plasma citrulline
+ Neonatal death
+ Death in infancy

Symptoms the patient does not have:
+ (No specific symptoms from the disease that are not reported)

+2. Argininosuccinic Aciduria:
Argininosuccinic aciduria is a urea cycle disorder resulting from a deficiency of argininosuccinate lyase, causing accumulation of argininosuccinic acid, citrulline, and ammonia.

Symptoms the patient has in common:
+ Hyperammonemia
+ Elevated plasma citrulline
+ Neonatal death
+ Death in infancy

Symptoms the patient does not have:
+ Increased total bilirubin (not a primary symptom)

+3. Neonatal Hemochromatosis:
Neonatal hemochromatosis is a severe liver disease in newborns characterized by iron overload, leading to liver failure and death.

Symptoms the patient has in common:
+ Increased total bilirubin
+ Neonatal death
+ Death in infancy

Symptoms the patient does not have:
+ Hyperammonemia
+ Elevated plasma citrulline

+4. Ornithine Transcarbamylase Deficiency:
This is an X-linked urea cycle disorder causing an accumulation of ammonia due to a deficiency of the enzyme ornithine transcarbamylase.

Symptoms the patient has in common:
+ Hyperammonemia
+ Neonatal death
+ Death in infancy

Symptoms the patient does not have:
+ Elevated plasma citrulline (levels are usually normal or decreased)
+ Increased total bilirubin (not typical)

+5. Galactosemia:
Galactosemia is a disorder affecting the metabolism of galactose, leading to liver dysfunction and other complications in newborns.

Symptoms the patient has in common:
+ Increased total bilirubin
+ Neonatal death
+ Death in infancy

Symptoms the patient does not have:
+ Hyperammonemia
+ Elevated plasma citrulline"
['3-hydroxy-3-methylglutaric aciduria'],"+1. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):**

A genetic disorder affecting fatty acid, amino acid, and choline metabolism due to defective multiple acyl-CoA dehydrogenase enzymes.

**Symptoms in common:** Lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, diarrhea, hepatomegaly, drowsiness, sleep abnormality, dicarboxylic aciduria, 3-Methylglutaric aciduria, elevated urinary carboxylic acid, death in infancy or childhood.

**Symptoms not in common:** Recurrent viral infections.

+2. **Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCAD Deficiency):**

An inherited disorder preventing the body from converting certain fats to energy, particularly during periods without food.

**Symptoms in common:** Lethargy, hypoglycemia, vomiting, hepatomegaly, drowsiness, dicarboxylic aciduria, elevated urinary carboxylic acid, death in infancy.

**Symptoms not in common:** Hyperammonemia (less common), 3-Methylglutaric aciduria, recurrent viral infections, sleep abnormality.

+3. **3-Methylglutaconic Aciduria:**

A group of metabolic disorders characterized by elevated levels of 3-methylglutaconic acid due to mitochondrial dysfunction.

**Symptoms in common:** Lethargy, metabolic acidosis, vomiting, hepatomegaly, drowsiness, sleep abnormality, 3-Methylglutaric aciduria, death in childhood.

**Symptoms not in common:** Hypoglycemia (may not be prominent), hyperammonemia (varies), recurrent viral infections.

+4. **Propionic Acidemia:**

An organic acidemia caused by deficiency of propionyl-CoA carboxylase, leading to accumulation of propionic acid.

**Symptoms in common:** Lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, drowsiness, death in infancy.

**Symptoms not in common:** Dicarboxylic aciduria, 3-Methylglutaric aciduria, elevated urinary carboxylic acid, recurrent viral infections.

+5. **Urea Cycle Disorders:**

Genetic defects in the urea cycle enzymes leading to the accumulation of ammonia in the blood.

**Symptoms in common:** Hyperammonemia, vomiting, lethargy, drowsiness, sleep abnormality, death in infancy or childhood.

**Symptoms not in common:** Hypoglycemia (not typical), metabolic acidosis (may have alkalosis instead), dicarboxylic aciduria, 3-Methylglutaric aciduria.

+6. **Severe Combined Immunodeficiency (SCID):**

A group of disorders marked by severe defects in both the T- and B-lymphocyte systems.

**Symptoms in common:** Recurrent viral infections, death in infancy.

**Symptoms not in common:** Metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, diarrhea, hepatomegaly, drowsiness, sleep abnormality, dicarboxylic aciduria, 3-Methylglutaric aciduria, elevated urinary carboxylic acid."
['Cystinuria'],"Based on the symptoms provided: ['Seizure', 'Death in infancy', 'Splenomegaly', 'Respiratory insufficiency'], here is a list of potential diseases:

+1. **Niemann-Pick Disease Type A**:
A rare genetic disorder causing harmful amounts of lipids to accumulate in the spleen, liver, lungs, bone marrow, and brain.
- **Common symptoms with the patient**: Splenomegaly, respiratory insufficiency, death in infancy.
- **Symptoms not present**: Feeding difficulties, developmental delay (not specified).

+2. **Gaucher Disease Type 2**:
An inherited metabolic disorder where fatty substances accumulate in certain organs and tissues.
- **Common symptoms with the patient**: Splenomegaly, seizures, respiratory insufficiency, death in infancy.
- **Symptoms not present**: Limb rigidity, eye movement disorders (not specified).

+3. **Tay-Sachs Disease**:
A genetic disorder that leads to the destruction of nerve cells in the brain and spinal cord.
- **Common symptoms with the patient**: Seizures, respiratory insufficiency, death in infancy.
- **Symptoms not present**: Muscle weakness, decreased alertness (not specified).

+4. **Krabbe Disease**:
A rare, inherited degenerative disorder affecting the nervous system.
- **Common symptoms with the patient**: Seizures, respiratory insufficiency, death in infancy.
- **Symptoms not present**: Irritability, stiffness (not specified).

+5. **Pompe Disease (Infantile-Onset)**:
A metabolic disorder affecting muscle function due to glycogen accumulation.
- **Common symptoms with the patient**: Respiratory insufficiency, death in infancy, enlarged organs including the spleen.
- **Symptoms not present**: Poor muscle tone, feeding difficulties (not specified).

+6. **Werdnig-Hoffmann Disease (Spinal Muscular Atrophy Type 1)**:
A genetic disease characterized by muscle weakness and atrophy.
- **Common symptoms with the patient**: Respiratory insufficiency, death in infancy.
- **Symptoms not present**: Splenomegaly, seizures.

+7. **Hemophagocytic Lymphohistiocytosis (HLH)**:
A severe systemic inflammatory syndrome that can be fatal.
- **Common symptoms with the patient**: Splenomegaly, respiratory distress, seizures.
- **Symptoms not present**: Fever, rash (not specified).

+8. **Menkes Disease**:
A disorder that affects copper levels in the body, leading to copper deficiency.
- **Common symptoms with the patient**: Seizures, respiratory issues, death in infancy.
- **Symptoms not present**: Hair abnormalities, temperature instability (not specified).

+9. **Leigh Syndrome**:
A severe neurological disorder that arises in infants.
- **Common symptoms with the patient**: Seizures, respiratory insufficiency, developmental delays leading to death in infancy.
- **Symptoms not present**: Feeding difficulties, vomiting (not specified).

+10. **Infantile Neuroaxonal Dystrophy**:
A degenerative disorder affecting the nervous system.
- **Common symptoms with the patient**: Seizures, respiratory problems, death in infancy.
- **Symptoms not present**: Vision problems, muscle stiffness (not specified).

These potential diseases share several symptoms with the patient, such as seizures, respiratory insufficiency, splenomegaly, and early mortality. However, specific symptoms not present in the patient's symptoms list could help narrow down the diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. Methylmalonic Acidemia:
Matching symptoms: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Hyperammonemia, Hypoproteinemia, Feeding difficulties, Methylmalonic aciduria, Death in infancy.
Non-matching symptoms: Recurrent viral infections, Hypervalinemia, Hyperthreoninemia.

+2. Propionic Acidemia:
Matching symptoms: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Hyperammonemia, Hypoproteinemia, Feeding difficulties, Decreased serum creatinine, Methylmalonic aciduria (sometimes observed), Death in infancy.
Non-matching symptoms: Hypervalinemia, Hyperthreoninemia, Abnormal circulating isoleucine concentration.

+3. Maple Syrup Urine Disease:
Matching symptoms: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Feeding difficulties, Hypervalinemia, Abnormal circulating isoleucine concentration, Death in infancy.
Non-matching symptoms: Methylmalonic aciduria, Hyperammonemia, Methylmalonic aciduria.

+4. Multiple Acyl-CoA Dehydrogenase Deficiency:
Matching symptoms: Hypotonia, Feeding difficulties, Vomiting, Hypoproteinemia, Abnormal circulating carnitine concentration, Death in infancy.
Non-matching symptoms: Methylmalonic aciduria, Hyperammonemia, Hypervalinemia.

+5. Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency):
Matching symptoms: Hyperammonemia, Vomiting, Intellectual disability, Death in infancy, Feeding difficulties.
Non-matching symptoms: Methylmalonic aciduria, Hypervalinemia, Hyperthreoninemia, Abnormal circulating isoleucine concentration."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Symptoms in common: **Hypertyrosinemia**, **Elevated urinary carboxylic acid**, **Death in infancy**.
Symptoms not in common: **Hyperphenylalaninemia**, **Recurrent viral infections**, **Death in childhood**.

Tyrosinemia Type I is a severe metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic substances that affect the liver and kidneys.

+2. **Phenylketonuria (PKU)**:
Symptoms in common: **Hyperphenylalaninemia**.
Symptoms not in common: **Hypertyrosinemia**, **Elevated urinary carboxylic acid**, **Recurrent viral infections**, **Death in infancy**, **Death in childhood**.

PKU is a metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, causing elevated levels of phenylalanine which can lead to intellectual disability if untreated.

+3. **Severe Combined Immunodeficiency (SCID)**:
Symptoms in common: **Recurrent viral infections**, **Death in infancy**.
Symptoms not in common: **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Elevated urinary carboxylic acid**, **Death in childhood**.

SCID is a group of disorders characterized by profound defects in both humoral and cellular immunity, leading to severe infections early in life.

+4. **Tyrosinemia Type II**:
Symptoms in common: **Hypertyrosinemia**, **Elevated urinary carboxylic acid**.
Symptoms not in common: **Hyperphenylalaninemia**, **Recurrent viral infections**, **Death in infancy**, **Death in childhood**.

Tyrosinemia Type II is caused by a deficiency of tyrosine aminotransferase, leading to elevated tyrosine levels affecting the eyes, skin, and mental development.

+5. **Organic Acidemias (e.g., Methylmalonic Acidemia)**:
Symptoms in common: **Elevated urinary carboxylic acid**, **Death in infancy**, **Death in childhood**.
Symptoms not in common: **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Recurrent viral infections**.

Organic acidemias are a group of metabolic disorders characterized by the accumulation of organic acids, leading to metabolic acidosis and other serious complications.

+6. **Hyperphenylalaninemia due to Tetrahydrobiopterin (BH4) Deficiency**:
Symptoms in common: **Hyperphenylalaninemia**, possibly **Recurrent viral infections**.
Symptoms not in common: **Hypertyrosinemia**, **Elevated urinary carboxylic acid**, **Death in infancy**, **Death in childhood**.

BH4 deficiency affects the metabolism of several neurotransmitters and can lead to elevated phenylalanine levels along with neurological symptoms.

+7. **Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy)**:
Symptoms in common: **Death in infancy**, **Death in childhood**, possibly **Elevated urinary carboxylic acid**.
Symptoms not in common: **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Recurrent viral infections**.

Leigh Syndrome is a severe neurological disorder that arises from mitochondrial dysfunction, leading to progressive loss of mental and movement abilities.

+8. **Peroxisomal Biogenesis Disorders (e.g., Zellweger Syndrome)**:
Symptoms in common: **Death in infancy**, **Elevated urinary carboxylic acid**.
Symptoms not in common: **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Recurrent viral infections**.

These disorders involve faulty peroxisome function, leading to the accumulation of very long-chain fatty acids and other substances, affecting multiple organ systems.

+9. **Combined Immunodeficiency with Metabolic Defects**:
Symptoms in common: **Recurrent viral infections**, **Death in infancy**, **Hyperphenylalaninemia**, possibly **Hypertyrosinemia**.
Symptoms not in common: **Elevated urinary carboxylic acid**, **Death in childhood**.

Certain rare conditions combine immune deficiencies with metabolic abnormalities, leading to severe infections and metabolic disturbances.

+10. **Multiple Carboxylase Deficiency**:
Symptoms in common: **Elevated urinary carboxylic acid**, **Death in infancy**, **Death in childhood**.
Symptoms not in common: **Hypertyrosinemia**, **Hyperphenylalaninemia**, **Recurrent viral infections**.

This disorder results from defects in biotin metabolism, affecting multiple carboxylase enzymes, leading to a range of metabolic problems."
['Phenylketonuria'],"+1. **Phenylketonuria (PKU)**:
PKU is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine (hyperphenylalaninemia).

**Symptoms in common**:
- Intellectual disability
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

**Symptoms not in common**:
- Strabismus
- Obesity
- Death in infancy (typically preventable with early treatment)
- Hypertyrosinemia
- Neonatal death
- Death in adolescence
- Death in early adulthood

+2. **Tyrosinemia Type I**:
A rare genetic disorder resulting in the accumulation of tyrosine (hypertyrosinemia) due to defective metabolism.

**Symptoms in common**:
- Hypertyrosinemia
- Death in infancy
- Neonatal death
- Abnormality of prenatal development or birth

**Symptoms not in common**:
- Strabismus
- Obesity
- Intellectual disability (may occur but less common)
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

+3. **Prader-Willi Syndrome**:
A genetic condition characterized by hypotonia, feeding difficulties, and later, excessive eating leading to obesity.

**Symptoms in common**:
- Intellectual disability
- Obesity
- Strabismus
- Abnormality of prenatal development or birth

**Symptoms not in common**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Death in infancy (rare)
- Neonatal death
- Death in adolescence
- Death in early adulthood

+4. **Maple Syrup Urine Disease (MSUD)**:
A metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation.

**Symptoms in common**:
- Intellectual disability
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- Strabismus
- Obesity
- Hypertyrosinemia
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

+5. **Tetrahydrobiopterin (BH4) Deficiency**:
A rare disorder affecting the metabolism of amino acids, causing hyperphenylalaninemia and neurotransmitter deficiencies.

**Symptoms in common**:
- Intellectual disability
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

**Symptoms not in common**:
- Strabismus
- Obesity
- Hypertyrosinemia (tyrosine levels may be affected indirectly)
- Death in infancy (possible if untreated)
- Neonatal death
- Death in adolescence
- Death in early adulthood

+6. **Leigh Syndrome**:
A severe neurological disorder that arises in the first year of life.

**Symptoms in common**:
- Death in infancy
- Intellectual disability
- Abnormality of prenatal development or birth

**Symptoms not in common**:
- Strabismus
- Obesity
- Hypertyrosinemia
- Hyperphenylalaninemia
- Neonatal death
- Death in adolescence
- Death in early adulthood

+7. **Smith-Lemli-Opitz Syndrome**:
A developmental disorder affecting multiple body parts and causing intellectual disability.

**Symptoms in common**:
- Intellectual disability
- Strabismus
- Abnormality of prenatal development or birth
- Death in infancy (in severe cases)

**Symptoms not in common**:
- Obesity (typically low birth weight and feeding difficulties)
- Hypertyrosinemia
- Hyperphenylalaninemia
- Neonatal death
- Death in adolescence
- Death in early adulthood

+8. **Nonketotic Hyperglycinemia**:
A metabolic disorder characterized by an accumulation of glycine.

**Symptoms in common**:
- Intellectual disability
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- Strabismus
- Obesity
- Hypertyrosinemia
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

+9. **Canavan Disease**:
A genetic disorder that causes progressive damage to nerve cells in the brain.

**Symptoms in common**:
- Intellectual disability
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not in common**:
- Strabismus
- Obesity
- Hypertyrosinemia
- Hyperphenylalaninemia
- Neonatal death
- Death in adolescence
- Death in early adulthood

+10. **Alpers-Huttenlocher Syndrome**:
A progressive neurologic disorder characterized by seizures and liver disease.

**Symptoms in common**:
- Intellectual disability
- Death in infancy
- Death in early adulthood

**Symptoms not in common**:
- Strabismus
- Obesity
- Hypertyrosinemia
- Hyperphenylalaninemia
- Neonatal death
- Death in adolescence"
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:
A urea cycle disorder caused by a deficiency of the OTC enzyme, leading to the accumulation of ammonia in the blood.

**Symptoms in common:** Hyperammonemia, vomiting, oroticaciduria, death in infancy.
**Symptoms not in common:** Abnormal bleeding, abnormality of the coagulation cascade.

+2. Tyrosinemia Type I:
A metabolic disorder affecting tyrosine degradation, resulting in liver and kidney dysfunction.

**Symptoms in common:** Vomiting, abnormal bleeding, abnormality of the coagulation cascade, death in infancy.
**Symptoms not in common:** Hyperammonemia, oroticaciduria.

+3. UMP Synthase Deficiency (Orotic Aciduria):
A rare genetic disorder affecting pyrimidine synthesis, leading to excessive excretion of orotic acid.

**Symptoms in common:** Oroticaciduria, abnormal bleeding.
**Symptoms not in common:** Hyperammonemia, vomiting, death in infancy, abnormality of the coagulation cascade.

+4. Lysinuric Protein Intolerance:
A defect in amino acid transport causing poor absorption and hyperammonemia after protein ingestion.

**Symptoms in common:** Hyperammonemia, vomiting, death in infancy.
**Symptoms not in common:** Oroticaciduria, abnormal bleeding, abnormality of the coagulation cascade.

+5. Severe Combined Immunodeficiency (SCID) with Adenosine Deaminase Deficiency:
A disorder causing immune dysfunction and potential metabolic abnormalities.

**Symptoms in common:** Death in infancy, abnormal bleeding.
**Symptoms not in common:** Hyperammonemia, vomiting, oroticaciduria, abnormality of the coagulation cascade."
['L-2-hydroxyglutaric aciduria'],"I'm sorry, but I can't provide a list of potential diseases or make a diagnosis. Please consult a qualified healthcare professional for an accurate assessment of these symptoms."
['PMM2-CDG'],"+1. Leigh Syndrome:
Symptoms in common: Intellectual disability, ataxia, cerebellar atrophy, death in infancy.
Symptoms not in common: Thromboembolism, stroke-like episodes, cerebellar agenesis.
Short description: Leigh Syndrome is a severe neurological disorder that arises in infancy or early childhood, characterized by progressive loss of mental and movement abilities due to degeneration of the central nervous system.

+2. MELAS Syndrome (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes):
Symptoms in common: Intellectual disability, ataxia, stroke-like episodes, death in infancy.
Symptoms not in common: Thromboembolism, cerebellar atrophy, cerebellar agenesis.
Short description: MELAS Syndrome is a mitochondrial disorder affecting the nervous system and muscles, leading to stroke-like episodes, muscle weakness, and progressive neurological decline.

+3. Pontocerebellar Hypoplasia:
Symptoms in common: Intellectual disability, ataxia, cerebellar atrophy, cerebellar agenesis, death in infancy.
Symptoms not in common: Thromboembolism, stroke-like episodes.
Short description: Pontocerebellar Hypoplasia is a group of disorders characterized by the underdevelopment of the cerebellum and brainstem (pons), resulting in severe developmental delays and movement disorders.

+4. Ataxia-Telangiectasia:
Symptoms in common: Intellectual disability, ataxia, cerebellar atrophy.
Symptoms not in common: Thromboembolism, stroke-like episodes, death in infancy, cerebellar agenesis.
Short description: Ataxia-Telangiectasia is a rare genetic disorder causing neurological problems like ataxia, weakened immune system, and an increased risk of cancers.

+5. Protein C Deficiency:
Symptoms in common: Thromboembolism, death in infancy.
Symptoms not in common: Intellectual disability, ataxia, cerebellar atrophy, stroke-like episodes, cerebellar agenesis.
Short description: Protein C Deficiency is a blood clotting disorder that increases the risk of developing abnormal blood clots (thromboembolism), which can be life-threatening, especially in infants.

+6. Krabbe Disease:
Symptoms in common: Intellectual disability, ataxia, death in infancy.
Symptoms not in common: Thromboembolism, stroke-like episodes, cerebellar atrophy, cerebellar agenesis.
Short description: Krabbe Disease is an inherited disorder affecting the nervous system, leading to severe degeneration of motor skills, muscle weakness, and developmental delays."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Tyrosinemia Type I is a severe hereditary disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. This leads to the accumulation of toxic substances in the liver and kidneys.

- **Symptoms in common**: Hypertyrosinemia, Death in infancy, Neonatal death.
- **Symptoms not in common**: Hyperphenylalaninemia, Premature birth.

+2. **Disorders of Tetrahydrobiopterin (BH4) Metabolism**:
Deficiencies in BH4 metabolism can disrupt the processing of amino acids like phenylalanine and tyrosine, leading to neurological complications.

- **Symptoms in common**: Hyperphenylalaninemia, Hypertyrosinemia, Potential for neonatal death.
- **Symptoms not in common**: Premature birth, Death in infancy (depends on severity and treatment).

+3. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a metabolic disorder affecting the breakdown of branched-chain amino acids, leading to toxic accumulation.

- **Symptoms in common**: Neonatal death, Potential death in infancy.
- **Symptoms not in common**: Hypertyrosinemia, Hyperphenylalaninemia, Premature birth.

+4. **Phenylketonuria (PKU)**:
PKU is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine.

- **Symptoms in common**: Hyperphenylalaninemia.
- **Symptoms not in common**: Hypertyrosinemia (tyrosine levels are typically low), Death in infancy (if untreated, can lead to intellectual disability), Premature birth, Neonatal death.

+5. **Homocystinuria**:
A metabolic disorder resulting from a deficiency of cystathionine beta-synthase, affecting the metabolism of methionine.

- **Symptoms in common**: Potential for neonatal death.
- **Symptoms not in common**: Hypertyrosinemia, Hyperphenylalaninemia, Premature birth, Death in infancy."
['Propionic acidemia'],"+1. **Non-Ketotic Hyperglycinemia**:
- **Symptoms in common**:
  - **Seizure**
  - **Lethargy**
  - **Generalized hypotonia**
  - **Delayed speech and language development**
  - **Intellectual disability**
  - **Motor delay**
  - **Drowsiness**
  - **Hyperglycinemia**
  - **Difficulty walking**
  - **Difficulty running**
- **Symptoms not present**:
  - **Apnea**
  - **Coma**
  - **Brain malformations**

---

+2. **Maple Syrup Urine Disease**:
- **Symptoms in common**:
  - **Lethargy**
  - **Vomiting**
  - **Seizure**
  - **Generalized hypotonia**
  - **Delayed speech and language development**
  - **Intellectual disability**
  - **Hyperammonemia**
  - **Hypervalinemia**
  - **Hypoglycinemia**
  - **Difficulty feeding (related to Gastroesophageal reflux)**
- **Symptoms not present**:
  - **Maple syrup odor in urine**
  - **Ketoacidosis**
  - **Coma**

---

+3. **Propionic Acidemia**:
- **Symptoms in common**:
  - **Vomiting**
  - **Lethargy**
  - **Seizure**
  - **Generalized hypotonia**
  - **Intellectual disability**
  - **Developmental delays (Motor delay)**
  - **Hyperammonemia**
  - **Increased circulating lactate concentration**
  - **Leukopenia**
  - **Recurrent infections**
- **Symptoms not present**:
  - **Neutropenia**
  - **Cardiomyopathy**
  - **Pancreatitis**

---

+4. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:
- **Symptoms in common**:
  - **Hyperammonemia**
  - **Vomiting**
  - **Lethargy**
  - **Seizure**
  - **Generalized hypotonia**
  - **Delayed speech and language development**
  - **Intellectual disability**
  - **Sleep abnormality**
  - **Difficulty walking**
  - **Difficulty running**
  - **Death in infancy/childhood**
- **Symptoms not present**:
  - **Coma**
  - **Anorexia**
  - **Aversion to protein-rich foods**

---

+5. **Leigh Syndrome**:
- **Symptoms in common**:
  - **Developmental delay (Motor delay, Delayed speech and language development)**
  - **Severe hypotonia (Generalized hypotonia)**
  - **Seizure**
  - **Lactic acidosis (Increased circulating lactate concentration)**
  - **Difficulty walking**
  - **Difficulty running**
  - **Respiratory problems (Tachypnea)**
  - **Feeding difficulties (Vomiting, Gastroesophageal reflux)**
  - **Sleep abnormality**
  - **Death in infancy/childhood**
- **Symptoms not present**:
  - **Eye movement disorders**
  - **Cardiac anomalies**
  - **Kidney problems**

---

+6. **Methylmalonic Acidemia**:
- **Symptoms in common**:
  - **Vomiting**
  - **Lethargy**
  - **Seizure**
  - **Hypotonia**
  - **Intellectual disability**
  - **Developmental delays**
  - **Hyperammonemia**
  - **Metabolic acidosis (Increased lactate levels)**
  - **Recurrent infections**
- **Symptoms not present**:
  - **Renal failure**
  - **Enlarged liver**
  - **Pancreatitis**

---

+7. **Tyrosinemia Type I**:
- **Symptoms in common**:
  - **Vomiting**
  - **Failure to thrive**
  - **Fever**
  - **Hepatic dysfunction (Increased blood urea nitrogen)**
  - **Hypertyrosinemia**
  - **Intellectual disability**
  - **Neurological crises (similar to seizures, lethargy)**
- **Symptoms not present**:
  - **Cabbage-like odor**
  - **Rickets**
  - **Jaundice**

---

+8. **Carnitine Transporter Deficiency**:
- **Symptoms in common**:
  - **Hypotonia**
  - **Lethargy**
  - **Muscle weakness (Difficulty climbing stairs, Difficulty walking, Difficulty running)**
  - **Abnormal circulating carnitine concentration**
  - **Cardiomyopathy symptoms (Tachypnea)**
- **Symptoms not present**:
  - **Hypoketotic hypoglycemia**
  - **Liver dysfunction**
  - **Enlarged heart**

---

+9. **Glycine Encephalopathy**:
- **Symptoms in common**:
  - **Hypotonia**
  - **Lethargy**
  - **Seizure**
  - **Delayed development**
  - **Intellectual disability**
  - **Hyperglycinemia**
  - **Drowsiness**
- **Symptoms not present**:
  - **Apnea**
  - **Spasticity**
  - **Brain malformations**

---

+10. **Branched-Chain Amino Acid Disorders**:
- **Symptoms in common**:
  - **Hypervalinemia**
  - **Hypotonia**
  - **Lethargy**
  - **Vomiting**
  - **Seizure**
  - **Developmental delays**
  - **Intellectual disability**
- **Symptoms not present**:
  - **Feeding difficulties unrelated to Gastroesophageal reflux**
  - **Coma**
  - **Maple syrup odor in urine (specific to Maple Syrup Urine Disease)**

---

These potential diagnoses consider the patient's symptoms and compare them with known features of each disease. The overlap in metabolic abnormalities such as **hyperammonemia**, **elevated amino acids**, and **increased lactate concentration** suggest inborn errors of metabolism. Neurological symptoms like **seizures**, **hypotonia**, and **developmental delays** support this consideration. It is important to conduct specific metabolic and genetic testing to confirm the exact diagnosis."
['Wilson disease'],"+1. **Menkes Disease**:

Menkes disease is a genetic disorder affecting copper levels in the body due to defective copper transport, leading to low copper and ceruloplasmin levels.

**Symptoms in common:**
+ Decreased circulating copper concentration
+ Decreased circulating ceruloplasmin concentration
+ Elevated circulating hepatic transaminase concentration
+ Death in adolescence

**Symptoms not in common:**
+ Polydipsia (not a typical symptom of Menkes disease)

+2. **Wilson's Disease**:

Wilson's disease is an inherited disorder causing copper accumulation in organs due to impaired copper excretion.

**Symptoms in common:**
+ Elevated circulating hepatic transaminase concentration
+ Decreased circulating ceruloplasmin concentration

**Symptoms not in common:**
+ Decreased circulating copper concentration (copper accumulates in tissues)
+ Polydipsia (not typical)
+ Death in adolescence (possible but less common without treatment)

+3. **Type 1 Diabetes Mellitus**:

Type 1 diabetes mellitus is an autoimmune condition leading to insufficient insulin production.

**Symptoms in common:**
+ Polydipsia

**Symptoms not in common:**
+ Elevated circulating hepatic transaminase concentration (not typical)
+ Decreased circulating ceruloplasmin concentration
+ Decreased circulating copper concentration
+ Death in adolescence (can occur if untreated but not due to copper levels)

+4. **Autoimmune Hepatitis**:

Autoimmune hepatitis is a chronic disease where the immune system attacks liver cells.

**Symptoms in common:**
+ Elevated circulating hepatic transaminase concentration

**Symptoms not in common:**
+ Polydipsia
+ Decreased circulating ceruloplasmin concentration
+ Decreased circulating copper concentration
+ Death in adolescence (possible if severe and untreated)

+5. **Chronic Liver Disease due to Copper Metabolism Disorders**:

This includes conditions affecting copper metabolism leading to liver damage.

**Symptoms in common:**
+ Elevated circulating hepatic transaminase concentration
+ Decreased circulating ceruloplasmin concentration
+ Decreased circulating copper concentration

**Symptoms not in common:**
+ Polydipsia
+ Death in adolescence (depends on severity and progression)"
['Ornithine transcarbamylase deficiency'],"+1. **Ornithine Transcarbamylase Deficiency (OTC Deficiency)**:

A urea cycle disorder caused by a deficiency of the OTC enzyme, leading to the accumulation of ammonia in the blood.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Death in infancy, Vomiting, Drowsiness, Hyperglutaminemia, Oroticaciduria, Neonatal death.
- **Symptoms not in common**: Sleep abnormality.

+2. **Carbamoyl Phosphate Synthetase I Deficiency (CPS I Deficiency)**:

A rare genetic disorder affecting the enzyme CPS I, leading to impaired ammonia detoxification.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Death in infancy, Vomiting, Drowsiness, Hyperglutaminemia, Neonatal death.
- **Symptoms not in common**: Oroticaciduria, Sleep abnormality.

+3. **Citrullinemia Type I**:

A urea cycle disorder caused by a deficiency of argininosuccinate synthetase, leading to ammonia accumulation.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Neonatal death.
- **Symptoms not in common**: Hyperglutaminemia, Oroticaciduria, Sleep abnormality, Death in infancy.

+4. **Hereditary Orotic Aciduria**:

A rare disorder of pyrimidine metabolism causing excessive excretion of orotic acid.

- **Symptoms in common**: Oroticaciduria.
- **Symptoms not in common**: Seizure, Lethargy, Generalized hypotonia, Death in infancy, Vomiting, Drowsiness, Sleep abnormality, Hyperglutaminemia, Neonatal death.

+5. **Nonketotic Hyperglycinemia**:

An inborn error of glycine metabolism leading to glycine accumulation in the brain.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Neonatal death.
- **Symptoms not in common**: Vomiting, Hyperglutaminemia, Oroticaciduria, Death in infancy.

+6. **Maple Syrup Urine Disease**:

A metabolic disorder affecting the breakdown of branched-chain amino acids.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Neonatal death.
- **Symptoms not in common**: Hyperglutaminemia, Oroticaciduria, Sleep abnormality, Death in infancy.

+7. **Glutaric Acidemia Type I**:

A disorder of lysine and tryptophan metabolism leading to accumulation of glutaric acid.

- **Symptoms in common**: Seizure, Generalized hypotonia, Vomiting, Drowsiness.
- **Symptoms not in common**: Lethargy, Sleep abnormality, Hyperglutaminemia, Oroticaciduria, Death in infancy, Neonatal death.

+8. **Mitochondrial Encephalopathies**:

A group of disorders caused by dysfunction of mitochondrial energy production.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Sleep abnormality, Drowsiness.
- **Symptoms not in common**: Vomiting, Hyperglutaminemia, Oroticaciduria, Death in infancy, Neonatal death.

+9. **Pyruvate Carboxylase Deficiency**:

A metabolic disorder affecting gluconeogenesis and the urea cycle.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness.
- **Symptoms not in common**: Sleep abnormality, Hyperglutaminemia, Oroticaciduria, Death in infancy, Neonatal death.

+10. **Argininosuccinic Aciduria**:

A urea cycle disorder due to deficiency of argininosuccinate lyase.

- **Symptoms in common**: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Neonatal death.
- **Symptoms not in common**: Hyperglutaminemia, Oroticaciduria, Sleep abnormality, Death in infancy."
['Classic galactosemia'],"+1. **Galactosemia**:
Symptoms in common: Hypergalactosemia, Abnormality of galactoside metabolism, Feeding difficulties, Neonatal death, Death in infancy, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia.
Symptoms not in common: Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Abnormal circulating porphyrin concentration, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+2. **Zellweger Syndrome**:
Symptoms in common: Microcephaly, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Neonatal death, Death in infancy.
Symptoms not in common: Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+3. **Congenital Erythropoietic Porphyria**:
Symptoms in common: Anemia, Abnormal circulating porphyrin concentration, Microcephaly, Delayed speech and language development, Motor delay.
Symptoms not in common: Obesity, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Feeding difficulties, Decreased circulating ferritin concentration, Decreased circulating iron concentration, Death in infancy, Neonatal death.

+4. **Iron-Refractory Iron Deficiency Anemia (IRIDA)**:
Symptoms in common: Anemia, Decreased circulating ferritin concentration, Decreased circulating iron concentration, Elevated circulating alkaline phosphatase concentration.
Symptoms not in common: Microcephaly, Obesity, Hypergalactosemia, Abnormality of galactoside metabolism, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Death in infancy.

+5. **Prader-Willi Syndrome**:
Symptoms in common: Intellectual disability, Motor delay, Generalized hypotonia, Obesity, Feeding difficulties, Delayed speech and language development.
Symptoms not in common: Microcephaly, Anemia, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Death in infancy, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+6. **Peroxisomal Biogenesis Disorders (e.g., Neonatal Adrenoleukodystrophy)**:
Symptoms in common: Microcephaly, Abnormality of prenatal development or birth, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Neonatal death.
Symptoms not in common: Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+7. **Lesch-Nyhan Syndrome**:
Symptoms in common: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia.
Symptoms not in common: Microcephaly, Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Feeding difficulties, Death in infancy, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+8. **Smith-Lemli-Opitz Syndrome**:
Symptoms in common: Microcephaly, Intellectual disability, Feeding difficulties, Delayed speech and language development.
Symptoms not in common: Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Generalized hypotonia, Death in infancy, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+9. **Congenital Disorders of Glycosylation**:
Symptoms in common: Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Elevated circulating alkaline phosphatase concentration.
Symptoms not in common: Microcephaly, Obesity, Anemia, Hypergalactosemia, Abnormality of galactoside metabolism, Abnormal circulating porphyrin concentration, Death in infancy, Decreased circulating ferritin concentration, Decreased circulating iron concentration.

+10. **Cerebral Palsy (Severe Forms)**:
Symptoms in common: Motor delay, Generalized hypotonia, Delayed speech and language development, Intellectual disability.
Symptoms not in common: Microcephaly, Obesity, Anemia, Elevated circulating alkaline phosphatase concentration, Hypergalactosemia, Abnormality of galactoside metabolism, Feeding difficulties, Death in infancy."
['Biotinidase deficiency'],"+1. **Urea Cycle Disorders**: A group of metabolic disorders caused by defects in the enzymes of the urea cycle, leading to the accumulation of ammonia (hyperammonemia). Symptoms include vomiting, lethargy, seizures, and can result in death in childhood.

**Symptoms in common with patient**: Hyperammonemia, Death in childhood  
**Symptoms not in common with patient**: Obesity, Abnormal foot morphology

+2. **Prader-Willi Syndrome**: A genetic disorder characterized by excessive appetite leading to obesity, developmental delays, and hypotonia. There may be abnormalities in physical development, which can include foot morphology.

**Symptoms in common with patient**: Obesity, Possible abnormal foot morphology  
**Symptoms not in common with patient**: Hyperammonemia, Death in childhood (though complications can reduce life expectancy)

+3. **Mucopolysaccharidosis Type I (Hurler Syndrome)**: A metabolic disorder caused by the deficiency of an enzyme needed to break down mucopolysaccharides, leading to their buildup. Symptoms include skeletal abnormalities (which may cause abnormal foot morphology), developmental delay, and often result in death in childhood.

**Symptoms in common with patient**: Abnormal foot morphology, Death in childhood  
**Symptoms not in common with patient**: Obesity, Hyperammonemia

+4. **Smith-Lemli-Opitz Syndrome**: A genetic disorder affecting cholesterol metabolism, leading to multiple congenital anomalies including abnormal foot structure, growth retardation, and developmental delays. Some cases might present with metabolic abnormalities.

**Symptoms in common with patient**: Abnormal foot morphology  
**Symptoms not in common with patient**: Obesity, Hyperammonemia, Death in childhood (though severe cases may have reduced lifespan)

+5. **Maple Syrup Urine Disease**: An inherited metabolic disorder characterized by the inability to break down certain amino acids, leading to toxic buildup. Symptoms include poor feeding, lethargy, hyperammonemia, and can result in death in childhood if untreated.

**Symptoms in common with patient**: Hyperammonemia, Death in childhood  
**Symptoms not in common with patient**: Obesity, Abnormal foot morphology

+6. **Congenital Myopathies**: A group of muscle disorders present at birth that can cause muscle weakness and hypotonia, potentially leading to abnormal foot morphology. Some severe forms may result in early death.

**Symptoms in common with patient**: Abnormal foot morphology, Possible death in childhood  
**Symptoms not in common with patient**: Obesity, Hyperammonemia

+7. **Laurence-Moon-Biedl Syndrome**: A rare genetic disorder that can cause obesity, polydactyly (extra fingers or toes), and developmental delays. Foot abnormalities may be present.

**Symptoms in common with patient**: Obesity, Abnormal foot morphology  
**Symptoms not in common with patient**: Hyperammonemia, Death in childhood

+8. **Hemochromatosis (Neonatal)**: A severe form of iron overload presenting in newborns, leading to liver failure and hyperammonemia, which can be fatal.

**Symptoms in common with patient**: Hyperammonemia, Death in childhood  
**Symptoms not in common with patient**: Obesity, Abnormal foot morphology

+9. **Lysosomal Storage Disorders (e.g., Niemann-Pick Disease Type A)**: Metabolic conditions causing the accumulation of lipids in cells, leading to organ dysfunction, developmental delays, and early death.

**Symptoms in common with patient**: Death in childhood  
**Symptoms not in common with patient**: Obesity, Abnormal foot morphology, Hyperammonemia

+10. **Congenital Hypothyroidism**: A deficiency of thyroid hormone present at birth, leading to growth retardation and developmental delays. Untreated cases can result in obesity and possible abnormalities in physical development.

**Symptoms in common with patient**: Obesity  
**Symptoms not in common with patient**: Abnormal foot morphology, Hyperammonemia, Death in childhood (though severe cases can lead to complications)"
['Canavan disease'],"+1. Canavan Disease:
Canavan disease is a rare genetic disorder characterized by the degeneration of the brain's white matter due to abnormal myelination. Symptoms the patient shares include **abnormal myelination**, **feeding difficulties**, and often **death in infancy**. The disease may also involve **abnormal circulating aspartate family amino acid concentration** due to the accumulation of N-acetylaspartate. **Hyperactivity** is not typically associated with Canavan disease.

+2. Krabbe Disease:
Krabbe disease is an inherited disorder affecting the nervous system, leading to the breakdown of myelin. Shared symptoms are **abnormal myelination**, **feeding difficulties**, and potential **death in infancy**. However, **hyperactivity** and **abnormal circulating aspartate family amino acid concentration** are not common features of Krabbe disease.

+3. Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder affecting the breakdown of branched-chain amino acids. The patient shares **feeding difficulties** and may have **abnormal amino acid concentrations**, though not specifically of the aspartate family. Severe cases can result in **death in infancy**. **Hyperactivity** and **abnormal myelination** are not typical symptoms.

+4. Phenylketonuria (PKU):
PKU is a metabolic disorder leading to the accumulation of phenylalanine. Shared symptoms include **hyperactivity** and **feeding difficulties**. If untreated, it can lead to **abnormal myelination**. However, PKU involves **phenylalanine** rather than the **aspartate family amino acids**, and **death in infancy** is rare with proper management.

+5. Non-Ketotic Hyperglycinemia:
This genetic disorder results in elevated levels of glycine. The patient shares **feeding difficulties**, **abnormal myelination**, and risk of **death in infancy**. While not from the aspartate family, **abnormal amino acid concentrations** are present. **Hyperactivity** is not a common symptom."
['Phenylketonuria'],"+1. **Phenylketonuria (PKU)**:
Symptoms in common: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Potential for death in infancy or neonatal death if untreated.
Symptoms not in common: None.

+2. **Biopterin Cofactor Deficiency**:
Symptoms in common: Hyperphenylalaninemia, Neurological symptoms leading to death in infancy or neonatal death.
Symptoms not in common: None.

+3. **Maple Syrup Urine Disease (MSUD)**:
Symptoms in common: Abnormality of prenatal development or birth, Neonatal death, Death in infancy.
Symptoms not in common: Hyperphenylalaninemia.

+4. **Non-Ketotic Hyperglycinemia**:
Symptoms in common: Abnormality of prenatal development or birth, Neonatal death, Death in infancy.
Symptoms not in common: Hyperphenylalaninemia.

+5. **Tyrosinemia Type I**:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy.
Symptoms not in common: Hyperphenylalaninemia, Neonatal death."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

Symptoms in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Death in early adulthood'

Symptoms not in common: 'Hyperphenylalaninemia'

---

+2. **Phenylketonuria (PKU)**:

Symptoms in common: 'Delayed speech and language development', 'Hyperphenylalaninemia'

Symptoms not in common: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Death in early adulthood'

---

+3. **Maple Syrup Urine Disease (MSUD)**:

Symptoms in common: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in early adulthood'

Symptoms not in common: 'Delayed speech and language development', 'Hypertyrosinemia', 'Hyperphenylalaninemia'

---

+4. **Dihydropteridine Reductase Deficiency (BH4 Deficiency)**:

Symptoms in common: 'Delayed speech and language development', 'Hyperphenylalaninemia', 'Death in infancy', 'Death in childhood'

Symptoms not in common: 'Hypertyrosinemia', 'Abnormality of prenatal development or birth', 'Neonatal death', 'Death in early adulthood'

---

+5. **Homocystinuria**

Symptoms in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Death in childhood', 'Death in early adulthood'

Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Neonatal death'

---

These potential diagnoses are considered based on the symptoms provided. Each condition shares certain symptoms with the patient while differing in others, guiding towards the most probable diagnosis."
[],"+1. **Pompe Disease**:
Pompe disease is a glycogen storage disorder characterized by the buildup of glycogen in the body's cells, leading to muscle weakness and heart problems.

**Symptoms in common**: Generalized hypotonia, Cardiomyopathy, Death in infancy.
**Symptoms not in common**: Nephritis, Ventricular septal defect, Pulmonic stenosis.

+2. **Alport Syndrome**:
Alport syndrome is a genetic condition affecting the kidneys, hearing, and eyes, often leading to progressive nephritis.

**Symptoms in common**: Nephritis.
**Symptoms not in common**: Generalized hypotonia, Death in infancy, Ventricular septal defect, Cardiomyopathy, Pulmonic stenosis.

+3. **Noonan Syndrome**:
Noonan syndrome is a genetic disorder that causes abnormal development in various parts of the body, including heart defects.

**Symptoms in common**: Generalized hypotonia, Ventricular septal defect, Pulmonic stenosis, Cardiomyopathy.
**Symptoms not in common**: Nephritis, Death in infancy.

+4. **Trisomy 13 (Patau Syndrome)**:
Trisomy 13 is a chromosomal disorder resulting in severe intellectual disability and physical abnormalities.

**Symptoms in common**: Generalized hypotonia, Ventricular septal defect, Cardiomyopathy, Death in infancy.
**Symptoms not in common**: Nephritis, Pulmonic stenosis.

+5. **Fabry Disease**:
Fabry disease is a lysosomal storage disorder affecting the heart and kidneys, among other organs.

**Symptoms in common**: Nephritis, Cardiomyopathy.
**Symptoms not in common**: Generalized hypotonia, Death in infancy, Ventricular septal defect, Pulmonic stenosis.

+6. **Danon Disease**:
Danon disease is a glycogen storage disease leading to cardiomyopathy and muscle weakness.

**Symptoms in common**: Generalized hypotonia, Cardiomyopathy.
**Symptoms not in common**: Nephritis, Death in infancy, Ventricular septal defect, Pulmonic stenosis.

+7. **Congenital Muscular Dystrophy**:
A group of disorders characterized by muscle weakness and possible heart defects from birth.

**Symptoms in common**: Generalized hypotonia, Cardiomyopathy, Ventricular septal defect.
**Symptoms not in common**: Nephritis, Death in infancy, Pulmonic stenosis.

+8. **Barth Syndrome**:
A rare metabolic disorder affecting the heart and muscles.

**Symptoms in common**: Generalized hypotonia, Cardiomyopathy.
**Symptoms not in common**: Nephritis, Death in infancy, Ventricular septal defect, Pulmonic stenosis.

+9. **Williams Syndrome**:
A developmental disorder characterized by cardiovascular disease.

**Symptoms in common**: Pulmonic stenosis, Ventricular septal defect.
**Symptoms not in common**: Nephritis, Generalized hypotonia, Death in infancy, Cardiomyopathy.

+10. **Systemic Lupus Erythematosus (Infantile onset)**:
An autoimmune disorder that can affect the kidneys and heart.

**Symptoms in common**: Nephritis, Cardiomyopathy.
**Symptoms not in common**: Generalized hypotonia, Death in infancy, Ventricular septal defect, Pulmonic stenosis."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Tyrosinemia Type I is a genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its toxic metabolites.

- **Symptoms in common**: Irritability, Hypertyrosinemia, Spasticity, Hyperreflexia, Death in infancy or childhood, Neonatal death.
- **Symptoms not present**: Recurrent viral infections, Hyperphenylalaninemia.

+2. **Phenylketonuria (PKU)**:
PKU is a metabolic disorder resulting from a deficiency of phenylalanine hydroxylase, causing accumulation of phenylalanine.

- **Symptoms in common**: Irritability, Hyperphenylalaninemia, Spasticity, Hyperreflexia.
- **Symptoms not present**: Hypertyrosinemia, Recurrent viral infections, Death in infancy (if untreated, severe cases can lead to neurological issues).

+3. **Biopterin (BH4) Deficiency**:
Defects in tetrahydrobiopterin (BH4) metabolism lead to hyperphenylalaninemia and neurotransmitter deficiencies affecting neurological function.

- **Symptoms in common**: Irritability, Hyperphenylalaninemia, Spasticity, Hyperreflexia, Death in infancy or childhood.
- **Symptoms not present**: Hypertyrosinemia, Recurrent viral infections.

+4. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a disorder affecting branched-chain amino acid metabolism, leading to accumulation of leucine, isoleucine, and valine.

- **Symptoms in common**: Irritability, Spasticity, Hyperreflexia, Neonatal death, Death in infancy.
- **Symptoms not present**: Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

+5. **Nonketotic Hyperglycinemia (Glycine Encephalopathy)**:
A disorder caused by a defect in glycine breakdown, leading to accumulation in the brain.

- **Symptoms in common**: Spasticity, Hyperreflexia, Neonatal death, Death in infancy, Irritability.
- **Symptoms not present**: Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

+6. **Severe Combined Immunodeficiency (SCID)**:
SCID is a group of disorders characterized by impaired development of functional T cells and B cells, leading to severe immune dysfunction.

- **Symptoms in common**: Recurrent viral infections, Death in infancy or childhood.
- **Symptoms not present**: Hypertyrosinemia, Hyperphenylalaninemia, Spasticity, Hyperreflexia (unless due to infections).

+7. **Lysinuric Protein Intolerance**:
A defect in amino acid transport causing poor absorption of certain amino acids and leading to a range of symptoms.

- **Symptoms in common**: Hyperammonemia leading to neurological symptoms like spasticity and irritability, Death in childhood, Hypertyrosinemia.
- **Symptoms not present**: Hyperphenylalaninemia (typically), Recurrent viral infections.

+8. **Mitochondrial Disorders (e.g., Leigh Syndrome)**:
Genetic mitochondrial abnormalities affecting energy production, leading to neurological deterioration.

- **Symptoms in common**: Spasticity, Hyperreflexia, Death in infancy or childhood, Irritability.
- **Symptoms not present**: Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

+9. **Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency**:
A rare genetic disorder affecting the synthesis of neurotransmitters dopamine and serotonin.

- **Symptoms in common**: Spasticity, Hyperreflexia, Irritability, Death in childhood.
- **Symptoms not present**: Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

+10. **Combined Tyrosine and Phenylalanine Metabolism Disorders**:
Rare metabolic conditions affecting enzymes shared in both tyrosine and phenylalanine pathways.

- **Symptoms in common**: Hypertyrosinemia, Hyperphenylalaninemia, Neurological symptoms like spasticity and hyperreflexia, Death in infancy or childhood.
- **Symptoms not present**: Recurrent viral infections."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. **Primary Carnitine Deficiency**:
A genetic disorder caused by mutations affecting the transportation of carnitine into cells, leading to impaired fatty acid metabolism.

**Symptoms in common**: Abnormal circulating carnitine concentration, death in infancy, neonatal death, abnormality of prenatal development or birth.

**Symptoms not in common**: Muscle weakness, hypoglycemia, hepatomegaly, cardiomyopathy.

+2. **Carnitine Transporter Defect (CTD)**:
An inherited condition where the carnitine transporter OCTN2 is defective, resulting in reduced cellular uptake of carnitine.

**Symptoms in common**: Abnormal circulating carnitine concentration, death in infancy, neonatal death.

**Symptoms not in common**: Hypotonia, recurrent infections, hypoketotic hypoglycemia, developmental delays.

+3. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:
A fatty acid oxidation disorder where the body cannot properly break down medium-chain fats.

**Symptoms in common**: Death in infancy, abnormality of prenatal development or birth.

**Symptoms not in common**: Hypoglycemia, lethargy, vomiting, seizures.

+4. **Carnitine Palmitoyltransferase I (CPT I) Deficiency**:
A metabolic disorder affecting the enzyme necessary for the transport of long-chain fatty acids into mitochondria for oxidation.

**Symptoms in common**: Abnormal circulating carnitine concentration, neonatal death.

**Symptoms not in common**: Hepatomegaly, hypoketotic hypoglycemia, elevated liver enzymes.

+5. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
Also known as Glutaric acidemia type II, it's a disorder affecting multiple steps of fatty acid oxidation.

**Symptoms in common**: Abnormal circulating carnitine concentration, neonatal death, abnormality of prenatal development or birth.

**Symptoms not in common**: Metabolic acidosis, muscle weakness, enlarged liver, hypoglycemia.

+6. **Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)**:
A condition disrupting the breakdown of long-chain fatty acids.

**Symptoms in common**: Death in infancy, neonatal death, abnormality of prenatal development or birth.

**Symptoms not in common**: Feeding difficulties, failure to thrive, liver dysfunction, retinal abnormalities.

+7. **Trifunctional Protein Deficiency**:
Affects mitochondrial beta-oxidation of long-chain fatty acids due to defects in the trifunctional protein complex.

**Symptoms in common**: Neonatal death, abnormality of prenatal development or birth.

**Symptoms not in common**: Cardiomyopathy, hypoglycemia, muscle hypotonia, neuropathy.

+8. **Barth Syndrome**:
An X-linked disorder affecting mitochondrial function, leading to cardiolipin deficiency.

**Symptoms in common**: Abnormality of prenatal development or birth, possible death in infancy.

**Symptoms not in common**: Cardiomyopathy, neutropenia, muscle weakness, growth delay.

+9. **Holocarboxylase Synthetase Deficiency**:
A metabolic disorder affecting multiple carboxylase enzymes, leading to biotin-responsive metabolic crises.

**Symptoms in common**: Neonatal death, abnormality of prenatal development or birth.

**Symptoms not in common**: Skin rash, seizures, developmental delay, metabolic acidosis.

+10. **Zellweger Spectrum Disorders**:
A group of peroxisomal biogenesis disorders affecting multiple organ systems.

**Symptoms in common**: Abnormality of prenatal development or birth, death in infancy.

**Symptoms not in common**: Hypotonia, vision and hearing loss, seizures, liver dysfunction."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
A rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its toxic metabolites.

- **Symptoms in common**: Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood.
- **Symptoms not in common**: Delayed speech and language development, Hyperphenylalaninemia.

+2. **Phenylketonuria (PKU)**:
An inherited metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, causing a buildup of phenylalanine in the body.

- **Symptoms in common**: Delayed speech and language development, Generalized hypotonia, Hyperphenylalaninemia.
- **Symptoms not in common**: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood.

+3. **Tyrosinemia Type II**:
A genetic disorder due to a deficiency of tyrosine aminotransferase, leading to elevated levels of tyrosine.

- **Symptoms in common**: Delayed speech and language development, Hypertyrosinemia.
- **Symptoms not in common**: Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Neonatal death, Death in childhood, Hyperphenylalaninemia.

+4. **Maple Syrup Urine Disease**:
An inherited disorder affecting branched-chain amino acid metabolism, characterized by sweet-smelling urine.

- **Symptoms in common**: Generalized hypotonia, Neonatal death, Death in infancy, Delayed speech and language development.
- **Symptoms not in common**: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia.

+5. **Non-ketotic Hyperglycinemia**:
A rare metabolic disorder caused by a defect in the glycine cleavage system, leading to accumulation of glycine.

- **Symptoms in common**: Generalized hypotonia, Neonatal death, Delayed speech and language development.
- **Symptoms not in common**: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia.

+6. **Tetrahydrobiopterin (BH4) Deficiency**:
A metabolic disorder affecting neurotransmitter synthesis and leading to elevated phenylalanine levels.

- **Symptoms in common**: Delayed speech and language development, Generalized hypotonia, Hyperphenylalaninemia.
- **Symptoms not in common**: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood."
['Glutaryl-CoA dehydrogenase deficiency'],"+1. **Glutaric Aciduria Type I**:

Glutaric Aciduria Type I is a metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid in body fluids.

*Symptoms patient has in common*:
- Seizure
- Encephalopathy
- Opisthotonus
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Elevated urinary carboxylic acid
- Death in infancy
- Death in childhood

*Symptoms patient does not have in common*:
- Decreased plasma free carnitine (not typically associated with this condition)

+2. **Glutaric Aciduria Type II (Multiple Acyl-CoA Dehydrogenase Deficiency)**:

This disorder affects multiple dehydrogenase enzymes, leading to the accumulation of various organic acids, including glutaric acid, and is associated with defects in energy metabolism.

*Symptoms patient has in common*:
- Seizure
- Encephalopathy
- Glutaric aciduria
- Elevated circulating glutaric acid concentration
- Elevated urinary carboxylic acid
- Decreased plasma free carnitine
- Death in infancy
- Death in childhood

*Symptoms patient does not have in common*:
- Opisthotonus (less commonly reported in this condition)

+3. **Multiple Carboxylase Deficiency**:

Multiple Carboxylase Deficiency is a metabolic disorder resulting from defects in biotin metabolism, leading to impaired functioning of carboxylase enzymes.

*Symptoms patient has in common*:
- Seizure
- Encephalopathy
- Elevated urinary carboxylic acid
- Death in infancy

*Symptoms patient does not have in common*:
- Glutaric aciduria (not typically present)
- Opisthotonus
- Decreased plasma free carnitine
- Elevated circulating glutaric acid concentration

+4. **Mitochondrial Encephalopathies**:

Mitochondrial encephalopathies are a group of disorders caused by dysfunction of the mitochondrial respiratory chain, leading to energy production deficits.

*Symptoms patient has in common*:
- Seizure
- Encephalopathy
- Death in infancy
- Death in childhood

*Symptoms patient does not have in common*:
- Glutaric aciduria (not a typical feature)
- Elevated circulating glutaric acid concentration
- Opisthotonus
- Decreased plasma free carnitine
- Elevated urinary carboxylic acid

+5. **Organic Acidurias (General)**:

Organic acidurias are metabolic disorders characterized by the accumulation of organic acids due to enzyme deficiencies affecting amino acid metabolism.

*Symptoms patient has in common*:
- Seizure
- Encephalopathy
- Elevated urinary carboxylic acid
- Death in infancy
- Death in childhood

*Symptoms patient does not have in common*:
- Specific glutaric aciduria (varies depending on the specific disorder)
- Opisthotonus
- Decreased plasma free carnitine (may or may not be present)
- Elevated circulating glutaric acid concentration (specific to certain types)"
[],"+1. **Zellweger Syndrome**:
A severe peroxisomal biogenesis disorder affecting multiple organ systems, leading to early death.

**Symptoms in common**: Strabismus, Nystagmus, Hypotonia, Seizures, Intellectual disability, Hepatomegaly, Hearing impairment, Death in infancy.

**Symptoms not in common**: Hyperactivity, Fair hair, White hair.

---

+2. **Menkes Disease**:
A disorder of copper metabolism causing defective copper absorption and transport.

**Symptoms in common**: Hypotonia, Seizures, Intellectual disability, Motor delay, Fair hair, White hair, Pneumonia, Death in infancy.

**Symptoms not in common**: Cyanosis, Edema, Hyperactivity.

---

+3. **Phenylketonuria (PKU)**:
An inborn error of metabolism leading to accumulation of phenylalanine, causing neurological damage.

**Symptoms in common**: Intellectual disability, Seizures, Hyperactivity, Fair hair, White hair, Motor delay.

**Symptoms not in common**: Cyanosis, Edema, Death in infancy (if untreated, can lead to severe complications but not typically immediate death).

---

+4. **Krabbe Disease**:
A lysosomal storage disorder affecting the nervous system due to deficient galactocerebrosidase enzyme.

**Symptoms in common**: Irritability, Spasticity (spastic diplegia and tetraplegia), Seizures, Motor delay, Developmental regression, Death in infancy.

**Symptoms not in common**: Fair hair, White hair, Hepatomegaly.

---

+5. **Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy)**:
A mitochondrial disorder leading to progressive loss of mental and movement abilities.

**Symptoms in common**: Hypotonia, Seizures, Motor delay, Metabolic acidosis, Respiratory issues (dyspnea, pneumonia), Death in infancy.

**Symptoms not in common**: Fair hair, White hair, Hepatomegaly.

---

+6. **Tay-Sachs Disease**:
A genetic disorder that results in the destruction of nerve cells in the brain and spinal cord.

**Symptoms in common**: Hypotonia, Seizures, Motor delay, Intellectual disability, Death in infancy.

**Symptoms not in common**: Hepatomegaly, Fair hair, White hair.

---

+7. **Maple Syrup Urine Disease**:
An amino acid metabolism disorder leading to accumulation of branched-chain amino acids.

**Symptoms in common**: Poor feeding, Vomiting, Hypotonia, Seizures, Metabolic acidosis, Death in infancy.

**Symptoms not in common**: Fair hair, White hair, Hepatomegaly.

---

+8. **Albinism**:
A group of genetic disorders characterized by a reduction or absence of melanin pigment.

**Symptoms in common**: Nystagmus, Strabismus, Fair hair, White hair.

**Symptoms not in common**: Seizures, Intellectual disability, Death in infancy.

---

+9. **Congenital Hypothyroidism**:
A thyroid hormone deficiency present at birth affecting growth and brain development.

**Symptoms in common**: Hypotonia, Intellectual disability, Motor delay, Edema.

**Symptoms not in common**: Seizures, Fair hair, White hair, Death in infancy (if untreated, can lead to severe complications).

---

+10. **Homocystinuria**:
A metabolic disorder affecting the metabolism of the amino acid methionine.

**Symptoms in common**: Intellectual disability, Seizures, Fair hair, Motor delay.

**Symptoms not in common**: Hypotonia, Hepatomegaly, Death in infancy.

---"
['PMM2-CDG'],"+1. **Congenital Disorder of Glycosylation (CDG):**
- **Symptoms in common:** Strabismus, intellectual disability, ataxia, motor delay, cerebellar atrophy, generalized hypotonia, hepatic fibrosis, cirrhosis, thromboembolism, reduced antithrombin III activity, lipodystrophy, death in infancy, childhood, or adolescence.
- **Symptoms not in common:** Cerebellar agenesis, although severe cerebellar hypoplasia can occur in some cases.

+2. **Zellweger Spectrum Disorder:**
- **Symptoms in common:** Hypotonia, intellectual disability, motor delay, hepatic fibrosis, cirrhosis, death in infancy or early childhood, cerebellar atrophy, ocular abnormalities which may include strabismus.
- **Symptoms not in common:** Thromboembolism, reduced antithrombin III activity, lipodystrophy, cerebellar agenesis is rare but can occur.

+3. **Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy):**
- **Symptoms in common:** Ataxia, motor delay, cerebellar atrophy, generalized hypotonia, death in infancy or early childhood.
- **Symptoms not in common:** Strabismus (though ocular abnormalities can occur), hepatic fibrosis and cirrhosis are less common, thromboembolism, reduced antithrombin III activity, lipodystrophy, cerebellar agenesis.

+4. **Wilson's Disease:**
- **Symptoms in common:** Ataxia, motor delay, hepatic fibrosis, cirrhosis, intellectual disability (in some cases), death in adolescence if untreated.
- **Symptoms not in common:** Strabismus, generalized hypotonia, thromboembolism, reduced antithrombin III activity, lipodystrophy, cerebellar atrophy or agenesis.

+5. **Niemann-Pick Disease Type C:**
- **Symptoms in common:** Ataxia, intellectual disability, motor delay, hypotonia, hepatic fibrosis, cirrhosis, death in childhood or adolescence, eye movement abnormalities which might include strabismus.
- **Symptoms not in common:** Thromboembolism, reduced antithrombin III activity, lipodystrophy, cerebellar agenesis.

+6. **Antithrombin III Deficiency:**
- **Symptoms in common:** Thromboembolism, reduced antithrombin III activity.
- **Symptoms not in common:** Neurological symptoms like strabismus, intellectual disability, ataxia, motor delay, cerebellar atrophy or agenesis, generalized hypotonia, hepatic fibrosis, cirrhosis, lipodystrophy, death in infancy, childhood, or adolescence.

+7. **Mitochondrial DNA Depletion Syndromes (MDDS):**
- **Symptoms in common:** Hypotonia, ataxia, motor delay, intellectual disability, hepatic fibrosis, cirrhosis, death in infancy or early childhood.
- **Symptoms not in common:** Strabismus, thromboembolism, reduced antithrombin III activity, lipodystrophy, cerebellar agenesis.

+8. **Cockayne Syndrome:**
- **Symptoms in common:** Intellectual disability, motor delay, generalized hypotonia, ataxia, death in childhood or adolescence.
- **Symptoms not in common:** Strabismus (rare), hepatic fibrosis, cirrhosis, thromboembolism, reduced antithrombin III activity, lipodystrophy, cerebellar atrophy or agenesis.

+9. **Pyruvate Carboxylase Deficiency:**
- **Symptoms in common:** Generalized hypotonia, motor delay, intellectual disability, lactic acidosis leading to hepatic dysfunction, death in infancy.
- **Symptoms not in common:** Strabismus, ataxia, cerebellar atrophy or agenesis, thromboembolism, reduced antithrombin III activity, lipodystrophy.

+10. **Gaucher Disease Type 2 (Acute Neuropathic Form):**
- **Symptoms in common:** Hypotonia, motor delay, strabismus, hepatic fibrosis, death in infancy.
- **Symptoms not in common:** Intellectual disability (due to neurodegeneration rather than developmental delay), ataxia, cerebellar atrophy or agenesis, thromboembolism, reduced antithrombin III activity, lipodystrophy."
['Canavan disease'],"+1. Maple Syrup Urine Disease:
Description: A metabolic disorder affecting the breakdown of branched-chain amino acids (leucine, isoleucine, and valine), leading to toxic accumulation and severe neurological symptoms.
Symptoms in common: Irritability, Seizure, Generalized hypotonia, Feeding difficulties, Death in infancy.
Symptoms not in common: Hyperreflexia (typically patients have decreased reflexes), Opisthotonus (not commonly associated), Abnormal circulating aspartate family amino acid concentration (MSUD involves branched-chain amino acids, not aspartate family).

+2. Nonketotic Hyperglycinemia (Glycine Encephalopathy):
Description: A disorder caused by a defect in the glycine cleavage system, resulting in accumulation of glycine in bodily fluids and severe neurological impairment.
Symptoms in common: Seizure, Generalized hypotonia, Feeding difficulties, Death in infancy.
Symptoms not in common: Irritability (may not be prominent), Hyperreflexia (usually presents with decreased reflexes), Opisthotonus (not typical), Abnormal circulating aspartate family amino acid concentration (elevated glycine, not aspartate family amino acids).

+3. Canavan Disease:
Description: A rare genetic disorder caused by deficiency of the enzyme aspartoacylase, leading to accumulation of N-acetylaspartic acid and demyelination in the central nervous system.
Symptoms in common: Generalized hypotonia, Seizure, Feeding difficulties, Death in infancy, Abnormal circulating aspartate family amino acid concentration (elevated N-acetylaspartic acid).
Symptoms not in common: Irritability (may be less pronounced), Hyperreflexia (spasticity may develop later), Opisthotonus (can occur but less common).

+4. Glutaric Acidemia Type I:
Description: A metabolic disorder affecting the breakdown of lysine, hydroxylysine, and tryptophan, leading to accumulation of toxic metabolites that can cause brain damage.
Symptoms in common: Seizure, Generalized hypotonia, Opisthotonus, Feeding difficulties.
Symptoms not in common: Irritability (may occur), Hyperreflexia (variable presentation), Death in infancy (variable prognosis), Abnormal circulating aspartate family amino acid concentration (elevated glutaric acid, lysine is part of the aspartate family).

+5. Krabbe Disease:
Description: A lysosomal storage disorder caused by deficiency of the enzyme galactocerebrosidase, leading to severe demyelination in the nervous system.
Symptoms in common: Irritability, Seizure, Hyperreflexia, Feeding difficulties, Death in infancy.
Symptoms not in common: Generalized hypotonia (patients often develop spasticity), Opisthotonus (less common), Abnormal circulating aspartate family amino acid concentration (not typical).

+6. Hyperlysinemia:
Description: A rare metabolic disorder caused by a deficiency of the enzyme saccharopine dehydrogenase, leading to elevated lysine levels.
Symptoms in common: Seizure, Generalized hypotonia, Feeding difficulties, Abnormal circulating aspartate family amino acid concentration (elevated lysine).
Symptoms not in common: Irritability (may be less prominent), Hyperreflexia (not commonly associated), Opisthotonus (not typical), Death in infancy (variable outcome).

+7. Lysinuric Protein Intolerance:
Description: A disorder affecting the transport of certain amino acids, leading to accumulation and neurological symptoms.
Symptoms in common: Feeding difficulties, Generalized hypotonia, Seizure.
Symptoms not in common: Irritability (may occur), Hyperreflexia (not typical), Opisthotonus (rare), Death in infancy (can occur but variable), Abnormal circulating aspartate family amino acid concentration (elevated lysine, arginine, ornithine).

+8. Urea Cycle Disorders (e.g., Argininosuccinic Aciduria):
Description: Metabolic disorders resulting from defects in the urea cycle, leading to hyperammonemia and neurological symptoms.
Symptoms in common: Irritability, Seizure, Generalized hypotonia, Feeding difficulties, Death in infancy.
Symptoms not in common: Hyperreflexia (may have decreased reflexes), Opisthotonus (not typical), Abnormal circulating aspartate family amino acid concentration (elevated argininosuccinic acid).

+9. Menkes Disease:
Description: A disorder of copper metabolism leading to deficiency, affecting the development of the nervous system.
Symptoms in common: Seizure, Generalized hypotonia, Feeding difficulties, Death in infancy.
Symptoms not in common: Irritability (may be less pronounced), Hyperreflexia (often hypotonia dominates), Opisthotonus (not common), Abnormal circulating aspartate family amino acid concentration (not typical).

+10. Leigh Syndrome:
Description: A severe neurological disorder due to mitochondrial dysfunction, causing progressive loss of mental and movement abilities.
Symptoms in common: Seizure, Generalized hypotonia, Feeding difficulties, Death in infancy.
Symptoms not in common: Irritability (may occur), Hyperreflexia (variable), Opisthotonus (not typical), Abnormal circulating aspartate family amino acid concentration (not typical)."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
A genetic disorder affecting the breakdown of tyrosine, leading to the accumulation of toxic substances in the body. Symptoms the patient has in common: Hypertyrosinemia, Gastrointestinal inflammation, Death in infancy, Neonatal death, Abnormality of prenatal development or birth. Symptoms not in common: Hyperphenylalaninemia.

+2. Phenylketonuria (PKU):
An inherited metabolic disorder causing elevated levels of phenylalanine, which can lead to intellectual disabilities if untreated. Symptoms the patient has in common: Hyperphenylalaninemia, Abnormality of prenatal development or birth. Symptoms the patient does not have in common: Hypertyrosinemia, Gastrointestinal inflammation, Death in infancy, Neonatal death.

+3. Tyrosinemia Type II:
A rare genetic disorder resulting in high levels of tyrosine, affecting the eyes, skin, and mental development. Symptoms the patient has in common: Hypertyrosinemia, Abnormality of prenatal development or birth. Symptoms not in common: Gastrointestinal inflammation, Death in infancy, Neonatal death, Hyperphenylalaninemia.

+4. Maple Syrup Urine Disease:
An inherited disorder affecting the metabolism of certain amino acids, leading to toxic buildup. Symptoms the patient has in common: Neonatal death, Gastrointestinal inflammation, Abnormality of prenatal development or birth. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

+5. Homocystinuria:
A genetic condition causing an accumulation of homocysteine, affecting connective tissue, brain, and vascular system. Symptoms the patient has in common: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation, Neonatal death."
['Maple syrup urine disease'],"+1. **Maple Syrup Urine Disease (MSUD):**

Symptoms in common: Coma, Reduced tendon reflexes, Metabolic acidosis, Cerebral edema, Hyperleucinemia, Death in childhood.

Symptoms not in common: Ataxia, Alopecia, Abnormal cerebral white matter morphology, Recurrent viral infections, Death in adolescence.

+2. **Leigh Syndrome:**

Symptoms in common: Ataxia, Coma, Reduced tendon reflexes, Metabolic acidosis, Cerebral edema, Death in childhood.

Symptoms not in common: Alopecia, Abnormal cerebral white matter morphology, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

+3. **Biotinidase Deficiency:**

Symptoms in common: Alopecia, Metabolic acidosis, Reduced tendon reflexes, Coma, Recurrent viral infections, Death in childhood.

Symptoms not in common: Ataxia, Cerebral edema, Abnormal cerebral white matter morphology, Hyperleucinemia, Death in adolescence.

+4. **Canavan Disease:**

Symptoms in common: Reduced tendon reflexes, Abnormal cerebral white matter morphology, Cerebral edema, Death in childhood.

Symptoms not in common: Ataxia, Coma, Alopecia, Metabolic acidosis, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

+5. **Adrenoleukodystrophy:**

Symptoms in common: Reduced tendon reflexes, Abnormal cerebral white matter morphology, Death in adolescence.

Symptoms not in common: Ataxia, Coma, Alopecia, Metabolic acidosis, Cerebral edema, Recurrent viral infections, Hyperleucinemia, Death in childhood.

+6. **Menkes Disease:**

Symptoms in common: Reduced tendon reflexes, Alopecia, Cerebral edema, Death in childhood.

Symptoms not in common: Ataxia, Coma, Metabolic acidosis, Abnormal cerebral white matter morphology, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

+7. **Alexander Disease:**

Symptoms in common: Ataxia, Seizures (which may lead to coma), Abnormal cerebral white matter morphology, Death in childhood.

Symptoms not in common: Reduced tendon reflexes, Alopecia, Metabolic acidosis, Cerebral edema, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

+8. **Krabbe Disease:**

Symptoms in common: Irritability leading to coma, Reduced tendon reflexes, Abnormal cerebral white matter morphology, Death in childhood.

Symptoms not in common: Ataxia, Alopecia, Metabolic acidosis, Cerebral edema, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

+9. **Severe Combined Immunodeficiency (SCID):**

Symptoms in common: Recurrent viral infections, Death in childhood.

Symptoms not in common: Ataxia, Coma, Reduced tendon reflexes, Alopecia, Metabolic acidosis, Cerebral edema, Abnormal cerebral white matter morphology, Hyperleucinemia, Death in adolescence.

+10. **Propionic Acidemia:**

Symptoms in common: Metabolic acidosis, Coma, Reduced tendon reflexes, Death in childhood.

Symptoms not in common: Ataxia, Alopecia, Cerebral edema, Abnormal cerebral white matter morphology, Recurrent viral infections, Hyperleucinemia, Death in adolescence."
['Acute intermittent porphyria'],"+1. ALAD Deficiency Porphyria:
This is a rare genetic disorder caused by a deficiency of the enzyme delta-aminolevulinic acid dehydratase (ALAD), leading to the accumulation of delta-aminolevulinic acid.

**Symptoms in common with the patient**: Abdominal pain, Elevated urinary delta-aminolevulinic acid, Death in childhood.

**Symptoms not present**: None.

+2. Tyrosinemia Type I:
A genetic disorder affecting tyrosine metabolism, resulting in the accumulation of toxic substances that can inhibit ALAD enzyme activity.

**Symptoms in common with the patient**: Abdominal pain, Elevated urinary delta-aminolevulinic acid, Death in childhood.

**Symptoms not present**: None.

+3. Lead Poisoning:
Exposure to high levels of lead can inhibit the ALAD enzyme, causing an increase in delta-aminolevulinic acid levels.

**Symptoms in common with the patient**: Abdominal pain, Elevated urinary delta-aminolevulinic acid.

**Symptoms not in common**: Death in childhood (typically not seen with timely diagnosis and treatment)."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Aciduria (Methylmalonic Acidemia):**

A rare inherited metabolic disorder where the body cannot process certain fats and proteins properly due to a deficiency of the enzyme methylmalonyl-CoA mutase. This leads to a buildup of methylmalonic acid in the blood.

- **Symptoms in common:** Seizure, Death in infancy, Metabolic acidosis, Neonatal death, Methylmalonic aciduria.
- **Symptoms not in common:** None.

+2. **Propionic Acidemia:**

An inherited metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid.

- **Symptoms in common:** Seizure, Death in infancy, Metabolic acidosis, Neonatal death.
- **Symptoms not in common:** Methylmalonic aciduria.

+3. **Multiple Carboxylase Deficiency:**

A genetic disorder affecting the body's ability to process proteins, fats, and carbohydrates due to defects in biotin metabolism, resulting in enzyme deficiencies.

- **Symptoms in common:** Seizure, Metabolic acidosis, Neonatal death.
- **Symptoms not in common:** Death in infancy, Methylmalonic aciduria.

+4. **Leigh Syndrome:**

A severe neurological disorder that arises in the first year of life due to mitochondrial dysfunction.

- **Symptoms in common:** Seizure, Metabolic acidosis, Death in infancy.
- **Symptoms not in common:** Neonatal death, Methylmalonic aciduria.

+5. **Maple Syrup Urine Disease:**

An inherited disorder affecting the breakdown of certain amino acids, leading to their accumulation in the body.

- **Symptoms in common:** Seizure, Metabolic acidosis.
- **Symptoms not in common:** Death in infancy, Neonatal death, Methylmalonic aciduria.

+6. **Isovaleric Acidemia:**

A metabolic disorder where the body cannot properly break down the amino acid leucine, resulting in a buildup of isovaleric acid.

- **Symptoms in common:** Seizure, Metabolic acidosis.
- **Symptoms not in common:** Death in infancy, Neonatal death, Methylmalonic aciduria.

+7. **Pyruvate Dehydrogenase Deficiency:**

A genetic disorder affecting the pyruvate dehydrogenase complex, leading to lactic acidosis and neurological issues.

- **Symptoms in common:** Seizure, Metabolic acidosis.
- **Symptoms not in common:** Death in infancy, Neonatal death, Methylmalonic aciduria."
['Alkaptonuria'],"+1. Maple Syrup Urine Disease:
A rare inherited metabolic disorder affecting the body's ability to process certain amino acids.

**Symptoms in common:** Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, Sleep abnormality, Death in childhood.

**Symptoms not in common:** Dark urine.

+2. Tyrosinemia Type I:
A genetic disorder affecting the breakdown of the amino acid tyrosine, leading to liver and kidney problems.

**Symptoms in common:** Lethargy, Growth delay, Drowsiness, Sleep abnormality, Death in childhood, Dark urine.

**Symptoms not in common:** Seizure, Generalized hypotonia.

+3. Urea Cycle Disorders:
A group of genetic disorders causing a deficiency of one of the enzymes in the urea cycle, leading to ammonia buildup.

**Symptoms in common:** Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, Sleep abnormality.

**Symptoms not in common:** Dark urine, Death in childhood.

+4. Mitochondrial Disorders:
Conditions resulting from dysfunction of the mitochondria, affecting energy production in cells.

**Symptoms in common:** Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, Sleep abnormality, Death in childhood.

**Symptoms not in common:** Dark urine.

+5. Phenylketonuria (PKU):
A metabolic disorder caused by a deficiency in the enzyme needed to process the amino acid phenylalanine.

**Symptoms in common:** Seizure, Growth delay, Drowsiness, Sleep abnormality.

**Symptoms not in common:** Lethargy, Generalized hypotonia, Death in childhood, Dark urine.

+6. Glycine Encephalopathy (Nonketotic Hyperglycinemia):
A genetic disorder affecting glycine metabolism, leading to excessive glycine in the brain.

**Symptoms in common:** Seizure, Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Death in childhood.

**Symptoms not in common:** Growth delay, Dark urine.

+7. Tyrosinemia Type II:
A disorder affecting tyrosine metabolism but primarily causing skin and eye symptoms.

**Symptoms in common:** Growth delay, Sleep abnormality.

**Symptoms not in common:** Seizure, Lethargy, Generalized hypotonia, Drowsiness, Death in childhood, Dark urine.

+8. Organic Acidemias:
A group of disorders resulting from defects in amino acid metabolism, leading to toxic accumulation of organic acids.

**Symptoms in common:** Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness.

**Symptoms not in common:** Sleep abnormality, Death in childhood, Dark urine."
['Maple syrup urine disease'],"+1. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a rare inherited metabolic disorder where the body cannot break down the branched-chain amino acids leucine, isoleucine, and valine. This leads to a harmful buildup of these substances in the blood and urine.

**Symptoms in common:**
- Seizure
- Death in infancy
- Neonatal death
- Aminoaciduria
- Abnormal circulating leucine concentration
- Abnormal circulating isoleucine concentration
- Abnormal circulating valine concentration

**Symptoms not present:**
- None noted

+2. **Isovaleric Acidemia**:
This is a metabolic disorder affecting the breakdown of the amino acid leucine, leading to a buildup of isovaleric acid.

**Symptoms in common:**
- Seizure
- Death in infancy
- Neonatal death
- Abnormal circulating leucine concentration

**Symptoms not present:**
- Aminoaciduria
- Abnormal circulating isoleucine concentration
- Abnormal circulating valine concentration

+3. **Propionic Acidemia**:
A genetic disorder where the body can't process certain parts of proteins and lipids properly, leading to a toxic buildup.

**Symptoms in common:**
- Seizure
- Death in infancy
- Neonatal death
- Aminoaciduria

**Symptoms not present:**
- Abnormal circulating leucine concentration
- Abnormal circulating isoleucine concentration
- Abnormal circulating valine concentration

+4. **Methylmalonic Acidemia**:
An inherited condition in which the body can’t break down certain proteins and fats, causing a buildup of methylmalonic acid.

**Symptoms in common:**
- Seizure
- Death in infancy
- Neonatal death

**Symptoms not present:**
- Aminoaciduria
- Abnormal circulating amino acid concentrations

+5. **Non-Ketotic Hyperglycinemia**:
A disorder characterized by the accumulation of glycine, leading to neurological symptoms.

**Symptoms in common:**
- Seizure
- Death in infancy
- Neonatal death

**Symptoms not present:**
- Aminoaciduria
- Abnormal circulating leucine, isoleucine, valine concentrations"
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:

MADD is a severe fatty acid oxidation disorder that impairs the body's ability to break down fats for energy, leading to energy deficiency and accumulation of fatty acids.

**Symptoms in common**: Death in infancy, cardiomegaly, hypoglycemia, increased circulating lactate concentration, hepatomegaly, tachypnea, dicarboxylic aciduria, neonatal death, death in childhood, abnormal circulating carnitine concentration.

**Symptoms not present**: Recurrent viral infections.

+2. **Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD Deficiency)**:

MCAD deficiency impedes the oxidation of medium-chain fatty acids, which can result in a lack of energy, especially during periods of fasting or illness.

**Symptoms in common**: Hypoglycemia, increased circulating lactate concentration, hepatomegaly, dicarboxylic aciduria, neonatal death, death in childhood, abnormal circulating carnitine concentration.

**Symptoms not present**: Cardiomegaly, tachypnea, recurrent viral infections, death in infancy.

+3. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency)**:

This condition results from defective transport of carnitine into cells, affecting energy production from fatty acids.

**Symptoms in common**: Cardiomegaly, hypoglycemia, hepatomegaly, recurrent viral infections, death in childhood, abnormal circulating carnitine concentration.

**Symptoms not present**: Increased circulating lactate concentration, tachypnea, dicarboxylic aciduria, neonatal death, death in infancy.

+4. **Pyruvate Dehydrogenase Complex Deficiency**:

A mitochondrial disorder that disrupts energy production by impairing the conversion of pyruvate to acetyl-CoA, leading to lactic acidosis.

**Symptoms in common**: Increased circulating lactate concentration, hypotonia, cardiomegaly, tachypnea, death in infancy, death in childhood.

**Symptoms not present**: Hypoglycemia, hepatomegaly, dicarboxylic aciduria, recurrent viral infections, abnormal circulating carnitine concentration.

+5. **Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD Deficiency)**:

LCHAD deficiency affects the breakdown of long-chain fatty acids, leading to energy production problems and accumulation of toxic substances.

**Symptoms in common**: Hypoglycemia, cardiomegaly, hepatomegaly, increased circulating lactate concentration, dicarboxylic aciduria, neonatal death, death in infancy.

**Symptoms not present**: Tachypnea, recurrent viral infections, abnormal circulating carnitine concentration, death in childhood."
['3-hydroxy-3-methylglutaric aciduria'],"+1. Glutaric Aciduria Type I:
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Vomiting, Drowsiness, Progressive neurologic deterioration, Glutaric aciduria, Elevated urinary carboxylic acid, Death in infancy or childhood.
Symptoms not in common: Recurrent viral infections, Abnormal circulating glycine concentration, Hypoglycemia, Fever.

+2. Nonketotic Hyperglycinemia:
Symptoms in common: Seizure, Lethargy, Sleep abnormality, Progressive neurologic deterioration, Abnormal circulating glycine concentration, Death in infancy.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Hypoglycemia, Fever, Recurrent viral infections.

+3. 3-Methylglutaconic Aciduria:
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Vomiting, Drowsiness, Progressive neurologic deterioration, 3-Methylglutaric aciduria, Elevated urinary carboxylic acid.
Symptoms not in common: Glutaric aciduria, Abnormal circulating glycine concentration, Hypoglycemia, Fever.

+4. Multiple Carboxylase Deficiency:
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Hypoglycemia, Vomiting, Drowsiness, Elevated urinary carboxylic acid.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Fever.

+5. Propionic Acidemia:
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Vomiting, Drowsiness, Progressive neurologic deterioration.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Hypoglycemia, Fever.

+6. Mitochondrial Disease (e.g., Leigh Syndrome):
Symptoms in common: Seizure, Lethargy, Progressive neurologic deterioration, Vomiting, Drowsiness.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Metabolic acidosis, Hypoglycemia.

+7. Organic Acidurias (General):
Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Vomiting, Drowsiness, Elevated urinary carboxylic acid.
Symptoms not in common: Specific markers like Glutaric aciduria or 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Hypoglycemia.

+8. Fatty Acid Oxidation Disorders:
Symptoms in common: Hypoglycemia, Lethargy, Vomiting, Drowsiness, Seizure.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Metabolic acidosis.

+9. Urea Cycle Disorders:
Symptoms in common: Lethargy, Vomiting, Progressive neurologic deterioration, Seizure.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Hypoglycemia, Metabolic acidosis.

+10. Infection-Induced Encephalopathy:
Symptoms in common: Fever, Seizure, Lethargy, Vomiting, Drowsiness, Recurrent viral infections.
Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Metabolic acidosis, Hypoglycemia."
['MODY'],"+1. **Porphyria**:
Porphyria is a group of rare genetic disorders resulting from buildup of natural chemicals that produce porphyrin, which is essential for hemoglobin function.

- **Symptoms the patient has in common**:
  - Abnormal circulating porphyrin concentration.

- **Symptoms the patient does not have in common**:
  - Hypoglycemia is not typically associated.
  - Glycosuria is not a common symptom.

+2. **Fanconi Syndrome**:
Fanconi Syndrome is a disorder of the kidney tubules where certain substances are released into the urine instead of being reabsorbed into the bloodstream.

- **Symptoms the patient has in common**:
  - Glycosuria (glucose in urine).

- **Symptoms the patient does not have in common**:
  - Hypoglycemia is not commonly seen.
  - Abnormal circulating porphyrin concentration is not typical.

+3. **Lead Poisoning**:
Lead poisoning occurs due to excessive exposure to lead, affecting multiple body systems, including heme synthesis.

- **Symptoms the patient has in common**:
  - Abnormal circulating porphyrin concentration.

- **Symptoms the patient does not have in common**:
  - Hypoglycemia is not usual.
  - Glycosuria is not typically present.

+4. **Hereditary Fructose Intolerance**:
A genetic condition where the body lacks the enzyme to break down fructose, leading to serious metabolic disturbances upon ingestion.

- **Symptoms the patient has in common**:
  - Hypoglycemia.

- **Symptoms the patient does not have in common**:
  - Glycosuria is not common.
  - Abnormal porphyrin levels are not associated.

+5. **Glycogen Storage Disease Type I (Von Gierke Disease)**:
A metabolic disorder caused by deficiency of glucose-6-phosphatase, leading to accumulation of glycogen in organs.

- **Symptoms the patient has in common**:
  - Hypoglycemia.

- **Symptoms the patient does not have in common**:
  - Glycosuria is not typical.
  - Abnormal porphyrin concentration is not associated.

+6. **Diabetes Mellitus**:
A metabolic disease characterized by high blood sugar levels over a prolonged period due to insulin deficiency or resistance.

- **Symptoms the patient has in common**:
  - Glycosuria.

- **Symptoms the patient does not have in common**:
  - Hypoglycemia is low blood sugar, whereas diabetes typically involves high blood sugar (hyperglycemia), though hypoglycemia can occur due to medication.
  - Abnormal porphyrin levels are not typical.

+7. **Acute Intermittent Porphyria**:
A form of porphyria that affects the nervous system, leading to abdominal pain and neuropsychiatric symptoms.

- **Symptoms the patient has in common**:
  - Abnormal circulating porphyrin concentration.

- **Symptoms the patient does not have in common**:
  - Hypoglycemia is not a usual symptom.
  - Glycosuria is not commonly associated.

+8. **Tyrosinemia Type I**:
A genetic disorder affecting tyrosine metabolism, leading to liver and kidney dysfunction.

- **Symptoms the patient has in common**:
  - Hypoglycemia.
  - Glycosuria due to renal tubular dysfunction.

- **Symptoms the patient does not have in common**:
  - Abnormal circulating porphyrin concentration is not typical.

+9. **Fructose-1,6-bisphosphatase Deficiency**:
A rare metabolic disorder affecting gluconeogenesis, resulting in hypoglycemia and metabolic acidosis.

- **Symptoms the patient has in common**:
  - Hypoglycemia.

- **Symptoms the patient does not have in common**:
  - Glycosuria is not typically observed.
  - Abnormal porphyrin levels are not associated.

+10. **Wilson's Disease**:
A genetic disorder causing excessive accumulation of copper in the body, affecting the liver and nervous system.

- **Symptoms the patient has in common**:
  - Abnormal circulating porphyrin concentration (in some cases).

- **Symptoms the patient does not have in common**:
  - Hypoglycemia is not common.
  - Glycosuria is not typically present."
['Phenylketonuria'],"+1. **Malignant Phenylketonuria (Malignant PKU)**:
Malignant PKU is a severe form of phenylketonuria caused by defects in tetrahydrobiopterin (BH4) metabolism, leading to high levels of phenylalanine (hyperphenylalaninemia) and neurotransmitter deficiencies.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Hyperphenylalaninemia
- Death in infancy
- Neonatal death

**Symptoms not present in the patient**:
- *(None; all listed symptoms are common with Malignant PKU.)*

+2. **Tetrahydrobiopterin (BH4) Deficiency**:
BH4 deficiency affects the synthesis of several neurotransmitters and leads to hyperphenylalaninemia due to impaired phenylalanine metabolism.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Hyperphenylalaninemia
- Potential for neonatal death
- Potential for death in infancy

**Symptoms not present in the patient**:
- *(None; all listed symptoms can be associated with BH4 deficiency.)*

+3. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a metabolic disorder characterized by the accumulation of branched-chain amino acids, leading to toxicity.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy

**Symptoms not present in the patient**:
- Hyperphenylalaninemia (MSUD typically does not cause elevated phenylalanine levels)

+4. **Non-Ketotic Hyperglycinemia**:
A disorder caused by defects in glycine cleavage system, leading to accumulation of glycine.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy

**Symptoms not present in the patient**:
- Hyperphenylalaninemia (elevated glycine, not phenylalanine)

+5. **Tyrosinemia Type I**:
A metabolic disorder affecting tyrosine degradation, leading to accumulation of toxic metabolites.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Potential for death in infancy

**Symptoms not present in the patient**:
- Hyperphenylalaninemia (elevated tyrosine levels, not phenylalanine)
- Neonatal death (symptoms usually develop after the neonatal period)"
['Glutaryl-CoA dehydrogenase deficiency'],I'm sorry to hear that you're experiencing these symptoms. It's important to consult a qualified healthcare professional who can provide a thorough evaluation and appropriate guidance.
['Phenylketonuria'],"+1. Tyrosinemia Type I:

Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. This leads to the accumulation of toxic metabolites of tyrosine, resulting in severe liver and kidney dysfunction, often presenting in infancy.

**Symptoms in common:** Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death.

**Symptoms not in common:** Hyperphenylalaninemia, Death in childhood (since death typically occurs in infancy if untreated).

+2. Biopterin (BH4) Cofactor Deficiency:

This is a rare metabolic disorder affecting the synthesis or recycling of tetrahydrobiopterin (BH4), a cofactor necessary for the metabolism of phenylalanine and tyrosine. Deficiency leads to hyperphenylalaninemia and can affect neurotransmitter synthesis.

**Symptoms in common:** Abnormality of prenatal development or birth, Death in infancy, Hyperphenylalaninemia, Hypertyrosinemia.

**Symptoms not in common:** Neonatal death (may vary), Death in childhood (some patients may survive infancy with treatment).

+3. Phenylketonuria (PKU):

PKU is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to elevated levels of phenylalanine. If untreated, it can cause intellectual disability and other neurological problems.

**Symptoms in common:** Abnormality of prenatal development or birth, Hyperphenylalaninemia.

**Symptoms not in common:** Death in infancy (rare with dietary management), Hypertyrosinemia, Neonatal death, Death in childhood.

+4. Maple Syrup Urine Disease (MSUD):

MSUD is an inherited disorder affecting the metabolism of branched-chain amino acids. Accumulation of these amino acids leads to severe neurological damage and can be life-threatening if untreated.

**Symptoms in common:** Abnormality of prenatal development or birth, Death in infancy, Neonatal death.

**Symptoms not in common:** Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood (typically occurs in infancy without treatment).

+5. Tyrosinemia Type II:

Tyrosinemia Type II results from a deficiency of the enzyme tyrosine aminotransferase, causing elevated levels of tyrosine. It primarily affects the eyes, skin, and intellectual development.

**Symptoms in common:** Abnormality of prenatal development or birth, Hypertyrosinemia.

**Symptoms not in common:** Death in infancy (less common), Neonatal death, Hyperphenylalaninemia, Death in childhood."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Symptoms in common with the disease: Hypertyrosinemia, Death in early adulthood.
Symptoms not in common with the disease: Hyperphenylalaninemia, Preeclampsia.
**Description:** Tyrosinemia Type I is a severe hereditary disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. This leads to the accumulation of toxic substances in the liver and kidneys, resulting in liver failure, renal dysfunction, and neurological complications. Without treatment, it can lead to death in early childhood or adolescence.

+2. Tetrahydrobiopterin (BH4) Deficiency:
Symptoms in common with the disease: Hyperphenylalaninemia, Hypertyrosinemia, Death in early adulthood.
Symptoms not in common with the disease: Preeclampsia.
**Description:** BH4 deficiency affects the metabolism of several amino acids, including phenylalanine and tyrosine. It leads to elevated levels of these amino acids in the blood. The condition can cause neurological symptoms, developmental delays, and, if untreated, may result in early death.

+3. Maternal Phenylketonuria (PKU):
Symptoms in common with the disease: Hyperphenylalaninemia, Preeclampsia.
Symptoms not in common with the disease: Hypertyrosinemia, Death in early adulthood.
**Description:** If a pregnant woman with PKU has uncontrolled phenylalanine levels, it can lead to high phenylalanine levels affecting the fetus, causing congenital heart defects, growth retardation, and intellectual disabilities. Preeclampsia can occur in such high-risk pregnancies.

+4. Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency:
Symptoms in common with the disease: Preeclampsia, Death in early adulthood.
Symptoms not in common with the disease: Hypertyrosinemia, Hyperphenylalaninemia.
**Description:** LCHAD deficiency is a fatty acid oxidation disorder that impairs the body's ability to break down long-chain fatty acids. Affected individuals may experience hypoglycemia, muscle weakness, and liver problems. Pregnant women carrying a fetus with LCHAD deficiency have an increased risk of developing preeclampsia.

+5. Alkaptonuria:
Symptoms in common with the disease: Hypertyrosinemia.
Symptoms not in common with the disease: Hyperphenylalaninemia, Preeclampsia, Death in early adulthood.
**Description:** Alkaptonuria is a rare metabolic disorder characterized by the accumulation of homogentisic acid, leading to darkening of urine and connective tissue. While it involves tyrosine metabolism and can cause hypertyrosinemia, it typically does not lead to early death or affect pregnancy.

+6. Homocystinuria:
Symptoms in common with the disease: Death in early adulthood.
Symptoms not in common with the disease: Hypertyrosinemia, Hyperphenylalaninemia, Preeclampsia.
**Description:** Homocystinuria is a disorder affecting methionine metabolism, leading to the accumulation of homocysteine. It can cause developmental delays, vision problems, and an increased risk of thromboembolic events, potentially leading to early death if untreated."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic metabolites of the amino acid tyrosine.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Death in infancy
- Hypertyrosinemia
- Neonatal death
- Elevated urinary carboxylic acid

**Symptoms not in common:**
- Hyperphenylalaninemia
- Death in early adulthood

---

+2. **Phenylketonuria (PKU)**:

PKU is a metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, causing an accumulation of phenylalanine in the body.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Hyperphenylalaninemia
- Elevated urinary carboxylic acid

**Symptoms not in common:**
- Death in infancy
- Hypertyrosinemia
- Neonatal death
- Death in early adulthood

---

+3. **Maple Syrup Urine Disease**:

This is an inherited disorder affecting the metabolism of branched-chain amino acids, leading to their accumulation and resulting in serious health issues.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Neonatal death
- Elevated urinary carboxylic acid

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Death in infancy
- Death in early adulthood

---

+4. **Methylmalonic Acidemia**:

A metabolic disorder where the body can't break down certain fats and proteins, leading to a buildup of methylmalonic acid.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Elevated urinary carboxylic acid
- Death in early adulthood

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Death in infancy
- Neonatal death

---

+5. **Nonketotic Hyperglycinemia**:

A rare genetic disorder characterized by the accumulation of glycine, leading to severe neurological symptoms.

**Symptoms in common with the patient:**
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy

**Symptoms not in common:**
- Hypertyrosinemia
- Hyperphenylalaninemia
- Elevated urinary carboxylic acid
- Death in early adulthood

---"
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

A rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its metabolites in the body.

**Symptoms in common with the patient**:
- Hypertyrosinemia
- Death in infancy
- Neonatal death
- Abnormality of prenatal development or birth
- Death in childhood

**Symptoms not present in the patient**:
- Liver failure
- Renal dysfunction
- Neurological crises

---

+2. **Phenylketonuria (PKU)**:

An inherited metabolic disorder resulting from a deficiency of phenylalanine hydroxylase, causing elevated levels of phenylalanine.

**Symptoms in common with the patient**:
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

**Symptoms not present in the patient**:
- Intellectual disability
- Seizures
- Eczema
- Musty body odor

---

+3. **Maple Syrup Urine Disease**:

A metabolic disorder caused by a deficiency in branched-chain alpha-keto acid dehydrogenase complex, leading to accumulation of certain amino acids.

**Symptoms in common with the patient**:
- Neonatal death
- Abnormality of prenatal development or birth
- Death in infancy

**Symptoms not present in the patient**:
- Sweet-smelling urine
- Lethargy
- Poor feeding
- Vomiting

---

+4. **Homocystinuria**:

A genetic disorder affecting the metabolism of the amino acid methionine, leading to an accumulation of homocysteine.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Death in childhood

**Symptoms not present in the patient**:
- Eye lens dislocation
- Skeletal abnormalities
- Thromboembolic events
- Developmental delays

---

+5. **Non-ketotic Hyperglycinemia**:

A rare metabolic disorder caused by a defect in the glycine cleavage system, resulting in high levels of glycine.

**Symptoms in common with the patient**:
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not present in the patient**:
- Hypotonia
- Seizures
- Lethargy
- Apnea

---

+6. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:

A group of genetic disorders that affect the urea cycle, leading to the accumulation of ammonia.

**Symptoms in common with the patient**:
- Death in infancy
- Neonatal death
- Abnormality of prenatal development or birth

**Symptoms not present in the patient**:
- Hyperammonemia
- Vomiting
- Respiratory alkalosis
- Coma

---

+7. **Galactosemia**:

A metabolic disorder affecting the body's ability to process the sugar galactose properly.

**Symptoms in common with the patient**:
- Death in infancy
- Neonatal death

**Symptoms not present in the patient**:
- Jaundice
- Hepatomegaly
- Cataracts
- E. coli sepsis

---

+8. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:

A fatty acid oxidation disorder affecting the body's ability to convert certain fats into energy.

**Symptoms in common with the patient**:
- Death in infancy
- Death in childhood

**Symptoms not present in the patient**:
- Hypoglycemia
- Vomiting
- Lethargy
- Seizures

---

+9. **Smith-Lemli-Opitz Syndrome**:

A developmental disorder caused by a deficiency of the enzyme 7-dehydrocholesterol reductase.

**Symptoms in common with the patient**:
- Abnormality of prenatal development or birth
- Death in infancy

**Symptoms not present in the patient**:
- Distinctive facial features
- Intellectual disability
- Behavioral problems
- Microcephaly

---

+10. **Argininosuccinic Aciduria**:

A urea cycle disorder leading to the accumulation of argininosuccinic acid and ammonia.

**Symptoms in common with the patient**:
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not present in the patient**:
- Hepatomegaly
- Hypotonia
- Trichorrhexis nodosa (brittle hair)
- Hyperammonemia

---

Please note that these are potential diagnoses based on the given symptoms. Further clinical evaluation and diagnostic testing are necessary to confirm any of these conditions."
['Hereditary orotic aciduria'],"+1. Glycine Encephalopathy (Nonketotic Hyperglycinemia):
Symptoms in common: Lethargy, Generalized hypotonia, Death in infancy, Drowsiness, Sleep abnormality, Hyperglycinuria, Feeding difficulties.
Symptoms not present: Skin rash, Splenomegaly, Fever, Vomiting, Pneumonia, Hepatomegaly, Cystinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+2. Ornithine Transcarbamylase Deficiency (Urea Cycle Disorder):
Symptoms in common: Lethargy, Vomiting, Generalized hypotonia, Drowsiness, Sleep abnormality, Ornithinuria, Death in infancy.
Symptoms not present: Skin rash, Splenomegaly, Fever, Pneumonia, Hepatomegaly, Hyperglycinuria, Cystinuria, Oroticaciduria, Death in childhood, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+3. Niemann-Pick Disease Type A:
Symptoms in common: Hepatomegaly, Splenomegaly, Generalized hypotonia, Feeding difficulties, Death in early childhood.
Symptoms not present: Skin rash, Lethargy, Fever, Vomiting, Pneumonia, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+4. Cystinuria:
Symptoms in common: Cystinuria.
Symptoms not present: Skin rash, Lethargy, Generalized hypotonia, Death in infancy, Splenomegaly, Fever, Vomiting, Pneumonia, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Oroticaciduria, Ornithinuria, Death in childhood, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque, Erythematous macule, Erythematous papule.

+5. Orotic Aciduria:
Symptoms in common: Oroticaciduria, Developmental delays (which may include lethargy and feeding difficulties), Abnormal circulating alanine concentration.
Symptoms not present: Skin rash, Generalized hypotonia, Death in infancy, Splenomegaly, Fever, Vomiting, Pneumonia, Hepatomegaly, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Ornithinuria, Death in childhood, Erythematous plaque, Erythematous macule, Erythematous papule.

+6. Congenital Infections (e.g., TORCH Infections):
Symptoms in common: Skin rash (erythematous macules, papules, plaques), Hepatomegaly, Splenomegaly, Pneumonia, Feeding difficulties, Death in infancy.
Symptoms not present: Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Abnormal circulating alanine concentration.

+7. Sepsis:
Symptoms in common: Fever, Lethargy, Vomiting, Drowsiness, Skin rash, Generalized hypotonia, Pneumonia.
Symptoms not present: Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Hepatomegaly, Splenomegaly, Death in childhood, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+8. Acute Lymphoblastic Leukemia:
Symptoms in common: Fever, Lethargy, Hepatomegaly, Splenomegaly, Drowsiness, Generalized hypotonia.
Symptoms not present: Skin rash, Vomiting, Pneumonia, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Death in infancy, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+9. Tay-Sachs Disease:
Symptoms in common: Generalized hypotonia, Drowsiness, Feeding difficulties, Death in childhood.
Symptoms not present: Skin rash, Lethargy, Fever, Vomiting, Pneumonia, Hepatomegaly, Splenomegaly, Sleep abnormality, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Abnormal circulating alanine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+10. Viral Exanthems (e.g., Measles):
Symptoms in common: Skin rash (erythematous macules, papules), Fever, Pneumonia, Lethargy, Drowsiness.
Symptoms not present: Generalized hypotonia, Hyperglycinuria, Cystinuria, Oroticaciduria, Ornithinuria, Hepatomegaly, Splenomegaly, Death in infancy, Abnormal circulating alanine concentration, Feeding difficulties, Erythematous plaque."
['Holocarboxylase synthetase deficiency'],"Please note that I'm not a medical professional, but I can provide some general information based on the symptoms provided. It's important to consult a qualified healthcare provider for an accurate diagnosis.

+1. **Propionic Acidemia:**
- **Symptoms in common:** Propionyl-CoA carboxylase deficiency, Metabolic acidosis, Hyperammonemia, Elevated urinary carboxylic acid, Aminoaciduria, Generalized hypotonia, Neonatal death, Anemia, Vomiting, Lethargy, Diarrhea
- **Symptoms not in common:** Decreased pyruvate carboxylase activity, Skin rash, Eczematoid dermatitis

+2. **Pyruvate Carboxylase Deficiency:**
- **Symptoms in common:** Decreased pyruvate carboxylase activity, Metabolic acidosis, Hyperammonemia, Elevated urinary carboxylic acid, Generalized hypotonia, Neonatal death, Lactic acidosis
- **Symptoms not in common:** Propionyl-CoA carboxylase deficiency, Skin rash, Cyanosis, Anemia

+3. **Methylmalonic Acidemia:**
- **Symptoms in common:** Metabolic acidosis, Hyperammonemia, Elevated urinary carboxylic acid, Aminoaciduria, Generalized hypotonia, Anemia, Neonatal death, Diarrhea
- **Symptoms not in common:** Propionyl-CoA carboxylase deficiency, Decreased pyruvate carboxylase activity, Skin rash

+4. **Nonketotic Hyperglycinemia (Glycine Encephalopathy):**
- **Symptoms in common:** Abnormal circulating glycine concentration, Generalized hypotonia, Neonatal death, Lethargy, Seizures
- **Symptoms not in common:** Metabolic acidosis (typically minimal or absent), Hyperammonemia, Skin rash, Anemia

+5. **Multiple Carboxylase Deficiency:**
- **Symptoms in common:** Skin rash, Eczematoid dermatitis, Metabolic acidosis, Alopecia (hair loss), Lethargy, Hypotonia, Seizures, Diarrhea
- **Symptoms not in common:** Propionyl-CoA carboxylase deficiency (though enzymes involved are biotin-dependent carboxylases), Decreased pyruvate carboxylase activity

+6. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency):**
- **Symptoms in common:** Hyperammonemia, Lethargy, Vomiting, Tachypnea, Neonatal death
- **Symptoms not in common:** Metabolic acidosis (often absent), Elevated urinary carboxylic acid, Propionyl-CoA carboxylase deficiency

+7. **Organic Acidurias (General):**
- **Symptoms in common:** Metabolic acidosis, Hyperammonemia, Elevated urinary carboxylic acid, Aminoaciduria, Generalized hypotonia, Developmental delay
- **Symptoms not in common:** Specific enzyme deficiencies (Propionyl-CoA carboxylase or Pyruvate carboxylase), Skin rash

+8. **Maple Syrup Urine Disease:**
- **Symptoms in common:** Generalized hypotonia, Lethargy, Poor feeding, Seizures, Neonatal death
- **Symptoms not in common:** Elevated urinary carboxylic acid (different metabolic profile), Skin rash, Anemia

+9. **Isovaleric Acidemia:**
- **Symptoms in common:** Metabolic acidosis, Vomiting, Lethargy, Seizures, Hypotonia
- **Symptoms not in common:** Propionyl-CoA carboxylase deficiency, Decreased pyruvate carboxylase activity, Skin rash

+10. **Glutaric Aciduria Type I:**
- **Symptoms in common:** Metabolic acidosis, Hypotonia, Seizures, Elevated urinary carboxylic acid
- **Symptoms not in common:** Propionyl-CoA carboxylase deficiency, Skin rash, Anemia

It's essential to follow up with a healthcare professional for laboratory tests and clinical evaluations to determine the exact cause of these symptoms."
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:

A genetic urea cycle disorder causing a deficiency in the OTC enzyme, leading to toxic accumulation of ammonia.

**Symptoms in common:** Apathy, Ataxia, Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality, Oroticaciduria, Death in adolescence.

**Symptoms not present:** None.

+2. Carbamoyl Phosphate Synthetase I Deficiency:

An inherited disorder affecting the first step of the urea cycle, resulting in ammonia accumulation.

**Symptoms in common:** Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

**Symptoms not present:** Apathy, Ataxia, Oroticaciduria.

+3. Argininosuccinic Aciduria:

A urea cycle disorder causing argininosuccinic acid and ammonia to accumulate in the body.

**Symptoms in common:** Lethargy, Ataxia, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

**Symptoms not present:** Apathy, Oroticaciduria.

+4. Citrullinemia Type I:

A genetic condition leading to the accumulation of ammonia and citrulline due to a urea cycle defect.

**Symptoms in common:** Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

**Symptoms not present:** Apathy, Ataxia, Oroticaciduria.

+5. Maple Syrup Urine Disease:

A metabolic disorder affecting branched-chain amino acids metabolism.

**Symptoms in common:** Lethargy, Ataxia, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

**Symptoms not present:** Apathy, Hyperammonemia, Oroticaciduria.

+6. Mitochondrial Encephalomyopathies:

A group of disorders caused by dysfunctional mitochondria affecting energy production.

**Symptoms in common:** Apathy, Ataxia, Lethargy, Vomiting, Drowsiness, Sleep abnormality.

**Symptoms not present:** Hyperammonemia, Oroticaciduria, Death in adolescence.

+7. Leigh's Disease:

A severe neurological disorder that arises in the first years of life.

**Symptoms in common:** Ataxia, Lethargy, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

**Symptoms not present:** Apathy, Hyperammonemia, Oroticaciduria.

+8. Reye's Syndrome:

A rare condition causing swelling in the liver and brain, often associated with aspirin use in children.

**Symptoms in common:** Lethargy, Vomiting, Drowsiness, Sleep abnormality.

**Symptoms not present:** Apathy, Ataxia, Hyperammonemia, Oroticaciduria, Death in adolescence.

+9. Wilson's Disease:

A genetic disorder causing copper accumulation in tissues, leading to neurological symptoms.

**Symptoms in common:** Apathy, Ataxia, Lethargy, Drowsiness, Sleep abnormality.

**Symptoms not present:** Hyperammonemia, Vomiting, Oroticaciduria, Death in adolescence.

+10. Urea Cycle Disorders (General):

A group of genetic disorders causing defects in the urea cycle, leading to ammonia buildup.

**Symptoms in common:** Apathy, Ataxia, Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

**Symptoms not present:** Oroticaciduria (except in specific disorders like OTC deficiency)."
[],"+1. **Ethylmalonic Encephalopathy**:
A rare metabolic disorder characterized by elevated levels of ethylmalonic acid, leading to neurological and vascular issues. It often results in early death during childhood.

- **Symptoms in common**: Vomiting, Ethylmalonic aciduria, Death in childhood
- **Symptoms not in common**: Abnormal circulating carnitine concentration, Death in adolescence, Decreased 3-hydroxyacyl-CoA dehydrogenase level

+2. **Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD Deficiency)**:
An inherited fatty acid oxidation disorder affecting the breakdown of long-chain fatty acids, leading to energy deficiency and organ dysfunction.

- **Symptoms in common**: Vomiting, Decreased 3-hydroxyacyl-CoA dehydrogenase level, Abnormal circulating carnitine concentration, Death in childhood
- **Symptoms not in common**: Ethylmalonic aciduria, Death in adolescence

+3. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
Also known as glutaric acidemia type II, this disorder affects multiple enzymes involved in fatty acid oxidation, causing energy production issues.

- **Symptoms in common**: Vomiting, Abnormal circulating carnitine concentration, Death in childhood or adolescence
- **Symptoms not in common**: Ethylmalonic aciduria, Decreased 3-hydroxyacyl-CoA dehydrogenase level

+4. **Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD Deficiency)**:
A condition where the body cannot effectively convert certain fats to energy during fasting, leading to hypoglycemia and other complications.

- **Symptoms in common**: Vomiting, Death in childhood
- **Symptoms not in common**: Ethylmalonic aciduria, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level, Death in adolescence

+5. **Carnitine Transporter Deficiency**:
A disorder resulting from impaired transport of carnitine into cells, leading to low levels of carnitine and affecting energy metabolism.

- **Symptoms in common**: Vomiting, Abnormal circulating carnitine concentration, Death in childhood
- **Symptoms not in common**: Ethylmalonic aciduria, Death in adolescence, Decreased 3-hydroxyacyl-CoA dehydrogenase level"
['Smith-Lemli-Opitz syndrome'],"+1. Smith-Lemli-Opitz Syndrome (SLOS):

Symptoms in common with the patient: Low-set ears, wide nasal bridge, anteverted nares, ptosis, syndactyly, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, hypocholesterolemia, elevated 8-dehydrocholesterol, elevated circulating 7-dehydrocholesterol concentration, death in infancy, neonatal death.

Symptoms not present in the patient: Genital abnormalities (such as hypospadias), microcephaly (if not observed).

+2. Patau Syndrome (Trisomy 13):

Symptoms in common with the patient: Low-set ears, wide nasal bridge, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, death in infancy, neonatal death.

Symptoms not present in the patient: Polydactyly (extra fingers or toes), cleft lip or palate, microphthalmia (small eyes), congenital heart defects.

+3. Zellweger Spectrum Disorders (Peroxisomal Biogenesis Disorders):

Symptoms in common with the patient: Low-set ears, wide nasal bridge, hypotonia, feeding difficulties, intellectual disability, motor delay, death in infancy.

Symptoms not present in the patient: Liver dysfunction, high forehead, seizures, vision and hearing loss.

+4. RSH Syndrome (Type II Lissencephaly):

Symptoms in common with the patient: Intellectual disability, motor delay, generalized hypotonia, feeding difficulties, ptosis.

Symptoms not present in the patient: Smooth brain surface (lissencephaly), severe seizures, distinctive facial features (if absent).

+5. Cornelia de Lange Syndrome:

Symptoms in common with the patient: Low-set ears, wide nasal bridge, anteverted nares, ptosis, intellectual disability, motor delay, feeding difficulties.

Symptoms not present in the patient: Limb abnormalities (typically upper limbs), arched eyebrows that meet in the middle, long eyelashes, growth delays before and after birth."
['L-2-hydroxyglutaric aciduria'],"+1. **L-2-hydroxyglutaric aciduria**:

This rare metabolic disorder is caused by a deficiency of the enzyme L-2-hydroxyglutarate dehydrogenase, leading to the accumulation of L-2-hydroxyglutaric acid in the body.

**Symptoms in common**:
- Intellectual disability
- Ataxia
- Tremor
- Cerebral atrophy
- Abnormal basal ganglia morphology
- L-2-hydroxyglutaric aciduria

**Symptoms not in common**:
- Death in infancy
- Neonatal death
- Death in childhood

---

+2. **Leigh syndrome**:

A severe neurological disorder that typically arises in infancy, characterized by progressive loss of mental and movement abilities.

**Symptoms in common**:
- Intellectual disability
- Ataxia
- Tremor
- Cerebral atrophy
- Abnormal basal ganglia morphology
- Death in infancy or childhood

**Symptoms not in common**:
- L-2-hydroxyglutaric aciduria
- Neonatal death

---

+3. **Glutaric acidemia type I**:

An inherited metabolic disorder affecting the breakdown of certain amino acids, leading to the accumulation of glutaric acid.

**Symptoms in common**:
- Ataxia
- Cerebral atrophy
- Abnormal basal ganglia morphology
- Death in infancy or childhood

**Symptoms not in common**:
- Intellectual disability
- Tremor
- L-2-hydroxyglutaric aciduria
- Neonatal death

---

+4. **Canavan disease**:

A rare genetic disorder that causes progressive damage to nerve cells in the brain.

**Symptoms in common**:
- Intellectual disability
- Cerebral atrophy
- Death in infancy or childhood

**Symptoms not in common**:
- Ataxia
- Tremor
- Abnormal basal ganglia morphology
- L-2-hydroxyglutaric aciduria
- Neonatal death

---

+5. **Krabbe disease**:

A rare inherited disorder affecting the nervous system due to the loss of myelin.

**Symptoms in common**:
- Intellectual disability
- Ataxia
- Tremor
- Cerebral atrophy
- Death in infancy or childhood

**Symptoms not in common**:
- Abnormal basal ganglia morphology
- L-2-hydroxyglutaric aciduria
- Neonatal death

---

Please note that these are potential diagnoses based on the provided symptoms. A thorough medical evaluation, including genetic testing and metabolic studies, is essential for an accurate diagnosis."
['3-hydroxy-3-methylglutaric aciduria'],"+1. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
- **Symptoms in common**: Seizures, Generalized hypotonia, Metabolic acidosis, Dicarboxylic aciduria, Elevated urinary carboxylic acid, Neonatal death.
- **Symptoms not in common**: Irritability, Opisthotonus, 3-Methylglutaconic aciduria, Death in infancy, Death in childhood.

+2. **3-Methylglutaconic Aciduria (Type I)**:
- **Symptoms in common**: Irritability, Seizures, Generalized hypotonia, Metabolic acidosis, 3-Methylglutaconic aciduria, Elevated urinary carboxylic acid, Death in infancy.
- **Symptoms not in common**: Opisthotonus, Dicarboxylic aciduria, Neonatal death, Death in childhood.

+3. **Propionic Acidemia**:
- **Symptoms in common**: Irritability, Seizures, Generalized hypotonia, Metabolic acidosis, Elevated urinary carboxylic acid, Neonatal death.
- **Symptoms not in common**: Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Death in infancy, Death in childhood.

+4. **Glutaric Aciduria Type I**:
- **Symptoms in common**: Irritability, Seizures, Generalized hypotonia, Metabolic acidosis, Elevated urinary carboxylic acid.
- **Symptoms not in common**: Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Neonatal death, Death in infancy, Death in childhood.

+5. **Leigh Syndrome**:
- **Symptoms in common**: Seizures, Generalized hypotonia, Metabolic acidosis, Death in infancy, Death in childhood.
- **Symptoms not in common**: Irritability, Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Elevated urinary carboxylic acid, Neonatal death.

+6. **Mitochondrial DNA Depletion Syndromes**:
- **Symptoms in common**: Seizures, Generalized hypotonia, Metabolic acidosis, Death in infancy, Death in childhood.
- **Symptoms not in common**: Irritability, Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Elevated urinary carboxylic acid, Neonatal death.

+7. **Barth Syndrome**:
- **Symptoms in common**: 3-Methylglutaconic aciduria, Hypotonia, Metabolic issues, Death in childhood.
- **Symptoms not in common**: Irritability, Seizures, Opisthotonus, Dicarboxylic aciduria, Elevated urinary carboxylic acid, Neonatal death.

+8. **Isovaleric Acidemia**:
- **Symptoms in common**: Irritability, Seizures, Metabolic acidosis, Elevated urinary carboxylic acid, Neonatal death.
- **Symptoms not in common**: Generalized hypotonia, Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Death in infancy, Death in childhood.

+9. **Maple Syrup Urine Disease**:
- **Symptoms in common**: Irritability, Seizures, Generalized hypotonia, Metabolic acidosis, Neonatal death.
- **Symptoms not in common**: Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Elevated urinary carboxylic acid, Death in infancy, Death in childhood.

+10. **Nonketotic Hyperglycinemia**:
- **Symptoms in common**: Seizures, Generalized hypotonia, Neonatal death.
- **Symptoms not in common**: Irritability, Metabolic acidosis, Opisthotonus, Dicarboxylic aciduria, 3-Methylglutaconic aciduria, Elevated urinary carboxylic acid, Death in infancy, Death in childhood.

Please note that these are potential conditions that may present with similar symptoms. A thorough medical evaluation and diagnostic testing are essential for an accurate diagnosis."
['L-2-hydroxyglutaric aciduria'],"+1. **L-2-Hydroxyglutaric Aciduria**:

A rare inherited metabolic disorder characterized by the accumulation of L-2-hydroxyglutaric acid, leading to progressive neurological symptoms.

**Symptoms in common**: Seizure, Death in infancy, L-2-hydroxyglutaric aciduria.

**Symptoms not in common**: Skin rash, Fever, Elevated circulating C-reactive protein concentration, Decreased circulating iron concentration, Obsolete eczematoid dermatitis.

+2. **Meningitis**:

An inflammation of the protective membranes covering the brain and spinal cord, often caused by infection.

**Symptoms in common**: Fever, Seizure, Skin rash (in some types), Elevated circulating C-reactive protein concentration.

**Symptoms not in common**: L-2-hydroxyglutaric aciduria, Death in infancy (though it can be fatal in infants), Decreased circulating iron concentration, Obsolete eczematoid dermatitis.

+3. **Kawasaki Disease**:

A condition in children causing inflammation of blood vessels throughout the body, including coronary arteries.

**Symptoms in common**: Fever, Skin rash, Elevated circulating C-reactive protein concentration.

**Symptoms not in common**: Seizure, Death in infancy (rarely fatal), L-2-hydroxyglutaric aciduria, Decreased circulating iron concentration, Obsolete eczematoid dermatitis.

+4. **Systemic Lupus Erythematosus (SLE)**:

An autoimmune disease where the immune system attacks healthy tissue, affecting skin, joints, and organs.

**Symptoms in common**: Skin rash, Fever, Elevated circulating C-reactive protein concentration, Decreased circulating iron concentration.

**Symptoms not in common**: Seizure (less common but possible), Death in infancy, L-2-hydroxyglutaric aciduria, Obsolete eczematoid dermatitis.

+5. **Iron-Deficiency Anemia**:

A condition resulting from insufficient iron, leading to reduced red blood cell production.

**Symptoms in common**: Decreased circulating iron concentration.

**Symptoms not in common**: Skin rash, Seizure, Fever, Elevated circulating C-reactive protein concentration, L-2-hydroxyglutaric aciduria, Death in infancy, Obsolete eczematoid dermatitis.

+6. **Atopic Dermatitis (Eczema)**:

A chronic skin condition causing itchy, inflamed skin.

**Symptoms in common**: Skin rash, Obsolete eczematoid dermatitis.

**Symptoms not in common**: Seizure, Fever, Elevated circulating C-reactive protein concentration, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased circulating iron concentration.

+7. **Septicemia (Blood Infection)**:

A serious bloodstream infection that can lead to sepsis.

**Symptoms in common**: Fever, Elevated circulating C-reactive protein concentration, Skin rash (petechiae or purpura), Seizure (in severe cases).

**Symptoms not in common**: L-2-hydroxyglutaric aciduria, Death in infancy (possible but depends on cause), Decreased circulating iron concentration, Obsolete eczematoid dermatitis.

+8. **Familial Hemophagocytic Lymphohistiocytosis (FHL)**:

A rare genetic disorder affecting the immune system's ability to regulate itself.

**Symptoms in common**: Fever, Elevated circulating C-reactive protein concentration, Decreased circulating iron concentration, Death in infancy.

**Symptoms not in common**: Skin rash, Seizure, L-2-hydroxyglutaric aciduria, Obsolete eczematoid dermatitis.

+9. **Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)**:

A condition hypothesized to occur in children following streptococcal infections.

**Symptoms in common**: Seizure (rare), Elevated circulating C-reactive protein concentration.

**Symptoms not in common**: Skin rash, Fever, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased circulating iron concentration, Obsolete eczematoid dermatitis.

+10. **Acute Lymphoblastic Leukemia (ALL)**:

A type of cancer of the blood and bone marrow common in children.

**Symptoms in common**: Fever, Decreased circulating iron concentration, Seizure (due to central nervous system involvement).

**Symptoms not in common**: Skin rash, Elevated circulating C-reactive protein concentration, Death in infancy (more common in older children), L-2-hydroxyglutaric aciduria, Obsolete eczematoid dermatitis."
['X-linked hypophosphatemia'],"+1. **Cystinosis**:
- **Symptoms in common**:
  - **Nephritis**: Due to accumulation of cystine crystals in the kidneys leading to nephropathy.
  - **Hypophosphatemia**: Resulting from renal Fanconi syndrome affecting phosphate reabsorption.
  - **Abnormal limb bone morphology**: Caused by disturbances in mineral metabolism affecting bone development.
  - **Abnormal circulating hormone concentration**: Hormonal imbalances may occur due to kidney dysfunction.
  - **Elevated circulating alkaline phosphatase concentration**: Reflects bone turnover abnormalities.
  - **Death in infancy or childhood**: Without treatment, the disease can be fatal early in life.
- **Symptoms not in common**:
  - None significantly absent.

+2. **Fanconi Syndrome (Hereditary Form)**:
- **Symptoms in common**:
  - **Nephritis**: Kidney dysfunction due to proximal tubular damage.
  - **Hypophosphatemia**: Caused by impaired reabsorption of phosphate in the kidneys.
  - **Abnormal limb bone morphology**: Results from phosphate wasting leading to rickets or osteomalacia.
  - **Elevated circulating alkaline phosphatase concentration**: Indicates bone disease activity.
- **Symptoms not in common**:
  - **Death in infancy or childhood**: Severity varies; not always fatal.
  - **Abnormal circulating hormone concentration**: Not a primary feature.
  - **Death in infancy**: May occur but not definitive.

+3. **X-Linked Hypophosphatemia**:
- **Symptoms in common**:
  - **Hypophosphatemia**: Due to genetic defects affecting phosphate regulation.
  - **Abnormal limb bone morphology**: Leads to rickets and bone deformities.
  - **Elevated circulating alkaline phosphatase concentration**: Associated with increased bone turnover.
- **Symptoms not in common**:
  - **Nephritis**: Kidney inflammation is not typical.
  - **Death in infancy or childhood**: Generally not fatal.
  - **Abnormal circulating hormone concentration**: Hormone levels usually normal.
  - **Death in childhood**: Life expectancy is typically normal.

+4. **Lowe Syndrome (Oculocerebrorenal Syndrome)**:
- **Symptoms in common**:
  - **Nephritis**: Due to kidney involvement leading to renal Fanconi syndrome.
  - **Hypophosphatemia**: From proximal tubule dysfunction affecting phosphate levels.
  - **Abnormal limb bone morphology**: Resulting from metabolic imbalances.
- **Symptoms not in common**:
  - **Elevated circulating alkaline phosphatase concentration**: Not a characteristic finding.
  - **Abnormal circulating hormone concentration**: Endocrine abnormalities are less prominent.
  - **Death in infancy or childhood**: Varies; some patients live into adulthood.

+5. **Hypophosphatasia (Severe Infantile Form)**:
- **Symptoms in common**:
  - **Abnormal limb bone morphology**: Due to defective bone mineralization.
  - **Death in infancy**: Severe forms can be fatal early in life.
- **Symptoms not in common**:
  - **Nephritis**: Kidney involvement is not typical.
  - **Hypophosphatemia**: Serum phosphate levels may be normal or elevated.
  - **Elevated circulating alkaline phosphatase concentration**: **Low** levels of alkaline phosphatase are characteristic, not elevated.
  - **Abnormal circulating hormone concentration**: Not a primary feature.
  - **Death in childhood**: If not fatal in infancy, survival may extend beyond childhood.

+6. **Denys-Drash Syndrome**:
- **Symptoms in common**:
  - **Nephritis**: Due to diffuse mesangial sclerosis affecting kidney function.
  - **Death in childhood**: High risk due to progressive kidney failure and tumor development.
- **Symptoms not in common**:
  - **Hypophosphatemia**: Not commonly observed.
  - **Abnormal limb bone morphology**: Bone structure typically unaffected.
  - **Elevated circulating alkaline phosphatase concentration**: Not a usual finding.
  - **Abnormal circulating hormone concentration**: Hormonal issues may relate to gonadal dysgenesis."
['Propionic acidemia'],"+1. **Nonketotic Hyperglycinemia (Glycine Encephalopathy)**:
A rare inherited metabolic disorder characterized by the accumulation of glycine in the body due to a defect in the glycine cleavage system.
- **Symptoms in common with the patient**:
  - Hyperglycinemia
  - Hyperglycinuria
  - Delayed speech and language development
  - Lethargy (if present)
  - Death in infancy, childhood, or adolescence
  - Abnormal circulating serine concentration
- **Symptoms not in common with the patient**:
  - Seizures (if not present)
  - Hypotonia (reduced muscle tone)

+2. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:
A group of genetic disorders caused by deficiencies of enzymes in the urea cycle, leading to hyperammonemia.
- **Symptoms in common with the patient**:
  - Hyperammonemia
  - Delayed speech and language development
  - Lethargy (if present)
  - Death in infancy or childhood
  - Abnormal circulating alanine concentration
- **Symptoms not in common with the patient**:
  - Vomiting (if not present)
  - Respiratory alkalosis (if not documented)

+3. **Propionic Acidemia**:
An inherited metabolic disorder affecting the breakdown of certain amino acids and lipids, resulting in the accumulation of propionic acid.
- **Symptoms in common with the patient**:
  - Elevated urinary carboxylic acid
  - Hyperammonemia
  - Leukopenia
  - Skin rash
  - Lethargy (if present)
  - Delayed development
  - Death in infancy
- **Symptoms not in common with the patient**:
  - Vomiting (if not present)
  - Hypotonia (if absent)
  - Ketoacidosis (if not documented)

+4. **Methylmalonic Acidemia**:
A metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, leading to the accumulation of methylmalonic acid.
- **Symptoms in common with the patient**:
  - Elevated urinary carboxylic acid
  - Hyperammonemia
  - Delayed speech and language development
  - Lethargy (if present)
  - Death in infancy or childhood
  - Abnormal circulating alanine and carnitine concentrations
- **Symptoms not in common with the patient**:
  - Failure to thrive (if not present)
  - Developmental regression (if not observed)

+5. **Multiple Carboxylase Deficiency**:
A disorder resulting from defects in biotin metabolism, leading to impaired function of carboxylase enzymes.
- **Symptoms in common with the patient**:
  - Skin rash (eczema-like dermatitis)
  - Elevated urinary carboxylic acid
  - Delayed development
  - Lethargy (if present)
  - Death in infancy
  - Alopecia (if present)
- **Symptoms not in common with the patient**:
  - Seizures (if not present)
  - Conjunctivitis (if absent)

+6. **Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome (HHH Syndrome)**:
A rare urea cycle disorder affecting the transport of ornithine into mitochondria, causing hyperammonemia.
- **Symptoms in common with the patient**:
  - Hyperammonemia
  - Delayed speech and language development
  - Lethargy (if present)
  - Death in childhood or adolescence
  - Abnormal circulating alanine and serine concentrations
- **Symptoms not in common with the patient**:
  - Spasticity (if not observed)
  - Cognitive impairment (degree unspecified)

+7. **Tyrosinemia Type I**:
A metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of tyrosine metabolites.
- **Symptoms in common with the patient**:
  - Skin rash
  - Elevated circulating alkaline phosphatase concentration
  - Hyperammonemia
  - Death in infancy or childhood
- **Symptoms not in common with the patient**:
  - Liver enlargement (hepatomegaly) (if not present)
  - Renal dysfunction (if absent)

+8. **Carnitine Transport Defect (Primary Carnitine Deficiency)**:
A disorder affecting the transport of carnitine into cells, leading to reduced energy production.
- **Symptoms in common with the patient**:
  - Abnormal circulating carnitine concentration
  - Lethargy (if present)
  - Hypoglycemia (if present)
  - Death in infancy or childhood
- **Symptoms not in common with the patient**:
  - Cardiomyopathy (if not observed)
  - Muscle weakness (if absent)

+9. **Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy)**:
A severe neurological disorder that arises from defects in mitochondrial energy production.
- **Symptoms in common with the patient**:
  - Delayed development
  - Elevated lactate levels (if present)
  - Death in infancy or childhood
- **Symptoms not in common with the patient**:
  - Neurological symptoms like ataxia (if not present)
  - Respiratory problems (if absent)

+10. **Organic Acidemias (General Category)**:
A group of metabolic disorders characterized by the accumulation of organic acids due to enzyme deficiencies.
- **Symptoms in common with the patient**:
  - Elevated urinary carboxylic acid
  - Hyperammonemia
  - Leukopenia
  - Skin rash
  - Delayed development
  - Death in infancy or childhood
- **Symptoms not in common with the patient**:
  - Specific organic acid elevations (if not identified)
  - Metabolic acidosis (if not documented)"
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1. **Combined Methylmalonic Aciduria and Homocystinuria (cblC type)**:
- **Shared symptoms**: Methylmalonic aciduria, hyperhomocystinemia, delayed speech and language development, generalized hypotonia, death in infancy, neonatal death, death in childhood, abnormal cerebral white matter morphology.
- **Symptoms not shared**: Gastrointestinal inflammation, decreased plasma free carnitine.

+2. **Methylmalonic Acidemia (MMA)**:
- **Shared symptoms**: Methylmalonic aciduria, delayed speech and language development, generalized hypotonia, death in infancy, neonatal death, death in childhood.
- **Symptoms not shared**: Hyperhomocystinemia, abnormal cerebral white matter morphology, gastrointestinal inflammation, decreased plasma free carnitine.

+3. **Propionic Acidemia**:
- **Shared symptoms**: Generalized hypotonia, delayed speech and language development, gastrointestinal inflammation, death in infancy, neonatal death, death in childhood.
- **Symptoms not shared**: Methylmalonic aciduria, hyperhomocystinemia, abnormal cerebral white matter morphology, decreased plasma free carnitine.

+4. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency)**:
- **Shared symptoms**: Decreased plasma free carnitine, generalized hypotonia, death in infancy, death in childhood.
- **Symptoms not shared**: Methylmalonic aciduria, hyperhomocystinemia, delayed speech and language development, abnormal cerebral white matter morphology, gastrointestinal inflammation.

+5. **Leukodystrophies (e.g., Metachromatic Leukodystrophy)**:
- **Shared symptoms**: Abnormal cerebral white matter morphology, delayed speech and language development, generalized hypotonia, death in childhood.
- **Symptoms not shared**: Methylmalonic aciduria, hyperhomocystinemia, decreased plasma free carnitine, gastrointestinal inflammation."
['Biotinidase deficiency'],"+1. **Propionic Acidemia**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, neonatal death, death in infancy.
- **Symptoms not present in the patient**: Vomiting, lethargy, hypotonia, metabolic acidosis.

+2. **Methylmalonic Acidemia**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, neonatal death, death in infancy.
- **Symptoms not present in the patient**: Developmental delays, feeding difficulties, hypotonia.

+3. **Multiple Carboxylase Deficiency**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, neonatal death, death in infancy.
- **Symptoms not present in the patient**: Skin rash, alopecia (hair loss), seizures.

+4. **Isovaleric Acidemia**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, possible neonatal death.
- **Symptoms not present in the patient**: Distinctive odor of sweaty feet, vomiting, irritability.

+5. **Glutaric Acidemia Type II**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, neonatal death.
- **Symptoms not present in the patient**: Hypotonia, hypoglycemia, hepatomegaly (enlarged liver).

+6. **Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid.
- **Symptoms not present in the patient**: Hypoglycemia, lethargy, seizures.

+7. **Biotinidase Deficiency**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, possible death in infancy.
- **Symptoms not present in the patient**: Skin rash, developmental delays, hearing loss.

+8. **Holocarboxylase Synthetase Deficiency**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, neonatal death.
- **Symptoms not present in the patient**: Eczema, vomiting, seizures.

+9. **Pyruvate Carboxylase Deficiency**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, death in infancy.
- **Symptoms not present in the patient**: Lactic acidosis, neurological deficits, developmental delays.

+10. **Organic Acidemias (general group)**:
- **Symptoms in common with the patient**: Elevated urinary carboxylic acid, potential neonatal death.
- **Symptoms not present in the patient**: Varies depending on specific disorder, may include metabolic acidosis, hypotonia."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. **Ornithine Transcarbamylase Deficiency (OTC Deficiency):**

OTC deficiency is a urea cycle disorder leading to the accumulation of ammonia in the blood (hyperammonemia), which is toxic to the brain. It often presents in newborn males and can be life-threatening without prompt treatment.

- **Symptoms in common:** Lethargy, Hyperammonemia, Drowsiness, Neonatal death, Feeding difficulties, Death in infancy.
- **Symptoms not in common:** Spasticity, Generalized hypotonia, Hyperreflexia, Sleep abnormality.

+2. **Maple Syrup Urine Disease (MSUD):**

MSUD is a metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation. It presents in neonates with neurological symptoms and can be fatal if untreated.

- **Symptoms in common:** Lethargy, Generalized hypotonia, Drowsiness, Feeding difficulties, Death in infancy.
- **Symptoms not in common:** Spasticity, Hyperreflexia, Hyperammonemia, Sleep abnormality, Neonatal death.

+3. **Nonketotic Hyperglycinemia (Glycine Encephalopathy):**

This is a genetic disorder where glycine accumulates in the body, particularly affecting the brain, leading to severe neurological symptoms starting soon after birth.

- **Symptoms in common:** Lethargy, Generalized hypotonia, Spasticity, Drowsiness, Seizures, Feeding difficulties, Neonatal death.
- **Symptoms not in common:** Hyperammonemia, Sleep abnormality, Hyperreflexia.

+4. **Leigh Syndrome:**

Leigh syndrome is a severe neurological disorder that arises due to mitochondrial dysfunction, leading to progressive loss of mental and movement abilities.

- **Symptoms in common:** Lethargy, Hypotonia, Feeding difficulties, Sleep abnormality, Developmental delay.
- **Symptoms not in common:** Hyperammonemia, Spasticity, Hyperreflexia, Death in infancy (though can lead to early death), Neonatal death.

+5. **Krabbe Disease:**

A rare, inherited degenerative disorder affecting the nervous system due to the loss of the protective myelin sheath around nerves.

- **Symptoms in common:** Hypertonia or hypotonia, Feeding difficulties, Lethargy, Developmental regression, Death in infancy.
- **Symptoms not in common:** Hyperammonemia, Sleep abnormality, Neonatal death.

+6. **Pompe Disease (Glycogen Storage Disease Type II):**

A metabolic disorder where glycogen accumulates in muscles, leading to muscle weakness and heart problems.

- **Symptoms in common:** Generalized hypotonia, Feeding difficulties, Lethargy, Respiratory difficulties.
- **Symptoms not in common:** Hyperammonemia, Spasticity, Hyperreflexia, Sleep abnormality, Neonatal death.

+7. **Canavan Disease:**

An inherited disorder that causes progressive damage to nerve cells in the brain.

- **Symptoms in common:** Generalized hypotonia, Feeding difficulties, Lethargy, Developmental delay, Sleep abnormality.
- **Symptoms not in common:** Hyperammonemia, Spasticity, Hyperreflexia, Neonatal death.

+8. **Zellweger Spectrum Disorders:**

A group of peroxisomal biogenesis disorders affecting multiple organ systems, particularly the brain and liver.

- **Symptoms in common:** Hypotonia, Feeding difficulties, Seizures, Developmental delay, Death in infancy.
- **Symptoms not in common:** Hyperammonemia, Spasticity, Hyperreflexia, Sleep abnormality.

+9. **Urea Cycle Disorders (General):**

A group of disorders affecting the body's ability to remove ammonia, leading to toxic accumulation.

- **Symptoms in common:** Hyperammonemia, Lethargy, Drowsiness, Vomiting, Neonatal death.
- **Symptoms not in common:** Spasticity, Hyperreflexia, Sleep abnormality.

+10. **Menkes Disease:**

A disorder of copper metabolism leading to neurodegeneration and connective tissue disorders.

- **Symptoms in common:** Hypotonia, Feeding difficulties, Seizures, Developmental delay.
- **Symptoms not in common:** Hyperammonemia, Spasticity, Hyperreflexia, Sleep abnormality, Neonatal death.

**Note:** The symptoms presented can be associated with various metabolic and genetic disorders. A thorough clinical evaluation, detailed patient history, and specific diagnostic tests are essential to determine the exact cause. It's important to consult a qualified healthcare professional for an accurate diagnosis and appropriate management."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1. **Methylmalonic Acidemia (MMA) due to Methylmalonyl-CoA Mutase Deficiency**:

**Symptoms in common:**
- Death in infancy
- Death in childhood
- Metabolic acidosis
- Decreased methylmalonyl-CoA mutase activity

**Symptoms not in common:**
- [No additional symptoms noted that are not in common]

+2. **Propionic Acidemia**:

**Symptoms in common:**
- Metabolic acidosis
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Decreased methylmalonyl-CoA mutase activity (this enzyme activity is typically normal in propionic acidemia)

+3. **Methylmalonic Acidemia due to Cobalamin (Vitamin B12) Deficiency**:

**Symptoms in common:**
- Metabolic acidosis
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Decreased methylmalonyl-CoA mutase activity (enzyme activity may be normal but there is a defect in cobalamin metabolism)

+4. **Isovaleric Acidemia**:

**Symptoms in common:**
- Metabolic acidosis
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Decreased methylmalonyl-CoA mutase activity (not affected in isovaleric acidemia)

+5. **Glutaric Acidemia Type I**:

**Symptoms in common:**
- Metabolic acidosis
- Death in infancy
- Death in childhood

**Symptoms not in common:**
- Decreased methylmalonyl-CoA mutase activity (not involved in this condition)"
[],"+1. Pyruvate Kinase Deficiency:
- **Shared symptoms**: Hemolytic anemia, increased total bilirubin, increased circulating lactate dehydrogenase concentration
- **Not shared symptoms**: Hyperactivity, spasticity, death in infancy, metabolic acidosis, neonatal death, recurrent viral infections, abnormal circulating porphyrin concentration

+2. Acute Intermittent Porphyria:
- **Shared symptoms**: Abnormal circulating porphyrin concentration, hyperactivity, metabolic acidosis
- **Not shared symptoms**: Spasticity, death in infancy, hemolytic anemia, increased total bilirubin, neonatal death, recurrent viral infections, increased circulating lactate dehydrogenase concentration

+3. Severe Combined Immunodeficiency (SCID):
- **Shared symptoms**: Recurrent viral infections, death in infancy, neonatal death
- **Not shared symptoms**: Hyperactivity, spasticity, hemolytic anemia, metabolic acidosis, increased total bilirubin, abnormal circulating porphyrin concentration, increased circulating lactate dehydrogenase concentration

+4. Krabbe Disease:
- **Shared symptoms**: Spasticity, death in infancy
- **Not shared symptoms**: Hyperactivity, hemolytic anemia, metabolic acidosis, increased total bilirubin, neonatal death, recurrent viral infections, abnormal circulating porphyrin concentration, increased circulating lactate dehydrogenase concentration

+5. Maple Syrup Urine Disease:
- **Shared symptoms**: Spasticity, metabolic acidosis, increased circulating lactate dehydrogenase concentration, neonatal death
- **Not shared symptoms**: Hyperactivity, hemolytic anemia, increased total bilirubin, recurrent viral infections, abnormal circulating porphyrin concentration, death in infancy

+6. Neonatal Hemochromatosis:
- **Shared symptoms**: Increased total bilirubin, neonatal death, metabolic acidosis
- **Not shared symptoms**: Hyperactivity, spasticity, hemolytic anemia, recurrent viral infections, abnormal circulating porphyrin concentration, increased circulating lactate dehydrogenase concentration, death in infancy

+7. Mitochondrial Disorders (e.g., Leigh Syndrome):
- **Shared symptoms**: Spasticity, metabolic acidosis, increased circulating lactate dehydrogenase concentration, death in infancy
- **Not shared symptoms**: Hyperactivity, hemolytic anemia, increased total bilirubin, neonatal death, recurrent viral infections, abnormal circulating porphyrin concentration

+8. Congenital Viral Infections (e.g., Cytomegalovirus infection):
- **Shared symptoms**: Recurrent viral infections, neonatal death, increased total bilirubin
- **Not shared symptoms**: Hyperactivity, spasticity, hemolytic anemia, metabolic acidosis, abnormal circulating porphyrin concentration, increased circulating lactate dehydrogenase concentration, death in infancy

+9. Glycogen Storage Disease Type II (Pompe Disease):
- **Shared symptoms**: Muscle spasticity, increased circulating lactate dehydrogenase concentration, death in infancy
- **Not shared symptoms**: Hyperactivity, hemolytic anemia, metabolic acidosis, increased total bilirubin, neonatal death, recurrent viral infections, abnormal circulating porphyrin concentration

+10. Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency):
- **Shared symptoms**: Hyperactivity (due to encephalopathy), metabolic acidosis, neonatal death
- **Not shared symptoms**: Spasticity, hemolytic anemia, increased total bilirubin, recurrent viral infections, abnormal circulating porphyrin concentration, increased circulating lactate dehydrogenase concentration, death in infancy"
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1. **Citrullinemia Type I**:
This is a urea cycle disorder caused by a deficiency of the enzyme argininosuccinate synthetase, leading to the accumulation of ammonia and citrulline in the blood.
- **Shared symptoms**: 'Death in infancy', 'Hyperammonemia', 'Elevated plasma citrulline', 'Respiratory distress', 'Neonatal death'.
- **Symptoms not present in this disease**: 'Premature birth', 'Apnea', 'Respiratory acidosis', 'Hypoxemia'.

+2. **Argininosuccinic Aciduria**:
A urea cycle disorder resulting from a deficiency of argininosuccinate lyase, causing elevated levels of ammonia and citrulline.
- **Shared symptoms**: 'Death in infancy', 'Hyperammonemia', 'Elevated plasma citrulline', 'Respiratory distress', 'Neonatal death'.
- **Symptoms not present**: 'Premature birth', 'Apnea', 'Respiratory acidosis', 'Hypoxemia'.

+3. **Ornithine Transcarbamylase (OTC) Deficiency**:
An X-linked urea cycle disorder leading to hyperammonemia due to a deficiency of the OTC enzyme.
- **Shared symptoms**: 'Death in infancy', 'Hyperammonemia', 'Respiratory distress', 'Neonatal death'.
- **Symptoms not present**: 'Premature birth', 'Elevated plasma citrulline', 'Apnea', 'Respiratory acidosis', 'Hypoxemia'.

+4. **Neonatal Respiratory Distress Syndrome**:
A condition commonly seen in premature infants due to insufficient surfactant in the lungs.
- **Shared symptoms**: 'Premature birth', 'Respiratory distress', 'Apnea', 'Hypoxemia', 'Neonatal death'.
- **Symptoms not present**: 'Death in infancy', 'Hyperammonemia', 'Elevated plasma citrulline', 'Respiratory acidosis'.

+5. **Congenital Heart Disease**:
Structural anomalies of the heart present at birth that can lead to compromised oxygenation.
- **Shared symptoms**: 'Death in infancy', 'Respiratory distress', 'Hypoxemia', 'Neonatal death'.
- **Symptoms not present**: 'Premature birth', 'Hyperammonemia', 'Apnea', 'Respiratory acidosis', 'Elevated plasma citrulline'."
[],"Based on the provided symptoms, here is a list of potential diseases:

+1. **Methylmalonic Acidemia (MMA):**
- **Description:** A rare inherited metabolic disorder where the body can't process certain fats and proteins, leading to a buildup of methylmalonic acid.
- **Symptoms in common:** Methylmalonic acidemia, Methylmalonic aciduria, Decreased methylmalonyl-CoA mutase activity, Vomiting, Hyperammonemia, Seizure, Coma, Intellectual disability, Generalized hypotonia, Death in infancy.
- **Symptoms not in common:** Hypertension, Gout, Pancreatitis.

+2. **Chronic Kidney Disease (CKD):**
- **Description:** A long-term condition where the kidneys don't work as well as they should, leading to waste buildup in the body.
- **Symptoms in common:** Chronic kidney disease, Acute kidney injury, Elevated circulating creatinine concentration, Increased blood urea nitrogen, Anemia, Edema, Hypertension, Hyperuricemia, Gout, Vomiting.
- **Symptoms not in common:** Autistic behavior, Seizure, Methylmalonic acidemia.

+3. **Organic Acidemias:**
- **Description:** A group of metabolic disorders characterized by the accumulation of organic acids due to enzyme deficiencies.
- **Symptoms in common:** Methylmalonic aciduria, Increased circulating lactate concentration, Hyperglycinemia, Elevated circulating alanine concentration, Seizure, Coma, Generalized hypotonia, Vomiting, Intellectual disability, Death in infancy.
- **Symptoms not in common:** Gout, Hypertension.

+4. **Hyperammonemia Disorders:**
- **Description:** Conditions leading to elevated ammonia levels in the blood, affecting the central nervous system.
- **Symptoms in common:** Hyperammonemia, Vomiting, Seizure, Coma, Intellectual disability, Generalized hypotonia.
- **Symptoms not in common:** Hypertension, Gout, Pancreatitis.

+5. **Gout and Hyperuricemia:**
- **Description:** A form of arthritis caused by excess uric acid forming crystals in the joints.
- **Symptoms in common:** Gout, Hyperuricemia, Hypertension, Elevated circulating creatinine concentration.
- **Symptoms not in common:** Methylmalonic acidemia, Seizure, Coma.

+6. **Pancreatitis:**
- **Description:** Inflammation of the pancreas that can cause severe abdominal pain and digestive issues.
- **Symptoms in common:** Pancreatitis, Vomiting, Hyponatremia, Elevated circulating alkaline phosphatase concentration.
- **Symptoms not in common:** Methylmalonic acidemia, Seizure, Coma, Intellectual disability.

+7. **Anemia and Atransferrinemia:**
- **Description:** Anemia due to lack of transferrin, leading to iron overload and associated complications.
- **Symptoms in common:** Anemia, Atransferrinemia, Hypoproteinemia, Increased circulating ferritin concentration.
- **Symptoms not in common:** Seizure, Coma, Gout.

+8. **Autism Spectrum Disorder (ASD):**
- **Description:** A developmental disorder affecting communication and behavior.
- **Symptoms in common:** Autistic behavior, Intellectual disability, Clumsiness, Poor coordination.
- **Symptoms not in common:** Metabolic abnormalities like methylmalonic acidemia, Hyperammonemia.

+9. **Kyphoscoliosis-Associated Disorders:**
- **Description:** Conditions causing abnormal curvature of the spine, potentially linked with neuromuscular symptoms.
- **Symptoms in common:** Kyphoscoliosis, Generalized hypotonia, Clumsiness, Poor coordination.
- **Symptoms not in common:** Metabolic issues like methylmalonic aciduria, Hyperammonemia.

+10. **Metabolic Disorders Affecting Amino Acid Concentrations:**
- **Description:** Disorders leading to abnormal levels of amino acids in the blood.
- **Symptoms in common:** Abnormal circulating aspartate family amino acid concentration, Abnormal circulating valine concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Hyperglycinemia.
- **Symptoms not in common:** Gout, Hypertension.

**Note:** The combination of symptoms such as methylmalonic acidemia, hyperammonemia, and neurological symptoms suggests a complex metabolic condition. It's crucial for the patient to undergo thorough medical evaluation, including genetic and metabolic testing, to determine the exact cause. Consulting with a healthcare professional or a metabolic specialist is highly recommended for accurate diagnosis and appropriate management."
['Dihydropteridine reductase deficiency'],"+1. Phenylketonuria (PKU):
Symptoms in common with the disease: Microcephaly, Intellectual disability, Seizure, Motor delay, Hyperphenylalaninemia.
Symptoms not in common: Nystagmus, Alopecia, Hypertyrosinemia.

+2. Tyrosinemia Type I:
Symptoms in common with the disease: Hypertyrosinemia, Intellectual disability, Seizure, Motor delay, Abnormality of prenatal development or birth, Death in infancy or childhood.
Symptoms not in common: Nystagmus, Alopecia, Hyperphenylalaninemia.

+3. Krabbe Disease:
Symptoms in common with the disease: Motor delay, Seizure, Generalized hypotonia, Nystagmus, Microcephaly, Cerebral atrophy, Abnormal cerebral white matter morphology, Death in infancy.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia.

+4. Pelizaeus-Merzbacher Disease:
Symptoms in common with the disease: Nystagmus, Motor delay, Generalized hypotonia, Intellectual disability, Abnormal cerebral white matter morphology.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy.

+5. Aicardi-Goutières Syndrome:
Symptoms in common with the disease: Microcephaly, Seizure, Intellectual disability, Motor delay, Cerebral atrophy, Abnormal cerebral white matter morphology, Death in infancy or childhood.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia.

+6. Zellweger Spectrum Disorders:
Symptoms in common with the disease: Hypotonia, Seizure, Intellectual disability, Abnormality of prenatal development or birth, Cerebral atrophy, Death in infancy.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia, Nystagmus.

+7. Nonketotic Hyperglycinemia:
Symptoms in common with the disease: Hypotonia, Seizure, Motor delay, Intellectual disability, Cerebral atrophy, Death in infancy.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia, Nystagmus.

+8. Canavan Disease:
Symptoms in common with the disease: Hypotonia, Motor delay, Intellectual disability, Cerebral atrophy, Abnormal cerebral white matter morphology, Seizure.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia, Microcephaly (often presents with macrocephaly instead).

+9. Menkes Disease:
Symptoms in common with the disease: Motor delay, Seizure, Hypotonia, Intellectual disability, Abnormality of prenatal development or birth, Death in infancy or childhood, Alopecia or sparse hair.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Nystagmus.

+10. Leigh Syndrome:
Symptoms in common with the disease: Hypotonia, Seizure, Motor delay, Intellectual disability, Cerebral atrophy, Death in infancy or childhood.
Symptoms not in common: Alopecia, Hypertyrosinemia, Hyperphenylalaninemia, Nystagmus."
[],"+1. **Ethylmalonic Encephalopathy**:
Ethylmalonic encephalopathy is a rare metabolic disorder characterized by the accumulation of ethylmalonic acid in the body, leading to multiple organ dysfunction. It typically presents in infancy with severe developmental delays, neurological deficits, and skin abnormalities.

**Symptoms in common with the patient**:
- Ethylmalonic aciduria
- Skin rash
- Death in infancy
- Feeding difficulties
- Functional abnormality of the gastrointestinal tract

**Symptoms not present in the patient**:
- The patient does not have specific mention of neurological symptoms such as hypotonia or seizures, which are commonly associated with this condition.

+2. **Nonketotic Hyperglycinemia**:
Nonketotic hyperglycinemia is a genetic disorder resulting in the accumulation of glycine in bodily fluids and tissues, particularly affecting the brain. This leads to severe neurological symptoms starting in infancy.

**Symptoms in common with the patient**:
- Abnormal circulating glycine concentration
- Feeding difficulties
- Death in infancy

**Symptoms not present in the patient**:
- The patient does not exhibit seizures, lethargy, or apnea, which are typical in nonketotic hyperglycinemia.

+3. **Mitochondrial Myopathy**:
Mitochondrial myopathies are a group of disorders caused by dysfunctional mitochondria, leading to muscle weakness and neurological deficits.

**Symptoms in common with the patient**:
- Cytochrome C oxidase-negative muscle fibers
- Feeding difficulties
- Functional abnormality of the gastrointestinal tract

**Symptoms not present in the patient**:
- The patient does not report exercise intolerance or lactic acidosis, often seen in mitochondrial myopathies.

+4. **Glucose Transporter Type 1 Deficiency Syndrome**:
This condition affects the transport of glucose into the brain, leading to a variety of neurological issues.

**Symptoms in common with the patient**:
- Glycosuria
- Feeding difficulties
- Developmental delays (implied by certain symptoms)

**Symptoms not present in the patient**:
- Seizures and movement disorders are common but not noted in the patient's symptoms.

+5. **Congenital Skin Disorders** (e.g., Atopic Dermatitis):
These are skin conditions that manifest early in life with various types of skin rashes and lesions.

**Symptoms in common with the patient**:
- Skin rash
- Erythematous plaque
- Erythematous macule
- Erythematous papule

**Symptoms not present in the patient**:
- There is no mention of itching or family history, which are often associated with atopic dermatitis.

+6. **Fanconi-Bickel Syndrome**:
A rare genetic disorder affecting glycogen storage and glucose transport, leading to glucose accumulation.

**Symptoms in common with the patient**:
- Glycosuria
- Feeding difficulties
- Functional abnormality of the gastrointestinal tract

**Symptoms not present in the patient**:
- Hepatomegaly and rickets are common features but are not reported in the patient.

+7. **Neonatal Onset Multisystem Inflammatory Disease (NOMID)**:
An autoinflammatory disorder presenting shortly after birth with rash and systemic symptoms.

**Symptoms in common with the patient**:
- Skin rash
- Feeding difficulties
- Erythematous plaque, macule, and papule

**Symptoms not present in the patient**:
- Joint swelling and fever are typical but not mentioned.

+8. **Glycine Encephalopathy**:
Similar to nonketotic hyperglycinemia, this disorder leads to elevated glycine levels affecting the brain.

**Symptoms in common with the patient**:
- Abnormal circulating glycine concentration
- Feeding difficulties
- Death in infancy

**Symptoms not present in the patient**:
- Seizures and hypotonia are common but not noted.

+9. **Maple Syrup Urine Disease**:
A metabolic disorder affecting amino acid metabolism, leading to severe symptoms in infancy.

**Symptoms in common with the patient**:
- Feeding difficulties
- Abnormal metabolic findings

**Symptoms not present in the patient**:
- The characteristic sweet-smelling urine and neurological symptoms are not reported.

+10. **Erythroderma (Exfoliative Dermatitis)**:
A severe skin condition involving widespread redness and scaling.

**Symptoms in common with the patient**:
- Skin rash
- Erythematous plaques, macules, and papules

**Symptoms not present in the patient**:
- There is no mention of scaling or widespread skin peeling.

---

**Note**: This list represents potential conditions based on the presented symptoms. A thorough clinical evaluation, including medical history, physical examination, and diagnostic testing, is essential to arrive at an accurate diagnosis. It is important to consult a specialist for comprehensive assessment and management."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:

A urea cycle disorder caused by a deficiency of the OTC enzyme, leading to the accumulation of ammonia and orotic acid in the body.

**Symptoms in common:** Hyperammonemia, Oroticaciduria, Low plasma citrulline, Cerebral edema, Seizure, Death in infancy, Neonatal death  
**Symptoms not present:** Cyanosis, Fasciculations, Hypoargininemia

+2. Carbamoyl Phosphate Synthetase I (CPS I) Deficiency:

A severe urea cycle disorder resulting from a deficiency of the CPS I enzyme, causing toxic levels of ammonia in the blood.

**Symptoms in common:** Hyperammonemia, Low plasma citrulline, Cerebral edema, Seizure, Death in infancy, Neonatal death  
**Symptoms not present:** Oroticaciduria, Cyanosis, Fasciculations, Hypoargininemia

+3. Lysinuric Protein Intolerance (LPI):

A rare metabolic disorder affecting the body's ability to transport certain amino acids, leading to protein intolerance and multi-organ complications.

**Symptoms in common:** Hyperammonemia, Hypoargininemia, Seizure, Death in infancy, Neonatal death  
**Symptoms not present:** Oroticaciduria, Low plasma citrulline, Cyanosis, Fasciculations

+4. N-Acetylglutamate Synthase (NAGS) Deficiency:

A rare genetic disorder causing a deficiency of NAGS enzyme activity, leading to impaired urea cycle function and elevated ammonia levels.

**Symptoms in common:** Hyperammonemia, Low plasma citrulline, Cerebral edema, Seizure, Death in infancy, Neonatal death  
**Symptoms not present:** Oroticaciduria, Cyanosis, Fasciculations, Hypoargininemia

+5. Citrullinemia Type I (Argininosuccinate Synthase Deficiency):

A urea cycle disorder caused by a deficiency of the argininosuccinate synthase enzyme, leading to the accumulation of ammonia and citrulline.

**Symptoms in common:** Hyperammonemia, Cerebral edema, Seizure, Death in infancy, Neonatal death  
**Symptoms not present:** Low plasma citrulline (citrulline levels are typically elevated in this condition), Oroticaciduria, Hypoargininemia, Cyanosis, Fasciculations"
['Canavan disease'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:

Shared symptoms: Hyperammonemia, seizures, aminoaciduria, neonatal death, death in infancy.

Symptoms not present: Skin rash, erythematous plaque, macule, papule, abnormal circulating glycine concentration.

+2. Nonketotic Hyperglycinemia (Glycine Encephalopathy):

Shared symptoms: Seizures, death in infancy, neonatal death, abnormal circulating glycine concentration.

Symptoms not present: Skin rash, hyperammonemia, aminoaciduria, erythematous plaque, macule, papule.

+3. Maple Syrup Urine Disease:

Shared symptoms: Seizures, aminoaciduria, neonatal death, death in infancy.

Symptoms not present: Skin rash, hyperammonemia, abnormal circulating glycine concentration, erythematous lesions.

+4. Propionic Acidemia:

Shared symptoms: Hyperammonemia, seizures, aminoaciduria, neonatal death.

Symptoms not present: Skin rash, death in infancy, abnormal circulating glycine concentration, erythematous plaque, macule, papule.

+5. Neonatal Lupus Erythematosus:

Shared symptoms: Skin rash, erythematous plaque, macule, papule.

Symptoms not present: Seizures, hyperammonemia, aminoaciduria, death in infancy, abnormal circulating amino acid concentrations.

+6. Multiple Carboxylase Deficiency:

Shared symptoms: Skin rash, seizures, aminoaciduria, hyperammonemia.

Symptoms not present: Death in infancy, neonatal death, abnormal circulating glycine concentration, erythematous plaque, macule, papule."
['Maple syrup urine disease'],"+1. **Maple Syrup Urine Disease (MSUD):**
A rare inherited metabolic disorder affecting the breakdown of branched-chain amino acids (leucine, isoleucine, and valine).

**Symptoms in common:**
- Seizure
- Death in infancy
- Respiratory insufficiency
- Opisthotonus
- Neonatal death
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Feeding difficulties

**Symptoms not present:**
- Sepsis

+2. **Organic Acidemia:**
A group of metabolic disorders characterized by the inability to properly metabolize certain organic acids.

**Symptoms in common:**
- Seizure
- Respiratory insufficiency
- Neonatal death
- Feeding difficulties
- Sepsis

**Symptoms not present:**
- Opisthotonus
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Death in infancy

+3. **Nonketotic Hyperglycinemia:**
A metabolic disorder caused by a defect in the breakdown of the amino acid glycine.

**Symptoms in common:**
- Seizure
- Respiratory insufficiency
- Opisthotonus
- Neonatal death
- Feeding difficulties

**Symptoms not present:**
- Death in infancy
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Sepsis

+4. **Urea Cycle Disorders:**
A group of genetic disorders caused by a deficiency of one of the enzymes in the urea cycle.

**Symptoms in common:**
- Seizure
- Respiratory insufficiency
- Neonatal death
- Feeding difficulties

**Symptoms not present:**
- Opisthotonus
- Death in infancy
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Sepsis

+5. **Meningitis (Neonatal Sepsis):**
A severe infection causing inflammation of the membranes surrounding the brain and spinal cord.

**Symptoms in common:**
- Seizure
- Respiratory insufficiency
- Neonatal death
- Feeding difficulties
- Sepsis

**Symptoms not present:**
- Opisthotonus
- Death in infancy
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia"
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. **Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency**:
A rare genetic disorder that impairs the body's ability to break down certain long-chain fatty acids, leading to energy deficiency.

**Symptoms in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Abnormal circulating carnitine concentration
- Abnormality of prenatal development or birth
- Death in infancy, neonatal death, death in childhood

**Symptoms not in common:**
- Obesity

+2. **Mitochondrial Trifunctional Protein (MTP) Deficiency**:
A metabolic disorder affecting fatty acid oxidation due to defects in the mitochondrial trifunctional protein complex.

**Symptoms in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Abnormal circulating carnitine concentration
- Abnormality of prenatal development or birth
- Neonatal death, death in infancy, death in childhood

**Symptoms not in common:**
- Obesity

+3. **Primary Carnitine Deficiency**:
A condition where the body lacks sufficient carnitine transporter function, leading to decreased energy production.

**Symptoms in common:**
- Abnormal circulating carnitine concentration
- Obesity
- Death in infancy, death in childhood

**Symptoms not in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Abnormality of prenatal development or birth
- Neonatal death

+4. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:
An inherited disorder that prevents the body from converting certain fats into energy, especially during periods without food.

**Symptoms in common:**
- Death in infancy, death in childhood
- Abnormality of prenatal development or birth (less common)

**Symptoms not in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Abnormal circulating carnitine concentration
- Obesity

+5. **Carnitine Acylcarnitine Translocase Deficiency**:
A severe fatty acid oxidation disorder affecting the transport of carnitine-fatty acid complexes into mitochondria.

**Symptoms in common:**
- Abnormal circulating carnitine concentration
- Neonatal death, death in infancy
- Abnormality of prenatal development or birth

**Symptoms not in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Obesity

+6. **Very-Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency**:
A metabolic disorder that affects the breakdown of very-long-chain fatty acids, leading to energy production issues.

**Symptoms in common:**
- Abnormal circulating carnitine concentration
- Death in infancy, death in childhood
- Abnormality of prenatal development or birth

**Symptoms not in common:**
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
- Obesity"
['Phenylketonuria'],"+1. **Phenylketonuria (PKU):**
Phenylketonuria is a genetic metabolic disorder characterized by a deficiency in the enzyme needed to process the amino acid phenylalanine.

- **Symptoms in common:** Intellectual disability, Seizure, Motor delay, Hyperphenylalaninemia.
- **Symptoms not in common:** Death in infancy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Death in childhood, Death in early adulthood, Dyskinesia.

+2. **Tyrosinemia Type I:**
Tyrosinemia Type I is a hereditary disorder causing a deficiency in the enzyme fumarylacetoacetate hydrolase, leading to an accumulation of tyrosine.

- **Symptoms in common:** Hypertyrosinemia, Death in infancy, Death in childhood.
- **Symptoms not in common:** Intellectual disability, Seizure, Motor delay, Abnormal cerebral white matter morphology, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+3. **Krabbe Disease:**
Krabbe disease is a lysosomal storage disorder affecting the white matter of the central nervous system due to defective galactocerebrosidase enzyme.

- **Symptoms in common:** Motor delay, Seizure, Abnormal cerebral white matter morphology, Death in infancy, Death in childhood.
- **Symptoms not in common:** Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+4. **Canavan Disease:**
Canavan disease is a rare inherited disorder that causes progressive damage to nerve cells in the brain due to a deficiency of the enzyme aspartoacylase.

- **Symptoms in common:** Intellectual disability, Motor delay, Abnormal cerebral white matter morphology, Seizure.
- **Symptoms not in common:** Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Death in childhood, Death in early adulthood, Dyskinesia.

+5. **Maple Syrup Urine Disease (MSUD):**
MSUD is a metabolic disorder affecting branched-chain amino acids due to a deficiency of the branched-chain alpha-keto acid dehydrogenase complex.

- **Symptoms in common:** Intellectual disability, Seizure, Motor delay, Death in infancy.
- **Symptoms not in common:** Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood, Death in early adulthood, Dyskinesia.

+6. **Leigh Syndrome:**
Leigh syndrome is a severe neurological disorder that arises in the first year of life due to defects in mitochondrial energy production.

- **Symptoms in common:** Seizure, Motor delay, Abnormal cerebral white matter morphology, Death in infancy, Death in childhood.
- **Symptoms not in common:** Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+7. **Glutaric Acidemia Type I:**
Glutaric acidemia type I is a metabolic disorder leading to the accumulation of glutaric acid, causing neurological symptoms.

- **Symptoms in common:** Motor delay, Seizure, Dyskinesia.
- **Symptoms not in common:** Intellectual disability, Death in infancy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood, Death in early adulthood.

+8. **Pelizaeus-Merzbacher Disease:**
This is a genetic disorder affecting the central nervous system characterized by hypomyelination.

- **Symptoms in common:** Motor delay, Abnormal cerebral white matter morphology, Seizure.
- **Symptoms not in common:** Intellectual disability, Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Death in childhood, Death in early adulthood, Dyskinesia.

+9. **Nonketotic Hyperglycinemia:**
A disorder characterized by an accumulation of glycine, leading to neurological issues.

- **Symptoms in common:** Intellectual disability, Seizure, Motor delay, Death in infancy.
- **Symptoms not in common:** Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood, Death in early adulthood, Dyskinesia.

+10. **Menke's Disease:**
A disorder of copper metabolism leading to neurodegeneration.

- **Symptoms in common:** Intellectual disability, Seizure, Motor delay, Death in childhood.
- **Symptoms not in common:** Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Death in early adulthood, Dyskinesia."
['Wilson disease'],"+1. **Wilson's Disease**:
A genetic disorder causing excessive accumulation of copper in the liver, brain, and other vital organs due to defective copper excretion.

**Common symptoms with the patient**:
- **Hepatomegaly**: Enlarged liver due to copper deposition.
- **Elevated circulating hepatic transaminase concentration**: Indicates liver damage.
- **Decreased circulating ceruloplasmin concentration**: Reduced levels of ceruloplasmin, a copper-carrying protein.
- **Increased urinary copper concentration**: Excess copper is excreted in urine.
- **Decreased circulating copper concentration**: Copper accumulates in tissues rather than circulating in the blood.
- **Copper accumulation in liver**: Excessive copper stored in the liver.
- **Generalized hypotonia**: Muscle weakness due to neurological involvement.
- **Death in childhood or adolescence**: If untreated, can be fatal.

**Symptoms not present**:
- **Kayser-Fleischer rings**: Brownish rings around the cornea (not mentioned).
- **Neurological symptoms like tremors or movement disorders**: Not specified.
- **Psychiatric symptoms**: Not indicated.

+2. **Menkes Disease**:
A genetic disorder characterized by poor distribution of copper in the body, leading to copper deficiency in some tissues and accumulation in others.

**Common symptoms with the patient**:
- **Decreased circulating ceruloplasmin concentration**: Low levels due to copper deficiency.
- **Decreased circulating copper concentration**: Poor absorption and transport of copper.
- **Generalized hypotonia**: Muscle weakness.
- **Death in childhood**: Severe cases can be fatal early in life.

**Symptoms not present**:
- **Copper accumulation in liver**: Typically, copper does not accumulate in the liver.
- **Increased urinary copper concentration**: Usually decreased.
- **Characteristic kinky hair**: A hallmark of Menkes Disease (not mentioned).
- **Developmental delay and seizures**: Not specified.

+3. **Glycogen Storage Disease Type IV (Andersen Disease)**:
A metabolic disorder caused by a deficiency of the glycogen branching enzyme, leading to abnormal glycogen accumulation in organs.

**Common symptoms with the patient**:
- **Hepatomegaly**: Due to glycogen accumulation in the liver.
- **Splenomegaly**: Enlarged spleen from abnormal storage.
- **Generalized hypotonia**: Muscle weakness from energy metabolism issues.
- **Elevated circulating hepatic transaminase concentration**: Liver dysfunction.
- **Death in childhood**: Progressive disease can lead to early fatality.

**Symptoms not present**:
- **Copper metabolism abnormalities**: No issues with copper levels.
- **Abnormal circulating amino acid concentrations**: Not typical.
- **Increased urinary copper concentration**: Not associated.

+4. **Niemann-Pick Disease Type C**:
A lysosomal storage disorder affecting lipid metabolism, leading to accumulation of cholesterol and lipids in the liver and spleen.

**Common symptoms with the patient**:
- **Hepatomegaly**: Enlarged liver due to lipid accumulation.
- **Splenomegaly**: Enlarged spleen.
- **Generalized hypotonia**: Muscle weakness.
- **Death in adolescence**: Progressive neurological decline.

**Symptoms not present**:
- **Copper metabolism issues**: Copper levels typically normal.
- **Elevated hepatic transaminases**: May not be significantly elevated.
- **Abnormal amino acid concentrations**: Not commonly seen.

+5. **Hereditary Tyrosinemia Type I**:
A metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to accumulation of toxic metabolites.

**Common symptoms with the patient**:
- **Hepatomegaly**: Liver enlargement due to damage.
- **Elevated circulating hepatic transaminase concentration**: Indicates liver injury.
- **Abnormal circulating aspartate family amino acid concentration**: Elevated tyrosine and related amino acids.
- **Death in childhood**: Severe cases can be fatal without treatment.

**Symptoms not present**:
- **Copper metabolism abnormalities**: Copper levels are not affected.
- **Increased urinary copper concentration**: Not associated.
- **Splenomegaly**: Less common."
['PMM2-CDG'],"+1. **Pontocerebellar Hypoplasia**:
Symptoms in common: Ataxia, Cerebellar atrophy, Cerebellar agenesis, Generalized hypotonia, Intellectual disability, Death in infancy.
Symptoms not in common: Strabismus, Abnormal facial shape, Abnormal calvaria morphology.

+2. **Joubert Syndrome**:
Symptoms in common: Ataxia, Cerebellar atrophy, Generalized hypotonia, Intellectual disability, Abnormal facial shape, Strabismus.
Symptoms not in common: Death in infancy (patients may survive into adulthood), Abnormal calvaria morphology, Cerebellar agenesis (typically hypoplasia instead).

+3. **Walker-Warburg Syndrome**:
Symptoms in common: Cerebellar atrophy, Generalized hypotonia, Intellectual disability, Death in infancy, Abnormal facial shape.
Symptoms not in common: Strabismus, Ataxia, Abnormal calvaria morphology, Cerebellar agenesis (though brain malformations are present).

+4. **Krabbe Disease**:
Symptoms in common: Generalized hypotonia, Intellectual disability, Ataxia, Death in infancy.
Symptoms not in common: Strabismus, Cerebellar atrophy, Cerebellar agenesis, Abnormal facial shape, Abnormal calvaria morphology.

+5. **Lissencephaly**:
Symptoms in common: Intellectual disability, Generalized hypotonia, Abnormal facial shape, Death in infancy.
Symptoms not in common: Strabismus, Ataxia, Cerebellar atrophy, Cerebellar agenesis, Abnormal calvaria morphology."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of tyrosine and its toxic metabolites in the body.

- **Symptoms in common with the patient**:
  + *Abnormality of prenatal development or birth*
  + *Hypertyrosinemia*
  + *Neonatal death*
  + *Death in infancy*

- **Symptoms not in common**:
  + *Hyperphenylalaninemia*
  + *Death in adolescence*

---

+2. **Phenylketonuria (PKU)**:
PKU is a metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, which leads to high levels of phenylalanine in the blood.

- **Symptoms in common with the patient**:
  + *Hyperphenylalaninemia*
  + *Abnormality of prenatal development or birth*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Neonatal death*
  + *Death in infancy*
  + *Death in adolescence*

---

+3. **Tyrosinemia Type II**:
Tyrosinemia Type II is caused by a deficiency of the enzyme tyrosine aminotransferase, leading to elevated levels of tyrosine.

- **Symptoms in common with the patient**:
  + *Hypertyrosinemia*

- **Symptoms not in common**:
  + *Abnormality of prenatal development or birth*
  + *Hyperphenylalaninemia*
  + *Neonatal death*
  + *Death in infancy*
  + *Death in adolescence*

---

+4. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation.

- **Symptoms in common with the patient**:
  + *Neonatal death*
  + *Death in infancy*
  + *Abnormality of prenatal development or birth*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Hyperphenylalaninemia*
  + *Death in adolescence*

---

+5. **Disorders of Tetrahydrobiopterin (BH4) Metabolism**:
BH4 deficiencies affect the metabolism of several amino acids, including phenylalanine, leading to hyperphenylalaninemia and neurological symptoms.

- **Symptoms in common with the patient**:
  + *Hyperphenylalaninemia*
  + *Abnormality of prenatal development or birth*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Neonatal death*
  + *Death in infancy*
  + *Death in adolescence*

---

+6. **Homocystinuria**:
Homocystinuria is a metabolic disorder affecting the metabolism of the amino acid methionine, leading to a range of symptoms.

- **Symptoms in common with the patient**:
  + *Death in adolescence*
  + *Abnormality of prenatal development or birth*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Hyperphenylalaninemia*
  + *Neonatal death*
  + *Death in infancy*

---

+7. **Gaucher Disease (Type 2)**:
Gaucher Disease Type 2 is a genetic disorder resulting in the accumulation of fatty substances in certain organs.

- **Symptoms in common with the patient**:
  + *Death in infancy*
  + *Abnormality of prenatal development or birth*
  + *Neonatal death*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Hyperphenylalaninemia*
  + *Death in adolescence*

---

+8. **Menkes Disease**:
Menkes Disease is a disorder of copper metabolism leading to severe developmental issues.

- **Symptoms in common with the patient**:
  + *Death in infancy*
  + *Abnormality of prenatal development or birth*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Hyperphenylalaninemia*
  + *Neonatal death*
  + *Death in adolescence*

---

+9. **Leigh Syndrome**:
Leigh Syndrome is a severe neurological disorder that arises in infants and affects the central nervous system.

- **Symptoms in common with the patient**:
  + *Death in infancy*
  + *Abnormality of prenatal development or birth*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Hyperphenylalaninemia*
  + *Neonatal death*
  + *Death in adolescence*

---

+10. **Ornithine Transcarbamylase Deficiency**:
This is a urea cycle disorder leading to the accumulation of ammonia in the blood.

- **Symptoms in common with the patient**:
  + *Neonatal death*
  + *Death in infancy*

- **Symptoms not in common**:
  + *Hypertyrosinemia*
  + *Hyperphenylalaninemia*
  + *Abnormality of prenatal development or birth*
  + *Death in adolescence*"
['Glutaryl-CoA dehydrogenase deficiency'],"+1. **Glutaric Aciduria Type I**:

Glutaric Aciduria Type I is a rare inherited metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid and related substances in the body.

**Symptoms in common with the patient:**
- Macrocephaly
- Generalized hypotonia
- Abnormal cerebral morphology
- Glutaric aciduria
- Abnormal circulating lysine concentration

**Symptoms not in common:**
- Increased circulating lactate concentration
- Hypercalcemia
- Death in infancy (though severe cases can be life-threatening)
- Abnormal circulating carnitine concentration

+2. **Multiple Acyl-CoA Dehydrogenase Deficiency (Glutaric Aciduria Type II)**:

This disorder affects the body's ability to break down fats and certain amino acids due to defective enzymes, leading to energy production problems.

**Symptoms in common with the patient:**
- Generalized hypotonia
- Death in infancy
- Increased circulating lactate concentration
- Glutaric aciduria
- Abnormal circulating carnitine concentration

**Symptoms not in common:**
- Macrocephaly
- Abnormal cerebral morphology
- Hypercalcemia
- Abnormal circulating lysine concentration

+3. **Leigh Syndrome**:

Leigh Syndrome is a severe neurological disorder characterized by progressive loss of mental and movement abilities, often resulting from mitochondrial dysfunction.

**Symptoms in common with the patient:**
- Generalized hypotonia
- Death in infancy
- Abnormal cerebral morphology
- Increased circulating lactate concentration

**Symptoms not in common:**
- Macrocephaly (may be present in some cases)
- Hypercalcemia
- Glutaric aciduria
- Abnormal circulating lysine concentration
- Abnormal circulating carnitine concentration

+4. **Canavan Disease**:

Canavan Disease is a rare genetic disorder that causes degeneration of the white matter in the brain due to defective aspartoacylase enzyme.

**Symptoms in common with the patient:**
- Macrocephaly
- Generalized hypotonia
- Abnormal cerebral morphology
- Death in infancy

**Symptoms not in common:**
- Increased circulating lactate concentration
- Hypercalcemia
- Glutaric aciduria
- Abnormal circulating lysine concentration
- Abnormal circulating carnitine concentration

+5. **Hyperparathyroidism**:

Hyperparathyroidism involves overactivity of the parathyroid glands, leading to excessive production of parathyroid hormone and elevated calcium levels in the blood.

**Symptoms in common with the patient:**
- Hypercalcemia

**Symptoms not in common:**
- Macrocephaly
- Generalized hypotonia
- Death in infancy (rare in primary hyperparathyroidism)
- Abnormal cerebral morphology
- Increased circulating lactate concentration
- Glutaric aciduria
- Abnormal circulating lysine concentration
- Abnormal circulating carnitine concentration

+6. **Carnitine Transporter Deficiency**:

This condition is characterized by defective transport of carnitine into cells, affecting energy production from fatty acids.

**Symptoms in common with the patient:**
- Generalized hypotonia
- Abnormal circulating carnitine concentration
- Death in infancy (in severe cases)

**Symptoms not in common:**
- Macrocephaly
- Abnormal cerebral morphology
- Increased circulating lactate concentration
- Hypercalcemia
- Glutaric aciduria
- Abnormal circulating lysine concentration

+7. **Organic Acidurias (General)**:

A group of metabolic disorders resulting from defects in the breakdown of amino acids and fats, leading to accumulation of organic acids.

**Symptoms in common with the patient:**
- Generalized hypotonia
- Abnormal cerebral morphology
- Increased circulating lactate concentration
- Glutaric aciduria (specific types)
- Abnormal circulating lysine concentration
- Abnormal circulating carnitine concentration
- Death in infancy (in severe cases)

**Symptoms not in common:**
- Macrocephaly
- Hypercalcemia

+8. **Mitochondrial Disorders (General)**:

These disorders result from failures of the mitochondria, affecting energy production in cells, particularly in muscle and nerve tissues.

**Symptoms in common with the patient:**
- Generalized hypotonia
- Death in infancy
- Abnormal cerebral morphology
- Increased circulating lactate concentration

**Symptoms not in common:**
- Macrocephaly (may vary)
- Hypercalcemia
- Glutaric aciduria
- Abnormal circulating lysine concentration
- Abnormal circulating carnitine concentration

+9. **Alexander Disease**:

A rare leukodystrophy characterized by the destruction of white matter in the brain and a buildup of abnormal proteins.

**Symptoms in common with the patient:**
- Macrocephaly
- Generalized hypotonia
- Abnormal cerebral morphology
- Death in infancy (infantile form)

**Symptoms not in common:**
- Increased circulating lactate concentration
- Hypercalcemia
- Glutaric aciduria
- Abnormal circulating lysine concentration
- Abnormal circulating carnitine concentration

+10. **Maple Syrup Urine Disease**:

An inherited disorder affecting the metabolism of certain amino acids, leading to their accumulation.

**Symptoms in common with the patient:**
- Generalized hypotonia
- Abnormal circulating lysine concentration
- Death in infancy (if untreated)

**Symptoms not in common:**
- Macrocephaly
- Abnormal cerebral morphology
- Increased circulating lactate concentration
- Hypercalcemia
- Glutaric aciduria
- Abnormal circulating carnitine concentration"
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Symptoms in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood.
Symptoms not in common: Hyperphenylalaninemia.

+2. Dihydropteridine Reductase Deficiency:
Symptoms in common: Hyperphenylalaninemia, Hypertyrosinemia, Abnormality of prenatal development or birth, Death in infancy, Death in childhood.
Symptoms not in common: Neonatal death.

+3. Tyrosinemia Type II:
Symptoms in common: Abnormality of prenatal development or birth, Hypertyrosinemia.
Symptoms not in common: Hyperphenylalaninemia, Death in infancy, Neonatal death, Death in childhood.

+4. Phenylketonuria (Classical PKU):
Symptoms in common: Hyperphenylalaninemia, Abnormality of prenatal development or birth.
Symptoms not in common: Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood.

+5. Maple Syrup Urine Disease:
Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood.
Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
This is a metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to an accumulation of tyrosine in the body.

**Shared symptoms with the patient**:
- Hypertyrosinemia
- Feeding difficulties
- Small for gestational age
- Severe short stature
- Death in infancy or childhood
- Hepatic complications that can cause pericardial and pleural effusions

**Symptoms not present in the patient**:
- Increased bleeding tendency
- Enlarged liver and spleen (hepatosplenomegaly)
- Rickets-like bone disease

+2. **Phenylketonuria (PKU)**:
A metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, leading to elevated levels of phenylalanine.

**Shared symptoms with the patient**:
- Hyperphenylalaninemia
- Microcephaly
- Feeding difficulties
- Developmental delays (implied by severe symptoms)

**Symptoms not present in the patient**:
- Musty odor of the breath, skin, or urine
- Light skin and hair compared to family members
- Eczema

+3. **Zellweger Spectrum Disorder**:
A peroxisomal biogenesis disorder affecting multiple systems in the body.

**Shared symptoms with the patient**:
- Abnormality of prenatal development or birth
- Feeding difficulties
- Severe hypotonia (implied by severe short stature and developmental issues)
- Death in infancy or childhood
- Hepatic dysfunction leading to possible pericardial and pleural effusions

**Symptoms not present in the patient**:
- Craniofacial abnormalities (high forehead, broad nasal bridge)
- Vision and hearing loss
- Calcific stippling of bones (chondrodysplasia punctata)

+4. **Trisomy 18 (Edwards Syndrome)**:
A chromosomal disorder caused by an extra copy of chromosome 18.

**Shared symptoms with the patient**:
- Microcephaly
- Small for gestational age
- Abnormality of prenatal development or birth
- Severe short stature
- Feeding difficulties
- Death in infancy or childhood
- Congenital heart defects that may lead to pericardial and pleural effusions

**Symptoms not present in the patient**:
- Clenched fists with overlapping fingers
- Rocker-bottom feet
- Low-set ears and other distinctive facial features

+5. **Non-Immune Hydrops Fetalis**:
A severe, life-threatening condition of excessive fluid accumulation in fetal compartments.

**Shared symptoms with the patient**:
- Pericardial effusion
- Pleural effusion
- Abnormality of prenatal development or birth
- Small for gestational age
- Neonatal death
- Feeding difficulties (due to severe illness)

**Symptoms not present in the patient**:
- Edema (swelling) in other fetal compartments
- Anemia or heart failure signs in utero (if not previously detected)

+6. **Congenital Pericardial Effusion**:
An accumulation of fluid in the pericardial sac around the heart present at birth.

**Shared symptoms with the patient**:
- Pericardial effusion
- Pleural effusion (due to fluid overload)
- Feeding difficulties
- Potential for neonatal death or death in infancy
- Severe short stature (due to chronic illness)

**Symptoms not present in the patient**:
- Cyanosis (bluish discoloration due to lack of oxygen)
- Respiratory distress at birth (unless implied)

+7. **Smith-Lemli-Opitz Syndrome**:
A genetic disorder affecting cholesterol metabolism.

**Shared symptoms with the patient**:
- Microcephaly
- Small for gestational age
- Feeding difficulties
- Severe short stature
- Developmental delays
- Possible death in infancy or childhood

**Symptoms not present in the patient**:
- Distinctive facial features (ptosis, small jaw)
- Limb abnormalities (syndactyly of toes)
- Genital abnormalities in males"
['Ornithine transcarbamylase deficiency'],"+1. Ornithine Transcarbamylase (OTC) Deficiency:
Common symptoms with the patient: Hyperammonemia, vomiting, hyperglutaminemia, orotic aciduria, death in childhood.
  
+2. Carbamoyl Phosphate Synthetase I (CPS I) Deficiency:
Common symptoms with the patient: Hyperammonemia, vomiting, hyperglutaminemia, death in childhood.
Symptoms not in common with the patient: Oroticaciduria (typically absent in CPS I deficiency).

+3. N-Acetylglutamate Synthase (NAGS) Deficiency:
Common symptoms with the patient: Hyperammonemia, vomiting, death in childhood.
Symptoms not in common with the patient: Hyperglutaminemia (may be less pronounced), oroticaciduria (usually absent).

+4. Argininosuccinic Aciduria (Argininosuccinate Lyase Deficiency):
Common symptoms with the patient: Hyperammonemia, vomiting, death in childhood.
Symptoms not in common with the patient: Oroticaciduria (not typically present), hyperglutaminemia (may be less elevated).

+5. Citrullinemia Type I (Argininosuccinate Synthetase Deficiency):
Common symptoms with the patient: Hyperammonemia, vomiting, death in childhood.
Symptoms not in common with the patient: Oroticaciduria (usually absent), hyperglutaminemia (levels may vary).

+6. Hereditary Orotic Aciduria (UMP Synthase Deficiency):
Common symptoms with the patient: Oroticaciduria, failure to thrive, possible early death.
Symptoms not in common with the patient: Hyperammonemia (typically absent), hyperglutaminemia (not associated), vomiting (may or may not be present).

+7. Multiple Carboxylase Deficiency:
Common symptoms with the patient: Vomiting, developmental delays, possible early death.
Symptoms not in common with the patient: Hyperammonemia (may be mild or absent), hyperglutaminemia (not typical), oroticaciduria (not associated).

+8. Leigh Syndrome (Subacute Necrotizing Encephalomyelopathy):
Common symptoms with the patient: Vomiting, developmental regression, early death.
Symptoms not in common with the patient: Hyperammonemia (not a primary feature), hyperglutaminemia (not typical), oroticaciduria (not associated).

+9. Mitochondrial Disorders (General):
Common symptoms with the patient: Vomiting, failure to thrive, possible early death.
Symptoms not in common with the patient: Hyperammonemia (not usually elevated), hyperglutaminemia (not typical), oroticaciduria (not associated).

+10. Organic Acidemias (e.g., Propionic Acidemia):
Common symptoms with the patient: Vomiting, metabolic acidosis, early death.
Symptoms not in common with the patient: Hyperammonemia (may be present but less pronounced), hyperglutaminemia (not characteristic), oroticaciduria (not associated)."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Tyrosinemia Type I is a rare inherited disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to the accumulation of toxic substances in the liver and kidneys.

**Symptoms the patient has in common:**
- Abnormality of prenatal development or birth
- Hyperphenylalaninemia
- Abnormal circulating tyrosine concentration
- Elevated urinary carboxylic acid
- Death in infancy
- Neonatal death
- Death in early adulthood

**Symptoms not present:**
- Obesity (not typically associated with Tyrosinemia Type I)

+2. Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder resulting from the inability to process certain amino acids, leading to their accumulation in the body.

**Symptoms the patient has in common:**
- Abnormality of prenatal development or birth
- Elevated urinary carboxylic acid
- Death in infancy
- Neonatal death

**Symptoms not present:**
- Obesity
- Hyperphenylalaninemia (not typically associated)
- Abnormal circulating tyrosine concentration

+3. Phenylketonuria (PKU):
PKU is caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body.

**Symptoms the patient has in common:**
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

**Symptoms not present:**
- Obesity (PKU patients are often under normal weight if untreated)
- Abnormal circulating tyrosine concentration (usually decreased in PKU)
- Elevated urinary carboxylic acid
- Death in infancy or early adulthood (with treatment, severe outcomes are preventable)

+4. Multiple Carboxylase Deficiency:
This condition is due to a deficiency of enzymes that require biotin, leading to multiple metabolic problems.

**Symptoms the patient has in common:**
- Elevated urinary carboxylic acid
- Abnormality of prenatal development or birth
- Death in infancy

**Symptoms not present:**
- Hyperphenylalaninemia
- Abnormal circulating tyrosine concentration
- Obesity

+5. Organic Acidemias (e.g., Propionic Acidemia, Methylmalonic Acidemia):
These disorders result from defects in the breakdown of certain amino acids and fats, leading to accumulation of organic acids.

**Symptoms the patient has in common:**
- Elevated urinary carboxylic acid
- Death in infancy
- Neonatal death
- Abnormality of prenatal development or birth

**Symptoms not present:**
- Hyperphenylalaninemia
- Abnormal circulating tyrosine concentration
- Obesity"
['Pearson syndrome'],"+1. **Pearson Syndrome**:
Symptoms in common: Exocrine pancreatic insufficiency, anemia, neutropenia, thrombocytopenia, acute kidney injury, renal Fanconi syndrome, hypoglycemia, vomiting, increased circulating lactate concentration, increased serum pyruvate, lethargy, generalized hypotonia, feeding difficulties, chronic kidney disease, short stature, death in infancy.
Symptoms not in common: Ptosis, photophobia, 3-methylglutaric aciduria, localized skin lesion.

+2. **Barth Syndrome**:
Symptoms in common: Congestive heart failure, neutropenia, anemia, hypotonia, lethargy, recurrent viral infections, decreased plasma free carnitine, feeding difficulties, short stature.
Symptoms not in common: Enlarged kidney, exocrine pancreatic insufficiency, thrombocytopenia, photophobia, ptosis, renal Fanconi syndrome, 3-methylglutaric aciduria.

+3. **3-Methylglutaconic Aciduria (Type I)**:
Symptoms in common: 3-Methylglutaric aciduria, elevated urinary 3-hydroxybutyric acid, vomiting, hypotonia, lethargy, developmental delays, feeding difficulties.
Symptoms not in common: Exocrine pancreatic insufficiency, anemia, neutropenia, thrombocytopenia, enlarged kidney, photophobia, ptosis, recurrent viral infections.

+4. **Mitochondrial Disease (e.g., Leigh Syndrome)**:
Symptoms in common: Increased circulating lactate concentration, increased serum pyruvate, hypotonia, lethargy, vomiting, feeding difficulties, sleep abnormality, developmental delays, death in infancy or childhood.
Symptoms not in common: Exocrine pancreatic insufficiency, anemia, neutropenia, thrombocytopenia, enlarged kidney, photophobia, ptosis.

+5. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency)**:
Symptoms in common: Hypoglycemia, decreased plasma free carnitine, cardiomyopathy leading to congestive heart failure, hypotonia, lethargy, vomiting.
Symptoms not in common: Exocrine pancreatic insufficiency, anemia, neutropenia, thrombocytopenia, enlarged kidney, photophobia, ptosis, renal Fanconi syndrome."
['Smith-Lemli-Opitz syndrome'],"+1. **Smith-Lemli-Opitz Syndrome**:
Smith-Lemli-Opitz Syndrome is a genetic disorder caused by a deficiency in cholesterol synthesis, leading to multiple congenital anomalies and developmental delays.

**Symptoms in common**:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Anteverted nares
- Syndactyly
- Generalized hypotonia
- Hypocholesterolemia
- Elevated 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Feeding difficulties
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- *(None; all listed symptoms are associated with this condition)*

---

+2. **RSH/Smith-Lemli-Opitz Syndrome (Type II)**:
A more severe form of Smith-Lemli-Opitz Syndrome characterized by profound developmental anomalies and often resulting in early death.

**Symptoms in common**:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Anteverted nares
- Syndactyly
- Generalized hypotonia
- Hypocholesterolemia
- Elevated 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol
- Feeding difficulties
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- *(None; this severe type exhibits all the listed symptoms)*

---

+3. **Desmosterolosis**:
A rare congenital disorder resulting from defects in cholesterol biosynthesis, leading to multiple malformations.

**Symptoms in common**:
- Broad philtrum
- Long philtrum
- Anteverted nares
- Generalized hypotonia
- Feeding difficulties
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- Syndactyly
- Deep philtrum
- Hypocholesterolemia
- Elevated 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol

---

+4. **Zellweger Spectrum Disorder**:
A group of peroxisomal biogenesis disorders affecting multiple organ systems with significant developmental delays.

**Symptoms in common**:
- Broad philtrum
- Long philtrum
- Generalized hypotonia
- Feeding difficulties
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- Anteverted nares
- Syndactyly
- Deep philtrum
- Hypocholesterolemia
- Elevated 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol

---

+5. **Holoprosencephaly Sequence**:
A developmental anomaly resulting in incomplete separation of the forebrain, often associated with facial abnormalities.

**Symptoms in common**:
- Broad philtrum
- Anteverted nares
- Generalized hypotonia
- Feeding difficulties
- Death in infancy
- Neonatal death

**Symptoms not in common**:
- Long philtrum
- Syndactyly
- Deep philtrum
- Hypocholesterolemia
- Elevated 7-dehydrocholesterol concentration
- Elevated 8-dehydrocholesterol

---

These potential conditions share several symptoms with the patient's presentation. It's important to conduct further evaluations and genetic testing to arrive at a definitive diagnosis."
['Acute intermittent porphyria'],"+1. Severe Combined Immunodeficiency (SCID):
Symptoms in common with the disease: Recurrent viral infections, death in childhood.
Symptoms not in common: Vomiting, abdominal pain.

+2. Acute Appendicitis:
Symptoms in common with the disease: Abdominal pain, vomiting.
Symptoms not in common: Recurrent viral infections, death in childhood.

+3. Leukemia:
Symptoms in common with the disease: Recurrent infections (including viral), abdominal pain, vomiting, possible death in childhood.
Symptoms not in common: None.

+4. Mitochondrial Disorders:
Symptoms in common with the disease: Vomiting, abdominal pain, death in childhood.
Symptoms not in common: Recurrent viral infections.

+5. Intestinal Obstruction:
Symptoms in common with the disease: Abdominal pain, vomiting.
Symptoms not in common: Recurrent viral infections, death in childhood."
['Citrullinemia type I'],"+1. Citrullinemia Type I:
A urea cycle disorder caused by deficiency of argininosuccinate synthetase, leading to accumulation of citrulline and ammonia.

Symptoms in common: Death in infancy, Metabolic acidosis, Hyperammonemia, Neonatal death, Elevated plasma citrulline.
Symptoms not in common: Hyperglycinuria, Hyperglutaminemia, Argininuria, Abnormal circulating arginine concentration.

+2. Argininosuccinic Aciduria:
A urea cycle disorder resulting from deficiency of argininosuccinate lyase, causing accumulation of argininosuccinic acid and ammonia.

Symptoms in common: Death in infancy, Metabolic acidosis, Hyperammonemia, Elevated plasma citrulline.
Symptoms not in common: Hyperglycinuria, Hyperglutaminemia, Argininuria, Abnormal circulating arginine concentration.

+3. Argininemia (Arginase Deficiency):
A urea cycle disorder caused by deficiency of arginase, leading to elevated arginine levels and ammonia accumulation.

Symptoms in common: Metabolic acidosis, Hyperammonemia, Argininuria, Abnormal circulating arginine concentration.
Symptoms not in common: Death in infancy, Elevated plasma citrulline, Hyperglycinuria, Hyperglutaminemia.

+4. Non-Ketotic Hyperglycinemia:
A metabolic disorder caused by defects in glycine cleavage system, leading to accumulation of glycine.

Symptoms in common: Death in infancy, Hyperglycinuria, Neonatal death, Metabolic acidosis.
Symptoms not in common: Hyperammonemia, Elevated plasma citrulline, Argininuria, Abnormal circulating arginine concentration.

+5. Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome:
A urea cycle disorder characterized by impaired ornithine transport across mitochondrial membranes.

Symptoms in common: Hyperammonemia, Metabolic acidosis, Elevated plasma citrulline.
Symptoms not in common: Hyperglycinuria, Hyperglutaminemia, Argininuria, Abnormal circulating arginine concentration, Death in infancy."
[],"+1. **Methylmalonic Acidemia (MMA)**:
A metabolic disorder caused by a deficiency in the enzyme methylmalonyl-CoA mutase, leading to accumulation of methylmalonic acid.

**Symptoms in common with the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperammonemia
- Decreased plasma free carnitine
- Lethargy
- Generalized hypotonia
- Drowsiness
- Dehydration
- Delayed speech and language development
- Sleep abnormality
- Death in infancy (in severe cases)

**Symptoms not present in the patient**:
- *(No major discrepancies)*

+2. **Combined Methylmalonic Aciduria and Homocystinuria (Cobalamin Disorders)**:
A group of disorders affecting vitamin B12 metabolism, leading to combined methylmalonic aciduria and elevated homocysteine levels.

**Symptoms in common with the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperhomocystinemia
- Hyperammonemia
- Decreased plasma free carnitine
- Lethargy
- Generalized hypotonia
- Drowsiness
- Dehydration
- Delayed speech and language development
- Sleep abnormality
- Death in infancy

**Symptoms not present in the patient**:
- *(No major discrepancies)*

+3. **Propionic Acidemia**:
An inherited disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid.

**Symptoms in common with the patient**:
- Hyperammonemia
- Decreased plasma free carnitine
- Lethargy
- Generalized hypotonia
- Drowsiness
- Dehydration
- Sleep abnormality
- Death in infancy
- Delayed speech and language development

**Symptoms not present in the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperhomocystinemia

+4. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:
Genetic disorders causing defects in the urea cycle, leading to accumulation of ammonia in the blood.

**Symptoms in common with the patient**:
- Hyperammonemia
- Lethargy
- Generalized hypotonia
- Drowsiness
- Dehydration
- Sleep abnormality
- Death in infancy

**Symptoms not present in the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperhomocystinemia
- Decreased plasma free carnitine
- Delayed speech and language development

+5. **Primary Carnitine Deficiency**:
A disorder affecting the transport of carnitine into cells, leading to decreased levels of carnitine and energy production issues.

**Symptoms in common with the patient**:
- Decreased plasma free carnitine
- Lethargy
- Generalized hypotonia
- Drowsiness
- Sleep abnormality
- Death in infancy

**Symptoms not present in the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperammonemia
- Hyperhomocystinemia
- Delayed speech and language development

+6. **Homocystinuria**:
A metabolic disorder characterized by high levels of homocysteine due to a deficiency of cystathionine beta-synthase.

**Symptoms in common with the patient**:
- Hyperhomocystinemia
- Delayed speech and language development
- Generalized hypotonia
- Sleep abnormality

**Symptoms not present in the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperammonemia
- Decreased plasma free carnitine
- Death in infancy

+7. **Maple Syrup Urine Disease**:
A disorder affecting the breakdown of certain amino acids, leading to their accumulation.

**Symptoms in common with the patient**:
- Lethargy
- Generalized hypotonia
- Drowsiness
- Dehydration
- Sleep abnormality
- Death in infancy

**Symptoms not present in the patient**:
- Methylmalonic acidemia
- Methylmalonic aciduria
- Hyperammonemia
- Hyperhomocystinemia
- Decreased plasma free carnitine
- Delayed speech and language development"
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1. **Nonketotic Hyperglycinemia (NKH):**
Symptoms in common:
- Hypotonia
- Neonatal death
- Death in infancy
- Abnormal circulating amino acid concentrations (elevated glycine can affect alanine and other amino acids)

Symptoms not in common:
- Hyperactivity
- Premature birth
- Hyperammonemia
- Death in childhood
- Decreased plasma free carnitine
- Abnormal circulating creatine kinase concentration

+2. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency):**
Symptoms in common:
- Decreased plasma free carnitine
- Hypotonia
- Hyperammonemia
- Elevated creatine kinase levels
- Muscle weakness

Symptoms not in common:
- Hyperactivity
- Death in infancy
- Premature birth
- Neonatal death
- Death in childhood
- Abnormal circulating aspartate family amino acid concentration
- Abnormal circulating alanine concentration

+3. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency):**
Symptoms in common:
- Hyperammonemia
- Lethargy leading to hypotonia
- Neonatal death
- Death in infancy or childhood
- Abnormal amino acid concentrations (elevated glutamine, decreased citrulline)

Symptoms not in common:
- Hyperactivity
- Premature birth
- Decreased plasma free carnitine
- Abnormal circulating creatine kinase concentration

+4. **Mitochondrial Disorders (e.g., Mitochondrial Myopathy):**
Symptoms in common:
- Hypotonia
- Elevated creatine kinase levels
- Developmental delays that could lead to early death
- Abnormal amino acid concentrations

Symptoms not in common:
- Hyperactivity
- Hyperammonemia
- Premature birth
- Decreased plasma free carnitine

+5. **Maple Syrup Urine Disease:**
Symptoms in common:
- Generalized hypotonia
- Poor feeding leading to neonatal death
- Abnormal circulating amino acid concentrations (leucine, isoleucine, valine)

Symptoms not in common:
- Hyperactivity
- Hyperammonemia
- Premature birth
- Decreased plasma free carnitine
- Abnormal circulating creatine kinase concentration

+6. **Congenital Muscular Dystrophy:**
Symptoms in common:
- Generalized hypotonia
- Elevated creatine kinase levels
- Muscle weakness potentially leading to early death

Symptoms not in common:
- Hyperactivity
- Hyperammonemia
- Premature birth
- Decreased plasma free carnitine
- Abnormal circulating amino acid concentrations

+7. **Smith-Lemli-Opitz Syndrome:**
Symptoms in common:
- Hypotonia
- Developmental delays
- Possible early death
- Abnormal biochemical profiles

Symptoms not in common:
- Hyperactivity
- Hyperammonemia
- Premature birth
- Decreased plasma free carnitine
- Elevated creatine kinase levels

+8. **Propionic Acidemia:**
Symptoms in common:
- Hyperammonemia
- Hypotonia
- Poor feeding leading to neonatal death
- Abnormal amino acid concentrations

Symptoms not in common:
- Hyperactivity
- Premature birth
- Decreased plasma free carnitine
- Elevated creatine kinase levels

+9. **Glycogen Storage Disease Type II (Pompe Disease):**
Symptoms in common:
- Generalized hypotonia
- Elevated creatine kinase levels
- Cardiomyopathy leading to death in infancy

Symptoms not in common:
- Hyperactivity
- Hyperammonemia
- Premature birth
- Decreased plasma free carnitine

+10. **Leigh Syndrome:**
Symptoms in common:
- Hypotonia
- Developmental regression
- Elevated lactate levels affecting amino acid metabolism
- Early death

Symptoms not in common:
- Hyperactivity
- Hyperammonemia
- Premature birth
- Decreased plasma free carnitine
- Elevated creatine kinase levels"
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:

Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. This leads to the accumulation of tyrosine and its toxic metabolites, affecting the liver, kidneys, and nervous system.

**Symptoms in common with the patient**:
- Hypertyrosinemia
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not in common with the patient**:
- Upper airway obstruction
- Hyperphenylalaninemia
- Chronic pulmonary obstruction

---

+2. **Phenylketonuria (PKU)**:

PKU is a metabolic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, leading to elevated levels of phenylalanine in the blood.

**Symptoms in common with the patient**:
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Upper airway obstruction
- Neonatal death
- Death in infancy
- Chronic pulmonary obstruction

---

+3. **Cystic Fibrosis**:

Cystic fibrosis is a genetic disease affecting the respiratory and digestive systems, characterized by thick, sticky mucus production that can obstruct airways.

**Symptoms in common with the patient**:
- Chronic pulmonary obstruction
- Upper airway obstruction (due to mucus buildup)

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Abnormality of prenatal development or birth
- Neonatal death
- Death in infancy

---

+4. **Maple Syrup Urine Disease (MSUD)**:

MSUD is a metabolic disorder caused by a deficiency in the branched-chain alpha-keto acid dehydrogenase complex, leading to accumulation of certain amino acids.

**Symptoms in common with the patient**:
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Upper airway obstruction
- Chronic pulmonary obstruction

---

+5. **Congenital Central Hypoventilation Syndrome (CCHS)**:

CCHS is a rare disorder of the autonomic nervous system characterized by inadequate breathing during sleep.

**Symptoms in common with the patient**:
- Upper airway obstruction
- Chronic pulmonary obstruction

**Symptoms not in common with the patient**:
- Hypertyrosinemia
- Hyperphenylalaninemia
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

---

+6. **Alpha-1 Antitrypsin Deficiency**:

This is a genetic condition that can lead to lung disease due to the lack of a protein that protects the lungs.

**Symptoms in common with the patient**:
- Chronic pulmonary obstruction

**Symptoms not in common with the patient**:
- Upper airway obstruction
- Hypertyrosinemia
- Hyperphenylalaninemia
- Neonatal death
- Death in infancy
- Abnormality of prenatal development or birth

---

These potential diagnoses consider the symptoms presented and highlight which are shared and which are not, aiding in narrowing down the possible conditions affecting the patient."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. **Long-chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD Deficiency):**
- **Symptoms in common:** 'Decreased 3-hydroxyacyl-CoA dehydrogenase level', 'Hypoxemia', 'Premature birth', 'Neonatal death', 'Death in infancy', 'Spasticity'
- **Symptoms not in common:** 'Ileus', 'Peritoneal effusion', 'Decreased plasma free carnitine', 'Decreased circulating ferritin concentration', 'Abnormal circulating vitamin B12 concentration'

+2. **Primary Carnitine Deficiency (Carnitine Transporter Defect):**
- **Symptoms in common:** 'Decreased plasma free carnitine', 'Hypoxemia', 'Death in infancy', 'Spasticity', 'Premature birth'
- **Symptoms not in common:** 'Ileus', 'Peritoneal effusion', 'Decreased circulating ferritin concentration', 'Abnormal circulating vitamin B12 concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'

+3. **Methylmalonic Acidemia:**
- **Symptoms in common:** 'Abnormal circulating vitamin B12 concentration', 'Spasticity', 'Ileus', 'Neonatal death', 'Death in infancy'
- **Symptoms not in common:** 'Decreased plasma free carnitine', 'Decreased circulating ferritin concentration', 'Hypoxemia', 'Peritoneal effusion', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'

+4. **Neonatal Hemochromatosis:**
- **Symptoms in common:** 'Decreased circulating ferritin concentration', 'Peritoneal effusion', 'Hypoxemia', 'Neonatal death', 'Death in infancy'
- **Symptoms not in common:** 'Spasticity', 'Ileus', 'Premature birth', 'Decreased plasma free carnitine', 'Abnormal circulating vitamin B12 concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'

+5. **Zellweger Spectrum Disorders:**
- **Symptoms in common:** 'Hypoxemia', 'Peritoneal effusion', 'Neonatal death', 'Death in infancy', 'Spasticity', 'Premature birth'
- **Symptoms not in common:** 'Decreased plasma free carnitine', 'Ileus', 'Decreased circulating ferritin concentration', 'Abnormal circulating vitamin B12 concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'"
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Symptoms in common: Hypertyrosinemia, death in infancy or childhood.
Symptoms not in common: Hyperphenylalaninemia, recurrent viral infections, death in adolescence.

+2. Dihydropteridine Reductase (DHPR) Deficiency:
Symptoms in common: Hyperphenylalaninemia, possible early death in childhood.
Symptoms not in common: Hypertyrosinemia, recurrent viral infections, death in adolescence.

+3. Severe Combined Immunodeficiency (SCID):
Symptoms in common: Recurrent viral infections, death in infancy or childhood.
Symptoms not in common: Hypertyrosinemia, hyperphenylalaninemia, death in adolescence.

+4. Phenylketonuria (PKU):
Symptoms in common: Hyperphenylalaninemia.
Symptoms not in common: Hypertyrosinemia, recurrent viral infections, death in infancy, childhood, or adolescence (with proper management).

+5. Immunodeficiency with Hyper-IgM Syndrome:
Symptoms in common: Recurrent viral infections, potential death in childhood.
Symptoms not in common: Hypertyrosinemia, hyperphenylalaninemia, death in adolescence.

+6. Maple Syrup Urine Disease (MSUD):
Symptoms in common: Early death in infancy if untreated.
Symptoms not in common: Hypertyrosinemia, hyperphenylalaninemia, recurrent viral infections, death in adolescence."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Nonketotic Hyperglycinemia (Glycine Encephalopathy):
A rare genetic disorder caused by a defect in the glycine cleavage system, leading to an accumulation of glycine in the body, particularly affecting the brain. It often presents in the neonatal period with severe neurological symptoms and can be fatal in infancy.

**Shared symptoms:**
- Death in infancy
- Aminoaciduria
- Abnormal circulating glycine concentration

**Symptoms not present:**
- Elevated urinary carboxylic acid

+2. Propionic Acidemia:
An inherited metabolic disorder resulting from a deficiency of the enzyme propionyl-CoA carboxylase, leading to the buildup of propionic acid in the body. This condition can cause severe metabolic acidosis and other life-threatening symptoms in infants.

**Shared symptoms:**
- Death in infancy
- Elevated urinary carboxylic acid
- Aminoaciduria (may be present due to metabolic disruptions)

**Symptoms not present:**
- Abnormal circulating glycine concentration

+3. Methylmalonic Acidemia:
A metabolic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, leading to accumulation of methylmalonic acid. Affected infants may experience developmental delays and metabolic crises.

**Shared symptoms:**
- Death in infancy
- Elevated urinary carboxylic acid
- Aminoaciduria (can occur due to impaired metabolism)

**Symptoms not present:**
- Abnormal circulating glycine concentration

+4. Multiple Carboxylase Deficiency:
A disorder characterized by defects in biotin metabolism affecting multiple carboxylase enzymes. It leads to accumulation of organic acids and can be life-threatening in early infancy.

**Shared symptoms:**
- Death in infancy
- Elevated urinary carboxylic acid

**Symptoms not present:**
- Aminoaciduria
- Abnormal circulating glycine concentration

+5. Isovaleric Acidemia:
A genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to accumulation of isovaleric acid. It can result in severe metabolic disturbances in infants.

**Shared symptoms:**
- Death in infancy
- Elevated urinary carboxylic acid

**Symptoms not present:**
- Aminoaciduria
- Abnormal circulating glycine concentration"
['Succinic semialdehyde dehydrogenase deficiency'],"+1. **Glutaric Aciduria Type I**:
Glutaric Aciduria Type I (GA-I) is a rare inherited metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. This leads to the accumulation of glutaric acid and other metabolic byproducts, causing neurological damage.

**Symptoms the patient has in common with GA-I**:
- Delayed speech and language development
- Hyperactivity
- Seizures
- Ataxia
- Motor delay
- Generalized hypotonia
- Elevated urinary carboxylic acid (specifically glutaric acid)
- Death in infancy or childhood

**Symptoms the patient does not have in common**:
- Macrocephaly (abnormally large head)
- Dystonia (involuntary muscle contractions)

+2. **Canavan Disease**:
Canavan Disease is a genetic neurological disorder characterized by the degeneration of white matter in the brain, leading to impaired nerve signal transmission.

**Symptoms the patient has in common with Canavan Disease**:
- Delayed speech and language development
- Seizures
- Ataxia
- Motor delay
- Generalized hypotonia
- Death in infancy or childhood

**Symptoms the patient does not have in common**:
- Megalencephaly (abnormally large brain)
- Poor head control
- Feeding difficulties
- Elevated urinary carboxylic acid is not typical

+3. **Propionic Acidemia**:
Propionic Acidemia is a metabolic disorder resulting from a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid.

**Symptoms the patient has in common with Propionic Acidemia**:
- Seizures
- Motor delay
- Generalized hypotonia
- Elevated urinary carboxylic acid (propionic acid)
- Possible death in infancy

**Symptoms the patient does not have in common**:
- Poor feeding
- Vomiting
- Lethargy
- Hyperammonemia
- Neutropenia (low white blood cell count)

+4. **Leigh Syndrome**:
Leigh Syndrome is a severe neurological disorder associated with mutations affecting mitochondrial function, leading to progressive loss of mental and movement abilities.

**Symptoms the patient has in common with Leigh Syndrome**:
- Delayed speech and language development
- Seizures
- Ataxia
- Motor delay
- Generalized hypotonia
- Death in infancy or childhood

**Symptoms the patient does not have in common**:
- Respiratory difficulties
- Ophthalmological issues (optic atrophy)
- Elevated lactate levels rather than elevated urinary carboxylic acids

+5. **Rett Syndrome**:
Rett Syndrome is a neurological disorder almost exclusively affecting females, characterized by normal early growth followed by a slowing of development.

**Symptoms the patient has in common with Rett Syndrome**:
- Delayed speech and language development
- Hyperactivity
- Seizures
- Motor delay
- Ataxia
- Generalized hypotonia

**Symptoms the patient does not have in common**:
- Loss of purposeful hand skills with stereotypic hand movements
- Breathing abnormalities
- Death in infancy is less common
- Elevated urinary carboxylic acid is not typical

+6. **Maple Syrup Urine Disease**:
Maple Syrup Urine Disease is a metabolic disorder affecting the breakdown of certain amino acids, leading to their accumulation.

**Symptoms the patient has in common with Maple Syrup Urine Disease**:
- Seizures
- Generalized hypotonia
- Elevated urinary carboxylic acid (branched-chain keto acids)

**Symptoms the patient does not have in common**:
- Sweet-smelling urine
- Poor feeding
- Vomiting
- Lethargy
- Death in infancy without treatment

+7. **Krabbe Disease**:
Krabbe Disease is a genetic disorder affecting the nervous system due to the deficiency of the enzyme galactocerebrosidase.

**Symptoms the patient has in common with Krabbe Disease**:
- Seizures
- Motor delay
- Generalized hypotonia
- Death in infancy

**Symptoms the patient does not have in common**:
- Irritability
- Stiff posture (spasticity)
- Vision loss
- Elevated urinary carboxylic acid is not typical"
['Argininosuccinic aciduria'],"+1. Glycogen Storage Disease Type II (Pompe Disease):

+ Symptoms the patient has in common: 'Death in infancy', 'Tachycardia', 'Hepatomegaly', 'Tachypnea'.
+ Symptoms typically present in this disease but not observed in the patient: 'Muscle weakness', 'Hypotonia'.

+2. Organic Acidemias (e.g., Propionic Acidemia):

+ Symptoms the patient has in common: 'Metabolic acidosis', 'Vomiting', 'Tachypnea', 'Neonatal death'.
+ Symptoms typically present in this disease but not observed in the patient: 'Lethargy', 'Seizures'.

+3. Mitochondrial Disorders (e.g., Leigh Syndrome):

+ Symptoms the patient has in common: 'Metabolic acidosis', 'Vomiting', 'Tachypnea', 'Neonatal death'.
+ Symptoms typically present in this disease but not observed in the patient: 'Developmental delays', 'Neurological deficits'.

+4. Fatty Acid Oxidation Disorders (e.g., LCHAD Deficiency):

+ Symptoms the patient has in common: 'Vomiting', 'Hepatomegaly', 'Metabolic acidosis', 'Neonatal death'.
+ Symptoms typically present in this disease but not observed in the patient: 'Hypoglycemia', 'Muscle weakness'.

+5. Congenital Heart Defects (e.g., Hypoplastic Left Heart Syndrome):

+ Symptoms the patient has in common: 'Tachycardia', 'Tachypnea', 'Neonatal death'.
+ Symptoms typically present in this disease but not observed in the patient: 'Cyanosis', 'Poor feeding'."
['Gyrate atrophy of choroid and retina'],"+1. **Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome**:
HHH syndrome is a rare inherited disorder affecting the urea cycle, leading to the accumulation of ammonia and ornithine in the blood.

**Symptoms in common with the patient**:
- Hyperammonemia
- Hyperornithinemia
- Feeding difficulties
- Death in childhood (in severe cases)

**Symptoms not in common with the patient**:
- Blindness
- Anemia
- Hyperglycinemia
- Hypoargininemia
- Abnormal circulating serine concentration

+2. **Nonketotic Hyperglycinemia (Glycine Encephalopathy)**:
This is a metabolic disorder characterized by an inability to break down glycine, resulting in its accumulation in the body.

**Symptoms in common with the patient**:
- Hyperglycinemia
- Seizures (though not listed, commonly associated)
- Feeding difficulties
- Death in childhood

**Symptoms not in common with the patient**:
- Blindness
- Anemia
- Hyperammonemia
- Hyperornithinemia
- Hypoargininemia

+3. **Serine Deficiency Disorders (e.g., 3-Phosphoglycerate Dehydrogenase Deficiency)**:
These are rare metabolic disorders leading to low levels of serine, an amino acid crucial for brain development and function.

**Symptoms in common with the patient**:
- Abnormal circulating serine concentration
- Severe short stature
- Feeding difficulties
- Death in childhood or early adulthood

**Symptoms not in common with the patient**:
- Blindness
- Anemia
- Hyperammonemia
- Hyperglycinemia
- Hyperornithinemia
- Hypoargininemia

+4. **Gyrate Atrophy of the Choroid and Retina**:
A genetic disorder caused by deficiency of the enzyme ornithine aminotransferase, leading to progressive vision loss.

**Symptoms in common with the patient**:
- Blindness
- Hyperornithinemia
- Severe short stature (in some cases)

**Symptoms not in common with the patient**:
- Anemia
- Hyperammonemia
- Hyperglycinemia
- Hypoargininemia
- Abnormal circulating serine concentration

+5. **Ornithine Translocase Deficiency (Ornithine Transcarbamylase Deficiency may be confused)**:
A urea cycle disorder resulting in impaired transport of ornithine into mitochondria, causing ammonia accumulation.

**Symptoms in common with the patient**:
- Hyperammonemia
- Feeding difficulties
- Death in childhood

**Symptoms not in common with the patient**:
- Blindness
- Anemia
- Hyperglycinemia
- Hyperornithinemia (may be elevated)
- Hypoargininemia

+6. **Pearson Marrow-Pancreas Syndrome**:
A mitochondrial disorder affecting the bone marrow and pancreas, leading to systemic symptoms.

**Symptoms in common with the patient**:
- Anemia
- Malabsorption
- Feeding difficulties
- Death in infancy or early childhood

**Symptoms not in common with the patient**:
- Blindness
- Hyperammonemia
- Hyperglycinemia
- Hyperornithinemia
- Hypoargininemia
- Abnormal circulating serine concentration

+7. **Arginase Deficiency (Argininemia)**:
A urea cycle disorder caused by arginase enzyme deficiency, leading to elevated arginine levels and neurological symptoms.

**Symptoms in common with the patient**:
- Hyperammonemia
- Severe short stature
- Feeding difficulties

**Symptoms not in common with the patient**:
- Hypoargininemia (patients typically have hyperargininemia)
- Blindness
- Anemia
- Hyperglycinemia
- Hyperornithinemia
- Abnormal circulating serine concentration

+8. **Citrullinemia Type I**:
A urea cycle disorder leading to ammonia and citrulline accumulation due to argininosuccinate synthetase deficiency.

**Symptoms in common with the patient**:
- Hyperammonemia
- Feeding difficulties
- Death in childhood (if untreated)

**Symptoms not in common with the patient**:
- Blindness
- Anemia
- Hyperglycinemia
- Hyperornithinemia
- Hypoargininemia
- Abnormal circulating serine concentration

+9. **Methionine Adenosyltransferase I/III Deficiency**:
A disorder affecting methionine metabolism, potentially causing neurological and developmental issues.

**Symptoms in common with the patient**:
- Severe short stature
- Feeding difficulties
- Abnormal amino acid concentrations

**Symptoms not in common with the patient**:
- Blindness
- Anemia
- Hyperammonemia
- Hyperglycinemia
- Hyperornithinemia
- Hypoargininemia

+10. **Lysinuric Protein Intolerance**:
A metabolic disorder affecting the transport of certain amino acids, leading to protein intolerance and other systemic symptoms.

**Symptoms in common with the patient**:
- Anemia
- Hyperammonemia
- Feeding difficulties
- Malabsorption
- Osteoporosis (may contribute to short stature)

**Symptoms not in common with the patient**:
- Blindness
- Hyperglycinemia
- Hyperornithinemia
- Hypoargininemia
- Abnormal circulating serine concentration

**Note**: The symptoms listed for each disease may vary among patients, and not all individuals will exhibit every symptom mentioned. A thorough medical evaluation, including genetic testing and metabolic studies, is essential for accurate diagnosis. Consulting a specialist in metabolic or genetic disorders is highly recommended to determine the exact cause of these symptoms."
['Phenylketonuria'],"+1. Tyrosinemia Type I:
Symptoms in common: 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Abnormality of prenatal development or birth'.
Symptoms not in common: 'Hyperphenylalaninemia', 'Death in childhood'.

+2. Phenylketonuria (PKU):
Symptoms in common: 'Hyperphenylalaninemia', 'Abnormality of prenatal development or birth'.
Symptoms not in common: 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Death in childhood'.

+3. Tetrahydrobiopterin (BH4) Deficiency:
Symptoms in common: 'Hyperphenylalaninemia', 'Hypertyrosinemia', 'Abnormality of prenatal development or birth'.
Symptoms not in common: 'Death in infancy', 'Neonatal death', 'Death in childhood'.

+4. Maple Syrup Urine Disease:
Symptoms in common: 'Death in infancy', 'Neonatal death', 'Abnormality of prenatal development or birth'.
Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in childhood'.

+5. Homocystinuria:
Symptoms in common: 'Death in childhood', 'Abnormality of prenatal development or birth'.
Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in infancy', 'Neonatal death'."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1. **Ornithine Transcarbamylase (OTC) Deficiency**:
- **Shared symptoms**: Apathy, generalized hypotonia, hyperammonemia, cerebral edema, neonatal death, feeding difficulties, death in infancy.
- **Symptoms not in common**: None.

+2. **Carbamoyl Phosphate Synthetase I Deficiency**:
- **Shared symptoms**: Apathy, generalized hypotonia, hyperammonemia, cerebral edema, feeding difficulties, neonatal death.
- **Symptoms not in common**: Death in infancy.

+3. **Citrullinemia Type I**:
- **Shared symptoms**: Apathy, generalized hypotonia, hyperammonemia, cerebral edema, feeding difficulties, neonatal death.
- **Symptoms not in common**: Death in infancy.

+4. **Argininosuccinic Aciduria**:
- **Shared symptoms**: Apathy, generalized hypotonia, hyperammonemia, feeding difficulties, neonatal death.
- **Symptoms not in common**: Cerebral edema, death in infancy.

+5. **N-Acetylglutamate Synthase Deficiency**:
- **Shared symptoms**: Hyperammonemia, cerebral edema, feeding difficulties.
- **Symptoms not in common**: Apathy, generalized hypotonia, neonatal death, death in infancy.

These potential conditions are urea cycle disorders that can cause severe hyperammonemia in neonates, leading to neurological symptoms and, in some cases, early death. A thorough medical evaluation, including genetic testing and metabolic studies, is essential for accurate diagnosis and timely management."
['Canavan disease'],"+1. **Canavan Disease**:
Symptoms in common with the patient: Blindness, Nystagmus, Seizures, Motor delay, Generalized hypotonia, Death in infancy, Abnormal myelination.
Symptoms not in common: Macrocephaly (enlarged head), Feeding difficulties.

+2. **Krabbe Disease**:
Symptoms in common with the patient: Blindness, Seizures, Motor delay, Generalized hypotonia, Death in infancy, Severe hearing impairment, Abnormal myelination.
Symptoms not in common: Irritability, Spasticity, Fever.

+3. **Tay-Sachs Disease**:
Symptoms in common with the patient: Blindness, Nystagmus, Seizures, Motor delay, Generalized hypotonia, Death in infancy.
Symptoms not in common: Cherry-red spot on the retina, Increased startle response.

+4. **Leigh Syndrome**:
Symptoms in common with the patient: Nystagmus, Seizures, Motor delay, Generalized hypotonia, Death in infancy, Abnormal myelination.
Symptoms not in common: Respiratory problems, Vomiting, Movement disorders.

+5. **Zellweger Spectrum Disorders**:
Symptoms in common with the patient: Seizures, Motor delay, Generalized hypotonia, Death in infancy, Severe hearing impairment, Abnormal circulating aspartate family amino acid concentration.
Symptoms not in common: Distinctive facial features, Liver dysfunction, Vision abnormalities other than blindness.

+6. **Menkes Disease**:
Symptoms in common with the patient: Seizures, Motor delay, Generalized hypotonia, Death in infancy.
Symptoms not in common: Sparse kinky hair, Temperature instability, Osteoporosis.

+7. **Pelizaeus-Merzbacher Disease**:
Symptoms in common with the patient: Nystagmus, Motor delay, Generalized hypotonia, Abnormal myelination.
Symptoms not in common: Involuntary movements, Difficulty speaking, Progressive spasticity.

+8. **Maple Syrup Urine Disease**:
Symptoms in common with the patient: Seizures, Generalized hypotonia, Motor delay, Death in infancy, Abnormal circulating aspartate family amino acid concentration.
Symptoms not in common: Sweet-smelling urine, Poor feeding, Lethargy.

+9. **Phenylketonuria (PKU)**:
Symptoms in common with the patient: Seizures, Motor delay, Abnormal myelination.
Symptoms not in common: Musty odor, Skin disorders, Intellectual disability (develops if untreated).

+10. **Mitochondrial Disorders**:
Symptoms in common with the patient: Nystagmus, Seizures, Motor delay, Generalized hypotonia, Severe hearing impairment, Death in infancy.
Symptoms not in common: Lactic acidosis, Diabetes, Cardiac issues.

+11. **Infantile Neuroaxonal Dystrophy**:
Symptoms in common with the patient: Seizures, Motor delay, Generalized hypotonia, Death in infancy.
Symptoms not in common: Muscle stiffness, Loss of developmental milestones, Dystonia."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1. **Combined Methylmalonic Acidemia and Homocystinuria (Cobalamin C Deficiency)**:
A genetic disorder affecting vitamin B12 metabolism, leading to the accumulation of methylmalonic acid and homocysteine.

**Symptoms in common**: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Intellectual disability, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Methylmalonic aciduria, Death in infancy, Death in childhood, Dyskinesia.

**Symptoms not in common**: Abnormal circulating carnitine concentration, Neonatal death (though early death is possible).

---

+2. **Methylmalonic Acidemia (MMA)**:
An inherited metabolic disorder where the body can't break down certain fats and proteins, leading to a buildup of methylmalonic acid.

**Symptoms in common**: Intellectual disability, Respiratory insufficiency, Methylmalonic aciduria, Premature birth, Death in infancy, Death in childhood.

**Symptoms not in common**: Hyperhomocystinemia (usually absent), Abnormal circulating carnitine concentration, Dyskinesia, Hyperhomocystinemia.

---

+3. **Homocystinuria (Due to CBS Deficiency)**:
A metabolic disorder resulting from a deficiency of the enzyme cystathionine beta-synthase, causing elevated homocysteine levels.

**Symptoms in common**: Strabismus, Nystagmus, Intellectual disability, Hyperhomocystinemia, Premature birth, Death in childhood, Dyskinesia.

**Symptoms not in common**: Methylmalonic aciduria, Abnormal circulating carnitine concentration, Hydrocephalus, Microcephaly.

---

+4. **Propionic Acidemia**:
A metabolic disorder where the body can't process certain parts of proteins and lipids properly, leading to a buildup of propionic acid.

**Symptoms in common**: Intellectual disability, Respiratory insufficiency, Premature birth, Death in infancy, Dyskinesia.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Abnormal circulating carnitine concentration (though secondary carnitine deficiency can occur).

---

+5. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
Also known as glutaric acidemia type II, it's a disorder affecting fatty acid oxidation.

**Symptoms in common**: Respiratory insufficiency, Abnormal circulating carnitine concentration, Premature birth, Neonatal death, Dyskinesia.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Hydrocephalus, Microcephaly.

---

+6. **Leigh Syndrome**:
A severe neurological disorder that arises in the first year of life.

**Symptoms in common**: Intellectual disability, Respiratory insufficiency, Strabismus, Nystagmus, Death in infancy or childhood.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Abnormal circulating carnitine concentration.

---

+7. **Krabbe Disease**:
A genetic disorder affecting the nervous system due to the buildup of galactolipids.

**Symptoms in common**: Intellectual disability, Strabismus, Nystagmus, Death in infancy or childhood.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Abnormal circulating carnitine concentration, Dyskinesia.

---

+8. **Canavan Disease**:
A disorder causing degeneration of the white matter in the brain.

**Symptoms in common**: Intellectual disability, Macrocephaly (opposite of microcephaly), Nystagmus, Death in childhood.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Hydrocephalus, Abnormal circulating carnitine concentration.

---

+9. **Nonketotic Hyperglycinemia**:
An inherited metabolic disorder characterized by abnormally high levels of glycine.

**Symptoms in common**: Intellectual disability, Respiratory insufficiency, Neonatal death, Death in infancy.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Abnormal circulating carnitine concentration, Dyskinesia.

---

+10. **Zellweger Spectrum Disorders**:
A group of conditions affecting peroxisome formation, leading to the accumulation of very long-chain fatty acids.

**Symptoms in common**: Intellectual disability, Respiratory insufficiency, Death in infancy, Dyskinesia.

**Symptoms not in common**: Methylmalonic aciduria, Hyperhomocystinemia, Abnormal circulating carnitine concentration, Hydrocephalus, Microcephaly."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. **Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency**:

LCHAD deficiency is a rare inherited disorder affecting the breakdown of long-chain fatty acids. It can lead to serious complications in infants.

- **Symptoms in common with the patient**:
  - Abnormality of prenatal development or birth
  - Vomiting
  - Neonatal death
  - Death in infancy
  - Abnormal circulating carnitine concentration
  - Decreased 3-hydroxyacyl-CoA dehydrogenase level
- **Symptoms not in common**:
  - Gastrointestinal inflammation

+2. **Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency**:

MCAD deficiency impairs the body's ability to convert certain fats to energy, particularly during fasting periods.

- **Symptoms in common with the patient**:
  - Vomiting
  - Hypoglycemia (which may be associated with abnormal carnitine levels)
  - Death in infancy
- **Symptoms not in common**:
  - Abnormality of prenatal development or birth
  - Neonatal death
  - Gastrointestinal inflammation
  - Decreased 3-hydroxyacyl-CoA dehydrogenase level

+3. **Carnitine Transporter Deficiency (Primary Carnitine Deficiency)**:

This condition affects the transport of carnitine into cells, crucial for energy production from fatty acids.

- **Symptoms in common with the patient**:
  - Vomiting
  - Abnormal circulating carnitine concentration
  - Hypotonia (muscle weakness, which might be inferred from other symptoms)
- **Symptoms not in common**:
  - Abnormality of prenatal development or birth
  - Neonatal death
  - Death in infancy
  - Gastrointestinal inflammation
  - Decreased 3-hydroxyacyl-CoA dehydrogenase level

+4. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:

Also known as Glutaric Acidemia Type II, MADD affects multiple steps in fatty acid oxidation.

- **Symptoms in common with the patient**:
  - Vomiting
  - Hypoglycemia
  - Neonatal death
  - Death in infancy
  - Abnormal circulating carnitine concentration
- **Symptoms not in common**:
  - Abnormality of prenatal development or birth
  - Gastrointestinal inflammation
  - Decreased 3-hydroxyacyl-CoA dehydrogenase level

+5. **Mitochondrial Trifunctional Protein Deficiency**:

This disorder affects enzymes involved in the metabolism of long-chain fatty acids.

- **Symptoms in common with the patient**:
  - Vomiting
  - Hypoglycemia
  - Neonatal death
  - Death in infancy
  - Abnormal circulating carnitine concentration
  - Decreased 3-hydroxyacyl-CoA dehydrogenase level
- **Symptoms not in common**:
  - Abnormality of prenatal development or birth
  - Gastrointestinal inflammation

**Note**: The symptoms listed suggest serious metabolic conditions that require immediate medical attention. It's important for the patient to consult a healthcare professional for accurate diagnosis and appropriate management."
['Biotinidase deficiency'],"+1. **Propionic Acidemia**:

A rare inherited metabolic disorder where the body is unable to process certain parts of proteins and lipids properly, leading to the accumulation of propionic acid.

- **Symptoms in common**: Generalized hypotonia, Metabolic acidosis, Hyperammonemia, Leukopenia, Death in infancy, Neonatal death.
- **Symptoms not in common**: None.

+2. **Methylmalonic Acidemia**:

An inherited disorder causing a deficiency in the enzyme methylmalonyl-CoA mutase, leading to a buildup of methylmalonic acid in the body.

- **Symptoms in common**: Generalized hypotonia, Metabolic acidosis, Hyperammonemia, Death in infancy, Neonatal death.
- **Symptoms not in common**: Leukopenia.

+3. **Ornithine Transcarbamylase (OTC) Deficiency**:

A urea cycle disorder resulting in the accumulation of ammonia due to the body's inability to eliminate it effectively.

- **Symptoms in common**: Hyperammonemia, Neonatal death.
- **Symptoms not in common**: Generalized hypotonia (may occur due to neurological effects but not primary), Metabolic acidosis (typically absent), Leukopenia.

+4. **Leigh Syndrome**:

A severe neurological disorder characterized by progressive loss of mental and movement abilities due to mitochondrial dysfunction.

- **Symptoms in common**: Generalized hypotonia, Metabolic acidosis, Death in infancy.
- **Symptoms not in common**: Hyperammonemia, Leukopenia, Neonatal death (onset is typically in infancy but not always neonatal).

+5. **Pearson Syndrome**:

A mitochondrial disorder affecting the bone marrow and pancreas, leading to multi-system dysfunction.

- **Symptoms in common**: Generalized hypotonia, Leukopenia, Metabolic acidosis.
- **Symptoms not in common**: Hyperammonemia, Death in infancy (can occur but variable), Neonatal death."
['Tyrosinemia type 2'],"+1. Tyrosinemia Type II:

Tyrosinemia Type II, also known as Richner-Hanhart syndrome, is a rare inherited disorder caused by a deficiency of the enzyme tyrosine aminotransferase, leading to elevated levels of tyrosine in the blood. This condition primarily affects the eyes, skin, and intellectual development.

**Symptoms in common with the patient**: Keratitis, Photophobia, Hyperkeratosis, Intellectual disability, Hypertyrosinemia.

**Symptoms not in common with the patient**: Seizures (less common in Tyrosinemia Type II), Death in childhood (patients can survive into adulthood with management), Conjunctivitis, Epiphora.

+2. Tyrosinemia Type I:

Tyrosinemia Type I is the most severe form of tyrosinemia, resulting from a deficiency of fumarylacetoacetate hydrolase. It leads to the accumulation of toxic metabolites affecting the liver, kidneys, and nervous system, often presenting in infancy.

**Symptoms in common with the patient**: Hypertyrosinemia, Seizures, Death in childhood.

**Symptoms not in common with the patient**: Keratitis, Photophobia, Hyperkeratosis, Intellectual disability (neurological symptoms are due to liver failure), Conjunctivitis, Epiphora.

+3. Herpetic Keratitis:

Herpetic keratitis is an eye infection caused by the herpes simplex virus affecting the cornea, leading to pain and vision problems.

**Symptoms in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Epiphora.

**Symptoms not in common with the patient**: Hyperkeratosis, Intellectual disability, Seizures, Hypertyrosinemia, Death in childhood.

+4. Vitamin A Deficiency:

Vitamin A deficiency can lead to various ocular symptoms and skin issues due to its role in maintaining healthy epithelial tissues.

**Symptoms in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis.

**Symptoms not in common with the patient**: Intellectual disability, Seizures, Hypertyrosinemia, Death in childhood, Epiphora.

+5. Tuberous Sclerosis Complex:

Tuberous sclerosis complex is a genetic disorder characterized by the growth of benign tumors in various organs, including the brain, skin, and eyes.

**Symptoms in common with the patient**: Seizures, Intellectual disability, Skin abnormalities (though different in presentation), Possible ocular involvement.

**Symptoms not in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Hypertyrosinemia, Death in childhood, Epiphora.

+6. Neurofibromatosis Type 1:

A genetic disorder causing tumors to form on nerve tissue, leading to skin changes and neurological problems.

**Symptoms in common with the patient**: Intellectual disability, Seizures, Skin manifestations.

**Symptoms not in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Hypertyrosinemia, Death in childhood, Epiphora.

+7. Alkaptonuria:

A rare genetic metabolic disorder characterized by the accumulation of homogentisic acid, leading to ochronosis and joint problems.

**Symptoms in common with the patient**: May have ocular manifestations and skin changes.

**Symptoms not in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Intellectual disability, Seizures, Hypertyrosinemia, Death in childhood, Epiphora.

+8. Wilson's Disease:

An inherited disorder causing copper accumulation in organs, leading to neurological and psychiatric symptoms.

**Symptoms in common with the patient**: Seizures, Intellectual disability, Ocular signs (Kayser-Fleischer rings).

**Symptoms not in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Hypertyrosinemia, Death in childhood, Epiphora.

+9. Sjögren's Syndrome:

An autoimmune disorder characterized by dry eyes and dry mouth due to the destruction of glands that produce tears and saliva.

**Symptoms in common with the patient**: Conjunctivitis, Epiphora (as a paradoxical response), Photophobia.

**Symptoms not in common with the patient**: Keratitis, Hyperkeratosis, Intellectual disability, Seizures, Hypertyrosinemia, Death in childhood.

+10. Congenital Ichthyosis:

A group of genetic skin disorders characterized by dry, scaly skin.

**Symptoms in common with the patient**: Hyperkeratosis.

**Symptoms not in common with the patient**: Keratitis, Conjunctivitis, Photophobia, Intellectual disability, Seizures, Hypertyrosinemia, Death in childhood, Epiphora.

**Note**: This list includes potential conditions based on the provided symptoms, but a thorough clinical evaluation and diagnostic testing are necessary to arrive at an accurate diagnosis."
['Phenylketonuria'],"+1. **Tyrosinemia Type I**:
Tyrosinemia Type I is a rare genetic disorder that affects the breakdown of the amino acid tyrosine, leading to the accumulation of toxic substances that can damage the liver, kidneys, and nervous system.

**Symptoms in common:**
+ Abnormal circulating tyrosine concentration
+ Hyperphenylalaninemia
+ Abnormality of prenatal development or birth
+ Death in infancy
+ Death in early adulthood

**Symptoms not in common:**
+ Neonatal death

+2. **Maple Syrup Urine Disease (MSUD)**:
MSUD is a metabolic disorder where the body cannot process certain amino acids, resulting in toxic buildup that affects the brain and other organs.

**Symptoms in common:**
+ Neonatal death
+ Death in infancy
+ Abnormality of prenatal development or birth

**Symptoms not in common:**
+ Hyperphenylalaninemia
+ Abnormal circulating tyrosine concentration
+ Death in early adulthood

+3. **Phenylketonuria (PKU)**:
PKU is a genetic disorder characterized by the body's inability to break down the amino acid phenylalanine, leading to its accumulation and potential brain damage.

**Symptoms in common:**
+ Hyperphenylalaninemia
+ Abnormality of prenatal development or birth

**Symptoms not in common:**
+ Abnormal circulating tyrosine concentration
+ Neonatal death
+ Death in infancy
+ Death in early adulthood

+4. **Nonketotic Hyperglycinemia**:
This is a metabolic disorder where glycine accumulates in the body, particularly affecting the nervous system.

**Symptoms in common:**
+ Neonatal death
+ Death in infancy
+ Abnormality of prenatal development or birth

**Symptoms not in common:**
+ Hyperphenylalaninemia
+ Abnormal circulating tyrosine concentration
+ Death in early adulthood

+5. **Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency)**:
These disorders impair the body's ability to remove ammonia, causing toxic levels that can damage the brain.

**Symptoms in common:**
+ Neonatal death
+ Death in infancy
+ Abnormality of prenatal development or birth

**Symptoms not in common:**
+ Hyperphenylalaninemia
+ Abnormal circulating tyrosine concentration
+ Death in early adulthood"
[],"+1. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:
This is a fatty acid oxidation disorder resulting in the accumulation of various organic acids, including 3-hydroxydicarboxylic acids. It often presents in the neonatal period with severe symptoms.

- **Symptoms in common**: Cyanosis, Seizures, Death in infancy, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria
- **Symptoms not in common**: None listed

+2. **Propionic Acidemia**:
A metabolic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid.

- **Symptoms in common**: Seizures, Death in infancy, Hyperammonemia, Neonatal death
- **Symptoms not in common**: Cyanosis, 3-hydroxydicarboxylic aciduria

+3. **Methylmalonic Acidemia**:
A disorder affecting the body's ability to process certain fats and proteins, due to a deficiency of methylmalonyl-CoA mutase.

- **Symptoms in common**: Seizures, Death in infancy, Hyperammonemia
- **Symptoms not in common**: Cyanosis, Neonatal death, 3-hydroxydicarboxylic aciduria

+4. **Ornithine Transcarbamylase Deficiency (OTC Deficiency)**:
An X-linked urea cycle disorder causing an accumulation of ammonia in the blood.

- **Symptoms in common**: Seizures, Death in infancy, Hyperammonemia, Neonatal death
- **Symptoms not in common**: Cyanosis, 3-hydroxydicarboxylic aciduria

+5. **Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD Deficiency)**:
A fatty acid oxidation disorder affecting the breakdown of long-chain fatty acids.

- **Symptoms in common**: Seizures, Death in infancy, Hypoglycemia (which can lead to seizures and death), 3-hydroxydicarboxylic aciduria
- **Symptoms not in common**: Cyanosis, Hyperammonemia, Neonatal death"
['Alkaptonuria'],"+1. Galactosemia:
- **Symptoms in common**: Vomiting, Dark urine, Death in infancy (if untreated)
- **Symptoms not in common**: Jaundice, Diarrhea

Galactosemia is a metabolic disorder where the body cannot process galactose, a sugar found in milk. Accumulation of galactose can lead to liver dysfunction, causing dark urine and vomiting. Without treatment, it can be fatal in infancy.

+2. Tyrosinemia Type I:
- **Symptoms in common**: Vomiting, Dark urine, Death in infancy (if untreated)
- **Symptoms not in common**: Enlarged liver, Failure to thrive

Tyrosinemia Type I is a genetic disorder affecting the breakdown of the amino acid tyrosine. This leads to toxic substances accumulating in the body, resulting in liver and kidney problems, vomiting, and dark urine. It can be life-threatening if not managed early.

+3. Biliary Atresia:
- **Symptoms in common**: Dark urine, Death in infancy (if untreated)
- **Symptoms not in common**: Jaundice (yellowing of the skin and eyes), Pale stools

Biliary atresia is a condition in infants where the bile ducts are blocked or absent, leading to bile buildup in the liver. This causes dark urine and can progress to liver failure, potentially resulting in death if not treated promptly.

+4. Hemolytic Uremic Syndrome:
- **Symptoms in common**: Vomiting, Dark urine
- **Symptoms not in common**: Diarrhea (often bloody), Decreased urination

Hemolytic uremic syndrome is a condition that results from the destruction of red blood cells, leading to kidney failure. The breakdown of red blood cells can cause dark urine and vomiting.

+5. Maple Syrup Urine Disease:
- **Symptoms in common**: Vomiting, Death in infancy (if untreated)
- **Symptoms not in common**: Sweet-smelling urine, Lethargy

This is a metabolic disorder where the body cannot break down certain amino acids, leading to their accumulation. Symptoms include vomiting and neurological signs. Without treatment, it can be fatal in infancy.

Please consult a qualified healthcare professional for an accurate diagnosis and appropriate management."
['Maple syrup urine disease'],"+1. Maple Syrup Urine Disease (MSUD):
Symptoms in common with the disease:
- Seizure
- Lethargy
- Growth delay
- Death in infancy
- Metabolic acidosis
- Hyperammonemia
- Drowsiness
- Sleep abnormality
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Feeding difficulties
- Elevated urinary carboxylic acid

Symptoms not in common:
- Severe hearing impairment

+2. Propionic Acidemia:
Symptoms in common with the disease:
- Seizure
- Lethargy
- Growth delay
- Metabolic acidosis
- Hyperammonemia
- Drowsiness
- Sleep abnormality
- Feeding difficulties
- Elevated urinary carboxylic acid

Symptoms not in common:
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Severe hearing impairment
- Death in infancy (though can be severe if untreated)

+3. Methylmalonic Acidemia:
Symptoms in common with the disease:
- Seizure
- Lethargy
- Growth delay
- Metabolic acidosis
- Hyperammonemia
- Drowsiness
- Sleep abnormality
- Feeding difficulties
- Elevated urinary carboxylic acid

Symptoms not in common:
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Severe hearing impairment
- Death in infancy (though can be severe if untreated)

+4. Isovaleric Acidemia:
Symptoms in common with the disease:
- Seizure
- Lethargy
- Metabolic acidosis
- Drowsiness
- Sleep abnormality
- Feeding difficulties
- Elevated urinary carboxylic acid

Symptoms not in common:
- Growth delay
- Death in infancy (though can be severe if untreated)
- Hyperammonemia (may be less prominent)
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Severe hearing impairment

+5. Urea Cycle Disorders (e.g., Ornithine Transcarbamylase Deficiency):
Symptoms in common with the disease:
- Seizure
- Lethargy
- Growth delay
- Hyperammonemia
- Drowsiness
- Sleep abnormality
- Feeding difficulties
- Death in infancy (if severe)

Symptoms not in common:
- Metabolic acidosis (usually there is respiratory alkalosis)
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Severe hearing impairment
- Elevated urinary carboxylic acid

+6. Peroxisomal Biogenesis Disorders (e.g., Zellweger Syndrome):
Symptoms in common with the disease:
- Seizure
- Lethargy
- Growth delay
- Feeding difficulties
- Severe hearing impairment
- Drowsiness
- Sleep abnormality

Symptoms not in common:
- Metabolic acidosis (may not be a primary feature)
- Hyperammonemia (not typical)
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Elevated urinary carboxylic acid
- Death in infancy (though prognosis is poor)

+7. Biotinidase Deficiency:
Symptoms in common with the disease:
- Seizure
- Lethargy
- Metabolic acidosis
- Growth delay
- Feeding difficulties
- Severe hearing impairment
- Drowsiness
- Sleep abnormality

Symptoms not in common:
- Hyperammonemia (not typical)
- Hypervalinemia
- Hyperleucinemia
- Hyperisoleucinemia
- Elevated urinary carboxylic acid
- Death in infancy (can occur if untreated)"
['Ornithine transcarbamylase deficiency'],"+1. **Ornithine Transcarbamylase (OTC) Deficiency**:

- **Common symptoms**: Hyperammonemia, vomiting, cerebral edema, coma, neonatal death, oroticaciduria, hyperglutaminemia, elevated plasma citrulline, aminoaciduria, abnormal circulating proline and arginine concentrations.
- **Symptoms not in common**: Skin rash, fever, obsolete eczematoid dermatitis, myocarditis.

+2. **Citrullinemia Type I**:

- **Common symptoms**: Elevated plasma citrulline, hyperammonemia, vomiting, cerebral edema, coma, generalized hypotonia, neonatal death, aminoaciduria, abnormal circulating arginine concentration.
- **Symptoms not in common**: Skin rash, fever, obsolete eczematoid dermatitis, myocarditis.

+3. **Argininosuccinic Aciduria**:

- **Common symptoms**: Hyperammonemia, elevated plasma citrulline, vomiting, cerebral edema, coma, generalized hypotonia, athetosis, neonatal death, aminoaciduria, abnormal circulating arginine concentration.
- **Symptoms not in common**: Skin rash, fever, obsolete eczematoid dermatitis, myocarditis.

+4. **Viral Myocarditis**:

- **Common symptoms**: Fever, vomiting, myocarditis, abnormal circulating creatine kinase concentration, death in childhood or adolescence.
- **Symptoms not in common**: Hyperammonemia, elevated plasma citrulline, hyperglutaminemia, uraciluria.

+5. **Neonatal Onset Multisystem Inflammatory Disease (NOMID)**:

- **Common symptoms**: Fever, skin rash, vomiting, generalized hypotonia, death in infancy, gastrointestinal inflammation.
- **Symptoms not in common**: Hyperammonemia, elevated plasma citrulline, oroticaciduria, aminoaciduria.

+6. **Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome**:

- **Common symptoms**: Hyperammonemia, vomiting, cerebral edema, coma, generalized hypotonia, neonatal death, abnormal circulating proline and arginine concentrations, aminoaciduria.
- **Symptoms not in common**: Skin rash, fever, obsolete eczematoid dermatitis, myocarditis.

+7. **Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)**:

- **Common symptoms**: Hypoglycemia, vomiting, generalized hypotonia, lethargy progressing to coma, neonatal death, abnormal circulating creatine kinase concentration.
- **Symptoms not in common**: Hyperammonemia, elevated plasma citrulline, skin rash, fever.

+8. **Urea Cycle Disorders (General)**:

- **Common symptoms**: Hyperammonemia, vomiting, cerebral edema, coma, generalized hypotonia, neonatal death, aminoaciduria, elevated plasma citrulline, oroticaciduria.
- **Symptoms not in common**: Skin rash, fever, myocarditis, obsolete eczematoid dermatitis.

+9. **Reye Syndrome**:

- **Common symptoms**: Vomiting, cerebral edema, hypoglycemia, elevated liver enzymes, death in childhood.
- **Symptoms not in common**: Skin rash, fever, hyperammonemia (may be mild), elevated plasma citrulline.

+10. **Severe Combined Immunodeficiency (SCID)**:

- **Common symptoms**: Recurrent viral infections, gastrointestinal inflammation, death in infancy, hypoglycemia.
- **Symptoms not in common**: Hyperammonemia, elevated plasma citrulline, skin rash (unless due to infections), myocarditis.

---

These potential conditions are associated with some or many of the symptoms presented, such as hyperammonemia, vomiting, coma, and neonatal death. However, symptoms like skin rash, fever, and obsolete eczematoid dermatitis are less common in certain metabolic disorders like urea cycle disorders but are noted in conditions like viral myocarditis and neonatal onset inflammatory diseases. It's important to consider that overlapping symptoms can occur in various diseases, and a thorough medical evaluation, including laboratory tests and imaging, is essential for an accurate diagnosis."
